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Abstract 
 
 The Lewis base activation of Lewis acids has been harnessed in the development of an 
enantioselective oxysulfenylation reaction for unactivated alkenes. The weak Lewis acid N-
(phenylthio)-phthalimide can be activated in the presence of a moderate Brønsted acid and chiral 
Lewis base donors. The resulting complex is a powerful sulfenylating agent capable of sulfenium 
transfer to simple mono-, di- and trisubstituted alkenes with high selectivity to form 
enantioenriched thiiranium ions. Stereospecific and site-selective capture of the thiiranium ions 
furnish vicinally functionalized thioethers. The nucleophile scope of the reaction encompasses 
alcohols, carboxylic acids and phenols. Both inter- and intramolecular sulfenylation reactions 
were realized. The reaction is highly robust and individual substrates usually did not require 
reoptimization. 
 Mechanistic, X-ray crystallographic and kinetic investigations enabled a complete 
catalytic cycle to be formulated. The proposed cycle was supported by both kinetic data and the 
characterization of reaction intermediates. The turnover-limiting and enantiodetermining steps 
were identified as thiiranium ion formation. X-ray crystallography of the active sulfenylating 
agent did not immediately identify a basis for the high selectivity. Instead, the origin of 
selectivity in the reaction of trans-alkenes was determined to be distortion-based with the aid of 
computational models.  
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Chapter 1: Introduction to Lewis Base 
Catalysis 
 1.1. Overview. 
 The field of chemistry encompasses the reactivity of atoms, functional groups and 
molecules. Reactivity is, in turn, dictated by the potential for electrons in atomic and molecular 
orbitals to achieve lower energy configurations as a result of orbital realignment. In general, the 
behavior of electrons, and their reorganization to low-energy alignments, constitutes a 
fundamental principle behind chemical reactivity. Thus, any study of catalysis and catalytic 
reactions necessitates a deep understanding of the theory underlying reactivity.  
 The octet rule has been developed as a widely applicable framework for the study of 
electron rearrangements in molecules.
1
 The rule, which states that atoms in molecules attempt to 
have a filled valence shell of electrons, is based on the observation that in molecules, atoms share 
electrons and orbitals such that each low-lying atomic orbital is filled. The thermodynamic 
electron redistribution leading to the octet rule is responsible for a wide variety of phenomena, 
such as molecular geometry and bond strengths.
2
 Stable molecules that are exceptions to the rule 
are uncommon, but have been isolated and characterized, primarily among group 13 elements.
3
 
Octet-deficient structures are commonly found in dimeric form to ameliorate the energy penalty 
associated with their inability to fully delocalize electrons within the available molecular orbitals 
in monomeric form.
4
 In general, molecules that contain octet-deficient electrons greatly desire 
electron density. Molecules that contain atoms with paired electrons represent the opposite end 
of the spectrum. The localized electron density in these atoms contain chemical potential that can 
be used to drive reactivity.  
 1.1.1. Lewis Acids and Bases. An electron-based approach to explain and categorize 
reactivity was proposed by G. N. Lewis in his theory of acids and bases.
5
 Atomic loci that accept 
electrons are identified as Lewis acids, and electron donors as Lewis bases. The outcome of the 
association between Lewis acids with Lewis bases is highly dependent on the nature of the 
interacting species. Thus, the combination of Lewis acidic BH3 and Lewis basic NH3 generates a 
stable, zwitterionic solid adduct.
4
 The delocalization of nitrogen electrons into the empty boron 
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atomic orbital is highly favorable, which overcomes the penalty associated with formation of 
charge-separated species. In contrast, the association of polar solvents such as THF or DMF with 
SbCl5 is dative in nature, and the strength of the interaction varies by the donicity of the solvent. 
The resulting complexes, while polarized, are not ionized (Scheme 1).
6
  
 
Scheme 1 
 1.1.2. Jensen's Orbital Analysis. The different types of Lewis acid- Lewis base 
interactions can be classified by the type of orbitals that participate in the bonding scheme. In the 
classification by Jensen, there are nine possible interactions, from one of either σ, π or n type 
filled orbitals to one of the σ*, π* or n* type empty orbitals.7 Of these, the most relevant to 
catalysis is the interaction of n-type orbitals with π* and σ* orbitals, represented by the green 
boxes in Table 1.
8
  
Table 1. Tabular representation of Lewis base - Lewis Acid interactions by Jensen.  
    Acceptor 
Donor 
n* π* σ* 
n n→n* n→π* n→σ* 
π π→n* π→π* π→σ* 
σ σ→n* σ→π* σ→σ* 
 
 The importance of the n→π* Lewis base-Lewis acid interaction has been widely 
recognized in the field of enone functionalizations.
8
 A salient example is the catalysis of the 
Morita-Bayliss-Hillman reaction by phosphine and amine catalysts.
9
 The n→π* interaction 
between the phosphine and the electron-deficient alkene leads to the formation of a charge-
separated enolate (Scheme 2). Attack of the enolate onto a second carbonyl compound, followed 
3 
 
by elimination of the phosphine catalyst, forms the final α-functionalized enone. The use of 
chiral phosphines in the reaction enables stereocontrol during the enolate addition step, which 
then leads to the formation of chiral, non-racemic alcohols and amines. The key role of the Lewis 
base (phosphine) to complex with the Lewis acid (alkene) in promoting reactivity can clearly be 
recognized from the high enantioselectivities observed in this class of transformations (Scheme 
2).
10
  
 
Scheme 2 
  The n→σ* complexation of Lewis bases with Lewis acids leads to bond polarization 
within the Lewis acidic moiety. Gutmann over 40 years ago identified a "spillover" effect that 
led to increased bond lengths upon complexation of a Lewis acid with a Lewis base.
6a,11
 In his 
four rules of bonding, Gutmann states that (1) the smaller the intramolecular distance between 
the donor (D) and the acceptor (A), the greater the induced lengthening of the peripheral bonds 
(A X), (2) the longer the bond between D and A, the greater the degree of polarization of 
electron density across that bond, (3) as the coordination number of an atom increases, so do the 
lengths of all the bonds originating from that coordination center, and (4) the bonds adjacent to D 
and A will either contract or elongate to compensate for the changes in electron density at D and 
A. This last rule was used to explain the variations in bond lengths observed in crystals of stable 
Lewis base - Lewis acid adducts with respect to their starting materials.  
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Figure 1. Gutmann Analysis of Donor-Acceptor Pairs 
 
 A particular example of this type of interaction can be found in the complexes of I2 with a 
variety of Lewis bases. In the HMPA(Se) •I2 complex 1, the Se-I-I bond angle is around 176
o
, 
displaying the collinear arrangement of the three atoms in the bonding scheme (Figure 2).
12
 The 
I-I bond is lengthened by 0.25 Å as a result of electron density in the σ*I-I orbital. A 0.065Å 
lengthening is also observed in the P-Se bond, as the electron density is transferred to the Se 
center, although the bond retains its double bond character. Stronger Lewis bases such as 
phosphazanes 2 are capable of inducing halogen bond scission, resulting in formation of I, Br 
and Cl salts. 
13
 
Figure 2. Crystal Structures of HMPA(Se)-I2  and 2-I2 Adduct 
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 The bonding scheme in a n→σ* type Lewis base - Lewis acid complex has some unusual 
properties, which are particularly prominent for Group 14-17 Lewis acids bearing ionizable 
groups. The bonding is hypervalent at the central atom, as the high-lying nature of the d orbitals 
of the central atom preclude them from participating in the bonding.
8
 The Lewis base - Lewis 
acid interaction is then best characterized as a 3-center-4-electron bond, involving the n atomic 
orbital on the Lewis base component and the σ and σ* orbitals on the Lewis acid component. 
The resulting MO diagram is shown in Figure 3. 
Figure 3. Donor-Acceptor Bonding Analysis for a Group 14 Lewis Acid 
 
 A peculiar characteristic of the 3-center-4-electron bonding scheme is that the terminal 
atoms are enriched in electron density, whereas the central atom is impoverished in electron 
density (Figure 4). This conclusion follows from an analysis of the nodes of the molecular 
orbitals involved in the bonding. For molecular orbital Ψ1 the electrons are shared equally across 
all atoms. However, molecular orbital Ψ2 has a node at the central atom, and increased density at 
the peripheral atoms. Consequently, the electrons in this orbital are localized at the periphery, 
increasing the electron density of the ligand atom. The central node results in impoverishment of 
the Lewis acidic atom above and beyond its starting electron density. This redistribution of 
electron density in the 3-center-4-electron bond leads to the aforementioned "spillover" 
phenomenon. As the band gap between Ψ1 and Ψ2 increases, the polarization of the bonds 
becomes greater. At its most extreme, the n→σ* interaction can result in complete ionization of 
the X ligand, and formation of a highly reactive [DA]
+ 
cation.    
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Figure 4. Molecular Orbitals of a 3c-4e Bond  
 
 1.1.3. Catalysis by Lewis Bases. The increased Lewis acidity as a consequence of 
electron redistribution can directly be translated into a catalytic protocol (Figure 5). Group 14, 16 
and 17 Lewis acids (generically represented as A-X) can be engaged by Lewis bases to form 
electron-deficient complexes. Their increased Lewis acidic nature would then promote the 
complexes' susceptibility to nucleophilic attack. The use of chiral non-racemic Lewis bases 
would enable the catalytic process to proceed in an enantioselective manner.  
Figure 5. A Generic Catalytic Cycle for Lewis Base Catalyzed Enantioselective 
Functionalization 
 
  The n→σ* type activation of Lewis Acids have been extensively developed in these 
laboratories. In the example of SiCl4, a group 14 Lewis acid, exposure of SiCl4 to a 
phosphoramide Lewis base 3 results in the formation of a [SiCl4LB2] complex, which has 
increased affinity towards carbonyl groups (Scheme 3a).
14
 In the presence of aldehydes, 
displacement of one of the peripheral chlorines by the aldehyde results in a highly reactive 
[SiCl3LB2(RCHO)]
+
 electrophile complex which can be nucleophilically attacked by enol 
ethers.
15
 Dissociation of the catalyst from the oxytrichlorosilane product completes the cycle. 
The application of this technology to diverse classes of enol ethers enabled the formation of 
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numerous aldol products with excellent yields and selectivities. (Scheme 3b)   
 
Scheme 3 
 The application of n→σ* activation to group 16 selenium electrophiles enabled an 
enantioselective selenofunctionalization of alkenes to be realized (Scheme 4).
16
 Protonation of 
benzeneselenyl succinimide creates a highly active Lewis acidic selenenium source. 
Displacement of succinimide by the phosphoramide catalyst forms the active, chiral, non-
racemic selenenylating agent 4. This complex can be directly attacked by an alkene to form an 
enantioenriched seleniranium intermediate. Nucleophilic capture of the seleniranium ion inter- or 
intramolecularly affords selenofunctionalized products. For example, the enantioselective, 
intramolecular selenofunctionalization of 5 formed 3-selenotetrahydropyran 6 in 86% yield and 
75:25 e.r. No reactivity of the selenium electrophile with the alkene was observed when the 
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catalyst 7 was omitted. The catalyst accelerates the reaction by increasing the reactivity of the 
Lewis acidic selenium center in accord with the principles of Lewis base activation. 
 
Scheme 4 
 The n→σ* activation model has also been extended to Group 17 Lewis acids (Scheme 
5).
17
 Halolactonization and haloetherification reactions of alkenes can be effected by the use of 
weak electrophilic halogen sources and a variety of Lewis bases. A protic activator is usually 
added to further promote formation of the active halogenating agent. The family of halogen 
electrophiles that can be utilized is quite diverse. Unfortunately, the resulting haliranium ions 
usually suffer from poor stability or undesirable reactivity, and chiral non-racemic Lewis bases 
that can effect an enantioselective halofunctionalization remain uncommon. Therefore, chiral 
Brønsted acidic coactivators are used to assist the enantioselectivity. Thus, in an example from 
these laboratories, the bromoetherification of 8 was accomplished using the Lewis acidic 
bromine source NBS, Ph3PS as the Lewis base and phosphoric acid 9 as a chiral Brønsted acidic 
co-activator.
18
 The chiral active brominating complex has not been characterized, but in some 
way incorporates the conjugate base of 9. A 55:45 isomer ratio of the 3-bromotetrahydropyran 
10a to the 6-bromo-tetrahydrofuran 10b was obtained in 77% yield. The enantioenrichment of 
each product differed significantly, with 10b being obtained in 93:7 e.r. and 10a in 58:42 e.r. 
This difference in selectivity was explained by the participation of the conjugate base of 9 in 
both the formation and capture steps.  
9 
 
 
Scheme 5 
 The common theme of the above-mentioned reactions is the use of alkenes as initial 
nucleophiles for the Lewis base - Lewis acid complex. In the last few decades, many techniques 
for the catalytic, enantioselective functionalization of alkenes with O and N electrophiles have 
been developed, including ones that utilize Lewis base catalysts.
19
 However, at the outset of this 
project, the corresponding catalytic, enantioselective electrophilic alkene 
sulfenofunctionalization reaction had not been developed.  
  
 1.2. Goals of the Project. 
 The application of Lewis base catalysis to the electrophilic functionalization alkenes has 
been successful with a wide variety of elements and electrophile families. The development of a 
Lewis base catalyzed electrophilic sulfenylation reaction seemed possible. The project thus 
entailed identification of suitable Lewis acids and bases, as well as conditions for an 
enantioselective, Lewis base catalyzed sulfenofunctionalization (Scheme 6). 
 
Scheme 6 
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Chapter 2: Catalyic, Enantioselective 
Sulfenoetherification of Alkenes  
2.1. Introduction.  
2.1.1. Sulfenylation. Few elements in the periodic table have as rich and varied 
participation in chemical reactions as sulfur.
20
 Poor overlap between the 3p orbitals of sulfur and 
the 2p orbitals of the 2
nd
 row elements such as carbon, nitrogen and oxygen leads to a marked 
decrease in bond strength between these elements. Consequently, molecules containing sulfur 
can undergo a dazzling variety of chemical transformations.
21
 Briefly, sulfur can act both as a 
nucleophile and an electrophile (Scheme 7, reactions a and b). Oxidation and reduction of the 
sulfur center is possible, as the -2, 0 and +2 oxidation states of sulfur are all stable under normal 
conditions (reaction c). Sulfur can also easily be removed from organic molecules under 
hydrogenative (reaction d) or radical conditions (reaction e). Rearrangements of sulfur moieties 
are also well-documented, a salient example is the [2,3]-rearrangement of allylic sulfoxides to 
sulfenic acids which can be cleaved to form allylic alcohols (reaction f). In the same vein, S-H 
bonds are significantly weaker due to meager 3(sp
n
)
 
- 1s overlap  This results in the formation of 
disulfides from thiols under aerobic conditions.
22
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Scheme 7 
There are numerous applications of sulfur in modern industrial chemistry.
23
 Most 
prominently, sulfurization of polymers leads to the formation of crosslinked polymers with 
varying mechanochemical and physical properties in the vulcanization process. In addition, the 
need for removal of sulfurous material from fuel feedstock has promoted substantial research 
into the behavior of sulfur compounds in refinery environments.
24
 
The propensity of sulfur to form strong disulfide linkages, as well as its soft donor nature 
has resulted in sulfur being the only third-row element that is incorporated into the 20 naturally-
occuring amino acids in the form of cysteine and methionine.
22
 Disulfides resulting from the 
oxidative dimerization of two cysteine residues force proteins to adopt specific conformations, 
playing a key role in the formation of tertiary structures of proteins.
22
 Furthermore, sulfur is 
centrally involved in the protection of biological systems against oxidative stress.
25
 Sulfurous 
compounds also serve as ligands in biological systems; for example many redox-active enzymes 
in living organisms use Fe-S tetrads as catalytic subunits.
26
  
The biological importance of sulfur extends to the level of small molecules (Chart 1). 
Numerous biologically active compounds containing sulfur have been isolated or prepared; the 
antibiotics penicillin and sulfanilamide were some of the first drugs used to treat bacterial 
infections,
27
 whereas allicin, which is derived from garlic, is currently being investigated as a 
12 
 
topical antibiotic against methycillin resistant S. aureus.
28
 Sulfur-containing natural products 
such as Ecteinascidin 743 and gliotoxin have been employed for their antiproliferative 
properties.
29
 Telomestatin has been shown to suppress telomerase, which leads to Hayflick 
senescence. Since non-cancerous cells generally do not express telomerase, this differential 
targeting has led to interest in telomerase-suppressors as anti-cancer therapeutics.
30
 There are 
also numerous nonproteinogenic amino acids derived from cysteine and methionine such as 
lanthionine, which is present in the lantibiotic peptides, as well as the cytotoxic methionine 
antagonist ethionine.
31
 
Chart 1 
 
In light of the prevalence of sulfur in biological systems and biologically active small 
molecules, it would be reasonable to postulate that sulfur should be widely represented in active 
pharmaceutical ingredients. However, this has unfortunately not been the case. Chemical 
transformations that incorporate sulfur into organic compounds, specifically ones which do so 
stereoselectively, have not been well developed.
32
 The dearth of robust methods has severely 
limited the exploration of design space for sulfur-containing molecules. Broadly applicable 
methods to stereoselectively introduce sulfur into small molecules could speed up the 
exploitation of this underutilized class of molecules, and furnish new molecules to probe 
biological systems. 
13 
 
 2.1.2. Electrophilic Sulfenylation. A typical method of introducing sulfur into small 
molecules is through the sulfenofunctionalization of alkenes. This transformation is commonly 
accomplished through the action of sulfenyl chlorides.
33
 The reaction of an alkene and sulfenyl 
chloride results in stereospecific difunctionalization of the alkene, with both the sulfenyl moiety 
as well as the chloride group being incorporated. The strongly electrophilic nature of sulfenyl 
chlorides allow the reaction to proceed at temperatures down to -70 
o
C. Both alkyl and aryl 
sulfenyl chlorides are competent for sulfenium transfer (Scheme 8).
34
  
 
Scheme 8 
 The difunctionalization of alkenes with nucleophiles other than chloride is also possible. 
However, the high nucleophilicity of chloride results in undesirable side products, necessitating 
optimized reaction conditions or superstoichiometric quantities of the desired nucleophile.
35
 
Thus, the need for sulfur electrophiles with less nucleophilic leaving groups stimulated the 
development of novel sulfenylating agents, including, but not limited to, sulfenyl acetates, 
sulfenate esters, and azaheterocycles.
36
 These new electrophiles enabled diverse vicinal 
functionalization products such as sulfeno acetates, sulfeno ethers, sulfeno amides and bisulfides 
to be obtained in good yields and with high chemoselectivity (Scheme 9). In addition to the 
extensive use of sulfenyl chlorides in these reactions, sulfenium and sulfonium salts also serve as 
sulfenyl transfer agents.
37
 Unlike sulfenyl chlorides, use of sulfenium and sulfonium salts enable 
the interception of intermediate thiiranium ions by weak as well as strong external nucleophiles. 
In all cases the anti stereospecific course of the reaction is retained.  
14 
 
 
Scheme 9 
 2.1.3. Mechanism of the Sulfenylation Process. The generality and predictable 
stereochemical course of the electrophilic sulfenylation reaction encouraged extensive studies 
into the mechanistic and stereochemical aspects the underlie these desirable properties. The anti 
stereospecificity for sulfenofunctionalization of trans alkenes was proposed to be the 
consequence of a bridged intermediate that preserves the stereochemical information of the 
alkene component (Scheme 10).
38
 In this hypothesis, approach of the alkene to the sulfenium ion 
source results in an π→σ* interaction that promotes the ionization of the leaving group (X) on 
the sulfur with simultaneous formation of a three-membered ring intermediate. Subsequent to 
this proposal, such bridged-ring intermediates (called thiiranium or episulfonium ions) (11) have 
been thoroughly characterized by computational, spectroscopic and crystallographic methods.  
 
Scheme 10 
 Computational transition state models show a strong directionality in thiiranium 
formation, in which approach of the alkene spiro with the S-X bond is highly favored (Scheme 
11).
39
 The sulfenium adopts an approach where the sulfur substituents are oriented orthogonal to 
the alkene.
40
 This type of spiro approach maximizes orbital overlap between the filled sp
3
 orbitals 
on the sulfur atom with the π* orbital of the alkene component. Notably, the σ* of the leaving 
15 
 
group X is not directly involved in the formation process. Thus, there are two possible pathways 
for thiiranium ion formation: (1) C-S bond formation that proceeds synchronously with S-X 
ionization (pathway A); or (2) S-X bond ionization occurs asynchronously, subsequent to C-S 
bond formation (pathway B) (Scheme 11). The former would then be similar to the "butterfly 
mechanism" observed in the epoxidation of alkenes with peracids.
41
 In the latter case, the X 
group may remain either covalently bound to what is now a sulfurane, or form an ion pair. The 
degree of synchronicity has not been well studied, and likely varies as a result of experimental 
parameters such as leaving group identity, solvent and temperature.  
 
Scheme 11 
 The 
1
H NMR spectra of thiiranium ions reveal a wealth of information regarding their 
structure (Table 2). The protons within the ring system for the thiiranium ion 12 appear at 4.0 
ppm (TMS) in SO2 at -60 
o
C (entry 1).
42
 These are shifted upfield in the thiiranium ion 14 to 3.56 
and 3.85 ppm, clearly showing their anisochronicity which results from the stereogenic sulfur 
center. Thiiranium 13 derived from a cis-alkene showed only one set of signals at 4.32 ppm. 
Thus, only one of two possible diasteromers is formed, which has been shown to be cis-13.
42,43
 
The propensity for formation of cis-13 results from decreased steric clash between the S-
substituent and the C-substituents. The 
13
C NMR shift of thiiranium ion 17 is at 76.2 ppm 
(CDCl3), far downfield of the starting thiirane 16 (50.7 ppm) (Scheme 12).
44
 This shift is taken 
as evidence of charge density at the ring carbons of thiiranium ions, in accord with their 
ambident electrophilic nature. Similar shifts are observed for 1,1- and trans-substituted alkenes.
45
  
  
16 
 
  
Table 2. Proton NMR Shifts of Thiiranium Ions. 
 
entry ion R
1
 R
2
 R
3
 R
4
 
1
H NMR shift of endocyclic protons (TMS) 
1 12 Me H H Me 4.0, m, 2H 
2 13 Me Me H H 4.32, m, 2H 
3 14 Me H Me H 
3.56, d, J = 6.0 Hz, 1H 
3.85 d, 1H 
4 15 Me Me Me H 4.09, q, 1H 
 
 
Scheme 12 
 The crystal structures of a number of thiiranium ions have been acquired. Diadamantyl 
phenyl thiiranium ion 18 shows the classical bent orientation of the sulfur substituent.
46
 The 
acute C-S-C angle of 46.3
o 
illustrates the deviation of the thiiranium ion from a perfect 
equilateral triangle as a consequence of the size of the sulfur atom. The C-S bond length is 1.904 
Å, which is elongated compared to the average C-S length of 1.82 Å.
47
 The C-S-CAryl
 
bond angle 
of 117.6
o
 shows that the sulfur atom is tetrahedrally hybridized. 
Figure 6. Crystal Structure of Adamantyl Thiiranium ion 18 
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 The comparison of methylthiiranium ions derived from cis- and trans- di-t-butylethene is 
also informative (Figure 7).
43
 The Ct-Bu-CS distance is only 3.288 Å for 19, which is smaller than 
the sum of the radii for the two methyl groups. The C-Cring-Cring-X dihedral angles also differ 
substantially between the two structures. For 19, the dihedral of  the opposing substituents is 
148.6
o
. In contrast, 20 has a dihedral angle of 134.6
o
. There is a similar difference in the dihedrals 
of the syn-substituents. The t-butyl substituents eclipse each other for 20, but the corresponding 
dihedral in 19 is 15.6
o
  The difference in angles confirms the greater stability of the cis-
thiiranium ion over the trans-thiiranium ion.  
Figure 7. Crystal Structures of cis- and trans-Thiiranium Ions 19 and 20 
20  19      
 The rate of sulfenofunctionalization of alkenes has been extensively investigated with a 
variety of substrates.
34a
 The rate of sulfenofunctionalization increases with solvent polarity. The 
relative rate of the reaction of styrene with PhSCl was 9250 times faster in CH2Cl2 than in CCl4 
(Scheme 13). Decreases in reactivity were sometimes observed in highly nonpolar solvents such 
as cyclohexane.
34a
 The polarity of the solvent likely assists in the stabilization of highly charged 
species like thiiranium ions, lowering the barrier to their formation.  
 
Scheme 13 
 A comprehensive table of relative reaction rates was compiled by Stirling.
34a
 The 
following general trends could be identified: (1) the reaction of alkyl-substituted alkenes is faster 
than those of aryl substituted alkenes. (2) increasing numbers of alkyl substituents increase the 
reaction rate, whereas increasing numbers of aryl substituents decrease it. (3) for cyclic alkenes, 
the reaction rate increases with alkene strain. (4) the presence of electron-withdrawing groups 
18 
 
conjugated to the alkene severely decreases the reaction rate and (5) inductively electron-
withdrawing groups retard the reaction, and correlate with σ* and ρ*. These results are consistent 
with thiiranium formation being the rate-limiting step. Modest buildup of positive charge on the 
carbons was inferred, however, these results were not consistent with open carbocation 
formation.
38
 
 It is worth noting that the mechanism of thiiranium formation and capture with sulfenyl 
chlorides appears to be dependent on the sulfenium source. Thus, the reactions with 2,4-
dinitrophenylsulfenyl chloride showed different characteristics with respect to phenylsulfenyl 
chloride, which has led to speculation that the reactions may be proceed through a qualitatively 
different thiiranium ions.
34a,38
 The different intermediates postulated are shown in Figure 8. 
These are, in increasing order of electrophilicity, a fully bound sulfurane, a datively bound 
thiiranium, a solvent-associated ion pair, or a fully solvent separated ion pair. The correct view is 
likely a continuum of reactivity that is dependent on sulfenium ion, solvent, alkene and 
nucleophile, thus comparisons of the mechanisms of different sulfenylating agents should be 
done with much care.  
Figure 8. The Types of Possible Thiiranium Ions 
 
 A thiiranium ion is an ambident electrophile, and is susceptible to nucleophilic attack at 
any of its constituents. The bridged nature of thiiranium ions lead to high stereospecificty of 
addition with sulfur electrophiles. The reaction of trans-alkenes with sulfur electrophiles leads to 
anti-functionalization, whereas the reaction of cis-alkenes leads to specific cis-functionalization. 
Nucleophilic attack by either X
-
 or an external nucleophile on the thiiranium ion proceeds 
stereospecifically, opening either at either carbon to selectively afford anti-functionalized 
products. In electronically biased thiiranium ions, capture follows Markovnikov selectivity.
48
 If 
the thiiranium ion is sterically and electronically unbiased, mixtures of constitutional isomers are 
obtained.
49
 Notably, sulfenyl chlorides are an exception to this rule, occasionally affording some 
anti-Markovnikov product even in biased alkenes.
34a
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 2.2. Enantioselective Sulfenylations.  
 2.2.1. Electrophilic Sulfenylation with Stoichiometric Reagents. The ease with which 
thiiranium ions can be generated and the valuable products derived from their subsequent 
reactions has generated broad interest to form them enantioselectively. Although the direct 
addition of sulfenyl electrophiles to olefins has been known for the better part of a century, 
enantioselective sulfenofunctionalization remains a young field.
50
 Early successes employed 
diastereoselective reactions of chirally-modified substrates, taking advantage of the 
stereochemical environment around the alkene to control the selectivity of thiiranium formation. 
The first such diastereoselective sulfenofunctionalization was accomplished by Effenberger and 
coworkers using chiral camphor diol derived auxiliaries (Scheme 14a).
51
 The auxiliary 
effectively controls the facial selectivity of thiiranium formation during the sulfenylation of 
acryloyl ester 21, even at ambient temperature. Subsequent introduction of amide-based 
auxiliaries led to higher selectivities.
52
 For example, sulfenylation of dimethyl N-
acryloylpyrrolidine-2,5-dicarboxylate 23 affords thioether 24 in 76% yield and >95:5 d.r 
(Scheme 14b). However, the reaction is limited to the use of unsubstituted acrylates and 
acrylamide substrates.   
 
Scheme 14 
 The auxiliary-based approach described above requires two additional steps to introduce 
and remove the auxiliary. Enantioselective sulfenylation of prochiral alkenes using chiral 
sulfenylating agents addresses this challenge. For example, treatment of alkene 25 with camphor-
derived sulfonium salt 26 affords thioether 27 in excellent yield albeit with poor 
enantioselectivity (less than 55:45 e.r.) (Scheme 15a).
37a
 The poor selectivity likely arises from 
initial sulfenylation of the amide moiety followed by intramolecular S-methyl group transfer to 
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afford the final product as a nearly racemic mixture. A more selective sulfenylating agent, S-
methylthio binaphthyl sulfonium salt 28, can transfer the S-methyl group to 3-hexene and the 
resulting thiiranium ion is captured by acetonitrile which upon hydrolysis provides methylthio 
acetamide 29 in 93:7 e.r. (Scheme 15b).
37b
 The authors did not present a stereochemical model 
for the transformation and the absolute configuration of the major enantiomer of the product was 
not established.  
 
Scheme 15 
 Although instances of successful enantioselective sulfenofunctionalization occurred in 
the literature, the lack of a detailed model for enantioinduction hampered the development of 
more selective chiral sulfenylating reagents. Furthermore, the necessity for use of chiral, 
stoichiometric reagents is disadvantageous. An ideal strategy would entail the in situ formation 
of enantioenriched thiiranium ions from readily available achiral sulfur electrophiles and 
substoichiometric amounts of a chiral additive.  
 2.2.2. Catalytic, Enantioselective Sulfenylation. The stereoselective introduction of sulfur 
has historically relied on its nucleophilicity, for example the use of sulfur nucleophiles in the 
invertive displacement of secondary leaving groups and enantioselective opening of epoxides 
with rare earth catalysts 30 and 31.(Scheme 16, a and b).
53
 The development of a catalytic 
asymmetric 1,4-addition of thiols to α,β-unsaturated carbonyl compounds was the first catalytic 
sulfenofunctionalization of an alkene moiety (Scheme 16c).
54
 The catalyst for this process was 
the well known proline derivative 32. Notably, a catalytic, asymmetric γ-sulfenylation of α,β,γ-
21 
 
unsaturated carbonyl allenes with a protected thiol which utilizes phosphine 33 as a complement 
to the aforementioned β-functionalization has also been developed (Scheme 16d).55  
 
Scheme 16 
The use of electrophilic sulfur reagents for olefin functionalization has been known for 
many decades.
50a
 Weak S-N, S-O and S-halogen bonds can be displaced by π-nucleophiles, 
leading to AdE-type displacements at the sulfur center.
56
 Specifically sulfenyl amides, acetates 
and halides have all been studied in the context of alkene functionalization. In contrast, only 
recently have examples of catalytic, stereoselective reactions involving electrophilic sulfur 
species been discovered. In 2005, Jørgensen disclosed a proline-catalyzed asymmetric α-
sulfenylation of carbonyl compounds (Scheme 17a).
57
 In this transformation, the prolinol 
enamines formed from prolinol derivatives react with N-benzylsulfenyltriazole to afford 
benzylsulfenylated aldehydes. Organocatalytic sulfenylation of carbonyl compounds has since 
been expanded to keto esters and other carbonyl compounds using cinchonine and TADDOL-
derived catalysts (Scheme 17b and c).
58
 Importantly, Cordova was able to use both the sulfenyl 
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electrophile and the transferring group in the catalytic asymmetric aminosulfenylation of α,β-
unsaturated carbonyl compounds (Scheme 17d).
59
  
 
 
Scheme 17 
 In the course of this work, other Lewis base catalyzed enantioselective functionalizations 
have been developed. The Shi group demonstrated the catalytic activity of 36 in the 
oxysulfenylation of (Z)-alkenes 37 with electrophile 38 (Scheme 18).
60
 The product 
tetrahydrofurans 39-41 were obtained with modest enantioselectivity. The chiral acid catalyzed 
sulfenofunctionalization of alkenes could be extended to nosylamine substrates 43 with 
electrophile 44 with substantially better enantioselectivity.
61
 The increase in enantioselectivity 
was driven by the use of highly sterically hindered chiral phosphoric acid 42. The 
enantioselectivity differed greatly based on alkene configuration, and products of (Z)-alkenes 
(45,46) were produced in significantly higher selectivity than (E)-alkenes (47). Although the 
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authors postulated a model for selectivity based on data for similar reactions, the unique 
properties of each sulfenylating agent renders such a comparison ill-advised. Mechanistic 
experiments or computational simulation to validate the proposed transition state model was not 
performed.  
 
Scheme 18 
 In all but the last of these transformations, the requirement for an activated alkene to be 
generated in situ limits the overall applicability of the reaction. Thus, the need for a 
complementary approach was obvious. The conceptual approach of activation of normally 
unreactive sulfenyl electrophiles towards nucleophilic displacement by electronically unactivated 
alkenes led to the formulation of a Lewis base catalyzed enantioselective 
sulfenofunctionalization framework.    
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 2.2.3. Application of Lewis Base Activation of Lewis Acids to Sulfenofunctionalization.  
The theoretical formulation of Lewis base activation of sulfur Lewis acids proceeds analogous to 
those developed for selenium and silicon. Sulfenyl electrophiles are Lewis acidic as a result of 
their ability to accept electrons into the S-X σ* orbital.23 Thus, the interaction of a suitable Lewis 
base with sulfenyl electrophiles is expected to increase their reactivity, ideally to the point where 
they can be engaged by simple alkenes. If the Lewis base is chiral, the resulting sulfenium source 
would also be chiral, and potentially able to impart stereochemical information to the nascent 
thiiranium ion. The ability of the Lewis base to increase the reactivity of the sulfenium moiety is 
paramount in avoiding a stereoselectively deleterious background reaction. In light of these 
requirements, a plausible framework for catalytic, enantioselective sulfenylation of alkenes can 
be formulated. The process commences with the activation of the sulfenylating reagent 49 by a 
chiral Lewis base (LB) 48 to generate intermediate activated sulfenium source 50 (Figure 9).
62
 
Consistent with the principles of Lewis base activation, the redistribution of the electron density 
from the S-atom toward the peripheral ligand (X) enhances the Lewis acidity of the S-center. The 
increased Lewis acidity facilitates the nucleophilic attack of the alkene onto 50 (step 2). The 
interception of the resulting thiiranium ion 51, enantioenriched as a consequence of the chirality 
of 48, by a nucleophile (step 3) leads to the formation of the product (53) and regenerates the 
Lewis base catalyst (step 4). In the desired reaction framework, both the enantioselectivity of 
thiiranium formation as well as the stereochemical integrity of the resulting thiiranium ion need 
to be well controlled. Furthermore, for high selectivity and chemical yield, nucleophilic attack on 
51 needs to proceed site selectively among the carbon and sulfur atoms of the thiiranium ion.   
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Figure 9. Mechanistic Framework for a Lewis Base Catalyzed Sulfenofunctionalization 
Process 
 
 Efforts toward achieving catalytic, enantioselective sulfenylation of alkenes have hinged 
upon the discovery of conditions that allow for the controlled formation and capture of 
enantioenriched thiiranium ions. Although the stereoselective, stoichiometric synthesis of 
thiiranium ions has been accomplished (see Section 2.1.3), these methods did not provide any 
insights into the configurational stability of thiiranium ions under catalytic conditions.  
 Mechanistically, three major pathways can result in thiiranium ion racemization (Scheme 
19).
63
 The first involves the unimolecular racemization of thiiranium ions through equilibrium 
with an open carbocation (path a). The second mechanism entails nucleophilic attack at the 
sulfur center followed by addition of the resulting sulfenium moiety to the alkene (path b). 
Finally, the racemization could occur via a bimolecular alkene-to-alkene transfer mechanism 
(path c). In a series of studies from these laboratories, each of these issues were separately 
addressed to provide the foundation for highly-enantioselective, catalytic, 
sulfenofunctionalization reactions.  
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Scheme 19 
 The configurational stability of thiiranium ions in the presence of hard nucleophiles was 
established by demonstrating high enantiospecificity in the formation and capture of 
enantiomerically enriched thiiranium ions.
63
 Specifically, thiiranium ion 54, prepared from 
enantioenriched β-chloro sulfide 55 at -40 oC, undergoes highly stereospecific capture with a 
variety of nucleophiles at -20 
o
C to afford the corresponding enantioenriched thioether products 
(Scheme 20). The use of neutral and anionic oxygen nucleophiles as well as azides results in the 
formation of β-thioethers, esters, and azides with high enantiospecificity. Thus, thiiranium ions 
are configurationally stable in the presence of hard nucleophiles at -20 
o
C. Additionally, the high 
enantiospecificity observed with all nucleophiles investigated suggests that a unimolecular 
racemization process does not occur on the timescale of nucleophilic capture (Scheme 19, paths 
a and b). 
 
Scheme 20 
 
27 
 
 Under catalytic conditions, thiiranium ions (e.g., 55, Scheme 21) are generated in low 
concentration in the presence of Lewis bases. Therefore, the configurational stability of 
thiiranium ions with respect to various Lewis bases is critical. The enantiospecificity for the 
methanolysis of thiiranium ion 55 is highly dependent on the nature of the Lewis base in the 
reaction mixture.
63
 Whereas complete loss of configurational homogeneity occurs in the presence 
of diphenyl disulfide, high enantiospecificity is observed for the reaction with 
tetrahydrothiophene as the Lewis base. These results suggest that the enantiomeric composition 
of the thiiranium ion in a reaction can be maintained using non-chalcophilic Lewis bases (e.g., 
tetrahydrothiophene) as catalysts. 
 
Scheme 21 
 The direct transfer of thiiranium ions between two alkenes has been studied both 
experimentally and computationally.
40,64
 Rapid sulfenium ion transfer between trans-thiiranium 
ions occurs at 0 
o
C (Table 3, entries 1 and 2). In addition, the sulfenium ion can be transferred 
between cis- and trans- thiiranium ions (entries 3 and 4).  
Table 3. Alkene-to-alkene Transfer of Thiiranium Ions. 
 
entry R
1
 R
2
 Keq 
1 (E)-n-Pr Bn 0 
2 Bn (E)-n-Pr 100 
3 (E)-n-Pr (Z)-n-Pr 2 
4 (Z)-n-Pr (E)-n-Pr 1
a
 
a 
decomposed before equilibrium could be reached. 
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 Consequently complete racemization of enantioenriched thiiranium ion 55 occurs in the 
presence of an excess of (E)-4-octene at 0 
o
C as evidenced by the formation of racemic 
methoxylated product (Scheme 22). However, the olefin-to-olefin transfer process proved to be 
temperature-dependent, as the racemization of 55 is completely suppressed at -20 
o
C. These data 
implicated that the racemization of thiiranium ions via path c can be prevented by judicious 
choice of reaction conditions. 
 
Scheme 22 
 2.3. Goals of the Project.  
 The detailed mechanistic experiments demonstrated that stereocontrol over thiiranium ion 
formation is possible. Furthermore, all known major racemization pathways of thiiranium ions 
can be suppressed for methanol capture. Thus, the challenge lay in identifying a suitable 
electrophile-Lewis base combination and reaction conditions that would allow for the catalytic 
formation of thiiranium ions with high stereoselectivity and prevent their racemization. 
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 2.4. Results.    
 2.4.1. Optimization. 2.4.1.1. Background and Initial Survey. To conduct a far-reaching 
Lewis base survey, a simple and robust test system needed to be determined. An intramolecular 
cyclization was considered easier to accomplish, due to the high effective concentration of 
nucleophile in solution, which reduces the necessary lifetime for the thiiranium ion. Furthermore, 
the existence of a chromophore was considered advantageous with regards to separation and 
enantiomer determination. Sulfenylating reagent 56 is a crystalline, commercially available, 
stable solid and was therefore highly suitable for optimization (Chart 2). Unsaturated alcohol 
57a, accessible by a known and scalable procedure in three steps, was selected as the initial 
substrate.
16
 The thiiranium derived from 57a can cyclize either in exo- or endo- fashion to afford 
tetrahydrofurans and tetrahydropyrans respectively. Thus, the choice of 57a also allows for 
investigation of the site selectivity of the alcohol nucleophile.   
  Chart 2 
 
As previosly mentioned, Lewis base activation of Lewis acids requires an ionizable group 
on the Lewis acidic center. Due to its high pKa, phthalimide is not an ideal leaving group, and 
attempts to effect the sulfenoetherification with just 56 was not successful.
65
 However, 
protonation of the phthalimide significantly enhances its competence as a leaving group.
16
 
Trifluoroacetic acid (TFA) was selected initially as a medium-strength acid to protonate the 
electrophile and enhance its reactivity.
66
 Unfortunately, the introduction of a proton source 
implies that the Lewis base must be tolerant of acidic reaction conditions. Hence the catalyst 
must balance strong Lewis basicity (to function as a sulfenyl transfer reagent) with weak 
Brønsted basicity (to be active in acidic reaction media).  
As the soft nature of sulfur favors interactions with easily polarizable groups, and in light 
of the weak Brønsted basicity of alkyl sulfides, the survey commenced with known transfer 
catalyst, tetrahydrothiophene (THT).
67
 THT, electrophile 56 and alkene 57a were combined with 
TFA, yielding thioether 58a (Table 4, entry 1). A stronger acid, MsOH, was a more potent 
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activator of 56 (entry 2).
66
 No conversion was observed in the absence of acid, which precludes a 
simple acid-catalyzed cyclization (entries 3 and 4).
68
 In light of these results, and the importance 
of chalcogenides for selenofunctionalization, other sulfur-containing Lewis bases were also 
tested.
18
 DMPU(S) was only a moderately successful catalyst, resulting in 55% conversion after 
24 h (entry 5). In contrast, phosphine sulfides Ph3P(S) and Cy3P(S) were highly reactive, both 
reactions giving complete conversion in less than 3 h (entries 6 and 7). No reaction was observed 
when HMPA was used (entry 8). In contrast, slow conversion was observed with 
thiophosphoramide HMPA(S) (entry 9). Replacing S with the more polarizable Se resulted in a 
more active catalyst, with complete conversion observed after 24 h for HMPA(Se) (entry 10). 
The results confirmed the importance of a soft, polarizable group in the catalyst backbone and 
optimization studies revolved around phosphorus(V) chalcogenides.  
Table 4. Survey of Lewis Base Catalysts for Oxysulfenylation. 
 
   conversion, %
a
 
entry acid Lewis base 3 h 24 h 
1 TFA THT 33 70 
2 MsOH THT 100 100 
3 TFA none 0 0 
4 MsOH none trace <10 
5 MsOH DMPU(S) 7 55 
6 MsOH Ph3P(S) 100 100 
7 MsOH Cy3P(S) 100 100 
8 MsOH HMPA 0 0 
9 MsOH HMPA(S) trace 35 
10 MsOH HMPA(Se) 31 100 
a
Determined by 
1
H NMR analysis of quenched mixture. 
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 2.4.1.2. Optimization of Chiral Lewis Base. The initial survey of chiral Lewis bases was 
conducted mainly by Dr. Thomas Vogler.
63,69
 The success of BINAM-phosphoramides in the 
related selenofunctionalization reaction indicated that the binaphthyl backbone may be a 
priviliged scaffold for the desired transformation.
16
 Selected results from these experiments are 
displayed in. Thio-BINAP 60 was found to be unselective (Table 5, entry 1). In contrast 
thiophosphoramide 61 afforded pyran 58a in 82:18 e.r. (entry 2). Replacing sulfur with selenium 
slightly lowered the e.r. but significantly increased reactivity (entry 3). Substitution of a 
hexahydroazepine ring in the place of the piperidine moiety as well as replacing sulfur with 
selenium resulted in a more active catalyst, 62a, allowing the reaction to be conducted at low 
temperature (entry 4). Furthermore, it was also discovered that 10 mol % catalyst was sufficient 
for this reaction. Under these optimized conditions 58a was obtained in 91:9 e.r. A 
heptahydroazocine moiety did not increase selectivity (62c, entry 5). Therefore 62b was chosen 
as the catalyst for further reaction development. In the course of this work more selective 
catalysts such as 62d and 62e have been developed (entries 6 and 7).
40
 They are shown here for 
comparison purposes. 
Table 5. Survey of Chiral, Nonracemic Lewis Bases for Sulfenofunctionalization. 
 
entry # catalyst electrophile equiv. 
time, 
h 
temp, 
o
C 
conversion, 
%
a
 
e.r.
b
 
1
c,d
 60 
 
 
0.2 3 23  100 46:54 
2
d
 61 
  
0.2 24 23 100 82:18 
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3 62a 
 
 
0.2 4  23 100 79:21 
4 62b 
 
 
0.1 30  -20 100 91:9 
5
c
 62c 
 
 
0.1 48  -20 100 91:9 
6 62d 
 
 
0.1 48 -20 100 93:7 
7 62e 
 
 
0.1 48 -20 100 95:5 
a
Determined by 
1
H NMR analysis of crude reaction mixture. 
b
Determined by CSP-SFC analysis. 
c
TFA was used instead of MsOH. 
d
1.2 equiv. of electrophile was used.  
 
On scale, 62b was prepared from racemic 1,1'-binaphthyl-2,2'-diamine. Condensation of 
naphthol with hydrazine under high temperature and pressure afforded a tarry mass, from which 
1,1'-binaphthyl-2,2'-diamine 63 was isolated in low yield (Scheme 23). The amine was resolved 
using (D)-camphorsulfonic acid, and a second neutralization afforded (R)-binaphthylamine 64 in 
89% yield over two steps, which was found to have an e.r. of 99.2:0.8 by chiral stationary phase-
supercritical fluid chromatography (CSP-SFC). Treatment of 64 with ethyl chloroformate 
followed by LiAlH4 reduction led to dimethyl derivative 65.
70
 Reaction of 65 with PCl3 followed 
by addition of amine 66 and powdered Se to yielded selenophosphoramide 62b in 5 steps and 
overall 28% yield from the racemic 1,1'-binaphthyl-2,2'-diamine. The first step in this process 
Table 5. (cont.) 
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has since been replaced through the use of a Cu-catalyzed coupling oxidative coupling that is 
more amenable to high throughput.
71
 
 
Scheme 23 
2.4.1.3. Evaluation of Electrophilic Sulfur Sources. The requirement for strong acid 
activation of 56 meant that many interesting nucleophiles such as cyanide, amines and conjugate 
bases of carbon acids cannot be used. If a more reactive electrophile/ leaving group combination 
could be found, this could lead to a significant increase in the nucleophile scope.  
The reason behind the low reactivity of 56 is most likely the poor nucleofugality of 
phthalimide.
23
 Thus groups on nitrogen better able to stabilize negative charge should lead to 
higher reactivity. To test this assumption, a series of electrophiles with increasing conjugate acid 
strength were tested (Table 6). The e.r. decreased modestly with increasing nucleofugality 
(entries 2 and 3). Unfortunately the reactions were run under different conditions so a direct 
comparison of the reactivity was not possible. Weaker Brønsted acids TFA and TCA 
(trichloroacetic acid) successfuly activated the benzotriazole and saccharin electrophiles 
respectively, although the overall solution was still highly acidic (pKa (TCA) < 1).
66
 Ultimately 
the highly reactive dimesylamide-derived electrophile 69 successfully effected the cyclization of 
57a in the presence of 2 equiv. of hindered base 73 (entry 4; use of Et3N and Hünig’s base 
resulted in N-sulfenylation). Unfortunately, the e.r. was significantly lower. More reactive 
sulfenylating agents were not prepared. Sulfenyl acetate 70, which corresponds to an 
intermediate nucleofuge strength was unreactive in the absence of acid (entry 5). Attempts to 
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decrease the electron density on the sulfur by introducing electron-withdrawing groups, such as 
in 71 and 72 led to exclusive O-sulfenylation (entries 6 and 7).  
Table 6. Survey of Electrophilic Sulfenylating Agents. 
 
entry electrophile # additive R 
time 
h 
temp 
o
C 
conversion 
%
a
 
e.r.
b
 
1 
 
56 MsOH Ph 30  -20 100 91:9 
2 
 
67 TFA Ph 40  -20 100 84:16 
3
c
 
 
68 TCA Ph 1.5 23 89 79:21 
4
d
 
 
69 
 
Ph 48  -20 100 68:32 
5 
 
70 - Ph 16  -20 0 - 
6 
 
71 - 
2-NO2-
C6H4 
16  -20 -
e
 - 
7 
 
72 - 
2,4-NO2-
C6H4 
16  -20 -
e
 - 
a
Determined by 
1
H NMR analysis of crude reaction mixture. 
b
Determined by CSP-SFC analysis. 
c
62a was used instead of 62b 
d
2 equiv.of base additive was used.
 e
O-sulfenylation was observed 
instead. 
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 The identity of the sulfenyl group was also investigated (Table 7). The use of methyl-
derivative 74 resulted in lower e.r. although it is currently unclear whether this is a steric or an 
electronic effect (entry 1). Trichloromethyl analog 75 proved completely unreactive under the 
reaction conditions (entry 2). Interestingly 76 was successful in effecting the cyclization, 
although the e.r. using a chiral Lewis base was not determined (entry 3). Further experimentation 
in this field was conducted by Dr. Eduard Hartmann.
72
  
Table 7. Survey of Sulfur Subsituent of the Sulfenium Source. 
 
a
Determined by 
1
H NMR analysis of crude reaction mixture. 
b
Determined by CSP-SFC analysis. 
c
Other species were observed as well. 
2.4.1.4. Optimization of Temperature. To determine the reactivity profile of the 
phthalimide electrophile, experiments at a number of different temperatures were performed 
using the parent substrate 57a. When conducted at room temperature, the thiofunctionalization of 
57a yielded 58a with an e.r. of 84:16 (Table 8, entry 1). However, at -10 
o
C this ratio could be 
improved to 89:11 (entry 2) and when the reaction was run at -20 
o
C, where thiiranium ions are 
entry electrophile # 
Lewis 
base 
additive R 
time, 
h 
temp, 
o
C  
conversion 
%
a
 
e.r.
b
 
1 
 
74 62b MsOH Me 48  -20 100 76:24 
2 
 
75 THT MsOH CCl3 24  23 0 - 
3 
 
76 THT MsOH 
4-NO2-
C6H4 
1 23 50
c
 - 
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known to be stable, the e.r. was 91:9 (entry 3). Further decrease in the temperature did not affect 
the enantioselectivity (entry 4). This increase in e.r. was accompanied by a significant increase in 
reaction time, from 1 h at 23 
o
C to 24 h at -10 
o
C and 48 h at -20 
o
C. The reaction did not reach 
full conversion even after 66 h at -30 
o
C.
69
 This trend was confirmed for a second substrate, 57k: 
the e.r. of 59k increased from 78:22 to 83:17 to 84:16 when the reaction temperature was 
lowered to -10 
o
C and -20 
o
C respectively (entries 5, 6 and 7). A similar increase in reaction time 
was observed.   
Table 8. Variation of Enantioselectivity as a Function of Temperature. 
 
entry substrate temp. 
o
C time  product e.r.
a
 
1 57a 23 1 h 58a 84:16  
2 57a -10 24 h 58a 89:11 
3 57a -20 48 h 58a 91:9 
4 57a -30 >66 h
b
 58a 91:9 
5 57k 23 2 h  59k 78:22 
6 57k -10 48 h 59k 83:17 
7 57k -20 >48 h
b
  59k 84:16 
a
Determined by CSP-SFC analysis
 b
full conversion was not achieved at the final data point.  
 2.4.2. Intramolecular Sulfenoetherification. 2.4.2.1. Preparation of Substrates. The 
synthesis of γ-alkoxystyrenes followed a 4-step synthetic sequence (Scheme 24). Aldehydes 77 
were treated with vinyl magnesium bromide to form secondary alcohol 78. A Johnson-Claisen 
rearrangement transformed the secondary alcohols into γ-carboxystyrenes 79. The ester was then 
reduced with LiAlH4 to afford the desired substrates 57a-c. Alkyl substituted 57g and 57h were 
prepared through an identical route.  
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Scheme 24 
 The synthesis of trisubstituted alkenes was also accomplished over four steps each. The 
preparation of 57m commenced with the treatment of benzaldehyde with cyclopropyl 
magnesium bromide to form secondary alcohol 80 (Scheme 25). Under acidic conditions, 
rearragement of the cyclopropane ring resulted in the formation of the (E)-alkene 81. Treatment 
of the bromide with Mg followed by CO2 formed acid 82, which was then transformed into 57m 
by exposure to LiAlH4. 
 
Scheme 25 
 The synthesis of 57n started with α-methyl-trans-cinnamaldehyde. The aldehyde was 
transformed into the allyl bromide 84 over two steps. Displacement of the allylic bromide with 
diethyl malonate afforded diester 85. Hydrolysis of 85 in the presence of LiOH proceeded 
smoothly, and the product 86 underwent spontaneous decarboxylation upon distillation to the 
desired acid 87. Reduction of 87 with LiAlH4 then afforded 57n.   
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Scheme 26  
2.4.2.2. Preparative Intramolecular Sulfenoetherification. A series of alkenes with 
differing electron density were subjected to the thiofunctionalization conditions. The parent 
substrate 57a yielded thioether 58a in 80% yield and 91:9 e.r. (Table 9, entry 1). When methoxy-
substituted substrate 57c was used, the product was obtained in 84% yield and 91:9 e.r. (entry 2). 
In contrast, the reaction of trifluoromethyl-substituted substrate 57b was found to be quite 
sluggish, leading to only 45% conversion even at -10 
o
C (entry 3). At this temperature 58b could 
be obtained in 88:12 e.r. When an even more electron poor α,β-unsaturated ester 57d was used, 
no reaction was observed even at elevated temperatures (entry 4). The electron density of the 
desired alkene appears to have an appreciable effect on reaction rate. Interestingly, even though 
considerable variation in rate was observed, the e.r. of the products was not affected. 
Furthermore, all products showed highly selective 6-endo closure, in contrast to previous reports 
suggesting that 5-exo closure was kinetically favored for such intramolecular capture reactions.
17
 
To determine the importance of substitutents in the carbon tether, substrates bearing 
tertiary and quaternary carbons were synthesized. Cyclization of tertiary alcohol 57e afforded 
pyran 58e with an e.r. comparable to the parent substrate (Table 9, entry 5). Substrate 57f bearing 
a quaternary carbon also yielded a similar result, indicating that the reaction is insensitive toward 
substitution in the intervening tether (entry 6). Notably, the endo:exo selectivity decreased 
slightly when more hindered substrates were used. The impact of substituents around the carbon-
carbon double bond was also investigated. A nonconjugated olefin 57g was tested first.  Under 
the standard reaction conditions 58g was obtained in 96:4 e.r., indicating that the reaction of 
dialkyl olefins is more stereoselective than their styryl counterparts (entry 7). Notably, 
significant quantitites of the 5-exo closure product 59g were obtained. The e.r. for 59g was 
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identical to that of 58g. The reaction of branched alkene 57h yielded 58h in 71% yield and 96:4 
e.r. (entry 8). The branched substrate showed similar stereoselectivity but increased endo 
selectivity compared to 57g. It appears that the introduction of branching at the nucleophile, in 
the tether, or around the unsaturation does not lead to significant changes in the 
enantioselectivity of the reaction, and has modest effects on exo:endo selectivity. No significant 
trends regarding the constitutional selectivity based on the size and location of the substitution 
could be determined. All reactions were complete after 48 h at -20 
o
C which indicates that any 
effects on rate are modest at best.  
 
Table 9. Survey of Substrates for Intramolecular Sulfenoetherification. 
 
entry alkenol R
1
 R
2
 R
3
 
temp, 
o
C 
product 
yield,
a 
% 
58/59 
b
 e.r.
c,d
 
1 57a Ph H H -20 58a 80 49:1 91:9 
2 57b 4-CF3C6H4 H H -10 58b 36 25:1 88:12 
3 57c 4-MeO-C6H4 H H -10 58c 84 >10:1 91:9 
4 57d COOMe H H rt
d
 - 0 - - 
5 57e 
 
-20 58e 84 13:1 92:8 
6 57f 
 
 
-20 58f 94 19:1 92:8 
7 57g CH2CH2Ph H H -20 
58g, 
59g 
88 5:1 
96:4  
(58g) 
96:4  
(59g) 
8 57h i-Pr H H -20 58h 71 17:1 96:4 
9
e
 57i H Ph H rt
d 
58i 41 N.D. 53:47 
10 57j H (CH2)2Ph H -10 59j 72 1:20 54:46 
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11 57k H H H -10 59k 72 <1:19 83:17 
12 57l H H Ph -20 59l 85 <1:99 62:38 
13 57m Ph H Me -20 58m 82 17:1 70:30 
14 57n Ph Me H 23 59n 24 1:18 60:40 
15 57o 
 
-10 59o 83 1:99 91:9 
  16 57p 
 
rt
d
 - 0 - - 
a
Isolated yield. 
b
Determined by 
1
H NMR analysis of crude reaction mixture. 
c
Determined by 
CSP-SFC analysis. 
d
Reaction run at rt for 96 h. 
e
Catalyst (R)-62a and electrophile 67 were used. 
 The hallmark of a robust catalyst for alkene functionalization is its ability to engage 
different alkene substitution patterns. To determine the behavior of the reaction toward the 
various alkene classes, representatives mono-, di-, and trisubstituted alkenes were used in 
thiofunctionalizations. Tetrasubstituted alkenes were expected to react sluggishly and were not 
tested; difficulties with trisubstituted alkenes bore out this expectation. (Z)-alkenes were much 
slower than their (E)-alkene counterparts. The cyclization of 57i took four days at elevated 
temperature, and afforded nearly racemic product (entry 9). Dialkyl substituted (Z)-57j was 
significantly faster, affording thioether 59j in 72% yield after 48 h at -10 
o
C (entry 10). 
Unfortunately, the product was once again nearly racemic. Terminal olefins are known to be 
difficult substrates for face-discriminating reactions due to the minimal difference between the 
enantiotopic faces.
73
 Thus, it was pleasing to discover that tetrahydrofuran 59k could be obtained 
in 72% yield and 83:17 e.r (Table 9, entry 11). Higher temperatures (-10 
o
C) were necessary for 
this substrate. In contrast to the cyclizations of (E)-alkenes high exo selectivity was observed. 
Disubsituted terminal alkenol 57l showed good reactivity, and 59l was obtained with very high 
exo-selectivity albeit with poor enantioselectivity. The use of trisubstituted alkenes did not 
improve the enantioselectivity significantly, as two different trisubstituted alkenes 57m and 57n 
gave products 58m and 59n with 70:30 and 60:40 e.r. respectively. Notably, for 59n the reaction 
was quite sluggish, and elevated temperatures were necessary. Many side products were also 
obtained. Interestingly the constitutional selectivity between 58m and 59n were switched. The 
obtained isomer in each case is consistent with nucleophilic attack at the more substituted 
carbon.  
Table 9. (cont.) 
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 Other nucleophiles also participated in the opening of thiiranium ions. In addition to 
alcohols, carboxylic acids were found to be effective nucleophiles, and the cyclization of 57o 
yielded 59o in 83% yield, 99:1 constitutional selectivity and 91:9 enantioselectivity (Table 9, 
entry 15). The reaction did require slightly elevated temperatures. When amide 57p was used, no 
reaction was observed (entry 16).
74
  
The absolute configuration of 58a was determined by X-ray analysis of single crystals. 
58a was obtained as a viscous oil which crystallized upon standing after distillation. X-ray 
analysis revealed the absolute configuration to be (2S,3R)-58a (Figure 2). The remaining 
thioethers are assigned by analogy, assuming the formation of the same configuration at the 
thiiranium center for the remaining substrates.  
Figure 10. X-Ray Crystal Structure of 58a 
 
 2.4.3. Intermolecular Sulfenoetherification. The intermolecular thiofunctionalization of 
alkenes represents an important avenue for the development of a general asymmetric 
sulfenylation reaction. Preparation of substrates for intramolecular thiofunctionalizations may 
not always be simple, and the obtained products are by necessity cyclic. Thus the 
functionalization of isolated alkenes with intermolecular nucleophiles introduces sulfur without 
ring formation, and with a much broader range of functionalized nucleophiles. However, 
intermolecular functionalizations also present some major challenges. The lifetime of the 
thiiranium ion in solution is lengthened, which presents greater opportunities for racemization. 
The lower effective nucleophile concentration may also result in slower reactions. Furthermore, 
for non-C2-symmetric alkenes, site selectivity may be an issue. A substrate survey to was 
initiated to investigate these issues.  
 The model substrate 88a was chosen due to its C2h-symmetry and information available 
regarding its reactivity.
63
 Exposing 88a to the standard thioetherification protocol in the presence 
of MeOH afforded the difunctionalized product 89a in 93% yield and 92:8 e.r (Table 10, entry 
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1). (Z)-Olefin 88b was an interesting substrate as the resulting thiiranium ion would be meso. 
Thus, if enantioinduction were observed, this could be evidence for the continued involvement of 
the catalyst after thiiranium ion formation. Unfortunately, the products obtained were within 
experimental error of being racemic (entry 2). Since (Z)-Olefins do not give high 
enantioselectivities with the current catalyst, no conclusions in either direction could be drawn. 
Terminal alkene 88c could be functionalized in 77% yield and 82:18 e.r., although constitutional 
isomers 89c and 90c were obtained in a 10:1 ratio (entry 3). The functionalization of 
unsymmetrically substituted alkene 88d resulted in 4:1 constitutional ratio of 89d:90d with 58% 
combined yield and 86:14 e.r. (entry 4). Trends that were apparent in the intramolecular 
thiofunctionalization reaction transferred well to the intermolecular thiofunctionalization, 
indicating that the mechanistic pathways may be similar.  
Table 10. Survey of Substrates for Intermolecular Sulfenoetherification. 
 
entry # R
1
 R
2
 R
3
 temp. 
o
C NuH yield, %
a
 89/90
b
 e.r.
c
 
1 88a n-Pr n-Pr H -20 MeOH 93 - 92:8 
2 88b n-Pr H n-Pr -20 MeOH n.d. - 52:48 
3 88c n-Hex H H -20 MeOH 77 10:1 82:18 
4 88d i-Pr n-Pr H -20 MeOH 58 4:1 
84:16 (89)
d
 
84:16 (90d)
d
 
5 88a n-Pr n-Pr H -20 AcOH 77 - 91:9 
6 88a n-Pr n-Pr H -20 MeCN
e
 35 - 89:11 
a
Isolated yield. 
b
Determined by 
1
H NMR analysis of crude reaction mixture. 
c
Determined by 
CSP-SFC analysis. 
d
E.r. determined after oxidation to the sulfones 91 and 92, see experimental 
section. 
e
10 equiv of nucleophile was used. 
 Nucleophiles other than alcohols were also tested in the intermolecular 
thiofunctionalization reaction. The thiiranium ion derived from 4-octene could also be captured 
by acetic acid, which formed 89e in 77% yield and 91:9 e.r. (Table 10, entry 5). Nitriles have 
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been shown to react with thiiranium ions to afford nitrilium ions that are hydrolyzed to amides 
upon workup.
37b
 Amide 89f resulting from nitrile capture was obtained in 89:11 e.r. (entry 6). 
The yields of the reaction were low, and a significant quantity of material resulting from 
thiiranium hydrolysis was recovered, even in the presence of excess CH3CN.  
 2.5. Discussion. 
 2.5.1. Optimization of Reaction Conditions. The use of Brønsted acids to activate sulfenyl 
and selenyl electrophiles is well known.
16,23
 Protonation of the imide moiety increases its 
nucleofugality. The increased S-N bond polarization increases Lewis acidity, which is then 
further bolstered by Lewis base complexation. Only then is the alkene a competent nucleophile 
for sulfenium transfer. Indeed, the combination of electrophile 56, alcohol 57a and Lewis base 
62b did not lead to product formation.
65
 However, upon addition of MsOH was clean conversion 
to 58a observed. Thus, the reactivity of the sulfenylimides as Lewis acids is modulated by the 
presence of a Brønsted acidic co-activator (Scheme 27). The decrease in reactivity as a 
consequence of lower acid strength suggests that the protonated imide fraction needs to be high 
for efficient turnover.  
 
Scheme 27 
 The rate of the reaction for electrophiles 56, 67 and 68 were comparable at -20 
o
C. Thus, 
the rate of the reaction is not a function of electrophile source. For reactions of substrates that are 
not compatible with strong acids, more reactive sulfenyl agents with less stringent acid 
requirements can be used. At the most extreme, disulfonylimides 69 allow the reaction to 
proceed without any acid activation (Table 6, Scheme 28). However, the downside of increasing 
the reactivity of the sulfenylating agent can be observed in the enantiomeric composition of the 
resulting products. More reactive sulfenylimides are also more apt to undergo an uncatalyzed 
sulfenium transfer reaction, leading to the formation of racemic product, polluting the highly 
enantioenriched material that results from the catalyzed pathway. The influence of the counterion 
on the facial selectivity for thiiranium formation is also a potential reason for the change in 
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selectivity, however it would not be expected to monotonically decrease as a function of 
counterion nucleofugality.   
 
Scheme 28 
 Sulfenyl acetates represent a different class of electrophile due to the differences between 
the S-N and S-O bonds.
54b
 Sulfenyl acetates displayed σ-electrophilicity as opposed to π-
electrophilicity, resulting in preferential O-sulfenylation (Scheme 29). Although the reaction of 
sulfenyl acetates with alkenes have been well studied, they had been performed in the absence of 
other nucleophilic groups.
75
 Electrophiles with S-O linkages were not studied further as a result 
of the observed undesirable reactivity.  
 
Scheme 29 
   The substituent on the sulfur atom can affect the sulfenofunctionalization process in two 
ways. Functional groups that stabilize positive charge on the sulfur promote ionization of the 
Lewis base - sulfenium complex, assisting in the formation of the chiral sulfenylating agent. 
However, they can also donate electron density into the Lewis acidic sulfur atom, decreasing its 
reactivity as a sulfenylating source. The replacement of the phenyl group by a methyl group did 
not have a major impact on reactivity, and the reaction proceeded to high conversion. In contrast, 
the much more electrophilic 75 bearing a trichloromethyl moiety failed to react even at elevated 
temperatures and with the more active THT catalyst. Thus, thiiranium ion appears to benefit 
from some stabilization at the sulfur center. This result is in agreement with those from Dr. 
Matthew Cullen, who observed increased reactivity for sulfenium sources bearing electron-rich 
arenes.
65
 The ability of the arene moiety to modulate the reaction rate is correlated with its 
45 
 
electron density, insofar as its ability to stoichiometrically sulfenylate the Lewis base complex. 
Therefore, no further sulfenium transfer agents bearing alkyl sulfides were tested. Further 
modifications to the electrophile were performed by other researchers from these laboratories.
40
  
 Only a subset of various Lewis bases previously tested in these laboratories are shown. 
The softness, i.e. polarizability of the Lewis basic atom was extremely important for reactivity.
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Thus, phospine oxides were poor catalysts, whereas increasing reactivity was observed for the 
corresponding sulfides and selenides. Thioureas were less effective, potentially due to increased 
Brønsted basicity or insufficient Lewis basic character. Interestingly, Lewis basic 
sulfenophosphoramides were less effective than the corresponding alkyl or aryl phosphine 
sulfides. Ds numbers for the series of Lewis bases (HMPA, 39; THT, 43; HMPA(S), 53, tri-n-
butylphosphite 56)
76
 did not correlate with reactivity, and therefore Lewis basicity may not be 
the sole factor governing the efficacy of a particular catalyst architecture. Unfortunately, 
comprehensive donor scales for phosphine sulfides are not available. Comparison with the Ds of 
the related alkyl phosphines (~80) suggest that they would be substantially more Lewis basic 
than HMPA(S), potentially contributing to their high reactivity.
76
 The Ds numbers of 
selenophosphoramides and phosphine selenides are unknown, although their increased 
polarizability would likely also increase their donactity with respect to their corresponding sulfur 
analogues. It is worth noting that all of these Lewis basic functionalities are poor Brønsted bases 
and are not protonated under the reaction conditions. Titration of selenophosphoramides with 
methanesulfonic acid revealed only minor shifts by 
31
P NMR up to 4 equiv of MsOH.
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 The best catalysts for the sulfenofunctionalization process differed from those for the 
analogous selenofunctionalization process in one important facet. For sulfenofunctionalization 
catalysts, selenophosphoramides displayed better catalytic activity than the corresponding 
sulfenophosphoramides, in contrast to selenofunctionalization for which sulfenophosphoramides 
were more efficient catalysts.
16
 The rate difference is hypothesized to be due to the formation of 
a strong homonuclear group 16 bond for S-S and Se-Se. In contrast, the S-Se bond is polarized 
and much weaker due to poor orbital overlap.
77 
This trend was confirmed by further X-ray 
crystallographic studies of reaction intermediates (Chapter 3.2.2).  
 The catalyst optimization process by researchers in these laboratories, primarily Drs. 
Thomas Vogler and Matthew Cullen, identified three major families of potential catalysts 
amenable to modification (1) aryl and alkyl phosphine sulfides, (2) dialkyl sulfides, (3) 
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selenophosphoramides. Extensive modification of families (1) and (2) were investigated 
(representative examples are shown in Table 5). The binaphthylphosphoramide backbone proved 
uniquely selective for the sulfenofunctionalization process. The biaryl moiety is a priviliged 
ligand, and has been featured in numerous highly selective catalysts, such as 3 for the Lewis base 
activation of silicon Lewis acids. Structural features of the catalyst architecture that enable the 
high selectivity will be discussed in Section 3.3.  
 The temperature-dependent racemization of thiiranium ions has been well documented.
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Thus, a temperature survey was undertaken to study both rate and enantioselectivity as functions 
of temperature. The rate of sulfenofunctionalization monotonously and rapidly decreased as a 
consequence of reaction temperature. A lower bound on reactivity was -20 
o
C, at lower 
temperatures the reaction time was unacceptably long. The enantioselectivity was temperature 
dependent, however much less so than expected. The e.r. of 58a decreased from 91:9 to 84:16 
when the reaction temperature was increased from -20 
o
C to rt (Scheme 30). In contrast, when 
thiiranium ions were generated stoichiometrically and allowed to equilibriate for 15 min at rt in 
the presence of excess olefin, complete racemization was observed.
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 The observed differences in enantioselectivity suggested that the thiiranium ion lifetime 
is unsurprisingly much shorter in the presence of a nucleophile. Thus, even at elevated 
temperature, capture is sufficiently fast to protect most of the stereochemical integrity of the 
thiiranium ion. The stabilization was not solely related to the presence of a stabilizing phenyl 
group on the alkene. The stereochemical integrity of thiiranium ions derived from terminal 
olefins was also mostly retained at rt (78:22 vs 84:16, Scheme 30). In the interest of observing 
the true intrinsic selectivity of the catalyst for the formation of thiiranium ions derived from 
various alkenes, the optimized reactions were conducted at -20 
o
C. 
 
Scheme 30 
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 2.5.2. Preparative Intramolecular Sulfenoetherification. The substrate scope for alkene 
sulfenofunctionalization was designed to investigate the effects on rate, enantio- and site-
selectivity as a consequence of alkene parameters. These changes are discussed in turn. 
 2.5.2.1. Rate. The rate of the sulfenofunctionalization reaction was sensitive to the 
electronic parameters of the alkene. Increased electron density did not have a measurable effect 
on rate. In contrast, the presence of an electron-withdrawing -CF3 moiety resulted in substantially 
lower reactivity (Scheme 31). Even at elevated temperatures, full conversion was not achieved. 
The lack of reactivity observed for 58d bearing an electron-withdrawing ester group is consistent 
with this hypothesis. 
 
Scheme 31 
 The electron density of the alkene affects the reaction rate insofar as it affects the 
nucleophilicity of the alkene towards attack at the thiiranium ion. Thus, substantial changes in 
rate as a consequence of alkene electron density is consistent with thiiranium formation being 
turnover-limiting. The high-energy of charge localization on the sulfur as well as the formation 
of a strained three-membered ring are invoked to explain the high energy barrier towards 
formation. Comparison with other -iranium functionalizations of Group 16 and Group 17 
elements shows that the formation of the three-membered intermediate is uaually turnover-
limiting, in agreement with the current results.
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 The rate of the reaction was not sensitive to steric parameters at the alcohol or along the 
tether (Table 9, entry 5 and 6). There also appeared to be no discernible difference in rate for 
aryl, hindered alkyl or unhindered alkyl (E)-disubstituted alkenes (Table 9, entries 1, 7 and 8). 
Thus, the electronic environment of the alkene is a much stronger predictor of cyclization rate 
than the steric parameter for (E)-alkenes.   
 The geometry of the alkene had a very prominent effect on rate. If the alkene geometry 
changed from (E) to (Z), the reaction proceeded more slowly. No rate difference was observed 
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between (E)- and 1,1-substituted alkenes. Given the small electronic differences between these 
alkene classes, steric considerations are likely affecting the rate of cyclization for (Z)-alkenes. 
This result stands in stark contrast with the relative rates of cyclization of cis- and trans-butene 
with Cl2 and MeSCl (Scheme 32).
78
 The dichlorination of cis-butene with Cl2 proceeds 1.25 
times faster than trans-butene, for sulfenochlorination krel of cis-butene to trans-butene is 18. In 
agreement with current results, krel of trans-butene to isobutylene is ~1 when MeSCl is used as 
the sulfenylating agent. The potential for sulfenyl chlorides to proceed through a qualitatively 
different thiiranium ion must not be forgotten. The alkene sensitivity may thus also represent 
differences in carbon charge density between the two thiiranium ions based on counterion. 
 
Scheme 32 
 The barrier to the aforementioned turnover-limiting thiiranium formation will be directly 
affected by the stability of the resulting thiiranium ion. The following ground-state arguments 
have been put forth to explain differences in reaction barriers towards thiiranium formation.
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The reaction of PhSCl and cis-butene gives rise to two diastereomers syn-93 and anti-93 
(Scheme 33). In syn-93 the substituent on the sulfur atom is in an unfavorable steric interaction 
with the alkene substituents, whereas the selfsame interaction is avoided in anti-93. Therefore, 
formation favors the less hindered anti-93. The addition of a sulfenium moiety to trans-butene 
results in two enantiomers of 94, neither of which can escape eclipsing of one of the sulfur 
substituents. More generally speaking, for trans-alkenes the resultant thiiranium ion must 
necessarily be experiencing steric repulsion with one alkene substituent. Thus, the formation of 
thiiranium ions from trans-alkenes should be slower than cis-alkenes, which is borne out by the 
rate data for MeSCl. The slow reactivity of cis-alkenes 57j and 57k under the current reaction 
conditions cannot be explained by an analysis excluding participation of the Lewis base in the 
transition state.  
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Scheme 33 
 The steric difference between the sulfenium substituents in the current Lewis-base 
catalyzed process is much different. The presence of the Lewis base forces the sulfenium moiety 
to have the equivalent of two large substituents (Scheme 35). The thiiranium ions anti-93-LB* 
and syn-93-LB* derived from a cis-alkene would then necessarily have at least one large 
sulfenium substituent eclipsing both alkene arms, disfavoring reaction of the cis-alkene. For the 
corresponding thiiranium ion derived from a trans-alkene, each sulfenium substituent eclipses 
only one alkene arm. The two empty alkene quadrants (occupied by Csp3-H atoms) can 
accomodate the remaining steric bulk of the substituents. The presence of the Lewis base likely 
retards the reactivity of the cis-alkenes significantly, to the point that trans-alkenes are the more 
reactive substrates.  
 
Scheme 34 
   Alkene electron density increases monotonically with the number of alkene substituents. 
The reaction of monosubstituted alkene 57k was somewhat slower than that of disubstituted 57a 
(Scheme 35). No change was observed for 57m. The corresponding krel between trans-butene 
and 2-methyl-2-butene is 11 (Scheme 32), again suggesting that the Lewis base appears to be 
significantly modulating the relative reactivity of alkene isomers for hindered systems. The 
reaction of trisubsituted alkenes was very sensitive to the location of the methyl group. Altering 
the position of methyl group led to very slow reactivity, requiring elevated temperatures. Thus, 
the catalyst appears to be highly selective for trans-alkenes over other alkene geometries. The 
presence of a substituent (Z)- to the alkyl chain is also disfavored by the catalyst.   
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Scheme 35 
 Carboxylic acids were competent nucleophiles for the oxysulfenylation reaction. The 
rates did not deviate from the corresponding alcohols. Thus, even though they are much weaker 
nucleophiles (pKa ROH2
+
 -2.2, pKa RCO2H2
+
 -6.5)
66
 the rate of capture by carboxylic acids still 
outpaces the rate of thiiranium formation. In contrast, amides were unreactive. The pKa of the 
conjugate acid for the amide (-0.2)
66,74
 is lower than the pKa of MsOH (-2.6)
66
, therefore the lack 
of amide reactivity can be traced back to stoichiometric protonation of the amide (and 
concomitant decrease in formation of sulfenylation complex 50). 
 2.5.2.2. Enantioselectivity. The enantioselectivity of the sulfenofunctionalization process 
was consistently high for (E)-styrenes. Changes in the electron density of the alkene did not have 
a substantial effect on selectivity (Table 9, entries 1, 2 and 3). Increased steric bulk at the alcohol 
or in the tether also did not result in changes in enantioselecitivity. In contrast to the reactivity, 
enantioselectivity for styrenes appears to be well-controlled by the catalyst, and similar 
selectivities are observed. The similar selectivities observed are in good agreement with a 
common, configurationally stable thiiranium ion intermediate. The intrinsic selectivity of the 
catalyst for styrene substrates is directly relayed to the product enantiomeric ratio with little 
sensitivity to the electronic properties of the thiiranium ion. 
 Interestingly, sulfenofunctionalization of alkenes with two alkyl substrates resulted in 
improved enantioselectivity. The effect is not simply related to changes in the steric environment 
around the alkene, as no change in enantioselectivity was observed between substrates bearing 
methylene and methine carbons at the α position of the alkene. Thus, the initial thiiranium 
formation appears to more selective for unconjugated substrates. The position of the conjugated 
phenyl may have a deleterious effect on selectivity, as the slight increase in selectivity for 
disubstituted alkenes has been replicated in the amino- and carbosulfenylation reactions.
79,83
 For 
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unconjugated substrates, the alkyl chain could potentially adopt a more selective conformer that 
is not accessible to the conjugated substrate as a result of planarization of the alkene and arene 
moieties.   
 In contrast, changes to the alkene geometry significantly impacted enantioselectivity. 
Substrate (Z)- 57j of  could be sulfenofunctionalized with only 55:45 e.r. in contrast to the result 
with the (E)-57g (96:4, Table 9, entries 7 and 10). The lack of a detailed model for 
enantioselectivity prevents an in-depth analysis of this change. However, a quadrant model of 
selectivity has been proposed for similar alkene functionalization reactions.
19f
 In this model, the 
catalyst is sterically hindered in two quadrants of the alkene approach, requiring the alkene to 
orient itself in a manner that places the small substituents in these quadrants (Figure 11, shaded 
areas are occupied by the catalyst). For (Z)-alkenes, no low energy approach is possible, and the 
transition states leading to the two enantiomers do not have large energy differences, which 
results in the product being obtained in nearly racemic form. This catalytic model also predicts 
poor selectivity for other classes of alkenes. Indeed, both 1,1- and trisubstituted alkenes formed 
sulfenofunctionalization products with diminished e.r. However, the enantioselectivity was much 
less diminished for a monosubstituted alkene. In the framework of the quadrant model, this result 
can be explained if the two sterically bulky quadrants contain unequal amounts of space. Thus, 
the orientation of the monosubstituted alkene is well controlled in terms of which quadrant the 
alkyl group occupies. While the experimental data does not refute this interpretation, without 
further data on transition states of less selective alkenes any general model for selectivity 
remains speculative. 
Figure 11. The Quadrant Model for Enantioselectivity. 
 
 The properties of the nucleophile also did not have a substantial impact on the selectivity. 
Both hindered alcohol and carboxylic acids resulted in sulfenofunctionalization with similar 
selectivities (Table 9, entries 5 and 15). Primary amides did not cyclize and therefore the 
enantioselectivity could not be determined. Interestingly, the intermolecular 
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sulfenofunctionalization of a nitrile led to the isolation of the secondary amide with an e.r. 
similar to that of alcohols and acids, which implied that nucleophile identity does not affect 
product enantioselectivity. Extension of this process to protected amines and amides has since 
confirmed this observation.
79
 Nitrile addition to thiiraniums reversibly forms nitrilium ions, thus 
the thiiranium ion can be reformed under the reaction conditions.
42
 The high configurational 
stability of the thiiranium ion, in conjunction with the strong preference of hard nucleophiles for 
C-attack, prevents stereoerosion at this critical juncture.  
 From this data, the enantioselectivity-determining step is conjectured to be thiiranium 
formation. The results indicate that the inherent catalyst selectivity is affected by the geometry of 
the alkene, but not by alkene electron density, steric properties of the tether, nucleophile steric 
bulk or nucelophile identity. The latter three factors would have all been expected to 
significantly impact selectivity if the enantioselectivity-determining step were thiiranium 
capture. The enantioselectivity of the sulfenofunctionalization reaction is thus governed by two 
primary factors, both involving thiiranium formation: the intrinsic selectivity of the catalyst for 
sulfenium transfer to a reference alkene and the geometrical configuration of the substrate 
alkene. The predictable nature of sulfenofunctionalization selectivity on the basis of these factors 
was then further confirmed in the optimization process for amino- and carbonsulfenylation 
reactions. 
 2.5.2.3. Site Selectivity. The three-membered ring of a thiiranium ion is electrophilic at 
each of its constituent atoms. The propensity of hard nucleophiles to prefer C-attack over S-
attack has been covered in Section 2.2.3. However, C-attack can happen at either carbon of the 
thiiranium ion, leading to constitutional isomers (Scheme 36). For intramolecular cyclizations, 
the designations endo and exo are used to signify modes of cyclization in which the sulfur-
bearing methylene is endocyclic or exocyclic with respect to ring formation. In the case of 
sulfenofunctionalization with alcohols, high endo selectivity was observed for alkenes displaying 
an electronic bias. Similarly, sterically biased dialkyl substituted alkene 57h also cyclized with 
high endo selectivity whereas the unbiased alkene 57g afforded 58g and 59g with only 5:1 
endo:exo selectivity.  
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Scheme 36 
 The observed site-selectivity can result from a number of different equilibria. 
Specifically, the site-selectivity can be under kinetic or thermodynamic control. If under kinetic 
control, the observed site-selectivities would represent the intrinsic relative rates of endo and exo 
cyclization of alcohols. If the site selectivity is instead under thermodynamic control, the relative 
stability of the tetrahydrofuran and tetrahydropyran products would be responsible for the 
observed ratios. A different way of phrasing this question would be to state whether the 
thiiranium capture step is reversible. For reversible capture, the thermodynamically more stable 
product is expected to be formed, whereas for irreversible capture, the kinetic product should 
predominate.  
 The relative kinetic reactivity for the cyclization of seleniranium ions has been 
established as 5-exo>6-endo>3-exo>4-endo.
80
 Thus, for a kinetically controlled cyclization of 
analogous thiiranium ions, the 5-exo product is expected to predominate. Instead, the 6-endo 
product was obtained, in accord with Markovnikov rules for nucleophilic attack. Notably, this 
result is also in accordance with the cyclization of haliranium ions, which generally proceed with 
high Markovnikov selectivity.
17
 The nature of the electrophilic atom in the -iranium ring appears 
to strongly affect site selectivity.  
 To ascertain the reversibility of thiiranium capture isomerization studies of exo-products 
59k, 59g and 59j were conducted (Section 3.2.3). Whereas terminal and (Z)-alkene derived 
thiiranium ions did not isomerize under the reaction conditions, thiiranium ions from (E)-alkenes 
did. Thus the high enantioselectivity appears to be at least partially due to the thermodynamic 
preference for tetrahydropyrans over tetrahydrofurans. Unfortunately, the exo-product could not 
be obtained in sufficient quantities from the cyclization of styrenes to test whether these 
substrates also undergo thermodynamic equilibriation. In this case, the Markovnikov and kinetic 
selectivity are working in conjunction, thus making it difficult to deconvolute their respective 
contributions. 
 Interestingly, cyclization of carboxylic acid 57o proceeded with high exo selectivity. 
There is substantial evidence showing that carboxylic acid cyclizations proceed under different 
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selection rules than alcohols based on both protonation state and -iranium source.
17
 Therefore, no 
direct comparison with the aforementioned alcohols is drawn.  
 2.5.3. Preparative Intermolecular Sulfenoetherification. The reactivity trends did not 
change when intermolecular sulfenylations were tested. Sulfenofunctionalization of 4-octene 
proceeded within 48 h at the same temperature as 57a. A larger difference was observed for 1-
octene, as the temperature needed to be raised higher for good reactivity. As expected, no rate 
change was observed as a consequence of increased steric encumbrance around the alkene 
moiety. This data suggests that thiiranium capture is faster than thiiranium formation during the 
intermolecular sulfenofunctionalizaiton process, and by extension during the intramolecular 
sulfenofunctionalization process.  
 The enantioselectivity for intermolecular sulfenofunctionalizations is mildly diminished 
compared to the intramolecular case. Thus, whereas 57g afforded sulfenofunctionalization 
products with 96:4 e.r., the corresponding intermolecular reaction with 4-octene proceeded with 
only 92:8 e.r. A similar decrease was observed in the reaction a terminal alkene. An even greater 
decrease was observed when the alkene was substituted at the α-position. These results suggest 
that a small amount of racemization may be occurring during the intermolecular 
sulfenofunctionalization reaction. In the intermolecular pathway, the molecularity of capture 
changes from unimolecular to bimolecular, resulting in a decrease in effective concentration of 
the nucleophile. The attendant retardation of the capture step leads to a direct increase in the 
lifetime of the thiiranium ion, which can then racemize by any of the pathways mentioned in 
Section 2.2.3 or by other as-yet uncharacterized mechanisms. The overall decrease is minor, 
which suggests that thiiranium stereointegrity is still retained to a large extent in the course of 
intermolecular sulfenofunctionalization. 
 In the intermolecular sulfenofunctionalization of 1-octene, high selectivity for internal 
capture was observed. There does appear to be a substantial bias towards capture at the more 
substituted position, as the thermodynamic difference between the two prodcuts is unlikely to 
account for the high selectivity. There impact of steric bias was modest, with the less hindered 
position being favored 4:1 in the sulfenofunctionalization of 88d. It is uncertain whether this is a 
kinetic or thermodynamic preference. Nitrile capture was found to be reversible as well, and 
even with excess nitrile in solution, the yield was modest at best. The site selectivity of nitrile 
capture for substrates other than 4-octene were not investigated. Further experimentation with 
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amines and amides showed that they, too, show substrate and condition-dependent reversibility 
of capture.   
 2.6. Conclusions. 
 The application of Lewis base catalysis to sulfenofunctionalization enabled the 
development of the first catalytic, enantioselective version of this venerable reaction. The current 
system displayed best results for trans- or monosubstituted, electron-rich or electron-neutral 
alkenes. The most relevant factor impacting rate was alkene electron density; impacting 
enantioselectivity was alkene geometry; and impacting site selectivity was the reversibility of 
capture and charge stabilization. This initial set of substrates also revealed clues regarding the 
turnover-limiting and enantiodetermining steps. The ability to observe and characterize reaction 
intermediates during the course of these studies stimulated a deeper investigation into the 
mechanism of the oxysulfenylation reaction.  
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Chapter 3: Formulation of Mechanistic 
Framework for the Catalytic, Enantioselective 
Sulfenylation Reaction. 
 3.1. Introduction.  
 The experimental results from the sulfenofunctionalization of alkene substrates hinted at 
the turnover-limiting and enantiodetermining steps. The optimized catalyst was useful with many 
substitution patterns, and selectivity was diminished as a result of changes in alkene geometry. 
The reaction was quite selective for trans- and monosubstituted alkenes. In an effort to improve 
catalyst design and to better understand the parameters that govern reactivity and selectivity, a 
deeper mechanistic investigation of the oxysulfenylation reaction was conducted  
 There have been extensive kinetic studies on the stoichiometric sulfenofunctionalization 
reaction.
32
 The reaction was found to be second order overall, consistent with an intermolecular 
rate-determining step. However, the order was not uniform and changed as a consequence of 
solvent polarity. A Hammett investigation found that the reaction had a negative σ value, which 
implied substantial buildup of positive charge at the benzylic position of styrenes undergoing 
sulfenofunctionalization. This evidence led to the conclusion that thiiranium ion formation is 
rate-determining in stoichiometric sulfenofunctionalization reactions with sulfenyl chlorides.  
Based on known mechanisms for electrophilic AdE functionalization of alkenes, a 
catalytic cycle can be formulated and is depicted in Figure 12.
81
 The reaction begins with 
displacement of the ionizable group on the sulfur electrophile by the chiral, non-racemic Lewis 
base. This results in a chiral, non-racemic sulfenylating reagent 95 that should also be a better 
electrophile due to increased Lewis acidity on the sulfur atom. The sulfenyl transfer from 95 to 
an unsaturated species can then proceed to generate thiiranium ion 96. Species 96 is most likely a 
high-energy species and will undergo nucleophilic attack by σ-nucleophiles in solution to afford 
protonated intermediate 97. Deprotonation of 98 leads to the desired product. Notably, the 
balanced equation yields only phthalimide as a byproduct, as the acid component solely acts in a 
cocatalytic manner. 
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Figure 12. Proposed Mechanistic Cycle for Enantioselective Sulfenofunctionalization. 
 
The postulated mechanism offers a number of testable hypotheses regarding the catalytic 
cycle to be formulated. There are two microscopic steps that could conceivably be the rate-
determining step. Electrophilic addition of the olefin to generate 96 forms a charged, strained 
species. Due to the high energy of the resulting products, a late transition state where bond 
breaking is more advanced than bond making can be envisioned, leading to a high barrier. If this 
step is rate-determining a significant effect of alkene electron density should be observable, as 
more electron rich alkenes should undergo more facile addition.  Capture of 96 by a σ-
nucleophile in solution, as well as deprotonation of 95 all appear to be low-barrier processes. 
Alternatively the formation of 95 could also be rate-determining, with subsequent thiiranium 
formation being favored due to scission of the weak LB-S dative bond. Identification of the 
catalyst resting state should be able to differentiate between the two alternatives.  
The formation of an enantiomerically enriched product requires an irreversible 
enantiodetermining step. Either the formation of 96 or 97 can fulfill this requirement. In the 
former scenario, thiiranium formation is irreversible. This implies that the catalyst, which is most 
likely thiophilic to some extent, is not sufficiently strong to abstract sulfur from thiiranium ions. 
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Subsequent stereospecific nucleophilic capture and deprotonation leads to the desired product. In 
this case the enantioinduction is derived from the catalyst being able to discriminate between 
enantiotopic olefin faces. In the latter scenario, the catalyst is sufficiently strong to form the 
thiiranium ion reversibly. Enantioinduction must then necessarily be derived from the relative 
rates of capture for complex 96 and its diastereomer. This mechanism would require that the 
catalyst remain associated with the thiiranium ion after formation, as decomplexation before 
capture would lead to racemic products. These considerations were taken into account during the 
design of experiments to determine the enantiodetermining step.  
  3.2. Goals of the Project.  
 The mechanistic investigations presented here focused on determining the following 
properties of the sulfenoetherification process: (1) the order of the reaction in each reactant, (2) 
the physicochemical properties of the active sulfenylating agent, (3) the constitutional and 
configurational stability of products under the reaction conditions, (4) the turnover-limiting and 
enantiodetermining steps and (5) the origin of rate differences and enantioselectivity between 
substrates.   
 3.3. Results.  
 3.3.1. Kinetic Experiments. A full investigation of the kinetic parameters was undertaken 
to identify the rate  equation. The conversion of 99 was monitored by 
19
F NMR (Fig. 2). Catalyst 
100 was chosen because the rates of reaction could be followed easily over a wide range of 
temperatures and concentrations. The order in each component was determined by the method of 
initial rate kinetics (Figures 12-15). Reactions, done in triplicate, were followed to 10% 
conversion and the initial rates were plotted against concentration to obtain straight lines. 
Standard deviations are displayed on the plots. The activation parameters of the reaction were 
obtained by carrying out the reactions in a temperature range from –20 oC to 20 oC (Figure 17). 
  
59 
 
Figure 13. Dependence of Reaction Rate on Substrate Concentration. 
 
Figure 14. Dependence of Reaction Rate on Electrophile Concentration. 
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Figure 15. Dependence of Reaction Rate on Catalyst Concentration. 
 
Figure 16. Dependence of Reaction Rate on Acid Concentration. 
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Figure 17. Dependence of Reaction Rate on Temperature. 
 
 The reaction was found to be first order in both catalyst and substrate. Zeroth order 
kinetics was observed for the electrophile. Interestingly, when the acid (MsOH) dependence was 
investigated, the rate dependence was found to be parabolic with a maximum at ca. 0.6 equiv. 
The enthalpy of the reaction was 8.9 +/–0.2 kcal/mol and the entropic contribution was 52.7 +/–
0.6 e.u. At 298 K, the entropy term is the primary contributor to the free energy of activation of 
24 kcal/mol. This data is summarized in Figure 18. 
Figure 18. Kinetic study of the Lewis base catalysed sulfenofunctionalisation.  
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 3.3.2. Isolation of the Catalytically Active Species. The proposed catalytically active 
species [(R2N)3P=Se–SPh]
+
X
–
 is assumed to transfer the sulfenium ion to an alkene, forming a 
thiiranium ion. Detailed knowledge about the stereostructure of the active species could help to 
understand the origin of enantioselectivity. Accordingly, the isolation and crystallographic 
characterisation of [(R2N)3P=Se–SPh]
+
X
–
 was investigated. 
  The requirement of a Brønsted acid co-activator for 56 is well-documented.
68
 Thus, 
when 56 was combined with 62b, no change in the 
31
P spectrum was observed. Upon addition of 
MsOH, the signal for 62b at 91.6 ppm is replaced by a signal at 60.4 ppm. The peak at 60.4 ppm 
can also be observed under the reaction conditions for slower-reacting substrates such as 57d or 
57j, indicating that the catalyst-resting state is the activated complex (no peak at 91.6 ppm was 
observed under these conditions). The 
31
P shift is comparable to other substrates that have the 
[P=Se-C]
+
 moiety.
82
  
Other selenophosphoramides that have been synthesized displayed similar upfield shifts 
in 
31
P NMR spectra after exposure to sulfenylating agents.
83
 The resulting compounds were 
persistent. After conversion of 62 to 95, no changes in 
31
P NMR spectra were observed after 4 d. 
The remarkable stability of putative complex 95 encouraged studies towards the crystallization 
and characterization of this species.   
First, a crystal structure of the parent species was obtained by crsytallization from 
CH2Cl2/pentane. The Se-P-Nendo angle was 109.0
o
 whereas the corresponding Se-P-Nexo angle 
was 111.6
o
. The P-center is almost completely tetrahedral. The P-Se bond distance is slightly 
shorter at 2.098 Å compared to HMPA(Se), which has a P-Se bond length of 2.120 Å.
84
 The 
packing of 62b was disordered at the external amine moiety, which suggests that the amine 
component can easily rotate. The rate of rotation of the groups on the exocyclic amine is 
substrate dependent and broadening of 
31
P NMR spectra was observed for the more hindered 
62e.
79
 Notably, electron density for the azepane carbons bound to nitrogen were localized close 
to the P-Se axis. Thus, it appears that the methyl groups on the endocyclic nitrogens act as 
gatekeepers, forcing the substituents on the exocyclic amine to adopt an eclipsing conformation 
with the P-Se bond. The N-Se bond lengths were within a 0.05Å range of each other, elongation 
was not observed.  
63 
 
Figure 19. Crystal Structure of Selenophosphoramide (R)-62b. 
   
Next, crystallization of sulfenylating agent 95 was attempted. Orienting experiments 
focused on the identification of suitable conditions for generating the active species 
[(R2N)3P=Se–SPh]
+
X
–
 without any byproducts that would disrupt the crystallization process. The 
first approach relied on the reaction of a selenophosphoramide with [PhS(SMe2)]SbCl6
85
 which 
had been used as an of the S-phenyl transfer agent to alkenes (Scheme 37, equation 1). This 
reagent was also competent in transferring the sulfenyl moiety to the catalyst forming the active 
species along with volatile Me2S as the sole byproduct. The formation of the active species was 
confirmed by the appearance of a diagnostic 
31
P resonance at 62.4 ppm. Unfortunately, during 
the crystallization attempts, a disproportionation reaction occurred reducing the sulfenyl group to 
PhSSPh while oxidizing the selenophosphoramide to the dicationic dimer [(R2N)3P=Se–
Se=P(NR2)3]
2+ 
2SbCl6
–
 (Scheme 37, equation 2). An X-ray crystal structure of the latter could be 
obtained, which demonstrated how the groups in the actual active species might be oriented. 
 
Scheme 37 
 In this complex, the N-P-Se angles are distinct, with the two endo nitrogens having N-P-
Se angles of 108.0
o
 and 115.1
o
. The Nexo-P-Se angle is also much more acute, at 105.4
o
. Thus, in 
the dimeric complex, all three nitrogens appear to be differentiated, and the phosphorus center is 
more planarized. The P-Se angle is greatly lengthened to 2.244 Å. The formal bond P-Se bond 
order is closer to a single bond with positive charge on the phosphorus as opposed to a P-Se 
double bond with charge on the selenium. The Nexo-P distance is 1.618 Å, compared to 1.633 and 
1.638 Å for the endocyclic nitrogens. The Cring-Nexo-P-Se dihedral is 31
o
, which suggests some 
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eclipsing interaction between the Nexo substituent and the Se-substituent. The Nexo-P-Se-Se 
dihedral is -162.8
o
 and the Se-substituent points directly over the biaryl ring. Experimentally, the 
disproportionation of sulfenylated selenophosphoramides could not be avoided. Eventually, the 
crystal structure of a sulfenylated sulfenophosphoramide was isolated by Dr. E. Hartmann, which 
further assisted the investigation.
40
    
Figure 20. Crystal structure of bisselenophosphoramide 102. 
   
 3.3.3. Stability of Thioethers.  The site-selectivity ratios obtained in the 
sulfenofunctionalization of alcohols can be the result of kinetic or thermodynamic capture. If 
capture is reversible, as evidenced in the nitrilium ion case, the observed isomer ratios would be 
expected to be thermodynamic. However, this possibility also raised the concern that 
enantioselectivity could be decreased if thiiranium ion stability was impacted as a consequence 
of reversible capture. In order to determine the configurational and constitutional stability of the 
products under the reaction conditions, isolated thioethers were resubjected to the reaction 
mixture. The thioethers under investigation were found to not be configurationally stable, and a 
range of behavior with regards to endo/exo interconversion was observed. When 59k was 
resubjected to the reaction mixture, no isomerization was observed at 23 
o
C (Table 11, entry 1). 
In contrast, 59j isomerized at 23 
o
C but not at -10 
o
C (entries 3 and 4). Furan 59g was found to 
isomerize quickly at 23 
o
C and slowly at -20 
o
C (entries 5, 6). The constitutional stability of the 
products appears to be dependent on the nature of the thiiranium intermediate: products that are 
obtained from the formation of less stable thiiranium ions isomerize slower. This data is 
consistent with regeneration of the thiiranium ion in solution from the products and reversible 
capture of the thiiranium ion by the nucleophile.
68
 This led to interesting questions regarding the 
stereochemical stability of the thiiranium ions; if they are accessible in solution, can any 
racemization of the thioethers be detected?  In all cases (59k, 59j and 59g), the re-isolated 
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material was obtained with 100% e.s. (entries 2,4 and 6). It can be concluded that the 
stereochemical purity of the products do not erode under the reaction conditions.
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Table 11. Determination of Constitutional and Configurational Stability of Products.   
 
entry thioether starting 
endo/exo
a
 
temp, 
o
C time, h final 
endo/exo
a
 
e.r.
b
 e.s., %
c
 
1 59k 1:50 23 3 1:50 - - 
2 59k - -10 48 - 83:17 100 
3 59j <1:99 23  3.5 3.5:1 - - 
4 59j <1:99 -10 48 <1:99 - - 
5 59g 1:8 23 16 30:1 96:4 100 
6 59g 1:1 -20 48 5.5:1 96:4 100 
a
Determined by 
1
H NMR analysis of crude reaction mixture. 
b
Determined by CSP-SFC analysis. 
c
e.s. = [eestart/eefinal]*100% 
 3.4. Discussion.  
3.4.1. Reactant Order. The reaction was found to be first order in catalyst and substrate 
but zero order in electrophile. Thus, whereas both catalyst and alkene participate in the turnover-
limiting step, the electrophile does not. The various 
1
H and 
31
P NMR experiments demonstrated 
that 62b is quickly converted to complex 95 under the reaction conditions. Conditions where 
there is less electrophile than catalyst were not tested.  
 The order in both substrate and catalyst was first order. Thus, the thiiranium ion is not 
ligated by more than one catalyst at any point before the turnover-limiting step. The reaction was 
also pseudo-first order overall. The concentraion of sulfenylating agent stays constant throughout 
the reaction, which implies that neither the Lewis base nor the sulfenylating complex experience 
product inhibition.  
The conversion of 56 and 62b to 95 is much faster than thiiranium formation. In addition, 
the equilibrium between 62b and 95 is very highly in favor of 95. Consequently, the catalyst is 
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saturated with electrophile in the initial phase of the reaction. Importantly, the concentration of 
sulfenylated catalyst does not change as a function of electrophile concentration above 1 equiv of 
electrophile with respect to catalyst.  Thus, with an excess of electrophile over catalyst zero-
order kinetics for the electrophile is obserbed. Properly, the electrophile is pseudo-zero order, as 
order in electrophile would be expected to be observable if less 56 than 62b were present in the 
reaction mixture.
86
  
 The order in acid is curved. Curvature in kinetic plots usually results from a change in 
mechanism. At low concentration, the order in acid appears to be close to 1. At these 
concentrations, there is likely insufficient acid to fully convert all of the catalyst to the 
sulfenylating complex. This conclusion agrees with results from these laboratories, which 
demonstrated that 3-4 equiv of acid with respect to catalyst is necessary for complete formation 
of 95e (R = i-Pr) from selenophosphoramide 62e.
87
 If this were the entire case, the curvature 
would be expected to level off and flatten once the catalyst is saturated. Instead, a downward 
curvature is observed. Excess methanesulfonic acid slows the reaction down. A possible 
explanation is protonation of the substrate. The presence of positive charge would disfavor the 
formation of a positively charged species such as a thiiranium ion. Thus, excess acid serves to 
reduce the effective concentration of substrate in the reaction. The overall rate equation is then 
shown in Figure 18. Alternatively, the addition of acid may result in changes in the overall 
dielectric of the solvent mixture. Sulfonic acids strongly hydrogen bond to each other in 
nonpolar media, and thus may be forming locales of higher dielectric constant.
88
 These areas 
could then potentially sequester acid or substrate, lowering the effective concentration. The 
current hypothesis based on the study of the related amino- and carbosulfenylation reactions is 
substrate protonation.
87
  
 Eyring analysis of the reaction was performed in order to obtain activation parameters for 
the reaction. The results were in qualitative agreement with calculations performed by Dr. Hao 
Wang.
40
 The activation parameters of ΔH‡ = 8.9 kcal/mol and ΔS‡= 52.7 e.u. imply a highly 
ordered transition state in which the reaction barrier is primarily entropy-driven. This profile 
results from the organizational requirement wherein the alkene must approach the catalyst in a 
highly restricted conformational landscape. In fact, the entropic barrier is comparable to those of 
other highly-conformationally-restricted, bimolecular transition states such as those of Diels-
Alder reactions
89
, MBH reactions
90
 or the Lewis base promoted aldol addition of trichlorosilyl 
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enolates.
91
 Notably, the entropic parameter is much larger than that for the simple stoichiometric 
sulfenofunctionalization of alkenes. Thus, it appears that while the catalyst substantially 
increases the entropic cost of the reaction, it reduces the enthalpic parameter by an even greater 
amount.  
 3.4.2. Turnover-Limiting Step. Transfer of the sulfenium ion to the alkene occurs from 
the sulfenylated selenophosphoramide [(R2N)3P=Se–SPh]
+
X
–
. First order kinetic behavior in both 
substrate and catalyst, as well as second-order overall kinetic behavior suggests that thiiranium 
ion formation is the turnover-limiting step of the reaction. If thiiranium ion capture were 
turnover-limiting, first order overall kinetic behavior would be expected, and species 95 should 
not be visible in the reaction. Furthermore, buildup of thiiranium ion 96 over the course of the 
reaction is not observed, which would have been the case for turnover-limiting thiiranium ion 
capture. The formation of 95 cannot be turnover-limiting either, as in that case, no order in 
alkene should be observed. The catalytically active species [(R2N)3P=Se–SPh]
+
X
–
, represents the 
resting state of the catalyst. Its existence is supported by 
31
P NMR spectroscopic analysis, in 
which the diagnostic signal for 62 (80–90 ppm, depending on the catalyst structure) disappears 
and a new resonance at ca. 60 ppm is observed, which is diagnostic fo 95. This value is in accord 
with previously reported, analogous compounds of the type [(R2N)3P=Se–YAr]
+
X
–
.
16,87
  
 3.4.3. Origins of Selectivity. In the process of catalyst optimization, product 
enantioenrichment was observed to vary widely with the choice of exocyclic amine. The crystal 
structures obtained for the first time delivered a structural basis of selectivity. The substituents 
on the exocyclic amine in 102 serve to orient the Se-S bond over one of the biaryl rings. The 
approach of the alkene, which occurs orthogonal to the Se-S bond to maximize overlap with the 
lone pairs on the sulfur, then proceeds in close proximity to the stereogenic axis of 102.  
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Table 12. Transition States at the B3LYP/6-31G(d) level with CPCM Correction.
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a 
 
 
 
 
b 
 
 
 
 
 
 
 
 
     
R = H 
H-TS-major1 
G = 0.0 kcal/mol 
H-TS-major2 
G = 1.5 kcal/mol 
H-TS-minor1 
G = 1.7  kcal/mol 
H-TS-minor2 
G = 3.0  kcal/mol 
     
R = Me 
Me-TS-major1 
G = 0.0 kcal/mol 
Me-TS-major2 
G = 1.8 kcal/mol 
Me-TS-minor1 
G = 3.5  kcal/mol 
Me-TS-minor2 
G = 5.4  kcal/mol 
     
 
spiroplanar
TS-spiro
Se
P
Ni-Pr2N
N
S
Me
Me
R
R
R1
R2
*
TS-planar
Se
P
Ni-Pr2N
N
S
Me
Me
R
R
*
R1
R2
R1
R2
LB*
SR
R
R1
R2
LB*
SR
R
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Table 13. Transition State Models and Distortion Interaction Values for Selected 
Transition States.
40
 
 
 
 
 
 
 
 
 
 
Edist_A
a Edist_B
b Ed Ei Eact
c H G 
(C=C)-
*(S-Se)d
H-TS-major1 9.6 26.1 35.7 -24.8 10.9 (0.0) 11.9 (0.0) 23.9 (0.0) 63.3 (6.7) 
H-TS-major2 10.7 27.4 38.1 -25.6 12.5 (1.6) 13.5 (1.6) 25.4 (1.5) 57.5 (0.9) 
H-TS-minor1 10.4 28.1 38.5 -25.9 12.6 (1.7) 13.6 (1.7) 25.6 (1.7) 64.2 (7.6) 
H-TS-minor2 13.3 33.5 46.8 -32.2 14.6 (3.7) 15.2 (3.3) 26.9 (3.0) 56.6 (0.0) 
Me-TS-major1 7.8 22.8 30.7 -19.9 10.8 (0.0) 11.2 (0.0) 25.0 (0.0) 61.7 (7.3) 
Me-TS-major2 9.0 27.2 36.1 -22.4 13.7 (2.9) 14.7 (3.5) 26.8 (1.8) 55.9 (1.5) 
Me-TS-minor1 9.4 28.6 38.0 -23.0 15.0 (4.2) 15.3 (4.1) 28.5 (3.5) 62.1 (7.7) 
Me-TS-minor2 9.1 29.9 39.0 -23.6 15.4 (4.6) 15.5 (4.3) 30.4 (5.4) 54.4 (0.0) 
 
The isolation and crystallization of 102 enabled a more detailed transition state model to 
be fromulated. The study of the competing transition states resulting from (Si) and (Re)-face 
attack of the alkene did not show any steric basis for energy difference. An interaction/distortion 
analysis identified catalyst distortion as the primary contributor to the energy difference in the 
transition states.
40
 Thus, the favored approach H-TS-major 1 is 1.7 kcal/mol more stable than H-
TS-Minor 1 at 253 K. The decomposition of this value into its components shows that the H-TS-
Minor 2 has a stronger interaction between sulfenium and alkene, with a difference of -1.1 
kcal/mol. However, the total distortion of the individiual components is much worse, at a total of 
+2.8 kcal/mol. This distortion drives the overall energy gap. The gapi is even bigger for sulfenyl 
groups with 2,6-substituents. The difference between Me-TS-Major 1 and Me-TS-Minor 1 is 3.5 
kcal/mol. The distortion energy in this case is a sizable 7.3 kcal/mol, which dominates the 
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interaction process. The low reactivity of catalysts of family 62 appears to be partially driven by 
the problems the catalyst encounters in accomodating the alkene moiety. The alternative 
transition states leading to the same enantiomer, designated TS-2, are uniformly higher in energy 
than TS-1 and are not expected to substantially contribute to the enantioselectivity.    
Thiiranium ion formation is also likely the enantiodetermining step. The competing 
hypothesis for the enantiodetermining step in accord with  Figure 12 is thiiranium capture. For 
such a mechanism to be operative two conditions need to be satisfied: (1) the "thiiranium ion" 
must exist in the form of a charged sulfurane, or at least in very tight association with the Lewis 
base 62 and (2) the Lewis base must not be able to exchange thiiranium ions once formed. There 
is no direct evidence that contradicts these requirements. However, in numerous iterations of the 
sulfenofunctionalization reaction, neither the elemental nature, nor the electronic nor the steric 
properties of the nucleophile was found to have a significant effect on enantioselectivity.
40,83,87
 In 
the regime of enantiodetermining thiiranium capture, the nucleophile, as opposed to the alkene, 
would be expected to dominate the selectivity effects, as the transition state for capture is 
expected to vary with nucleophile properties. The uniform selectivity observed as a consequence 
solely of alkene geometry is inconsistent with enenatiodetermining capture.  
An analysis of the transition state for cis-alkenes revealed why selenophosphoramide 
catalyst family were unsuitable for the functionalization of cis alkenes.
83
 The competing 
transition states for cis thiiranium ion formation are not differentiated on the basis of their 
substituent size, and both substituents encounter unfavorable steric clashes with the S-aryl 
moiety. These interactions account for both the low reactivity and low selectivity observed for 
(Z)-alkenes. The combined calculations did not suggest any possible improvements in catalyst 
architecture for increased selectivity. However, they were successful in predicting increased 
selectivity as a consequence of increased bulk of the sulfenylating agent. The combination of 
crystal structures and calculations directly led to the development of electrophile 103, which 
showed a significantly improved selectivity profile for the sulfenofunctionalization of alkenes 
(Scheme 38). Because the energy difference between the competing transition states comes about 
as a result of catalyst distortion, no simple modifications to increase the selectivity for poorly 
performing substrate classes were found. The design and synthesis of catalysts to expand the 
alkene scope for enantioselective sulfenofunctionalization is left to future generations.  
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Scheme 38 
 3.4.4. Configurational and Constitutional Stability of Products. Thiiranium ions were 
found to be uniformly configurationally stable under the reaction conditions. In all cases, no 
change in enantioselectivity was observed after resubjecting the products to the reaction 
conditions. For furan 59k this result is inconclusive, as there were no indications that the 
thiiranium ion reformed under the reaction conditions. However, in the case of 59g and 59h, 
although isomerization was observed, complete enantiospecificity was retained. Mechanistically, 
reformation of the thiiranium ion under the reaction conditions essentially significantly prolongs 
the thiiranium ion lifetime in solution, as it now spends some non-negligible portion of its time 
in thiiranium ion form. However, the lack of enantioerosion implies that capture still 
outcompetes racemization processes. Thus, the mechanistic groundwork developed during the 
intermolecular stoichiometric sulfenylation helped identify conditions where enantioenrichment 
is retained even in the presence of excess olefin and other potential Lewis bases. Notably, 
phthalimide incorporation was not observed in this case. The fast intramolecular cyclization 
outcompetes the intermolecular capture process even when the thiiranium ion can be reformed.  
 The constitutional integrity of the thiiranium ions was not constant across the substrates. 
Thiiranium ions isomerized in direct correlation with their reactivity in the reaction, i.e. the more 
reactive substrates reformed their thiiranium ions faster. Re-formation of the thiiranium ion is the 
microscopic reverse reaction of thiiranium capture. Thus, the energy barrier to re-formation will 
be dictated both by the strength of the nucleophile and the stability of the thiiranium ion. Since in 
all cases the nucleophiles are alcohols, the energy associated with nucleophile departure is close 
to constant across the thiiranium ions. Consequently, thiiranium ions that are more stable, i.e. 
have lower ground-state energies can re-form faster. Thus, a direct comparison to the initial 
thiiranium ion formation can be drawn. And since thiiranium formation is turnover-limiting, a 
clear downward trend in reactivity (i.e. higher energy to initial formation) can then be translated 
into a clear downward trend in rate of reformation. 
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 3.5. Conclusions. 
 The kinetic and crystallographic studies described in this section definitively established 
both the properties and the behavior of intermediate 95. The formation of 95 from 62b proceeds 
quickly in the presence of MsOH and 56. Sulfenylating agent 95 was observed and characterized 
spectroscopically. The reaction of 95 with alkene 57 was established as the turnover-limiting step 
of the reaction based on the order of the reactants. The turnover-limiting thiiranium ion 
formation step accounts for the dependence of reaction rate on alkene electron density and its 
insensitivity to the nucleophile. The enantiodetermining step was assigned as thiiranium ion 
formation as well, albeit indirectly. The definitive reaction, which is to observe the stereoerosion 
during the isomerization of products in the presence of the opposite enantiomer of the catalyst, 
has not yet been performed. However, the insensitivity of enantioselectivity to the nucleophile 
component, coupled with its high sensitivity to changes in the alkene component, also suggest 
that thiiranium ion formation is enantiodetermining. A comprehensive model for the 
enantioselectivity could not be generated from calculation of the transition state. Instead, the 
diastereomeric transition states leading to the two enantiomers were found to primarily differ in 
distortion energy. However, in conjunction with X-ray crystallography data, the unique 
selectivity of the catalysts of family 62 could be explained: the exogenous amine substituent 
forces the SAr moiety over the biaryl backbone. The approach of the alkene over the biaryl 
backbone spiro to the SAr group induces conformational changes in the catalyst that then dictate 
selectivity. 
 At this juncture, the project diverged in different directions. Development of novel 
electrophiles for sulfenofunctionalization was performed by Dr. Eduard Hartmann. The use of 
carbon nucleophiles for thiiranium capture was performed by Drs. Alex Jaunet, Sergio Rossi and 
Matthew Webster. The aminosulfenylation reaction was taken up by Mr. H. M. Chi. The 
extension of the sulfenylation to new classes of oxygen-bearing nucleophiles then constitutes the 
remainder of this thesis.   
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Chapter 4:  Catalytic Enantioselective 
Functionalization of Alkenes with Phenols 
 4.1. Introduction. 
 The initial substrate survey and subsequent mechanistic experiments painted a more 
complete picture of sulfenofunctionalization. The successful extension of Lewis base catalysis 
principles to carbosulfenylation and aminosulfenylation has greatly expanded the nucleophile 
scope of the sulfenofunctionalization reaction.
79,83,134
 So far, both alcohols and carboxylic acids 
proved to be competent nucleophiles. However, phenols, which constitute the other major class 
of oxygen nucleophile had not been tested so far. Thus, the extension of sulfenofunctionalization 
chemistry to the functionalization of phenols was undertaken. 
 4.2. Background. 
 One of the simplest benzofused heterocycles, the chroman core is a privileged scaffold 
for bioactive compounds, with representatives displaying antioxidant, antitumor, antibacterial, 
and other therapeutic properties (Chart 3).
92
 Its presence in pharmaceutically relevant targets has 
led to a variety of methods for its enantioselective construction. 
Chart 3 
 
 The importance of the chroman motif in organic molecules is reflected in the myriad 
protocols that have been developed for its synthesis. Five major disconnections have been 
identified, each of which leads to a different starting material (Scheme 39). These are: (a) 
cyclization of a 2-allylphenol 104, (b) C-H functionalization of an O-alkyl phenol 105, (c) 
intermolecular double Michael reaction of a phenol, 106, with an unsaturated carbonyl 
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derivative, (d) intramolecular Friedel-Crafts-type cyclization of an O-allylphenol 107 and (e) 
direct functionalization of the 2-position of the parent chroman 108. 
 
Scheme 39 
 To date, for each of the pathways (a)-(c), enantioselective versions have been developed, 
whereas pathway (d) is diastereoselective due to the presence of a stereogenic center. The 
enantioselective variant of pathway (b) has been accomplished under Rh(II) catalysis,
93
 pathway 
(c) is amenable to enantioselective catalysis by secondary amines,
94
 whereas pathway (d) can be 
accessed either as a two-step epoxidation-ring opening process or in a single step using transition 
metal catalysis.
95
 Each of these pathways have distinct substitution requirements that are 
reflected in the products they afford. Notably, none of these approaches directly lead to the 2- or 
2,3-difunctionalized chromans that are accessible through pathway (a).  
 Because many important natural products bear the 2-substituted chroman motif, 
substantial effort has been devoted to developing enantioselective reactions that proceed through 
pathway (a).
96
 Selected examples include: (1) asymmetric allylic substitution, which proceeds 
through capture of an allylpalladium intermediate by the phenol oxygen (Scheme 40a);
97
 (2) 
tandem oxidative functionalization/Heck-coupling, wherein a similar allylpalladium intermediate 
is generated from an isolated alkene (Scheme 40b);
98
 (3) oxidative functionalization of a skipped 
diene precursor to form an allylpalladium complex (Scheme 40c);
99
 and (4) Lewis-base catalyzed 
cyclofunctionalization of the γ-position of an ynoate with a phenolic hydroxyl group (Scheme 
40d).
100
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Scheme 40 
 Despite the impressive selectivities and obvious utility of these methods, they are not 
applicable to the synthesis of chromans bearing an additional substituent at the 3-position. 
Hence, direct synthesis of enantioenriched, anti-2,3-difunctionalized chromans is usually 
accomplished diastereoselectively from an acyclic epoxide or diol precursor (Scheme 41a).
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The difunctionalization of γ-substituted 2-allylphenol to afford chromans with stereocenters at 
both the 2- and 3- positions remains rare.
102
 A recent example involves the stereocontrolled 
generation and intramolecular opening of a seleniranium ion by a phenolic hydroxyl group to 
form a 2-seleno-3-arylchroman (Scheme 41b).
103
 The reaction proceeds as a DYKAT, since the 
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seleniranium ion in question is not stable under the reaction conditions. Only aryl substituents 
were incorporated at the 2-position. The product could be functionalized further by formation of 
a C-C bond through the intermediacy of a C-centered radical. The diastereoselectivity was poor 
but the stereocenter adjacent to the oxygen atom remained unaffected. 
 
 
Scheme 41 
 As part of the ongoing program on enantioselective sulfenofunctionalization of alkenes, 
extension of the sulfenofunctionalization reaction to the synthesis of chromans represented an 
appealing target. Sulfenofunctionalization of alkenes is a longstanding strategy for the efficient 
introduction of sulfur moieties into organic molecules.
62,104
  We sought to apply the expertise 
gained in the study of enantioselective oxysulfenylation of alkenes to the synthesis of 
difunctionalized chroman derivatives. If both the 2- and the 3-positions of the newly formed ring 
system are functionalized, the final products can be transformed into a variety of useful 
compounds, thus constituting a general and selective method for the synthesis of chroman 
derivatives.  
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 4.3. Goals of the Project. 
 In the course of previous work from these laboratories, the dependence of rate-, enantio- 
and site-selectivity of sulfenoetherification on the substitution pattern and electron density of the 
alkene component have been investigated.
20
 However, changes in the reaction outcome as a 
function of structural variations at the nucleophile were not determined. Furthermore, the tether 
length was kept constant across the different substrates. The primary goals of this study were to 
evaluate the influence of: (1) the steric and electronic properties of the nucleophile, in isolation 
and in competition, (2) the tether length, and (3) the presence of other Lewis basic functional 
groups for the sulfenoetherification of alkenes with phenolic hydroxyl groups as nucleophiles.  
To achieve this goal, a study for the synthesis of 2-cinnamylphenols was undertaken.   
 4.4. Results. 
 4.4.1. Synthesis of 2-Cinnamylphenols. The direct electrophilic alkylation of phenols is a 
longstanding method of phenol functionalization.
105
 Cinnamyl chloride is a well-known, 
commonly available and reactive alkylating agent.
106
 Thus, the alkylation of phenols or 
phenolates with cinnamyl chloride promised expedient access to a variety of 2-cinnamylphenols. 
 Phenols are ambident nucleophiles, and the alkylation of phenols is non-trivial due to the 
numerous products that can be formed (Scheme 42).
107
 The alkylation can take place at the 
phenol oxygen, termed O-alkylation, at the ortho-position, or at the para-position. Furthermore, 
an ambident electrophile such as cinnamyl chloride  can react in either SN2 or SN2' fashion to 
afford two different sets of products.  
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Scheme 42 
 The O-alkylation of cinnamyl chloride results in the formation of an aryl allyl ether, 
which further complicates the situration (Scheme 43). Aryl allyl ethers can undergo [3,3]-
sigmatropic rearrangements at elevated temperature.
108
 This has the effect of turning an O-
alkylation product 109 into C-alkylation intermediate 110. The course of the [3,3]-sigmatropic 
rearrangement also depends on how quickly the substrate can rearomatize. If rearomatization is 
slow, the immediate product can undergo a Cope rearrangement, effectively changing the 
position of C-alkylation.
108
 Thus, even if the initial alkylation is selective, interconversion of the 
products is possible under some conditions.  
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Scheme 43 
 Clearly, the alkylation of phenols is dependent on a large number of variables. In a lone 
study, the alkylation of phenol with prenyl chloride was followed by gas chromatographic 
analysis (Scheme 44).
109
 The sterically hindered nature of prenyl chloride enforces high SN2 
selectivity in this transformation. Under the reaction conditions, the alkylation afforded primarily 
112 and 113. The product distribution was highly solvent dependent, and increasing solvent 
polarity led to higher quantities of O-alkylation product. Notably, the solely para-alkylation 
product was not detected in the reaction mixture, which suggested that at least the para-
alkylation pathway would be disfavored. Reaction conditions for the alkylation of phenols were 
investigated based on this initial report. 
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Scheme 44 
 The alkylation of phenol in THF using metallic sodium as the base resulted in the 
formation of three major identifiable components (Table 14). Alkenes 114 and 115 were 
inseparable from each other under standard purification techniques, and hence the yields 
provided are for the mixture of materials. In the case of THF, a total yield of 12% was obtained, 
and significant quantities of O-alkylation product 116 was observed (entry 1). The reaction 
proceeded with greater selectivity in diethyl ether, and afforded the 114 and 115 in 65% 
combined yield (entry 2). In an effort to increase the site selectivity of the alkylation 
dichloromethane was employed as a reaction solvent. While the selectivity was still high, the 
yield suffered. Lithium was not compatible with the reaction conditions (entries 3 and 4). 
Metallic potassium resulted in a lower ratio (2:1) of 114:115 (entry 5).  The dissolution of the 
metallic reagent to form the active alkoxide was visually slow, and therefore sodium hydride was 
employed as the base. This change resulted in almost immediate deprotonation as evidenced by 
both gas evolution and an exothermic reaction. Alkylation under these conditions resulted in an 
improved 7:1 ratio of 114:115, and also restored the high yield observed for the reaction in ether 
(entry 6). Further optimization of solvents identified both CCl4 and the more environmentally 
friendly benzene as appropriate reaction solvents, with 114:115 ratio of >9:1 and 68 and 74% 
yield respectively (entries 7 and 8). The development of a direct C-alkylation of phenols thus 
opened the route to an expedient synthesis of 2-cinnamylphenols. 
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Table 14. Optimization of C-alkylation of Phenols. 
 
entry solvent base temp, 
o
C 
ratio
a
 
114:115:116 
yield of 
114+115, %
b
 
1 THF Na rt 1: trace : 2.5 12 
2 Et2O Na rt 4.5 : 1 : 0.3 65 
3 CH2Cl2 Na rt 4 : 1 :0 37 
4 CH2Cl2 Li rt Complex 
mixture 
0 
5 CH2Cl2 K rt 2 : 1 : 0.4 29 
6 CH2Cl2 NaH 40 
o
C 7 : 1 : trace 66 
7 CCl4 NaH 80 
o
C 9.5:1:0.4 68 
8 Benzene NaH 80 
o
C 9 : 1 : 1.5 74 
 
a
Determined by 
1
H NMR spectroscopy of crude reaction mixture 
b
 Isolated yield. 
 The generality of the cinnamylation reaction was then tested by subjection of a number of  
2- and 4- substituted phenols to the optimized conditions. The reaction of phenol with cinnamyl 
chloride under the optimized conditions produced 114 in 71% yield (Table 15, entry 1). Both 2- 
and 4-methyl-substituted phenols could be alkylated under the same conditions in 47% and 62% 
yield respectively (entries 2 and 3). Cinnamylation of 4-hydroxy anisole afforded 114d in 49% 
yield (entry 4). Modestly electron-poor phenols such as 116e, 116f and 116g were also reactive 
under these conditions, albeit with somewhat extended reaction times (entries 5, 6 and 7). The 
highly electron poor 4-CF3-substituted 116h required refluxing toluene to proceed (entry 8). 2-
naphthol was alkylated at the 1-position selectively in 79% yield (entry 10). The reaction was not 
limited to cinnamyl chlorides: phenethyl allyl chloride also reacted with phenol to afford 114i in 
51% yield (entry 9). Isoprenyl chloride could also be used in a similar fashion to afford the 
desired trisubsituted alkene with 65% yield (entry 11).
110
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Table 15. Alkylation of Substituted Phenols with Cinnamyl Chloride. 
 
entry phenol R
1
 R
2
 R
3
 time, h product yield, %
a
 
1 116a H H Ph 16 114 71% 
2 116b Me H Ph 16 114b 47% 
3 116c H Me Ph 16 114c 62% 
4 116d OMe H Ph 16 114d 49% 
5 116e F H Ph 24 114e 71% 
6 116f Cl H Ph 24 114f 60% 
7 116g Br H Ph 24 114g 56% 
8 116h CF3 H Ph 24
c
 114h 64% 
9 116i H H CH2CH2Ph 16 114i 51% 
10 116j 
 
Ph 16 
 
114j 
79% 
11 116k H H -
b
 20  
114k 
65% 
a
Isolated yield of pure 114.
 b
Prenyl chloride was used as the electrophile. 
c
Toluene was used as 
the reaction solvent 
 4.4.2. Synthesis of other 2-Substituted Phenols. The extension of the C-alkylation method 
to heterocycles would involve the synthesis of 1-heterocyclic allyl chlorides. These substrates 
were both difficult to synthesize, as the corresponding alcohols could not be converted into the 
chloride easily, and prone to decomposition and polymer formation.
111
 Therefore an alternative 
synthesis was devised. The reduction of easily synthesized 2-carbonoylchalcones by sodium 
borohydride results in the complete reduction of the ketone to the methylene (Scheme 45).
101b,112
 
Importantly, this route avoids exposure of 119a and 119b to acidic reaction conditions, thereby 
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minimizing the opportunity for decomposition. Chalcones 118a and 118b were accessed in one 
step from 2-hydroxy acetophenone. Formation of the phenol carbonate and subsequent reduction 
with sodium borohydride afforded 119a and 119b in 66 and 48% yield respectively.  
 
Scheme 45 
 In previous communications, the sulfenofunctionalization reaction has shown significant 
changes in both stereo- and site selectivity based on the geometry of the alkene in question as 
well as the distance between the alkene and the nucleophile (Chapter 2). Therefore, efforts were 
directed at accessing substrates which could help elucidate these effects with respect to the 
functionalization with phenolic nucleophiles. The synthesis of geometrically pure (E)-alkenes 
necessary for these reactions was surprisingly difficult. To solve this problem, a number of 
approaches were considered (Scheme 46). These are (a) Wittig and Schlosser-Wittig reactions, 
(b) the stereospecific elimination from diastereopure alkyldiphenylphosphine oxides, i.e. Horner-
Wittig, (c) the SN2 and SN2' displacement of allyl and benzyl halides with organometallic 
reagents, (d) an intermolecular cross-coupling of alkenyl and aryl halides and (e) olefin 
metathesis of a terminal alkene and a styrene.  
  
Scheme 46 
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.  4.4.2.1. Wittig and Schlosser-Wittig Reactions.
113
 The first attempt to form the (E)-alkene 
junction employed benzyltriphenylphosphonium bromide and 2-hydroxy-(4H)-dihydrochroman 
as the reaction partners. With a Na-counterion the E:Z selectivity was about 6:1. Therefore, the 
Schlosser modification was tested as an alternative approach. In this case, PhLi was used as the 
base to equilibriate the intermediate betaine before the final elimination. Unfortunately, under the 
best conditions tested with the Schlosser modification, the selectivity did not exceed 4:1. 
 
Scheme 47 
 4.4.2.2. Horner-Wittig Reaction.
114
 The disappointing failure of the direct Wittig 
methodology suggested that the intrinsic E:Z selectivity for this substrate may not be great. 
Therefore, an alternative approach that utilizes the Horner method was generated. The α-oxo 
diphenylphosphines 123 are isolable intermediates, and separation of the diastereomers would 
lead to diastereopure 123. The elimination from α-oxo diphenylphosphines is stereospecifically 
syn and therefore 120 should be produced as the geometrically pure (E)-isomer. The percursor 
synthesis began with the nucleophilic attack of benzyldiphenylphosphine anion onto 
dihydrocoumarin. The resulting ketone was reduced with NaBH4  in 9:1 selectivity favoring the 
desired trans-isomer. However, the final elimination proved problematic. Although only (E)-120 
was visible by 
1
H NMR spectroscopy, the reaction proved to be very irreproducible, with 
mixtures of starting material, low amounts of alkene and other unidentified products. Although a 
few conditions were tested, this route, too did not ultimately prove successful.  
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Scheme 48 
 4.4.2.3. Organometallic Reagents.
115
 The problems encountered setting the (E)-alkene 
geometry led to the investigation of alternative approaches that would take advantage of 
preformed geometrically pure alkenes. The C-C bond disconnect along the alkene tether led to 
the consideration of SN2-type reactions on activated centers. Thus, either the combination of an 
allyl organometal with a benzyl halide or of a benzyl organometal with an allyl halide would 
both lead to the desired product. Thus, a wideranging investigation into the possible conditions 
for such a coupling was performed.   
 
Scheme 49 
 The Wurtz-type coupling and homocoupling of activated organometallic reagents was an 
expected side reaction.
116
 Unfortunately, in most of the conditions tested, homocoupling to 125 
was observed. Primarily, the initial formation of organometallic reagents proved problematic as 
the organometallic species generated immediately reacted with the remaining reagent leading to 
homocoupling. Thus, no clean generation of cinnamyl organometallic reagents was possible. The 
homocoupling was problematic even when the conjugation was interrupted by replacement of the 
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aryl moiety with a phenethyl moiety. The generation of benzyl organometallic species was 
similarly problematic with predominantly bibenzyl derivative 124 observed as the primary 
constituent of reaction mixtures. Conditions that employed organometallic reagents with lower 
reactivities such as In
117
 and Zn
118
 also did not lead to successful couplings.    
 4.4.2.4. Synthesis of Vinyl Halogens. The cross coupling of various alkenyl halides and 
with aryl boronates
119
 or aryl silicon reagents
120
 is well developed. Therefore, vinyl halides of 
type 128 were targeted. Treatment of 126 with the Ohira-Bestmann reagent
121
 led to the 
formation of alkyne 127. However, Al-H reduction of the alkyne followed by I2 quench primarily 
afforded the terminal alkene. The Takai reaction
122
 of protected aldehyde 129 was also 
unsuccessful. Further optimization of this route was not attempted based on the success obtained 
in the cross-metathesis reaction. 
 
Scheme 50 
 4.4.2.5. Alkene Metathesis. Olefin metathesis reactions that employ Grubbs-I and 
Grubbs-II type catalysts generally proceed with high (E)-selectivity.
123
 Thus, metathesis of a 
styrene with a terminal olefin was seen as a possible answer to the problem of E:Z selectivity. 
The requisite terminal alkenes 131 were prepared from 2-methoxybenzyl bromide by displacing 
the bromide with a preformed Grignard reagent (Scheme 51).
124
 Deprotection with sodium 
ethanethiolate in refluxing DMF produced terminal alkenes 131a and 131b in 89 and 68% yield 
over two steps.
19f
 
 
Scheme 51 
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 The use of Hoveyda-Grubbs II catalyst 135 for the metathesis of alkenes 131 was 
unsuccessful. No reaction was observed at low temperature. When the temperature was raised to 
reflux, homocoupling product 136 was observed. The Grubbs-I-indenylidene type catalyst 134 
was much more successful at catalyzing the reaction. Metathesis of 130a and 131a with excess 
styrene was found to deliver protected styrenes with  high geometrical selectivity.
125
 Usually, 
addition of a second portion of catalyst was necessary for high conversion. Protection of the 
phenol as the methyl ether led to slightly higher yields in the reaction. Subsequent demethylation 
under identical conditions resulted in the formation of 120 and 120b in high yield.  
Table 16. Grubbs Metathesis of Butenyl- and Pentenylphenols. 
 
entry R n cat. styrene temp, 
o
C time, h yield, %
a
 
1 H 1 135 1.2 rt 24 0 
2 H 1 135 1.2 reflux 6 n.d. 
3 H 1 134 5 rt 36 62% 
4 Me 1 134 5 rt 36 69% 
5 H 2 134 5 rt 36 42% 
a
Isolated yield.  
 The (E)-selectivity of the olefin metathesis reaction does not extend to isolated alkenes 
under cross-metathesis conditions.
123
 Therefore a new route was devised to access substrates 
with a two-methylene tether but with alkyl substituents. The Pd-mediated opening of 2-
vinylchroman by malonate nucleophiles mediated by palladium had been studied by Murahashi 
in 1986.
126
 Under similar conditions, diethylmalonate intermediate 137 could be accessed rapidly 
(Scheme 52).  The decarboxylation of the malonate was effected using Krapcho conditions.
127
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NaCl was sufficient to decarboxylate the diester, but the high temperatures and long reaction 
times necessary led to uncharacterized polymerization products were observed by 
1
H NMR 
spectroscopy. Instead, use of NaCN resulted in rapid decarboxylation at only 160 
o
C, with a 
minimal amount of side products.
128
 Under the optimized conditions, the desired ester substrate 
could be obtained in 85% yield.  
 
Scheme 52 
 Ester 138 then served as a linchpin for diversification to study the effects of Lewis basic 
groups on the reaction. Hydrolysis yielded 139 in 93% yield, and reduction of the ester afforded 
140 in 91% yield (Scheme 53). Ether 141 was synthesized from the corresponding bromoarene. 
 
Scheme 53 
 4.4.3. Optimization of the Phenoxysulfenylation Reaction.  The use of a phenolic 
hydroxyl group as the nucleophile afforded a unique opportunity to systematically vary both the 
steric and the electronic properties of the nucleophile. The reaction temperature was chosen as    
-20 
o
C to avoid any potential enantioerosion of the thiiranium ion.
63
 Previous studies suggested 
that only 1.0 equiv of 56 was necessary for the reaction.
20
 The initial-rate experiments revealed 
that an excess amount of acid was detrimental to the reaction rate, thus 0.75 equiv was chosen as 
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the starting point for optimization. Solvent and concentration were unchanged from the previous 
conditions for sulfenoetherification reactions. For catalysts of type 62, exocyclic amine 
substituent strongly affects the enantioselectivity of the sulfenofunctionalization process. Thus, 
catalyst 62b afforded the desired product with poor selectivity (Table 17, entry 1). Catalyst 62e 
formed product 143a in 46% yield and with an e.r. of 95.1:4.9 (entry 2). Changing to catalyst 
62d resulted in slightly lower enantioselectivity of 93.1:6.9 e.r (entry 3). Reducing the 
concentration of the reaction using catalyst 62e allowed the product to be obtained in 95% yield 
(entry 4).  
Table 17. Optimization of the Sulfenocyclization Reaction.
a
 
 
entry substrate [3], M acid, equiv catalyst time, h  yield, %
b
 e.r.
c
 
1 142a 0.4 0.75 62b 24 35
d
 65.6:34.4 
2 142a 0.4 0.75 62e 24 46
e
 95.1:4.9 
3 142a 0.4 0.75 62d 24 27
f
 93.1:6.9 
4 142a 0.15 0.75 62e 24 95 -
i
 
5 142a 0.15 0.5 62e 24 95 95.3:4.7 
6 142a 0.15 0.25 62e 24 94 95.7:4.3 
7 142a 0.15 0.1 62e 24
h
 32 94.9:5.1 
8 142a 0.15  0.5
g
 62e 24 96 94.3:5.7 
a 
Reactions run on 0.1 mmol scale. 
b 
Yield of isolated, purified product. 
c 
Determined by 
CSP-SFC. 
d 
Also isolated product contaminated with 2a. 
e 
Also isolated product 
contaminated with 2b.
 f 
Also isolated product contaminated with 2c.
 g 
EtSO3H was used.
 h 
Incomplete conversion. 
i
 Not determined. 
 In all preceding sulfenofunctionalization studies, the loading of the Brønsted acid proved 
to greatly affect the rate and selectivity of the reaction.
18,20
 In the sulfenoetherification with 
alcohols, maximum reactivity was reached at 0.6 equiv of methanesulfonic acid. Cyclization of 
substrate 114 (hereforth referred to as 142a) using 0.75 equiv of acid was complete within 24 h. 
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Decreasing the amount of acid to 0.5 equiv or even 0.25 equiv did not decrease the yield in the 
same time frame (entries 5 and 6). In all cases, high selectivity (>30:1) for endo capture to form 
the chroman was observed. Further decrease in the acid loading resulted in reduced yield (entry 
7). The use of ethanesulfonic acid did not affect the enantioselectivity and was not pursued 
further (entry 8). 
 4.4.4. Sulfenocyclizations of Substituted (E)-2-Cinnamylphenols: Influence of Phenol 
Ring Substituents. The nucleophilicity of phenolic hydroxyl groups is influenced by both steric 
and electronic properties of ring substituents.
129
 Accordingly, a series of substituted (E)-2-
cinnamylphenols was prepared and evaluated (Table 2). The parent substrate, 142a, which 
afforded 143a in 84% yield, 94.9:5.1 e.r. and >30:1 endo-selectivity was used as a benchmark 
(Table 2, entry 1). Methyl substituents at the 4- and 6- positions on the ring did not alter the 
reaction outcome meaningfully (entries 2 and 3). The presence of an extended π-system resulted 
in no change in yield and a very small decrease in e.r. (entry 4). In all cases high (>30:1) 
consitutional selectivity was observed.  
 Next, the influence of heteroatom substituents on reaction outcome was evaluated. 
Electron-donating groups had little influence, for example 142e bearing a 4-methoxy group 
cyclized to form 143e in 84% yield and 94.4:5.6 selectivity (entry 5). Bromophenol 142f 
cyclized to afford 143f in 81% yield and 93.8:6.2 e.r (entry 6), albeit with slightly extended 
reaction time. The more electronegative chloro- and fluoro-substituted substrates reacted in the 
same time frame, 143g and 143h being produced in 70 and 82% yields respectively (entries 7 
and 8). The enantioselectivity of the reactions remained high with these substrates.  
 Phenol 142i, bearing a highly electron-withdrawing 4-CF3 group, was insufficiently 
reactive at -20 
o
C. When the reaction temperature was increased to 22 
o
C, significant 
enantioerosion was observed (e.r. 70.7:29.3, SI). Sterically bulky N-2,6-
diisopropylphenylthiophthalimide electrophile 103 prevents erosion at elevated reaction 
temperatures by shielding the intermediate thiiranium ion.
40
 Cyclization of 142i at room 
temperature using 103 proceeded smoothly, and 143i was isolated with 89% yield and 95.2:4.8 
e.r (entry 9). 
  
91 
 
 
Table 18. Sulfenocyclizations of Substituted (E)-2-Cinnamylphenols.
a
 
 
entry phenol  time, h product  yield, %
b
 e.r.
c
 
1 
 
3a 24 
 
4a 84 94.9:5.1 
2 
 
3b 24 
 
4b 82 95.0:5.0 
3 
 
3c 24 
 
4c 78 96.0:4.0 
4 
 
3d 24 
 
4d 79 93.2:6.8 
5 
 
3e 24 
 
4e 84 94.4:5.6 
6 
 
3f 36 
 
4f 81 93.8:6.2 
7 
 
3g 36 
 
4g 70 93.8:6.2 
8 
 
3h 36 
 
4h 86 93.2:6.8 
9 
 
3i 12
d,e
 
 
4i 89 95.2:4.8
f
 
a 
Reactions run on 1.0 mmol scale. 
b 
Yield of isolated, purified product. 
c
 Determined by 
CSP-SFC. 
d 
Electrophile 1c was used, Ar
iPr
 = 2,6-(i-Pr)-C6H3 
e
 Reaction run at 22 
o
C 
f 
Determined after oxidation to the sulfone. 
 4.4.5. Sulfenocyclization of 2-Substituted Phenols. Changes in the alkene substitution 
pattern have been documented to dramatically alter selectivity for the sulfenofunctionalization 
process.
18,20,79,83
 (E)-substituted alkenes were the most selective substrates for 
sulfenoetherification, whereas terminal alkenes were only slightly less so. Trisubstituted, (Z)- 
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and 1,1-substituted alkenes reacted with poor selectivity. Thus, primarily (E)- and terminal 
alkenes were employed in this study. Initially, the (E)-phenyl substituent was varied. Furan-
substituted benzopyran 143j was produced in 88% yield and 92.7:7.5 e.r, whereas thiophene-
substituted substrate 142k produced the desired product in 86% yield and 93.9:6.1 e.r.(Table 3, 
entries 1 and 2). Changing the alkene substituent to an aliphatic group as in substrate 142l led to 
a 74% combined yield of a 1.5:1.0 mixture of isomers 143l and 144l with 96.6:3.4 e.r. for 143l  
(entry 3). Trisubstituted alkenes generally lead to less selective cyclizations with 56.
83
 To 
increase selectivity, electrophile 103, which has an improved selectivity profile, was tested with 
substrate 142m.
40
 In this case, use of 103 led to the formation of gem-disubstituted benzopyran 
143m in 93% yield and 95.4:4.6 e.r. (entry 4). 
Table 19. Sulfenocyclizations of 2-Substituted Phenols.
a
 
 
entry  substrate 
sulf. 
agent 
time
h 
temp 
o
C 
product
c
  
yield 
%
b
 
endo: 
exo
d
 
e.r.
e
 
1
f
 142j 
 
56 24 -20 
 
143j 88 >30:1 92.5:7.5 
2
f
 142k 
 
56 24 -20 
 
143k 86 >30:1 93.9:6.1 
3
f
 142l 
 
56 24 -20 
 
143l, 
144l 
74 1.5:1 
96.6:3.4 
(143l) 
96.3:3.7 
(144l) 
93 
 
4
f
 142m 
 
103 24 0 
 
143m 93 >30:1 95.4:4.6
g
 
5 142n 
 
56 18 -20 
 
143n 92 >30:1 94.4:5.6 
6 142o 
 
103 24 0 
 
144o 76 <1:30 92.6:7.4
g
 
7 142p 
 
103 12 0 
 
144p 91 <1:30 97.2:2.8
g
 
8 142q 
 
103 48 0 
 
144q 84 <1:30 97.7:2.3
g
 
9 142r 
 
56 24 -20 
 
144r 80 1:12 93.2:6.8 
10 142s 
 
56 24 -20 
 
144s 85 <1:30 96.7:3.3 
11 145t 
 
56 24 -20 
 
147t 92 <1:30 92.2:7.8 
12 146u 
 
56 24 -20 
 
147u, 
148u 
88 1.1:1
h
 
96.9:3.1 
(8u) 
97.1:2.9 
(9u) 
a 
Reactions run on 1.0 mmol scale. 
b 
Yield of isolated product. 
c
Ar
iPr
 = 2,6-(i-Pr)-C6H3. 
d
 Determined by 
1
H NMR analysis of crude reaction mixtures. 
e 
Determined by CSP-SFC. 
f 
0.25 equiv MsOH was used. 
g
 Determined after oxidation to the sulfone. 
h 
endo:exo ratio for alcohol capture. 
 The site-selectivity of thiiranium ion capture during intramolecular sulfenocyclization is 
expected to be strongly influenced by the relative rates of formation of different size rings. The 
preparation of substrates with varying tether length enabled for a systematic study of ring size 
  Table 19. (cont.) 
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effects (Table 3). Substrate 142n, which contains an (E)-2-styryl group at the end of a two 
carbon tether, afforded the 7-endo cyclization product benzoxepane 143n in 92% yield and 
94.4:5.6 e.r (entry 5). Further extending the tether to three methylene groups in substrate 142o 
proved problematic: under the optimized conditions using electrophile 56, no desired product 
was observed. Gratifyingly, use of electrophile 103 led to the surprising formation of exo 
cyclization product 144 in 76% yield and 92.6:7.4 e.r (entry 6). Next, the electronic bias 
imparted by the phenyl group was removed to evaluate the site-selectivity of closure with a 
terminal alkene in the reaction with electrophile 103. Substrate 142p reacted via a 6-exo-mode 
cyclization to afford 144p with high site-selectivity, 91% yield and 97.2:2.8 e.r (entry 7). 
Extension of the tether length by one more methylene group, as in substrate 142q, was 
gratifyingly successful, as the cyclization proceeded in a 7-exo mode to afford product 144q, 
with 84% yield and 97.7:2.3 e.r (entry 8).  
 The Lewis basic nature of the selenophosphoramide moiety prompted an investigation 
into the compatibility of the reaction conditions with other Lewis basic functional groups in the  
substrate. Substrate 142r, containing a carboxylic ester group three carbons removed from the 
reacting olefin, afforded 144r in good yield albeit with somewhat diminished enantioselectivity 
compared to 142a (c.f. entry 9 and Table 2, entry 1). Replacement of the ester by the 
corresponding ether in 142s restored the enantioselectivity in comparable yield (entry 10). The 
relative reactivity of other oxygen nucleophiles with respect to phenolic hydroxyl groups was 
also tested. Both carboxylic acids and alcohols outcompeted phenols for thiiranium ion capture. 
Substrate 142t, bearing a carboxylic acid moiety, preferentially afforded lactone 147t in 92% 
yield and 92.2:7.8 e.r. (entry 11). In the presence of a remote hydroxyl group, such as in 
substrate 142u, saturated oxacycles 147u and 148u were formed as a 1.1:1 mixture of 
constitutional isomers in 88% combined yield and with 96.9:3.1 e.r. (entry 12). 
 4.4.6. Intermolecular Sulfenylation of Alkenes with Phenols. The intermolecular 
sulfenofunctionalization of alkenes with phenols would greatly extend the potential applications 
of the reaction. Thus, the functionalization of representative alkenes with phenols were tested.  
The cyclization of 4-octene with phenol under the standard reaction conditions afforded 149 in 
75% yield and 93:7e.r. However, when β-methylstyrene  was tested, both the yield and the 
enantioselectivity for 150 were much lower (44% and 86:14). High site selectivity for capture at 
95 
 
the benzylic position was observed. Stilbene was completely unreactive under the standard 
conditions, even at elevated temperature. 
Table 20. Intermolecular Sulfenofunctionalization with Phenol Nucleophiles. 
 
entry R,R product time, h temp, 
o
C yield
a
 
site 
selectivity
b
 
e.r.
c
 
1 n-Pr,n-Pr 
 
24 -20 75 N/A 93:7 
2 Ph, Me 
 
48 -20 44 <1:30 86:14 
3 Ph,Ph - 48 23 0 - - 
a
Isolated yield. 
b
Determined by 
1
H NMR analysis of crude mixture. 
c
Determined by CSP-SFC. 
 4.4.7. Transformations of Sulfenofunctionalization Products. The sulfenyl moiety in the 
product thioether can act as a functional handle for further transformations. Thus, a series of 
manipulations to explore the reactivity of the thioether group were carried out (Scheme 54). 
Reductive cleavage of 143a with nickel boride formed 2-phenylchroman in 35% yield. Oxidation 
of 143a with sodium metaperiodate led to sulfoxide 151 in 85% yield and in a 2:1 diastereomer 
ratio. Both diastereomers underwent thermal elimination in toluene, leading to the formation of 
2-phenylchromene in 92% yield. Attempts to engage the sulfoxide in a Pummerer process was 
not successful. Instead, vinyl thioether 152, which results from elimination of the thiocarbenium 
intermediate, was formed under a variety of conditions (see experimental section). In the 
presence of trifluoroacetic anhydride and pyridine, 152 was obtained in 94% yield.  
96 
 
 
Scheme 54 
 Conversion of sulfoxide 151 to ketone 153 under other Pummerer conditions were 
attempted. Representative examples of conditions are shown in (Table 21). Treatment of the 
sulfoxide with acetic anhydride in the presence and absence of acetate led to the exclusive 
formation of chromene 154. Interestingly, other dehydrating agents such as thionyl and oxalyl 
chlorides resulted in the formation of the sulfide, formally oxidizing the reagent. The addition of 
both soluble and insoluble bases did not lead to product formation. Other activating agents such 
as PIDA and TBSOTf were also ineffective at promoting the Pummerer rearrangement.  
Table 21. Survey of Pummerer Rearrangement Conditions for 151. 
 
entry solvent reagent base temp, 
o
C time, h 153:154:152:143a
a
 
1 Ac2O - - 110 2 0:1:0:0 
2 Ac2O AcOH - 110 2 0:1:0:0 
3 CH2Cl2 SOCl2 - rt 1 0:0:1:7.5 
4 CH2Cl2 (COCl)2 - rt 1 0:0:1:1 
5 CH2Cl2 (COCl)2 K2CO3 rt 2 0:0:1:3.5 
6 CH2Cl2 (COCl)2 KOAc rt 2 0:0:1:4.8 
7 CH2Cl2 (COCl)2 Pyr rt 2 0:0:1.25:1 
8 DCE PIDA - rt 12 No Reaction 
9 CH2Cl2 TBSOTf Et3N rt 3 0:0:1:0 
a 
Determined by 
1
H NMR spectroscopy of crude reaction mixture. 
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 4.5. Discussion. 
 The synthesis and reactivity of phenolic substrates was unexpectedly difficult. Phenols 
with one and two-carbon methylene tethers each had unique challenges associated with their 
synthesis. In the first section of the discussion some of the challenges related to geometrical and 
constitutional purity will be discussed. 
 4.5.1. Optimization of the Phenol Alkylation Process.  The selectivity of phenolate 
alkylation is affected by both reaction solvent and counterion. Therefore, these variables will be 
treated sequentially. Alkylation of sodium phenolate was slightly more selective for 114 than 
with potassium phenolate. Lithium phenolates reacted slower than their sodium counterparts. 
Interestingly, the use of potassium in polar media with allyl chloride results in clean ether 
formation.
130
 In contrast, sodium phenolates were more problematic substrates for the reaction 
with an allyl halide.  Calculation of charge densities for phenol and its alkali metal salts at the 
B3LYP level shows that the partial negative charge at C(2) increases monotonically moving 
down the group (Scheme 55). Greater O-alkylation over ether formation would be expected as a 
consequence, in contrast to the observed trend. However, these calculations were performed in 
the gas phase. The aggregation of phenols in nonpolar media may alter the relative reactivities of 
these enolates. The strongly coodinating nature of Li-ate complexes in nonpolar media probably 
attenuates the reactivity of the phenolate anion. Furthermore, coordination of the oxygen can 
both sterically encumber and electronically deactivate it, favoring C- over O-alkylation. 
  
 
Scheme 55 
 Indeed, changes in the solvent had a great effect on the site of alkylation. Thus, whereas 
high selectivity for 114 was observed in ether, the reaction in THF afforided primarily the 
undesired isomer 115. These results were in agreement with previous results for ethereal 
solvents.
109
 Thus, the alkylation was performed in highly nonpolar solvents. Under these 
conditions the reaction is usually heterogenous, as the phenoxide ion can crash out of solution. 
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NaH was significantly more effective at deprotonating the phenol. Deposition of phenolate on 
the metal surface can retard the further formation of anions in dissolving metal deprotonations. 
Alkali metals can also undergo SET reactions with chlorinated and aromatic solvents. The clean 
reactivity profile of NaH led to it being the best choice for this reaction.     
 The alkylation of phenols under these conditions resulted in the formation of two major 
isomers.  High selectivity for the desired isomer 114 was observed, the SN2' alkylation product 
was difficult to remove from the reaction mixture. Although a number of conditions were tested, 
its production could not be fully suppressed. The relative ratio of 114/115 appears to be better in 
highly nonpolar solvents. The SN2' alkylation of cinnamyl chloride would require the phenolate 
to approach a secondary methine as opposed to a primary methylene for SN2 alkylation. Thus, 
the formation of aggregates may actually be beneficial. Increased nucleophile size as a 
consequence of aggregation would then favor attack at the less hindered position of cinnamyl 
chloride. Unfortunately, even under the optimized conditions, the production of isomer 115 
could not be fully suppressed. The separation of 114 and 115 was not possible on silica. Thus, 
new purification techniques needed to be developed. Unfortunately, the sacrificial reaction with 
K2OsO4/NMO, which had previously been successfully employed in these laboratories did not 
fully remove the minor isomer.
131
 Finally, AgNO3 on SiO2 (10% w/w) was found to separate the 
two isomers. The operational overhead on the direct alkylation of phenols proved to be 
considerable.  
  4.5.2. Synthesis of 2-Substituted Phenols. The synthesis of phenols with more than one 
methylene linker was successful only after numerous different attempts. The initial failure of 2
nd
 
generation Hoveyda-Grubbs led fruitless efforts at either geometrically constructing the (E)-
alkene in a geometrically pure manner or disconnecting somewhere else in the tether. After much 
effort, the efforts came full circle, and the alkene could be constructed in >50:1 E/Z selectivity 
using 1
st
 generation Grubbs catalyst 134  
 The success of 134  over 135 is comment worthy. NHC ligands are known to decrease 
the reactivity of the Ru center, while substantially increasing catalyst stability. In the current 
system, no reactivity was observed with 130 at room temperature. If the Ru center is 
insufficiently reactive, the initial [2+2] addition to form the [Ru(substrate)] complex can not take 
place. As a result, starting material is recovered. The selectivity of the two catalysts was also 
different. Whereas 135 gave a mixture of homo- and heterocoupling products, 134 afforded 
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primarily the heterocoupling product. The reactivity of terminal alkenes in cross-metathesis 
reactions is greater than styrenes, therefore an initial addition to form the homocoupling product 
is plausible. However, the carbene complex derived from 134 can add back into the dimer 136 to 
reform starting material and the [Ru(substrate)] complex. The mixture observed for 135 suggests 
that the carbene derived from 135 can either not add back into the internal alkene or that this 
addition is much slower than the initial rate of reaction with the terminal alkene in solution. 
Either way, catalyst 134 was much better suited to the reaction. However, the low stability of 
134 required two portions of catalyst to be added over the timeframe of the reaction. Since the 
overall total catalyst loading is still 3-4 mol %, this was not particularly problematic. The effect 
of the hydroxyl group was not prominent.  
 The low selectivity of intermolecular metathesis reactions is a result of the low energy 
difference between alkyl substituted (E)- and (Z)-alkenes. In light of the difficulties encountered 
with the aforementioned methods of making geometrically pure (E)-alkenes, a different approach 
was tested. The palladium catalyzed opening of 2-vinylchroman proceeded with very high (E)-
selectivity. The original proposal for the selectivity is the preference for the Pd-allyl complex 
that forms upon opening of vinyl chroman to adopt a preferentially trans configuration. 
Subsequent displacement of the Pd-allyl complex by malonate preserves the high (E)-selectivity 
on account of an outer-shell SE2-type transition state that is formally related to the Tsuji-Trost 
process.
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 4.5.3.  Optimization of the Phenoxysulfenylation Reaction. The systematic variation of 
reaction conditions, phenol substituents, tether length and functional groups enabled a more 
thorough understanding of the factors governing the sulfenofunctionalization process. In this 
section, the influences of each of these components on observable reaction outcomes such as 
rate, enantioselectivity and site-selectivity will be discussed in turn. 
 4.5.3.1. Catalyst. The optimization of the sulfenofunctionalization reaction focused on 
two main variables, the catalyst and the loading of the Brønsted acid. Of the three best catalysts 
for sulfenofunctionalization, optimum selectivity was achieved with 62e. The high selectivity for 
this catalyst can be traced to the increased steric encumbrance provided by the N,N-diisopropyl 
substituents, accentuating the degree to which the catalyst backbone must distort to 
accommodate the alkene.
40
 Conversion across all catalysts was comparable.  
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 4.5.3.2. Brønsted Acid.  The kinetic studies established that for an alcohol nucleophile, 
the υmax was reached with 0.6 equiv of methanesulfonic acid (MsOH).
40
 Further increases in the 
Brønsted acid loading led to decreases in reaction rate. Two major factors need to be considered 
for optimal MsOH loading: (1) the amount of acid necessary to fully transform the catalyst into 
active complex 95, (2) the effective acidity of the reaction mixture as a result of solvation effects 
in nonpolar reaction media. In the proposed mechanistic cycle, the acid is present only in 
cocatalytic amounts, therefore only 1.0 equiv of acid with respect to catalyst should be 
necessary. However, titration studies with ethanesulfonic acid together with 56 and 62d 
established that up to 4 equiv of acid are needed before full conversion to the sulfenylated 
species is observed.
87
 In the case of cyclizations of phenolic hydroxyl groups, high conversion 
could be achieved with as little as 2.5 equiv of MsOH with respect to catalyst. Small differences 
in the pKa values of MsOH and ethanesulfonic acid as well as the pKb values of 62d and 62e 
may account for the reduced acid loading necessary for good reactivity. In contrast to alcohols, 
the phenolic hydroxyl group does not appear to act as a proton buffer. 
 The cyclization of 142a was complete within 24 h at -20 
o
C, compared to 93% after 24 h 
at the same temperature for the corresponding alcohol substrate.
20
 Thus, the rate of phenol 
cyclization is comparable to that of the alcohols. In the prior set of experiments a large excess 
(10 equiv with respect to catalyst) of MsOH was employed, which led to rates slower than υmax. 
The decrease in rate at high MsOH concentrations was ascribed to protonation of the substrate by 
excess acid.
40
 In the case of phenols, no substantial changes in rate were observed as a result of 
increased acid concentration in the range of 2.5 to 7.5 equiv of MsOH with respect to catalyst. 
The substantially lower Brønsted basicity of phenols (pKa of PhOH2
+
: -6.5, pKa EtOH2
+
: -2.2)
66
 
implies that a much smaller fraction of substrate is protonated even in the presence of an excess 
of acid. Thus similar reaction rates are observed over a much broader range of acid 
stoichiometry.  
 4.5.4. Structural Effects on Rate and Selectivity. 4.5.4.1. Influence of the Nucleophile. 
The rate, enantio- and site-selectivity of sulfenofunctionalization of any alkene with a pendant 
nucleophile is dependent on a multitude of structural factors. The initial studies showed a 
substantial impact of alkene environment on all three of these observables.
20
 However, no such 
systematic investigation for the nucleophile was undertaken. In an isolated example, the 
cyclization of a tertiary alcohol was comparable with that of a primary alcohol (Scheme 56, c.f. 
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Table 9). A previous study regarding the rate of sulfenocyclization of a number of protected 
amines did not identify specific reactivity trends.
79
 Thus, the cyclization of (E)-2-
cinnamylphenols provided an opportunity to understand how the aforementioned observables are 
impacted by the steric and electronic properties of the nucleophile. 
 
Scheme 56 
 4.5.4.2. Reaction Rate.  The turnover-limiting step of the sulfenofunctionalization 
reaction for alcohols is thiiranium ion formation, hence for these substrates thiiranium ion 
capture is fast. (Chapter 3). As mentioned previously, phenols are substantially weaker 
nucleophiles than alcohols.
66
 However, the rates of cyclization of 142a, 142b, 142c and 142e 
were comparable. Thus, the turnover-limiting step does not change for electron-neutral or -rich 
phenol nucleophiles. Naphthols are slightly stronger nucleophiles than phenols, and, in 
agreement with the aforementioned turnover-limiting thiiranium ion formation, the rate of 
cyclization of 142d was not affected.
66
  
 Introduction of weakly electron-withdrawing substituents led to slightly slower overall 
rates. The electron-withdrawing properties of substituents on phenols is a composite effect of the 
inductive (σI) and resonance (σR) contributions of the substituent to the electron density on the 
phenol.
133
 Chlorine and bromine both strongly withdraw electron density inductively (σI
 
Br, 0.49; 
Cl, 0.43) but also donate electron density through π-resonance (σR Br, -0.16; Cl, -0.16).
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Fluorine is a strongly withdrawing substituent inductively, but also a much better π-donor (σI F, 
0.57; σR F, -0.33) such that its overall effect is comparable. In contrast, a trifluoromethyl group is 
both inductively and mesomerically electron-withdrawing (σI CF3, 0.46; σR CF3, 0.09). The 
reaction of Br, Cl and F-substituted phenols (142f, 142g, 142h, respectively) were all only 
slightly slower at -20 
o
C compared to parent substrate 142a. The reaction does not appear to be 
sensitive to either of these parameters. However, for CF3-bearing substrate 142i the reaction 
needed to be performed at room temperature.  
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 The substantial difference in rate between 142a and 142i (c.f. Table 18, entries 1 and 9) 
suggests that the turnover-limiting step may change from formation to capture of the thiiranium 
ion for electronically deactivated nucleophiles. Although the lifetime of the thiiranium ion 
intermediate derived from 142i likely increases as a result of slow capture, the high chemical 
yield implies that the thiiranium ion is stable when 103 is used as the electrophile. 
 4.5.4.3. Enantioselectivity. The configurational stability of thiiranium ions at -20 
o
C in 
dichloromethane has been established.
63
 Thus, the enantiomeric composition of the thiiranium 
ion upon its genesis is retained throughout the remaining reaction steps.
40
 Notably, capture of 
thiiranium ions derived from styrenes by C, N and O-nucleophiles resulted in the same absolute 
configuration and comparable levels of product enantioenrichment (Scheme 57).
20,79,83
  
 
Scheme 57 
 For the participation of phenolic hydroxyl groups, the enantioselectivity of 
sulfenocyclization remained uniformly high for electron-rich phenols. However, the change in 
mechanism from turnover-limiting formation to turnover-limiting capture raises the possibility of 
erosion of enantioselectivity as a consequence of increased thiiranium ion lifetime and attendant 
racemization. Previous studies on the intermolecular sulfenoetherification reaction showed that 
under the optimized conditions at -20 
o
C, the configurational integrity of the thiiranium ion is 
retained.
63
 No decrease in enantioselectivity is observed for substrates bearing halogen 
substituents, confirming the overall stereochemical stability of the thiiranium ion for slightly 
extended lifetimes at -20 
o
C For the trifluoromethyl-substituted phenol, the lack of reactivity 
required that the reaction be run at 23 
o
C, leading to decreased product enantioselectivity with 
electrophile 56 (Scheme 58).  
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Scheme 58 
 To attenuate the racemization, electrophile 103, bearing a bulky 2,6-diisopropylphenyl 
group was used. The 2,6-substituents impart both slightly higher intrinsic selectivity to 103 as 
well as increased stability to the resulting thiiranium ions (Scheme 59).
40
 The use of 103 in the 
reaction of 142i resulted in a dramatic increase in selectivity, albeit not to the level observed with 
alcohol 57a (Scheme 58).
40
 Thus, configurational erosions of thiiranium ions can be ameliorated 
through increased steric shielding of the sulfur atom. 
 
Scheme 59 
 4.5.4.4. Site-selectivity. The site-selectivity for the sulfenoetherification follows the 
established Markovnikov rule.
48
 Reaction of (E)-2-cinnamylphenols can proceed through either a 
5-exo cyclization to afford a benzofuran or a 6-endo cyclization to afford a chroman. Only 
chromans were observed as reaction products in the cyclization of (E)-2-cinnamylphenols. 
Changes in the electron density or steric bulk of the nucleophile had no effect on site-selectivity. 
Opening of the thiiranium ion through a Friedel-Crafts-type process (i.e. C-aryl cyclization) was 
not observed, demonstrating that the chemoselectivity of capture is high, irrespective of arene 
electron density.
 83,95c
  
 The reversible capture observed for alcohol cyclizations prevented conclusions about the 
intrinsic site selectivity of the sulfenoetherification process. Therefore, an isomerization 
experiment with product 143d was set up. Even at elevated temperature, only a minute amount 
of isomerization was observed (Scheme 60). Thus, in the case of phenoxysulfenylation at 
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subambient temperatures and substoichiometric acid concentrations, no product isomerization is 
expected. Therefore, the observed ratios represent the kinetic site selectivity of thiiranium ion 
functionalization. 
 
Scheme 60 
 4.5.5. Influence of Alkene Environment. The alkene environment represents the most 
important variable that can influence both the rate and the selectivity of the sulfenocyclization 
process.
40
 This sensitivity has been evident in numerous sulfenofunctionalizations.
20,79,83,134 
In 
general, higher alkene electron density leads to increased reactivity. Enantioselectivity is most 
sensitive to the alkene substitution pattern, whereas site-selectivity is governed by the 
aforementioned Markovnikov selectivity, albeit complicated by the potential for isomerization of 
certain sets of constitutional isomers under the reaction conditions. 
 4.5.5.1. Rate. The rate of cyclization was expected to follow a well-defined trend of 
alkene electron density. The reaction times of substrates with disubstituted alkenes demonstrated 
that the reactivity difference between heteroaryl, aryl and alkyl substituents was not substantial 
for disubstituted alkenes (142a, 142k, 142l, 142s 24 h at -20 
o
C). However, because both mono- 
and trisubstituted alkenes required electrophile 103 for high selectivity, direct comparison of the 
rate of cyclization for terminal alkene 142p and trisubsituted alkene 142m with their respective 
analogs 142s and 142l is not possible.  
 The strongly acidic nature of the reaction conditions raised the possibility of cationic 
alkene cyclization or polymerization as a competitive side reaction, especially for substrates with 
electron-rich alkenes.
135
 For example, in the cyclization of a 4-tolyl substituted alkene 143x in 
the absence of Lewis basic functionality, a proton initiated cyclization was observed (Scheme 
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61).
87
 No evidence of acid-catalyzed polymerization or cyclization was observed for the current 
set of styrenes.  
 
Scheme 61 
 Conjugated electron-rich heteroarenes are significantly more susceptible to 
polymerization. Thus, when MsOH was added to a mixture of 142j, 62e, and 56 in 
dichloromethane at -20 
o
C, rapid polymerization was observed and no identifiable product was 
obtained. If the order of addition was changed to introduce 142j last, the desired reaction 
pathway was restored. The effective acid concentration in solution clearly has a substantial 
impact on the rate of polymerization for sensitive alkenes. Incubation of the methanesulfonic 
acid with the remaining reagents solubilizes MsOH, removing local concentrations of acid.
87
  
 4.5.5.2. Enantioselectivity. The enantiomeric composition of the final products in 
sulfenofunctionalizations is determined by the enantioenrichment of their precursor thiiranium 
ions.
20,79
 The enantioselectivity of thiiranium ion formation is, in turn, determined by the 
transition state complex consisting of alkene and intermediate 95. Computation of the energies of 
the diastereomeric transition states revealed that catalyst distortion as the most important 
contributor to the difference in transition state free energies.
40
 Thus, changes in alkene 
substitution pattern and consequently the degree of distortion that the catalyst experiences to 
accomodate the substituents, are expected to substantially impact the stereoselectivity of the 
process. Indeed, foregoing studies have demonstrated that the enantiotopic faces of (Z)- and 1,1-
disubstituted alkenes were poorly differentiated by the active sulfenylating agent derived from 
62e.
20,40
  
 The enantioselectivity of the sulfenoetherifications herein was consistent among aryl, 
heteroaryl and alkyl-substituted (E)-alkenes (143a, 94.9:5.1; 143k, 93:9:6.1; 143l, 96.6:3.4). The 
nature of the oxygen nucleophile played only a minor role as phenols, alcohols and carboxylic 
acids cyclized with comparable enantioselectivities (143a, 94.9:5.1; 147u, 96.9:3.1; 147t, 
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92.2:7.8). The high enantioselectivities observed independent of nucleophile parameters is in 
good agreement with the current hypothesis of stereodetermining thiiranium ion formation. 
 Terminal alkenes are usually difficult substrates for enantioselective alkene 
functionalizations due to absence of steric differentiation at the terminus.
136
 Lower 
enantioselectivities have been observed previously for sulfenofunctionalization with this class of 
substrates (Scheme 62).
20,83
 Therefore, more selective electrophile 103 was employed for the 
cyclization of terminal alkenes 142p and 142q. Thus, when 1c was used for the cyclization of 
142p, the enantioselectivity was found to be 97.2:2.8. (c.f. Table 19, entries 5 and 7). Similarly, 
cyclization of 142q proceeded with high enantioselectivity even at elevated temperature 
(97.7:2.3).  
 
Scheme 62 
 Trisubstituted alkenes are challenging substrates for selective sulfenofunctionalization. In 
the cyclization of pendant alcohols, both (E)- and (Z)-trisubstituted alkenes afford the 
corresponding products with poor enantioselectivities (60:40 and 70:30 respectively, Scheme 
63). The higher intrinsic selectivity of sulfenylating agent 103 was beneficial to this class of 
substrates as well, as benzopyran 143m was produced with 95.4:4.6 e.r. The stereochemical 
model for enantioselectivity posits that bulky electrophiles accentuate the difference in catalyst 
distortion during the transition state for thiiranium ion formation. Thus, the respective position of 
the (Z)-methyl group to the enantiotopic faces of 142m appears to cause a much greater 
distortion in the complex 95 derived from 103 than that from 56.
40
  
 
Scheme 63 
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 4.5.5.3. Site-selectivity. The Markovnikov rule for site-selectivity holds well for the 
cyclization of alkenes wherein the nucleophile is three atoms removed (Section 4.5.4.4). The 
investigation of constitutional site-selectivity of the reaction alcohols to thiiranium ions derived 
from biased alkenes demonstrated that cyclization preferentially occurs at the stabilized position. 
For unbiased alkenes, a mixture of isomers is obtained, although an in situ isomerization process 
from the 5-exo isomer to the 6-endo isomer precluded analysis of kinetically controlled 
selectivity (Table 11).
18
 In contrast, high 5-exo selectivity is observed for carboxylic acid 
cyclizations. The cyclization of phenolic hydroxyl groups proceeds similarly to the alcohols, 
with high Markovnikov site-selectivity being observed. The presence of resonance stabilization 
(presence of a Ph substituent, c.f. Table 19, entry 5) or inductive stabilization (disubsituted 
carbon atom of the thiiranium ion, Table 19, entry 4) is sufficient for high selectivity. Moreover, 
a mixture of isomers is observed in the absence of electronic bias (Table 19, entry 3). The 
presence of a phenolic hydroxyl group did not otherwise impact selectivity, as the cyclization of 
142u proceeded to give a mixture of isomers, whereas carboxylic acid 145t displayed very high 
5-exo selectivity, confirming previous trends (Table 19, entries 11 and 12).
137
  
 For capture of an electronically unbiased thiiranium ion by a phenolic hydroxyl group 
three atoms away, the Markovnikov rule predicts poor selectivity. Instead, the controlling factor 
is the relative rate of 5-exo to 6-endo cyclization. For epoxides, exo opening to afford furans is 
preferred.
141b
 In the case of substrate 142l, a 1.5:1 ratio of 143l/144l from endo vs. exo 
cyclization respectively was obtained. Direct comparison to the corresponding alcohol substrate, 
which afforded a 5:1 ratio of endo/exo isomers, is not warranted due to the presence of Csp2 
atoms in the tether.
20
 Instead, comparisons can be drawn to intramolecular phenol capture of 
other tethered three-membered rings. The opening of a disubstituted alkyl epoxide by a phenolic 
hydroxyl proceeds exclusively exo, whereas the iodine-mediated cyclization of 2-crotylphenol, 
which proceeds through an iodonium intermediate, affords solely the endo product (Scheme 
64).
138
 The intrinsic selectivity of phenol capture is therefore highly dependent on the nature of 
the electrophilic moiety, wherein increased charge and larger atoms in the three-membered ring 
result in higher formation of the endo product. Thiiranium ions are between these two extremes, 
and consequently low selectivity is observed.  
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Scheme 64 
 The ratio 143l/144l is independent of conversion. In this particular case, the reduced 
basicity of a benzopyran oxygen compared to a pyran, as well as the reduced MsOH loading 
likely retard isomerization, leading to poor site selectivity that represents kinetic control.  
 4.5.6. Influence of Tether Length. On the basis of the observed characteristics of the 
sulfenofunctionalization reaction, changes in the tether length were primarily expected to affect 
the rate- and site-selectivity of the process. As the alkene environment is constant among the 
various substrates, the enantioselectivity was not expected to vary. Indeed, comparable substrates 
displayed similar enantioselectivities irrespective of tether length (142a and 142n, 142p and 
142q).  
 4.5.6.1. Rate. The free energy barrier to cyclization for medium sized rings is highly 
dependent on ring size.
139
 Consequently, the relative rates of endo and exo capture of the 
thiiranium ions are dependent on the sizes of the rings being formed. The rate of cyclization of 
substrate 142n, bearing one more atom in the tether than 142a, is similar to the rate of 142a (c.f. 
Table 18, entry 1 and Table 19, entry 5, Scheme 65a). Similarly, the rates of cyclization of 
dialkyl-substituted substrates 142l and 142s are comparable (Table 19, entries 3 and 10, Scheme 
65b and Scheme 65c). Overall, for 5-exo, 6-endo, 6-exo and 7-endo capture, thiiranium ion 
formation appears to be turnover-limiting, and no effect on rate as a function of tether length is 
observed. In contrast, substantially different rates are observed for the cyclization of 142p and 
142q (12 h vs 48 h) which have, respectively, two and three methylene units in their tethers 
(Table 19, entries 7 and 8, Scheme 65d). The cyclization of 142o, also bearing a three carbon 
tether, with 1c, required elevated temperature compared to the shorter 142n (22 
o
C vs -20 
o
C, 
Table 3, entries 5 and 6). Attempts to cyclize 142o with 56 for comparison purposes failed, with 
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primarily decomposition products being formed (Scheme 65a). Thus, both 7-exo and 8-endo 
cyclizations are generally disfavored in comparison to the aforementioned modes. The overall 
relative rates as a function of cyclization mode can then be expressed as 8-endo << 7-exo < 7-
endo ~ 6-exo ~ 6-endo ~ 5-exo. In conjunction with these rates, a regime for change of the rate-
determining step can be established. For 7-endo and more facile closures, thiiranium formation 
remains turnover-limiting, however, for less favored closures such as 7-exo and 8-endo, capture 
becomes turnover-limiting. The importance of sterically shielding the thiiranium ion reactions 
with turnover-limiting capture is clearly illustrated by the failure of 56 to promote the cyclization 
of 142o.  
  
 
  
 
Scheme 65 
 4.5.6.2. Site-selectivity.  Changing the tether length introduces substantial bias into the 
cyclization due to the higher energy associated with forming 7-membered and larger rings.
,139,140
 
The cyclization of electronically unbiased alkenes with two-carbon tethers (142s and 142r) show 
that the intrinsic selectivity for 6-exo over 7-endo highly favors the 6-exo product. However, 
142n, which bears a phenyl substituent, cyclized selectively to the less favored benzoxepane 
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143n. Thus, there exists a kinetic preference for cyclization following the Markovnikov rule. 
Surprisingly, the cyclization of 142o did not follow the expected trend. Under standard reaction 
conditions, decomposition was observed. The increased kinetic barrier to either 8-endo or 7-exo 
cyclization likely extends thiiranium lifetime to the point where decomposition processes 
intervene. The use of the electrophile 103 led to preferential 7-exo cyclization. Electrophile 103 
has been known to substantially increase thiiranium lifetime, enabling intramolecular 
sulfenofunctionalization reactions to be run at ambient temperature.
18,40
 In this case, the 
increased stability imparted to the thiiranium ion is sufficient to prevent decomposition, 
whereupon successful phenol capture can take place. The observed site-selectivity is dominated 
by the kinetic preference for formation of a seven- vs. eight-membered ring. The subtle interplay 
between enthalpic and entropic contributions is similar to that exhibited with epoxide substrates 
wherein the cyclization of an electronically-unbiased epoxide affords the 5-exo isomer vs. the 6-
endo isomer with high selectivity whereas an electronically biased epoxide opens with opposite 
selectivity (Scheme 66).
141
  
 
Scheme 66 
 4.5.7. Influence of Lewis Basic Functional Groups. The sulfenofunctionalization process 
relies on a moderately Lewis basic selenophosphoramide to promote the catalytic process. 
Therefore, the sensitivity of the reaction to other Lewis basic functional groups that may be 
present in the reaction was of interest. In comparison with the reaction of 142a, no effect on rate 
was observed for any of the four Lewis basic groups tested (alcohol, acid, ester, ether), although 
in these cases 0.5 equiv acid was used to counteract any potential buffering effects.  
 The enantioselectivity of the reactions were consistently high except for 143r and 147t 
which showed a slight erosion. The interaction of the carbonyl group either directly with the 
thiiranium ion during its formation or with the complex during its capture may lead to this 
erosion. Given the small magnitude of the change, the interaction appears to be weak. The site 
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selectivity for ester 143r was slightly lower than for 142s, which also suggests an interaction not 
present with the ether functional group.  
 If two competent nucleophiles are present in the molecule, such as in 145t and 146u, 
capture with either nucleophile is possible. The chemoselectivity of the reaction is then 
dependent on, in addition to the ring size as discussed, the relative rates of cyclization for either 
nucleophile. Both a carboxylic acid and an alcohol outcompeted the phenolic hydroxyl group for 
thiiranium capture. Clearly, the  deactivation of the phenolic hydroxyl group, a consequence of 
electron delocalization, with respect to other oxygen nucleophiles is sufficient to disfavor aryl 
ether formation.
129
 Interestingly, the chemoselectivity does not correlate with proton affinity, as 
the pKa of a protonated carboxylic acid is somewhat higher than a protonated phenol (pKa,aq. 
PhCO2H2
+
: -7.8 vs PhOH2
+
: -6.5).
66
 The discrepancy suggests the existence of a secondary 
interaction that favors capture by the carboxylic acid, similar to what was observed during the 
cyclization of ester 142r.  
 The site-selectivity for the formation of lactone 147t was consistent with high 5-exo 
preference for cyclization of carboxylic acid substrates with phosphoramides.
20
 In contrast, the 
alcohol 142u formed 147u and 148u in almost equimolar ratio, compared to previous results 
where a 5:1 isomer ratio favoring the pyran was observed (Scheme 67a).
20
 There appears to be 
no intrinsic kinetic preference for 5-exo vs. 6-endo cyclization for alcohols with three carbon 
tethers, in agreement with the low kinetic preference observed in the cyclization of phenol 142l 
(Scheme 67b and Scheme 67c).  
 
 
 
Scheme 67 
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Scheme 67 (cont.) 
 4.5.8. Intermolecular Sulfenylation. The phenoxysulfenylation reaction could also be 
performed intermolecularly. The production of 149 ensued in comparable yield and selectivity to 
143a. Although the selectivity was slightly lower (93:7 compared  to 95:5), such small decreases 
were also observed in the comparison of inter- and intramolecular sulfenylation. However, the 
sulfenofunctionalization of β-methylstyrene was much less successful. The lower nucleophilicity 
of phenols with respect to alcohols now allows substantial racemization to take place. Stilbene 
was completely unreactive. Increased conjugation is known to decrease reactivity with respect to 
thiiranium ions, and the result was not particularly unexpected. The applicability of 
intermolecular sulfenylation remains limited based on the current substrate scope. 
 4.6. Conclusions. 
 The highly enantioselective sulfenocyclization of alkenes with tethered phenolic 
hydroxyl groups to afford substituted chromans has been accomplished. A systematic variation 
of the nucleophile component and tether length allowed further trends in sulfenofunctionalization 
to be identified. The reaction was insensitive to changes in the steric properties of the 
nucleophile. The nucleophile electron density only made a difference for highly electron-
deficient phenols. The reaction rate did not change for one- and two-methylene tethers, and both 
benzopyrans and benzoxepanes were readily prepared, whereas further increases in tether length 
resulted in slower reactions. Enantioselectivity was unaffected by changes in the nucleophile 
component or tether length. Nucleophilic capture occurred at the more electronically biased 
location of the thiiranium ion. In the absence of electronic bias, the intrinsic site selectivity of 
sulfenofunctionalization was low for one-methylene tethers but high for two-methylene tethers. 
Carboxylic acids and alcohols were more reactive towards thiiranium ions than phenolic 
hydroxyl groups, and high chemoselectivity was observed in competition experiments. 
Substrates which displayed low reactivity at -20 
o
C were amenable to sulfenofunctionalization 
with hindered 103 at higher temperatures. The increased thiiranium ion stability as a result of 
113 
 
shielding prevented enantioerosion that had previously plagued reactions at such elevated 
temperature.  
 4.7. Outlook. 
 The sulfenofunctionalization of alkenes has enabled the rapid synthesis of diverse 
sulfenylated heterocycles. In the presence of oxygen based nucleophiles pyrans, benzopyrans and 
lactones can be formed. The enantioselectivity of the reaction remained high throughout a 
diverse set of modifications, a result of the configurational stability of the thiiranium ion. Only 
changes in the alkene geometry were not well tolerated.  
 The development of new sulfenofunctionalization catalysts is necessary for the extension 
of the reaction to other alkene geometries such as cis- or 1,1-substituted. Steric differentiation of 
cis-alkenes usually requires catalysts of ungerade symmetry, thus, these catalysts will likely not 
exhibit the C2 symmetry present in the current catalyst architecture. Some architectures that have 
been proposed so far are the C3 symmetric propellane architectures 155 and 156 (Scheme 68).  
 
Scheme 68 
 The thiiranium ion that results from initial alkene sulfenofunctionalization remains a 
strong electrophile. Thus, other alkenes of sufficient electron density may be able to engage the 
thiiranium ion in C-C bond formation. The resulting carbocation would then serve as a locus for 
further ring formation or rearrangement. These well known polyene cyclization processes have 
been triggered by the formation of other -iranium ions before, however current enantioselective 
polyene cyclization methods remain limited (Scheme 69).
142
 The broad nucleophile and 
substituent tolerance of the sulfenofunctionalization process and high selectivity independent of 
substrate are well suited towards this type of cyclization. 
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Scheme 69 
 The highly selective functionalization of terminal alkenes remains an area of active 
research, and the sulfenofunctionalization reaction could be employed to synthesize terminal 
aziridines with high selectivity in a Payne-type reaction.
143
 The sulfenofunctionalization of an 
allyl amine would lead to the formation of a thiiranium ion with an α-amine. Anchimeric 
opening of the thiiranium ion would lead to α-thioaziridine formation (Scheme 70).  
 
Scheme 70 
 The deprotection of the thioether moiety has remained problematic throughout the course 
of these investigations. Attempts at cross coupling with an Fe-based system were met with mixed 
success, and, as detailed above, the direct deprotection also proved difficult.
144
 Conversion of the 
sulfoxide to the ketone failed as well. Thus, changes to the aryl group that make it easier to 
deprotect are necessary. These may be either increasing electron density on the arene, to better 
undergo oxidative deprotection, or completely changing the electrophile to better accommodate 
deprotection strategies. These approaches remain active areas of research in these laboratories.      
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Chapter 5: Experimental Procedures 
 
 5.1. General Experimental.  
 All reactions were performed in oven- (160 °C) and/or flame-dried glassware under an 
atmosphere of dry argon unless otherwise noted. Reaction solvents tetrahydrofuran (Fisher, 
HPLC grade), ether (Fisher, BHT stabilized ACS grade), and dichloromethane (Fisher, 
unstabilized HPLC grade), were dried by percolation through two columns packed with neutral 
alumina under a positive pressure of argon. Reaction solvents hexanes (Fisher, OPTIMA grade) 
and toluene (Fisher, ACS grade) were dried by percolation through a column packed with neutral 
alumina and a column packed with Q5 reactant (supported copper catalyst for scavenging 
oxygen) under a positive pressure of argon. Solvents for filtration, transfers, and chromatography 
were certified ACS grade. “Brine” refers to a saturated solution of sodium chloride in water. All 
reaction temperatures correspond to internal temperatures measured with Teflon coated 
thermocouples. A ThermoNesLab CC-100 or a ThermoNesLab IBC-4A cryocool with an 
attached cryotrol was used for reactions at subambient temperatures.  
 
1
H and 
13
C NMR spectra were recorded on Varian Unity (400 MHz, 
1
H; 101 MHz, 
13
C) 
or Inova (500 MHz, 
1
H; 126 MHz, 
13
C) spectrometers. 
31
P NMR and 
19
F spectra were recorded 
on Inova (202 MHz) and Inova (470 MHz) spectrometers respectively. Acquisition times were 
4.096 s for 
1
H NMR, 1.024 s for 
13
C NMR, 0.655 s for 
31
P NMR, and 0.328 s for 
19
F NMR. 
Spectra are referenced to residual chloroform (δ = 7.26 ppm, 1H; 77.0 ppm, 13C). Chemical shifts 
are reported in parts per million, multiplicities are indicated by s (singlet), d (doublet), t (triplet), 
q (quartet), p (pentet), h (hextet), sept (septet), m (multiplet), and br (broad). Coupling constants, 
J, are reported in Hertz, and integration is provided and assignments are indicated. Assignments 
were confirmed through 2-D COSY and HMQC experiments. Elemental analysis was performed 
by the University of Illinois Microanalysis Laboratory or Robertson Microlit Laboratories. Mass 
spectrometry (MS) was performed by the University of Illinois Mass Spectrometry Laboratory. 
Electron Impact (EI) spectra were performed at 70 eV using methane as the carrier gas on a 
Finnegan-MAT C5 spectrometer. Chemical Ionization (CI) spectra were performed with 
methane reagent gas on a Micromass 70-VSE spectrometer. Electrospray Ionization (ESI) 
spectra were performed on a Micromass Q-Tof Ultima spectrometer. Data are reported in the 
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form of m/z (intensity relative to the base peak = 100). Infrared spectra (IR) were recorded on a 
Perkin-Elmer FT-IR system and peaks are reported in cm
-1
 with indicated relative intensities: s 
(strong, 0–33% T); m (medium, 34–66% T), w (weak, 67–100% %), and br (broad). Melting 
points (mp) were determined on a Thomas-Hoover capillary melting point apparatus in sealed 
tubes under vacuum and are corrected.  
 Analytical thin-layer chromatography (TLC) was performed on Merck silica gel 60 F254 
or Merck silica gel 60 RP-18 F254s plates. Silver impregnated silica was prepared by first 
dissolving 5 g of AgNO3 in 30 mL of deionized water. The resulting homogenous solution was 
added to 50 g of SiO2 in a mortar. The clumpy silica was ground with a pestle until free-flowing. 
The mortar was then covered in aluminium foil and placed in an oven (160 
o
C) for 3 h. The 
vessel was then removed from the oven, and allowed to cool in a dessicator. No special 
precautions were necessary during the chromatography process, however, prolonged (>6 h) 
exposure to visible light resulted in the formation of black Ag nanoparticles and a loss of column 
separation power. Visualization was accomplished with UV light and/or Ceric Ammonium 
Molybdenate (CAM) solution. Rf values reported were measured using a 10 × 2 cm TLC plate in 
a developing chamber containing the solvent system described. Flash chromatography was 
performed using Merck silica gel 60 230–400 mesh (60–63 µ, 60 Å pore size). Analytical chiral 
stationary phase supercritical fluid chromatography (CSP-SFC) was performed on an Agilent 
1100 HPLC equipped with an Aurora Systems A-5 supercritical CO2 adapter for supercritical 
fluid chromatography and a UV detector (220 nm or 254 nm) using Daicel Chiralcel OD, OJ, OB 
or Chiralpak AD, and AS columns as well as a Regis Whelk-O1 column. Normal Phase HPLC 
was performed on an Agilent 1100 HPLC equipped with AD-H, OJ-H, IB-3, Naphtholeucine and 
R,R-Beta-Gem columns. Reverse-Phase HPLC was performed on an Agilent 1100 HPLC using a 
Chiralpak AD-RH or Chiralcel OJ-RH column.  
 Commercial reagents were purified by distillation or recrystallization prior to use unless 
noted. Solvents for chromatography, filtration and recrystallization were toluene (Fisher, ACS 
grade), dichloromethane (Aldrich, ACS grade), ethyl acetate (Fisher, ACS grade), and hexane 
(Fisher, Optima). Isopropylamine (Aldrich), triethylamine (Alfa-Aesar) and pyridine (Fisher) 
were distilled from CaH2. 
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 5.2. Literature Preparations. 
 
 Literature Preparations for Chapter 2: 
 Electrophiles N-(phenylthio)-phthalimide 56
145
, N-(phenylthio)-benzotriazole 67
69
, N-
(phenylthio)saccharin 68
146
, N-(phenylthio)bismethylsulfonamide 69
147
, phenylsulfenyl acetate 
70
75
, 2-nitrophenylsulfenyl acetate 71
75
, 2,4-dinitrophenylsulfenylacetate 72
75
, N-(methylthio)-
phthalimide 74
148
, N-(trichloromethylthio)-phthalimide 75
149
, N-(4-nitrophenylthio)phthalimide 
76
148
 and N-(2,6-diisopropylphenylthio) phthalimide 103
40 
were prepared as decribed.  
 Alkenes (E)-5-phenyl-pent-4-en-1-ol 57a
20
, (E)-5-(4-trifluoromethylphenyl)-pent-4-en-1-
ol 57b
20
, (E)-5-(4-methoxyphenyl)-pent-4-en-1-ol 57c
20
, methyl (E)-6-hydroxyhex-2-enoate 
57d
20
, (E)-2-methyl-6-phenylhex-5-en-2-ol 57e
150
, (E)-2,2-dimethyl-5-phenylpent-4-en-1-ol 
57f
20
, (E)-7-phenylhept-4-en-1-ol 57g
20
, (E)-6-methylhept-4-en-1-ol 57h
20
, (Z)-5-phenyl-pent-4-
en-1-ol 57i
20
, (Z)-7-phenylhept-4-en-1-ol 57j
151
, pent-4-en-1-ol 57k
20
, 4-phenylpent-4-en-1-ol 
57l
20
, (E)-5-phenylhex-4-en-1-ol 57m
20
, (E)-4-methyl-5-phenylpent-4-en-1-ol 57n
20
, (E)-5-
phenylpent-4-enoic acid 57o
20
, (E)-5-phenylpent-4-enamide 57p
152
 were prepared as described.  
 Catalysts 61
69
, (R)-4-(piperidin-1-yl)-3,5-dimethyl-4,5-dihydro-3H-dinaphtho[2,1-d:1',2'-
f][1,3,2]diazaphosphepine-4-selenide 62a
16
, (R)-4-(diisobutyl)-3,5-dimethyl-4,5-dihydro-3H-
dinaphtho[2,1-d:1',2'-f][1,3,2]diazaphosphepine-4-selenide 62d
83
, di-Me-BINAM
71
, (R)-4-
(diisopropyl)-3,5-dimethyl-4,5-dihydro-3H-dinaphtho[2,1-d:1',2'-f][1,3,2]diazaphosphepine-4-
selenide 62e
40
, and azocane
153
 were prepared according to their published procedures.  
 
 Literature Preparations for Chapter 3: 
 (E)-5-(2-fluorophenyl)-pent-4-en-1-ol 99
154
, (R)-6,6- dimethyl-2,2-di(methylamino)-1,1-
biphenyl
155
, benzenesulfenyl chloride
156
, 1,1-dimethyl-2-phenyldisulfan-1-ium 
hexachloroantimonate ([PhS(SMe2)]SbCl6)
85
 were prepared according to their published 
procedures.  
 
 Literature Preparations for Chapter 4: 
 2-((E)-3-thiophenylprop-2-en-1-yl)phenol 119a
157
, 2-(but-3-en-1-yl)phenol
96b
,  142p
158
, 
2-(pent-4-en-1-yl)phenol 142q
96b
, (E)-3-(furan-2-yl)-1-(2-hydroxyphenyl)prop-2-en-1-one 
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118b
159
 and diethyl (E)-2-(5-(2-hydroxyphenyl)pent-2-en-1-yl)malonate 138
160
 were prepared as 
described. 
 
 5.3. Experimental Procedures for Chapter 2. 
 
Survey of Achiral Lewis Bases (Table 4)  
 
General Procedure 1 
 
 An oven-dried, 5-mm NMR tube was charged with N-phenylthiophthalimide (56, 1.2 
equiv) in a glovebox and capped with a septum. Outside of the glovebox, 5-phenyl-4-penten-1-ol 
(57a), the indicated amount of catalyst and 0.62 mL of CDCl3 was added and the mixture was 
shaken well. Subsequently, the corresponding amount of acid was added and the mixture was 
shaken again. Spectra were recorded at 3 h and 24 h time points. Conversion to product was 
measured by the appearance of the diagnostic 
1
H NMR resonance for the product at 4.14 ppm 
with respect to the substrate peaks at 6.23 ppm and 3.72 ppm. Generally, no other products were 
observed in the 
1
H NMR spectra. Formation of phthalimide byproduct was visually confirmed by 
the precipitation out of the solution.  
Data for 58a: 
 1
H NMR:  (500 MHz, CDCl3) 
  7.32 (m, 2 H, H(C-aryl)), 7.28 – 7.16 (m, 3 H, H(C-aryl)), 7.14 – 7.03 (m, 5 H, 
H(C-aryl)), 4.14 (d, J = 10.1 Hz, 1 H, HC(2)), 4.09 – 4.00 (m, 1 H, HC(6)), 3.53 
(td, J = 11.9, 2.2 Hz, 1 H, HC(6)), 3.20 (ddd, J = 11.5, 10.2, 4.0 Hz, 1 H, HC(3)), 
2.32 – 2.17 (m, 1 H, HC(4)), 1.93 – 1.73 (m, 1 H, HC(5)), 1.66 (m, 2 H, HC(4), 
HC(5)). 
 
 Sulfenocyclization with Tetrahydrothiophene and TFA (Table 4, Entry 1) [DJK-3-34A] 
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 Following General Procedure 1, an oven-dried NMR tube was charged with 56 (20 mg, 
0.078 mmol 1.2 equiv), 57a (9.9 mg, 0.062 mmol), THT (Tetrahydrothiophene, 1.2 µL, 0.013 
mmol, 0.22 equiv) and CDCl3 (0.62 mL). Trifluoroacetic acid (4.7 µL, 0.061 mmol, 1.0 equiv) 
was added and the tube was shaken well. Spectral analysis revealed 33% and 70% conversion 
after 3 h and 24 h respectively.  
 
Sulfenocyclization with Tetrahydrothiophene and MsOH (Table 4 Entry 2) [DJK-3-34B] 
 
 Following General Procedure 1, an oven-dried NMR tube was charged with 56 (20 mg, 
0.078 mmol 1.2 equiv), 57a (9.7 mg, 0.062 mmol), THT (1.2 µL, 0.013 mmol, 0.23 equiv) and 
CDCl3 (0.62 mL). Methanesulfonic acid (4.0 µL, 0.061 mmol, 1.0 equiv) was added and the tube 
was shaken well. Spectral analysis revealed 100% conversion after 3 h.  
 
Background Sulfenofunctionalization with TFA (Table 4 Entry 3) [DJK-3-34D] 
 
 Following General Procedure 1, an oven-dried NMR tube was charged with 56 (20 mg, 
0.078 mmol 1.2 equiv), 57a (10.2 mg, 0.063 mmol) and CDCl3 (0.62 mL). Trifluoroacetic acid 
(4.7 µL, 0.061 mmol, 1.0 equiv) was added and the tube was shaken well. Spectral analysis 
revealed no conversion after 24 h. 
 
Background Sulfenofunctionalization with MsOH (Table 4 Entry 4) [DJK-3-34E] 
 
 Following General Procedure 1, an oven-dried NMR tube was charged with 56 (20 mg, 
0.078 mmol 1.2 equiv), 57a (10.0 mg, 0.062 mmol) and CDCl3 (0.62 mL). Methanesulfonic acid 
(4.0 µL, 0.062 mmol, 1.0 equiv) was added and the tube was shaken well. Spectral analysis 
revealed trace and 10% conversion after 3 and 24 h respectively. 
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Sulfenofunctionalization with 1,3-Dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinthione 
(DMPU(S))  (Table 4 Entry 5) [DJK-3-25-M] 
 
 Following General Procedure 1, an oven-dried NMR tube was charged with 56 (20 mg, 
0.078 mmol 1.2 equiv), 57a (10.2 mg, 0.063 mmol), 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-
pyrimidinethione (1.9 mg, 0.013 mmol, 0.21 equiv) and CDCl3 (0.62 mL). Methanesulfonic acid 
(4.0 µL, 0.062 mmol, 1.0 equiv) was added and the tube was shaken well. Spectral analysis 
revealed 7% and 55% conversion after 3 and 24 h respectively. 
 
Sulfenofunctionalization with Triphenylphosphine sulfide (Table 4 Entry 6) [DJK-3-25-G] 
 
Following General Procedure 1, an oven-dried NMR tube was charged with 56 (20 mg, 
0.078 mmol 1.2 equiv), 57a (10.2 mg, 0.063 mmol), triphenylphosphine sulfide (3.63 mg, 0.012 
mmol, 0.20 equiv) and CDCl3 (0.62 mL). Methanesulfonic acid (4.0 µL, 0.062 mmol, 1.0 equiv) 
was added and the tube was shaken well. Spectral analysis revealed 100% conversion after 3 h. 
 
Sulfenofunctionalization with Tricyclohexylphosphine sulfide  (Table 4 Entry 7) [DJK-3-
25-L] 
 
Following General Procedure 1, an oven-dried NMR tube was charged with 56 (20 mg, 
0.078 mmol 1.2 equiv), 57a (10.1 mg, 0.062 mmol), tricyclohexylphosphine sulfide (3.89 mg, 
0.012 mmol, 0.20 equiv) and CDCl3 (0.62 mL). Methanesulfonic acid (4.0 µL, 0.062 mmol, 1.0 
equiv) was added and the tube was shaken well. Spectral analysis revealed 100% conversion 
after 3 h. 
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Sulfenofunctionalization with Hexamethylphosphoramide (Table 4 Entry 8) [DJK-3-25-I] 
 
Following General Procedure 1, an oven-dried NMR tube was charged with 56 (20 mg, 
0.078 mmol 1.2 equiv), 57a (10.1 mg, 0.062 mmol), hexamethylphosphoramide (2.1 µL, 0.012 
mmol, 0.20 equiv) and CDCl3 (0.62 mL). Methanesulfonic acid (4.0 µL, 0.062 mmol, 1.0 equiv) 
was added and the tube was shaken well. Spectral analysis revealed 0% conversion after 24 h. 
 
Sulfenofunctionalization with Hexamethylsulfenophosphoramide (Table 4 Entry 9) [DJK-
3-25-H] 
 
Following General Procedure 1, an oven-dried NMR tube was charged with 56 (20 mg, 
0.078 mmol 1.2 equiv), 57a (9.8 mg, 0.061 mmol), hexamethylthiophosphoramide (2.42 mg, 
0.012 mmol, 0.2 equiv) and CDCl3 (0.62 mL). Methanesulfonic acid (4.0 µL, 0.062 mmol, 1.0 
equiv) was added and the tube was shaken well. Spectral analysis revealed 35% conversion after 
24 h. 
 
Sulfenofunctionalization with Hexamethylselenophosphoramide (Table 4 Entry 10) [DJK-
3-25-J] 
 
Following General Procedure 1, an oven-dried NMR tube was charged with 56 (20 mg, 
0.078 mmol 1.2 equiv), 57a (10.2 mg, 0.063 mmol), hexamethylselenophosphoramide (3.06 mg, 
0.012 mmol, 0.2 equiv) and CDCl3 (0.62 mL). Methanesulfonic acid (4.0 µL, 0.062 mmol, 1.0 
equiv) was added and the tube was shaken well. Spectral analysis revealed 31% and 100% 
conversion after 3 and 24 h respectively. 
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Survey of Chiral, Nonracemic Lewis Bases for Sulfenofunctionalization 
 
Preparation of Catalysts for Table 5: 
 
Preparation of (R)-4-(Azepan-1-yl)-3,5-dimethyl-4,5-dihydro-3H-dinaphtho[2,1-d:1',2'-
f][1,3,2]diazaphosphepine-4-selenide (62b) [DJK-2-27] 
 
To a flame-dried, 50-mL Schlenk flask equipped with a magnetic stir bar and septum 
were added amine 65 (1.048 g, 3.35 mmol) and anhydrous toluene (10.0 mL) via syringe under 
argon. The solvent was removed under high vacuum (30 °C, 0.05 mm Hg) for 30 min. 
Anhydrous THF (30.0 mL) and Et3N (1.167 mL, 8.38 mmol, 2.5 equiv) were added via syringe 
and the homogeneous mixture was cooled to 0 °C. Phosphorus trichloride (880 µL, 10.0 mmol, 
3.0 equiv) was added dropwise via syringe whereupon a colorless precipitate formed 
immediately. The reaction mixture was stirred at 0 °C for 1.5 h, then was allowed to warm to 
room temperature and was stirred for another 3 h. The volatiles were removed under high 
vacuum (30 °C, 0.05 mm Hg) and anhydrous Et2O (10.0 mL) was added via syringe and the 
mixture was stirred for 5 min. The supernatant was cannula filtered into a tared, flame-dried, 
argon filled, 50-mL Schlenk flask equipped with a rubber septum. The remaining precipitate in 
the reaction flask was washed with anhydrous Et2O (5.0 mL) and then was filtered into the 
receiver Schlenk flask. The volatiles were removed under high vacuum (30 °C, 0.05 mm Hg) to 
afford 1.262 g of a colorless foam. The solid was redissolved in anhydrous Et2O (10.0 mL) and 
the volatiles were again removed under high vacuum (30 °C, 0.05 mm Hg) to remove traces of 
HCl. The solid was then dried for 2.5 h at reduced pressure (23 
o
C, 0.05 mm Hg) to give a 
colorless foam. Anhydrous CH2Cl2 (30.0 mL) was added via syringe and the mixture was cooled 
to 0 °C. Triethylamine (560 µL, 4.0 mmol, 1.2 equiv) and hexahydro-1H-azepine (411 µL, 3.65 
mmol, 1.1 equiv) were added via syringe and the reaction mixture was allowed to warm to room 
temperature and then was stirred for 24 h. Powdered selenium (796 mg, 10.1 mmol, 3.0 equiv) 
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was added and the mixture was stirred for 50 h, whereupon the mixture was filtered through a 
pad of Celite (5 g, 35 mm). The pad was washed with EtOAc (50 mL) and the filtrate was 
concentrated in vacuo (40 °C, 10 mm Hg) and the residue was purified by silica gel flash column 
chromatography (SiO2, 15 g, 20 mm Ø, hexanes/EtOAc, 60:1 to 40:1) to afford 1.233 g (71%) of 
62b as an off-white solid.Data for (R)-62b: 
 mp:  252-253 °C (decomposition) 
 1
H NMR:  (500 MHz, CDCl3) 
  8.06 (d, J = 8.8 Hz, 1 H, HC(4,4’)), 8.01 (d, J = 8.8 Hz, 1 H, HC(4,4’)), 7.96 (d, J = 
8.1 Hz, 1 H, HC(6)), 7.93 (d, J = 8.2 Hz, 1 H, HC(6’)), 7.72 (d, J = 8.2 Hz, 1 H, 
HC(3,3’)), 7.71 (d, J = 8.4 Hz, 1 H, HC(3,3’)), 7.47 (t, J = 7.2 Hz, 1 H, HC(7)), 
7.41 (t, J = 7.2 Hz, 1 H, HC(7’)), 7.34 (d, J = 8.4 Hz, 1 H, HC(9)), 7.27 (t, J = 7.4 
Hz, 1 H, HC(8)), 7.18 (t, J = 7.4 Hz, 1 H, HC(8’)), 7.14 (d, J = 8.4 Hz, 1 H, 
HC(9’)), 3.46 - 3.36 (m, 2 H, H2C(12) and H2C(12’)), 3.33 (d, J = 12.3 Hz, 3 H, 
H3C(11,11’)), 3.17 - 3.02 (m, 2 H, H2C(12) and H2C(12’)), 2.95 (d, J = 13.4 Hz, 3 
H, H3C(11,11’)), 1.72 (bs, 8 H, H2C(13), H2C(14)) 
13
C NMR:  (125 MHz, CDCl3) 
  142.9 (d, J = 11.3 Hz, C(2,2’)), 141.8 (C(2,2’)), 132.4 (C(aryl)), 132.2 (C(aryl)), 
131.2 (C(aryl)), 130.9 (C(aryl)), 129.3 (C(4,4’)), 128.7 (C(6)), 128.5 (C(1,1’)), 
128.0 (C(4,4’)), 2 × 127.8 (C(6’) and C(8’)), 127.4 (d, J = 2.5 Hz, C(1,1’)), 127.1 
(C(9’)), 126.0 (C(9)), 125.7 (C(8’)), 125.1 (C(7)), 124.7 (C(7’)), 123.0 (C(3,3’)), 
122.1 (C(3,3’)), 49.6 (C(12)), 37.9 (d, J = 11.3 Hz, C(11,11’)), 35.2 (d, J = 6.3 Hz, 
C(11,11’)), 30.3 (d, J = 3.8 Hz, C(13)), 26.7 (C(14)) 
 31
P NMR:  (202 MHz, CDCl3) 
  91.64  
 IR: (KBr) 
  3046 (w), 2993 (w), 2929 (m), 2858 (w), 1618 (m), 1593 (s), 1506 (s), 1466 (s), 
1329 (s), 1274 (s). 1147 (s), 1090 (s), 1052 (s), 934 (s), 815 (s), 753 (s) 
 MS: (ESI) 
522 (25), 521 (34), 520 (100, M+H
+
), 518 (57), 517 (24), 516 (21) 
 HRMS: calcd for C28H31N3PSe
+
: 520.1415, found: 520.1422 
 TLC: Rf 0.17 (hexanes/EtOAc, 20:1) [CAM] 
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 Opt Rot. : [α] D
24 
-318.1 (c = 0.25, CHCl3) 
 SFC: (R)-3c, tR, 15.75 min (99.2%); (S)-3c, tR 19.42 min (0.8%) (Chiralpak AD, 15% 
MeOH in CO2, 2 mL/min, 220 nm.) 
  Analysis: C28H30N3PSe (518.49) 
  Calcd:  C, 64.86;  H, 5.83% N, 8.10% 
  Found:  C, 64.88;  H, 5.83% N, 7.98% 
 
Preparation of (R)-4-(Azocin-1-yl)-3,5-dimethyl-4,5-dihydro-3H-dinaphtho[2,1-d:1',2'-
f][1,3,2]diazaphosphepine-4-selenide (62c) [DJK-1-56] 
 
To a flame-dried, 50-mL Schlenk flask equipped with a magnetic stir bar and septum 
were added amine 65 (161.2 mg, 0.5 mmol) and anhydrous toluene (10.0 mL) via syringe under 
argon. The solvent was removed under high vacuum (30 °C, 0.05 mm Hg) for 30 min. 
Anhydrous THF (30.0 mL) and Et3N (174 µL, 1.25 mmol, 2.5 equiv) were added via syringe and 
the homogeneous mixture was cooled to 0 °C. Phosphorus trichloride (131 µL, 1.5 mmol, 3.0 
equiv) was added dropwise via syringe whereupon a colorless precipitate formed immediately. 
The reaction mixture was stirred at 0 °C for 1.5 h, then was allowed to warm to room 
temperature and was stirred for another 24 h. The volatiles were removed under high vacuum (30 
°C, 0.05 mm Hg) and anhydrous Et2O (15.0 mL) was added via syringe and the mixture was 
stirred for 5 min. The supernatant was cannula filtered into a tared, flame-dried, argon filled, 50-
mL Schlenk flask equipped with a rubber septum. The remaining precipitate in the reaction flask 
was washed with anhydrous Et2O (5.0 mL) and then was filtered into the receiver Schlenk flask. 
The volatiles were removed under high vacuum (30 °C, 0.05 mm Hg). The solid was redissolved 
in anhydrous Et2O (10.0 mL) and the volatiles were again removed under high vacuum (30 °C, 
0.05 mm Hg) to remove traces of HCl. The solid was then dried for 2.5 h at reduced pressure (23 
o
C, 0.05 mm Hg) to give 188.4 mg of a colorless foam. Anhydrous CH2Cl2 (10.0 mL) was added 
via syringe and the mixture was cooled to 0 °C. Triethylamine (90 µL, 0.63 mmol, 1.2 equiv) 
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and heptahydro-1H-azocine (80 mg, 0.58 mmol, 1.1 equiv) were added via syringe and the 
reaction mixture was allowed to warm to room temperature and then was stirred for 24 h. 
Powdered selenium (120 mg, 1.5 mmol, 3.0 equiv) was added and the mixture was stirred for 50 
h, whereupon the mixture was filtered through a pad of Celite (5 g, 35 mm). The pad was washed 
with EtOAc (50 mL) and the filtrate was concentrated in vacuo (40 °C, 10 mm Hg) and the 
residue was purified by silica gel flash column chromatography (SiO2, 15 g, 20 mm Ø, 
hexanes/EtOAc, 60:1 to 40:1) to afford 223.1 mg (71%) of 62c as an off-white solid.Data for 
62c: 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 8.01 – 7.97 (d, J = 8.9 Hz, 1H, HC(4,4’)), 7.97 – 7.92 (d, J = 8.8 Hz, 1H, 
HC(4,4’)), 7.93 – 7.88 (d, J = 8.2 Hz, 1H, HC(6)), 7.89 – 7.85 (d, J = 8.1 Hz, 1H, 
HC(6’)), 7.70 – 7.65 (d, J = 9.0 Hz, 1H, HC(3,3’)), 7.65 – 7.61 (dd, J = 8.9, 1.3 Hz, 
1H, HC(3,3’)), 7.46 – 7.40 (ddd, J = 8.1, 6.4, 1.5 Hz, 1H, HC(7)), 7.39 – 7.34 (t, J = 
7.5 Hz, 1H, HC(7’)), 7.30 – 7.20 (m, 2H, HC(8,9)), 7.17 – 7.10 (ddd, J = 8.1, 6.7, 
1.2 Hz, 1H, HC(8’)), 7.09 – 7.02 (d, J = 8.5 Hz, 1H, HC(9’)), 3.33 – 3.18 (d, J = 
12.2 Hz, 4H, HC(11,11’,12)), 3.04 – 2.91 (tdd, J = 14.5, 8.1, 4.0 Hz, 2H, HC(12’)), 
2.91 – 2.84 (d, J = 13.4 Hz, 3H, HC(11,11’)), 1.79 – 1.70 (m, 2H, HC(13,14,15), 
1.70 – 1.63 (m, 6H, HC(13,14,15)), 1.62 – 1.55 (m, 2H, HC(13,14,15)). 
 31
P NMR:  (202 MHz, CDCl3) 
  92.44  
 
Sulfenofunctionalization with Chiral Nonracemic Lewis Bases (Table 5) 
 
General Procedure 
An oven-dried 5-mm NMR tube was charged with 56 in a glovebox. The tube was taken 
out of the box and the Lewis base, 57a, and 0.7 mL CDCl3 was added. If indicated, the tube was 
cooled to the appropriate temperature in a -20 
o
C freezer or cryocool unit. The acid was added at 
the indicated temperature and the mixture was shaken well. The reaction was quenched after the 
indicated time with excess Et3N, and the product was purified by silica gel flash column 
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chromatography prior to SFC analysis.  
Data for 58a: 
 1
H NMR:  (500 MHz, CDCl3) 
  7.32 (m, 2 H, H(C-aryl)), 7.28 – 7.16 (m, 3 H, H(C-aryl)), 7.14 – 7.03 (m, 5 H, 
H(C-aryl)), 4.14 (d, J = 10.1 Hz, 1 H, HC(2)), 4.09 – 4.00 (m, 1 H, HC(6)), 3.53 
(td, J = 11.9, 2.2 Hz, 1 H, HC(6)), 3.20 (ddd, J = 11.5, 10.2, 4.0 Hz, 1 H, HC(3)), 
2.32 – 2.17 (m, 1 H, HC(4)), 1.93 – 1.73 (m, 1 H, HC(5)), 1.66 (m, 2 H, HC(4), 
HC(5)). 
 
Sulfenofunctionalization with (R)-4-(1-Azepano)-3,5-dimethyl-4,5-dihydro-3H-
dinaphtho[2,1-d:1’,2’-f][1,3,2]diazaphosphepine-4-selenide (62b) (Table 5 Entry 4) [DJK-1-
17] 
 
Following General Procedure 2, an oven-dried NMR tube was charged with 56 (25.5 mg, 
0.1 mmol, 1 equiv), and 57a (16.2 mg, 0.1 mmol). To this was added (R)-62b (5.2 mg, 0.01 
mmol, 0.1 equiv), CDCl3 (0.7 mL). The reaction was cooled to -20 
o
C in a freezer and MsOH 
(6.5 µL, 0.1 mmol, 1.0 equiv) was added. After 30 h, the reaction was quenched with Et3N (10 
µL). Purification by flash chromatography (SiO2, 20 g, 20 mm Ø, hexanes/EtOAc, 30:1) afforded 
16 mg (59%) of 58a as a white solid. 
Data for 58a: 
 SFC: (2R,3S)-58a, tR 4.29 min (90.6%); (2S,3R)-58a, tR 5.35 min (9.4%) (Chiralpak AD, 
5% MeOH in CO2, 3 mL/min, 220 nm, 40 
o
C) 
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Sulfenofunctionalization with (R)-4-(1-Azocano)-3,5-dimethyl-4,5-dihydro-3H-
dinaphtho[2,1-d:1’,2’-f][1,3,2]diazaphosphepine-4-selenide (62c) (Table 5 Entry 5) [DJK-1-
66] 
 
Following General Procedure 2, an oven-dried NMR tube was charged with 56 (30.6 mg, 
0.12 mmol, 1.2 equiv), and 57a (16.2 mg, 0.1 mmol). To this was added (R)-62c (5.4 mg, 0.01 
mmol, 0.1 equiv), CDCl3 (0.7 mL) and the reaction was cooled to -20 
o
C in a freezer. MsOH (6.6 
µL, 0.1 mmol, 1.0 equiv) was added and the tube was shaken well. After 96 h, the reaction was 
quenched with Et3N (10 µL). Purification by silica gel flash column chromatography (SiO2, 20 g, 
20 mm Ø, hexanes/EtOAc, 40:1) afforded 12 mg (44%) of 58a as a white solid.  
Data for 58a: 
 SFC: (2R,3S)-58a, tR 4.29 min (90.7%); (2S,3R)-58a, tR 5.35 min (9.3%) (Chiralpak AD, 
5% MeOH in CO2, 3 mL/min, 220 nm, 40 
o
C) 
 
Sulfenofunctionalization with (R)-4-(Diisobutylamino)-3,5-dimethyl-4,5-dihydro-3H-
dinaphtho[2,1-d:1’,2’-f][1,3,2]diazaphosphepine-4-selenide (62d) (Table 5 Entry 6) [DJK-3-
75] 
 
An oven-dried Schlenk flask was charged with 56 (64 mg, 0.25 mmol, 1 equiv), and 57a 
(40.6 mg, 0.25 mmol). To this was added (S)-62d (13.7 mg, 0.025 mmol, 0.1 equiv), CDCl3 (0.7 
mL). The reaction was cooled to -20 
o
C in an i-Pr bath with stirring and MsOH (17 µL, 0.25 
mmol, 1.0 equiv) was added. After 48 h, the reaction was quenched with Et3N (50 µL). 
Purification by silica gel flash chromatography (SiO2, 20 g, 20 mm Ø, hexanes/EtOAc, 40:1) 
afforded 25 mg (37%) of 58a as a white solid. 
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Data for 58a: 
 SFC: (2R,3S)-58a, tR 4.29 min (7.1%); (2S,3R)-58a, tR 5.35 min (92.9%) (Chiralpak AD, 
5% MeOH in CO2, 3 mL/min, 220 nm, 40 
o
C) 
 
Sulfenofunctionalization with (R)-4-(Diisopropylamino)-3,5-dimethyl-4,5-dihydro-3H-
dinaphtho[2,1-d:1’,2’-f][1,3,2]diazaphosphepine-4-selenide (62e)  (Table 5 Entry 7) [DJK-
10-55] 
 
An oven-dried Schlenk flask was charged with 56 (26 mg, 0.1 mmol, 1 equiv), and 57a 
(16.2 mg, 0.1 mmol). To this was added (S)-62e (5.2 mg, 0.01 mmol, 0.1 equiv), CDCl3 (0.7 
mL). The reaction was cooled to -20 
o
C in an i-Pr bath with stirring and MsOH (4.8 µL, 0.75 
mmol, 0.75 equiv) was added. After 48 h, the reaction was quenched with Et3N (50 µL). 
Purification by flash chromatography (SiO2, 20 g, 20 mm Ø, hexanes/EtOAc, 40:1) afforded 14 
mg (52%) of 58a as a white solid. 
Data for 58a: 
 SFC: (2R,3S)-58a, tR 4.29 min (5.3%); (2S,3R)-58a, tR 5.35 min (94.7%) (Chiralpak AD, 
5% MeOH in CO2, 3 mL/min, 220 nm, 40 
o
C) 
 
Sulfenofunctionalization with Electrophilic Sulfenium Sources (Table 6) 
 
General Procedure  
 An oven-dried NMR tube was charged with 56, 57a and catalyst. To this was added 
CDCl3, followed by MsOH. If necessary, the reaction was cooled to the appropriate reaction 
temperature. The reaction was monitored by 
1
H NMR spectroscopy. After the specified time, the 
reaction was quenched with excess Et3N, and purified by silica gel flash column 
chromatography.  
 
Sulfenofunctionalization with N-Phenylthiophthalimide 56 (Table 6 Entry 1) [DJK-1-17] 
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An oven-dried NMR tube was charged with 56 (25.5 mg, 0.1 mmol, 1 equiv), and 57a 
(16.2 mg, 0.1 mmol). To this was added (R)-62b (5.2 mg, 0.01 mmol, 0.1 equiv) and CDCl3 (0.7 
mL). The reaction was cooled to -20 
o
C in a freezer and MsOH (6.5 µL, 0.1 mmol, 1.0 equiv) 
was added. After 30 h, the reaction was quenched with Et3N (10 µL). Purification by silica gel 
flash column chromatography (SiO2, 20 g, 20 mm Ø, hexanes/EtOAc, 30:1) afforded 6 mg (22%) 
of 58a as a white solid. 
Data for 58a: 
 1
H NMR:  (500 MHz, CDCl3) 
  7.32 (m, 2 H, H(C-aryl)), 7.28 – 7.16 (m, 3 H, H(C-aryl)), 7.14 – 7.03 (m, 5 H, 
H(C-aryl)), 4.14 (d, J = 10.1 Hz, 1 H, HC(2)), 4.09 – 4.00 (m, 1 H, HC(6)), 3.53 
(td, J = 11.9, 2.2 Hz, 1 H, HC(6)), 3.20 (ddd, J = 11.5, 10.2, 4.0 Hz, 1 H, HC(3)), 
2.32 – 2.17 (m, 1 H, HC(4)), 1.93 – 1.73 (m, 1 H, HC(5)), 1.66 (m, 2 H, HC(4), 
HC(5)). 
 SFC: (2R,3S)-58a, tR 4.29 min (90.6%); (2S,3R)-58a, tR 5.35 min (9.4%) (Chiralpak AD, 
5% MeOH in CO2, 3 mL/min, 220 nm, 40 
o
C) 
 
Sulfenofunctionalization with N-Phenylthiobismethanesulfonamide 69 (Table 6 Entry 4) 
[DJK-4-10] 
 
An oven-dried NMR tube was charged with 69 (60 mg, 0.2 mmol, 2 equiv), and 57a 
(16.2 mg, 0.1 mmol). To this was added (R)-62b (10.3 mg, 0.02 mmol, 0.2 equiv) and CDCl3 
(0.7 mL). The reaction was cooled to -20 
o
C in a freezer and 2,6-di-t-butyl-4-methylpyridine (44 
mg, 0.2 mmol, 2 equiv) was added. After 18 h, the reaction was quenched with Et3N (50 µL). 
Purification by silica gel flash column chromatography (SiO2, 20 g, 20 mm Ø, hexanes/EtOAc, 
30:1) afforded 5 mg (19%) of 58a as a white solid.  
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Data for 58a: 
 1
H NMR:  (500 MHz, CDCl3) 
  7.32 (m, 2 H, H(C-aryl)), 7.28 – 7.16 (m, 3 H, H(C-aryl)), 7.14 – 7.03 (m, 5 H, 
H(C-aryl)), 4.14 (d, J = 10.1 Hz, 1 H, HC(2)), 4.09 – 4.00 (m, 1 H, HC(6)), 3.53 
(td, J = 11.9, 2.2 Hz, 1 H, HC(6)), 3.20 (ddd, J = 11.5, 10.2, 4.0 Hz, 1 H, HC(3)), 
2.32 – 2.17 (m, 1 H, HC(4)), 1.93 – 1.73 (m, 1 H, HC(5)), 1.66 (m, 2 H, HC(4), 
HC(5)). 
 SFC: (2R,3S)-58a, tR 4.29 min (68.3%); (2S,3R)-58a, tR 5.35 min (31.7%) (Chiralpak AD, 
5% MeOH in CO2, 3 mL/min, 220 nm, 40 
o
C) 
 
Attempted Sulfenofunctionalization with Phenylsulfanyl ethanoate (Table 6 Entry 5) [DJK-
3-80] 
 
An oven-dried Schlenk flask was charged with PhSCl (14.5 mg, 0.1 mmol, 1 equiv) and 
CH2Cl2 (0.7 mL). AgOAc (16.7 mg, 0.1 mmol, 1 equiv.) was added and the reaction was cooled 
to -20 
o
C and stirred 16 h. Afterwards, 57a (16.2 mg, 0.1 mmol) and (R)-62b (2.6 mg, 0.005 
mmol, 0.05 equiv) were added. After 12 h, no change was visible by 
1
H NMR. No further 
manipulations were done. 
 
Attempted Sulfenofunctionalization with 2-Nitrophenylsulfanyl ethanoate (Table 6 Entry 
6) [DJK-3-79] 
 
An oven-dried Schlenk flask was charged with 2-NO2-C6H4-SCl (19 mg, 0.1 mmol, 1 
equiv) and CH2Cl2 (0.7 mL). AgOAc (16.7 mg, 0.1 mmol, 1 equiv.) was added and the reaction 
was cooled to -20 
o
C and stirred 16 h. Afterwards, 57a (16.2 mg, 0.1 mmol) and (R)-62b (2.6 
mg, 0.005 mmol, 0.05 equiv) were added. After 16 h, no desired product was visible by 
1
H 
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NMR. No further manipulations were done. 
 
Attempted Sulfenofunctionalization with 2,4-Dinitrophenylsulfanyl ethanoate  (Table 6 
Entry 7) [DJK-3-77] 
 
An oven-dried NMR tube was charged with 2,4-NO2-C6H3-SOAc (10.4 mg, 0.04 mmol, 
1 equiv) and CDCl3 (0.7 mL). 57a (16.2 mg, 0.1 mmol) was added and after 2h, (R)-62b (1 mg, 
0.002 mmol, 0.05 equiv) were added. After 16 h, no desired product was visible by 
1
H NMR. No 
further manipulations were done. 
 
Sulfenofunctionalization with N-methylthiophthalimide (Table 7 Entry 1) [DJK-4-14] 
 
An oven-dried Schlenk flask was charged with 74 (19.3 mg, 0.1 mmol, 1 equiv) and 
CH2Cl2 (0.7 mL). 57a (16.2 mg, 0.1 mmol) was added and (R)-62b (5.1 mg, 0.01 mmol, 0.1 
equiv) were added. The reaction was cooled to -20 
o
C and MsOH (6.4 µL, 0.1 mmol, 1 equiv) 
was added. After 48 h, the reaction was quenched with Et3N (50 µL Et3N). Purification by flash 
chromatography (SiO2, 8 g,  10 mm Ø, hexanes/EtOAc, 60:1) afforded 5 mg (24%) of pure 77.  
Data for 74a: 
 1
H NMR:  (500 MHz, CDCl3) 
  7.45 – 7.39 (m, 2H), 7.39 – 7.26 (m, 83), 4.14 (m, 2H), 3.61 (td, J = 11.9, 2.4 Hz, 
1H), 2.92 (s, 3H), 2.68 (ddd, J = 12.3, 10.2, 4.0 Hz, 1H), 2.01 (m, 1H), 1.89 (tdd, J 
= 17.1, 8.7, 4.2 Hz, 1H), 1.76 (dddd, J = 11.3, 9.5, 6.6, 4.6 Hz, 1H), 1.62 (m, 1H). 
 SFC: (2R,3S)-74a, tR 3.43 min (76.3%); (2S,3R)-74a, tR 4.95 min (23.7%) (Chiralpak AD, 
5% MeOH in CO2, 2 mL/min, 220 nm, 40 
o
C) 
 
Attempted Sulfenofunctionalization with N-Trichloromethylthiophthalimide (Table 7 
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Entry 2) [DJK-4-21] 
 
An oven-dried 5-mm NMR tube was charged with 75 (29.6 mg, 0.1 mmol, 1 equiv) and 
CDCl3 (0.7 mL). 57a (16.2 mg, 0.1 mmol), THT (1.8 µL, 0.02 mmol, 0.2 equiv) and MsOH (6.4 
µL, 0.1 mmol, 1 equiv) were added. After 24 h, no reaction was observed. No further 
manipulations were made.  
 
Attempted Sulfenofunctionalization with N-(4-Nitrophenyl)thiophthalimide (Table 7 Entry 
3) [DJK-4-17] 
 
An oven-dried 5-mm NMR tube was charged with 76 (29.9 mg, 0.1 mmol, 1 equiv) and 
CDCl3 (0.7 mL). 57a (16.2 mg, 0.1 mmol), THT (1.8 µL, 0.02 mmol, 0.2 equiv) and MsOH (6.4 
µL, 0.1 mmol, 1 equiv) were added. After 2 h, substantial conversion was observed by 
1
H NMR. 
However, no product was isolated from the reaction. 
 
Evaluation of Enantioselectivity as a Function of Temperature (Table 8) 
 
General Procedure 
An oven-dried 5-mm NMR tube was charged with 1 in a glovebox. The tube was taken 
out of the box and the Lewis base, 57a, and 0.7 mL CDCl3 was added. If indicated, the tube was 
cooled to the appropriate temperature in a cryocool unit. The acid was added at the indicated 
temperature and the mixture was shaken well. The reaction was quenched after the indicated 
time with excess Et3N, and the product was purified by silica gel column chromatography prior 
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to SFC analysis. 
Data for 58a: 
 1
H NMR:  (500 MHz, CDCl3) 
  7.32 (m, 2 H, H(C-aryl)), 7.28 – 7.16 (m, 3 H, H(C-aryl)), 7.14 – 7.03 (m, 5 H, 
H(C-aryl)), 4.14 (d, J = 10.1 Hz, 1 H, HC(2)), 4.09 – 4.00 (m, 1 H, HC(6)), 3.53 
(td, J = 11.9, 2.2 Hz, 1 H, HC(6)), 3.20 (ddd, J = 11.5, 10.2, 4.0 Hz, 1 H, HC(3)), 
2.32 – 2.17 (m, 1 H, HC(4)), 1.93 – 1.73 (m, 1 H, HC(5)), 1.66 (m, 2 H, HC(4), 
HC(5)). 
Data for 59k: 
 
1
H NMR: (500 MHz, CDCl3) 
  7.37 (d, J = 7.9 Hz, 2 H, HC(9)), 7.28 (t, J = 7.7 Hz, 2 H HC(10)), 7.17 (t, J = 7.4 
Hz, 1 H, HC(11)), 4.11 – 4.00 (tt, J = 6, 7 Hz, 1 H, HC(2)), 3.91 (dd, J = 14.4, 7.3 
Hz, 1 H, HC(5)), 3.77 (dd, J = 14.4, 7.8 Hz, 1 H, HC(5)), 3.16 (dd, J = 13.0, 5.8 
Hz, 1 H, HC(6)), 2.97 (dd, J = 13.0, 6.8 Hz, 1 H, HC(6)), 2.06 (m, 1 H, HC(3)), 
1.91 (m, 2 H, HC(4)), 1.66 (m, 1 H, HC(3)). 
 
Evaluation of Enantioselectivity for the Sulfenofunctionalization of 57a at -10 
o
C (Table 8 
Entry 2) [DJK-1-80] 
 
Following General Procedure 4, an oven-dried NMR tube was charged with 56 (64 mg, 
0.25 mmol, 1 equiv), and 57a (40.0 mg, 0.25 mmol). To this was added (R)-62b (13 mg, 0.025 
mmol, 0.1 equiv), CDCl3 (0.7 mL). The reaction was cooled to -10 
o
C in a cryocool. MsOH (17 
µL, 0.25 mmol, 1.0 equiv) was added. After 24 h, the reaction was quenched with Et3N (50 µL). 
Purification by silica gel flash column chromatography (SiO2, 20 g, 20 mm Ø, hexanes/EtOAc, 
30:1) afforded 42 mg (63%) of 58a as a white solid. 
Data for 58a: 
 SFC: (2R,3S)-58a, tR 4.29 min (89.4%); (2S,3R)-58a, tR 5.35 min (10.6%) (Chiralpak AD, 
5% MeOH in CO2, 3 mL/min, 220 nm, 40 
o
C) 
 
Evaluation of Enantioselectivity for the Sulfenofunctionalization of 57a at -20 
o
C (Table 8 
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Entry 3) [DJK-1-84] 
 
Following General Procedure 4, an oven-dried NMR tube was charged with 56 (64 mg, 
0.25 mmol, 1 equiv), and 57a (40.0 mg, 0.25 mmol). To this was added (R)-62b (13 mg, 0.025 
mmol, 0.1 equiv), CDCl3 (0.7 mL). The reaction was cooled to -20 
o
C in a cryocool. MsOH (17 
µL, 0.25 mmol, 1.0 equiv) was added. After 48 h, the reaction was quenched with Et3N (50 µL). 
Purification by silica gel flash column chromatography (SiO2, 20 g, 20 mm Ø, hexanes/EtOAc, 
30:1) afforded 50 mg (74%) of 58a as a white solid.  
Data for 58a: 
 SFC: (2R,3S)-58a, tR 4.29 min (91.1%); (2S,3R)-58a, tR 5.35 min (8.9%) (Chiralpak AD, 
5% MeOH in CO2, 3 mL/min, 220 nm, 40 
o
C) 
Evaluation of Enantioselectivity for for the Sulfenofunctionalization of 57k at 23 
o
C   (Table 
8 Entry 5) [DJK-1-21] 
 
Following General Procedure 4, an oven-dried NMR tube was charged with 56 (28.4 mg, 
0.11 mmol, 1.2 equiv), and 57k (8.2 mg, 0.09 mmol). To this was added (R)-62b (4.8 mg, 0.009 
mmol, 0.1 equiv), CDCl3 (0.7 mL). MsOH (6 µL, 0.09 mmol, 1.0 equiv) was added. After 16 h 
the reaction was judged to be complete by 
1
H NMR. After 24 h, the reaction was quenched with 
Et3N (50 µL). Purification by silica gel flash column chromatography (SiO2, 20 g, 20 mm Ø, 
hexanes/EtOAc, 75:1) afforded 6 mg (34%) of 59k as a white solid.  
Data for 59k: 
 SFC: (2S)-59k, tR 4.97 min (21.8%); (2R)-59k, tR 6.07 min (78.2%) (Chiralpak AD, 5 
% MeOH in CO2, 2 mL/min, 220 nm, 40 
o
C) 
 
Evaluation of Enantioselectivity for for the Sulfenofunctionalization of 57k at -10 
o
C  
(Table 8 Entry 6) [DJK-2-31] 
 
Following General Procedure 4, an oven-dried Schlenk flask was charged with 56 (64 
mg, 0.25 mmol, 1 equiv), and 57k (21.8 mg, 0.25 mmol). To this was added (R)-62b (13.1 mg, 
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0.025 mmol, 0.1 equiv), CDCl3 (0.7 mL). The reaction was cooled to -10 
o
C in a cryocool. 
MsOH (17 µL, 0.25 mmol, 1.0 equiv) was added. After 48 h the reaction was quenched with 
Et3N (50 µL). Purification by silica gel flash column chromatography (SiO2, 20 g, 20 mm Ø, 
hexanes/EtOAc, 75:1) afforded 41 mg (85%) of 59k as a white solid.  
Data for 59k: 
 SFC: (2S)-59k, tR 4.97 min (16.8%); (2R)-59k, tR 6.07 min (83.2%) (Chiralpak AD, 5  
  % MeOH in CO2, 2 mL/min, 220 nm, 40 
o
C) 
 
Evaluation of Enantioselectivity for for the Sulfenofunctionalization of 57k at -20 
o
C    
(Table 8 Entry 7) [DJK-2-13] 
 
Following General Procedure 4, an oven-dried Schlenk flask was charged with 56 (66 
mg, 0.26 mmol, 1.04 equiv), and 57k (21.2 mg, 0.25 mmol). To this was added (R)-62b (13 mg, 
0.025 mmol, 0.1 equiv), CDCl3 (0.7 mL). The reaction was cooled to -20 
o
C. MsOH (17 µL, 0.25 
mmol, 1.0 equiv) was added. After 72 h, the reaction was quenched with Et3N (50 µL). 
Purification by flash chromatography (SiO2, 20 g, 20 mm Ø, hexanes/EtOAc, 75:1) afforded 49 
mg (98%) of 59k as a white solid.  
Data for 59k: 
 SFC: (2S)-59k, tR 4.97 min (13.9%); (2R)-59k, tR 6.07 min (86.1%) (Chiralpak AD, 5 
% MeOH in CO2, 2 mL/min, 220 nm, 40 
o
C) 
 
Preparative Sulfenofunctionalization of Alkenes (Table 9) 
 
General Procedure  
  In a glovebox, a 5-mL Schlenk flask equipped with a stirbar was charged with 1 (255 mg, 
1.0 mmol, 1.0 equiv). The flask was transferred to a vacuum manifold and the corresponding 
alkene (1.0 mmol, 1.0 equiv), catalyst (R)-3c (52 mg, 0.1 mmol, 0.1 equiv), nucleophile (if 
indicated, 1.0 mmol, 1.0 equiv) and CH2Cl2 (2.5 mL) were added. The flask was placed into 
either a 1:1 ethylene glycol/water or isopropyl alcohol bath, and the bath was cooled to the 
appropriate temperature via a cryocool unit. The temperature of the mixture was monitored via a 
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thermocouple digital temperature probe. After the temperature stabilized, MsOH (65 µL, 1.0 
mmol, 1.0 equiv) was added and the mixture was allowed to stir for the indicated time. The 
reaction was quenched while cold by the addition of 150 µL of Et3N. The resulting mixture was 
poured into 20 mL of 1 M HCl in a separatory funnel, 30 mL of CH2Cl2 was added and the 
layers were thoroughly mixed. The organic layer was poured into 20 mL of 1 M NaOH and the 
layers were thoroughly mixed and then separated. The acidic layer was back-extracted with 30 
mL CH2Cl2, which was then poured into the basic layer and used to extract that layer as well. 
Both organic portions were combined, dried over MgSO4, filtered through glass wool and then 
concentrated on a rotavap (20-23 
o
C, 3 mm Hg). The product thioethers were purified by silica 
gel flash chromatography. 
 
Preparation of (2R,3S)-Tetrahydro-2-phenyl-3-(phenylthio)-2H-pyran (58a)  (Table 9 
Entry 1) [DJK-3-67] 
 
 Following General Procedure 5, a 5-mL Schlenk flask was charged with 56 (255 mg, 1.0 
mmol, 1.0 equiv), 57a (162 mg, 1.0 mmol), (R)-62b (52 mg, 0.1 mmol, 0.1 equiv) and CH2Cl2 
(2.5 mL). The mixture was cooled to -20 
o
C in an i-PrOH bath. Methanesulfonic acid (65 µL, 1.0 
mmol, 1.0 equiv) was added and the mixture was allowed to stir for 48 h. The reaction was 
worked up following the General Procedure. The product 58a was purified by flash 
chromatography (SiO2, 26 g, 20 mm Ø, hexanes/EtOAc, 80:1 to 40:1) to afford 216.1 mg, (80%) 
of a pale yellow oil. Kugelrohr distillation afforded 171 mg of analytically pure 58a which 
crystallized upon standing. The crystals were of suitable quality for single crystal X-ray 
diffraction, which unambiguously established relative and absolute configurations (see pp. 266)  
 
 Data for 58a : 
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 bp:  100 
o
C (ABT), 2 x 10
-4
 mm Hg 
 1
H NMR:  (500 MHz, CDCl3) 
  7.32 (m, 2 H, H(C-aryl)), 7.28 – 7.16 (m, 3 H, H(C-aryl)), 7.14 – 7.03 (m, 5 H, 
H(C-aryl)), 4.14 (d, J = 10.1 Hz, 1 H, HC(2)), 4.09 – 4.00 (m, 1 H, HC(6)), 3.53 
(td, J = 11.9, 2.2 Hz, 1 H, HC(6)), 3.20 (ddd, J = 11.5, 10.2, 4.0 Hz, 1 H, HC(3)), 
2.32 – 2.17 (m, 1 H, HC(4)), 1.93 – 1.73 (m, 1 H, HC(5)), 1.66 (m, 2 H, HC(4), 
HC(5)). 
13
C NMR:  (125 MHz, CDCl3) 
  139.9 (C(7)), 133.7 (C(12)), 133.0 (C-aryl), 128.5 (C-aryl), 128.2 (C-aryl), 128.1 
(C-aryl), 127.7 (C-aryl), 127.0 (C-aryl), 85.1 (C(2)), 68.5 (C6)), 50.7 (C(3)), 32.3 
(C(4)), 27.0 (C(5)) 
 IR: 3033 (s), 2937 (s), 2850 (s), 2720 (m), 1951 (m), 1872 (m), 1809 (w), 1741 (w), 
1583 (s), 1493 (s), 1473 (s), 1436 (s), 1369 (s), 1346 (m), 1325 (s), 1308 (m), 1256 
(s), 1230 (m), 1213 (m), 1179 (s), 1077 (s), 1024 (s), 1002 (s), 968 (s), 941 (s), 909 
(s), 883 (m), 851 (m), 819 (m), 780 (s), 755 (s), 696 (s), 636 (m)    
 MS: (EI) 
  270 (65), 161 (35), 160 (40), 149 (24), 136 (100), 135 (43), 91 (52), 77 (19)  
 TLC: Rf  0.27 (hexanes/EtOAc, 20:1) [CAM] 
 Opt Rot. : [α] D
24 
 -35.1 (c = 0.42, CHCl3) 
 SFC: (2R,3S)-58a, tR 5.53 min (91.1%); (2S,3R)-58a, tR 7.49 min (8.9%) (Chiralpak AD, 
5% MeOH in CO2, 2 mL/min, 220 nm, 40 
o
C) 
   Analysis: C17H18OS (270.11) 
  Calcd:  C, 75.51;  H, 6.71%  
  Found:  C, 75.73;  H, 6.55%  
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Preparation of (2R,3S)-Tetrahydro-3-(phenylthio)-2-(4-(trifluoromethyl)phenyl)-2H-pyran 
(58b) (Table 9 Entry 2) [DJK-3-43] 
 
Following General Procedure 5, a 5-mL Schlenk flask was charged with 56 (255 mg, 1.0 
mmol, 1.0 equiv), 57b (230 mg, 1.0 mmol), (R)-62b (52 mg, 0.1 mmol, 0.1 equiv) and CH2Cl2 
(2.5 mL). The mixture was cooled to -10 
o
C in a glycol/water bath. Methanesulfonic acid (65 µL, 
1.0 mmol, 1.0 equiv) was added and the mixture was allowed to stir for 48 h. The reaction was 
worked up following the General Procedure. The product 58b was purified by flash 
chromatography (SiO2, 27 g, 20 mm Ø, hexanes/dichloromethane, 9:1 to 4:1 to 0:100) to afford 
120.1 mg (36%) of 58b along with 125.5 mg (55%) of unreacted 57b. Recrystallization from hot 
hexanes (5 mL) followed by sublimation (refluxing ethanol) yielded 30.2 mg (9%) of 
analytically pure 58b as a white solid. 
Data for 58b : 
 mp:  86-88 
o
C (hexane) 
 1
H NMR:  (500 MHz, CDCl3) 
7.44 (m, 4 H, H(C-aryl)), 7.10 (m, 3 H, H(C-aryl)), 7.02 (m, 2 H, H(C-aryl)), 4.24 
(d, 1 H, J = 10.2 Hz, HC(2)), 4.09 (m, 1 H, HC(6)), 3.57 (dt, 1 H, J = 2.3, 12 Hz, 
HC(6)), 3.18 (ddd, 1 H, J = 10.1, 4, 12 Hz, HC(3)), 2.34 (m, 1 H, HC(4)), 1.89 (m, 
1H, HC(5)), 1.72 (m, 2 H, HC(4), HC(5)) 
13
C NMR:  (126 MHz, CDCl3) 
  143.77 (C(7)), 133.64 (C(13)), 132.65 (C-aryl), 130.17 (q, J = 32 Hz, C(10)), 
128.58 (C-aryl), 128.15 (C-aryl), 127.12 (C-aryl), 124.96 (q, J = 3.8 Hz, C(9)), 
124.06 (q, J = 272 Hz, C(11)), 85.02 (C(2)), 68.50 (C(6)), 50.98 (C(3)), 32.07 
H(C(4)), 27.05 (HC(5)).  
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19
F NMR:  (470 MHz, CDCl3) 
  
-63.04 
 IR:  (KBr) 
  2975 (m), 2952 (m), 2925 (m), 2863 (m), 1618 (w), 1572 (w), 1481 (w), 1439  (m), 
1425 (m), 1326 (s), 1261 (m), 1161 (s), 1134 (s), 1118 (s), 1095 (s), 1068 (s), 1018 
(s), 943 (m), 844 (m), 824 (m), 782 (m), 739 (s), 688 (m), 666 (m), 604 (m)    
 MS: (EI) 
  338 (81), 229 (27), 228 (28), 173 (20), 159 (29), 149 (40), 136 (100), 135 (40), 91 
(19), 71 (17) 
 TLC: Rf  0.31 (hexanes/EtOAc, 20:1) [CAM] 
 Opt Rot. : [α] D
24 
 -19.6 (c = 0.16, CHCl3)  
 SFC: (2R,3S)-58b, tR 4.77 min (88.1%); (2S,3R)-58b, tR 5.79 min (11.9%) (Chiralpak 
AD, 4% MeOH in CO2, 2 mL/min, 220 nm, 40 
o
C) 
 Analysis: C18H17F3OS (338.42) 
  Calcd:  C, 63.89;  H, 5.06%  
  Found:  C, 63.59;  H, 4.91%  
 
Preparation of (2R,3S)-Tetrahydro-2-(4-methoxyphenyl)-3-(phenylthio)-2H-pyran (57c) 
(Table 9 Entry 3) [DJK-3-41] 
 
Following General Procedure 5, a 5-mL Schlenk flask was charged with 56 (255 mg, 1.0 
mmol, 1.0 equiv), 57c (192 mg, 1.0 mmol, 1.0 equiv), (R)-62b (52 mg, 0.1 mmol, 0.1 equiv) and 
CH2Cl2 (2.5 mL). The mixture was cooled to -20 
o
C in a glycol/water bath. Methanesulfonic acid 
(65 µL, 1.0 mmol, 1.0 equiv) was added and the mixture was allowed to stir for 48 h. The 
reaction was worked up following the General Procedure. The product 58c was purified by flash 
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chromatography (SiO2, 27 g, 20 mm Ø, hexanes/dichloromethane, 9:1) to afford 250 mg (84%) 
of 58c as a white solid. Recrystallization from hot pentane provided 220 mg (73%) of 
analytically pure 58c as a white solid.  
Data for 58c : 
 mp:  71-73 
o
C (pentane)  
 1
H NMR:  (500 MHz, CDCl3) 
 7.26 (d, 2 H, J = 8.6 Hz, HC(8)), 7.15 (m, 5 H, H(C-aryl)), 6.80 (d, 2 H, J = 8.7Hz, 
HC(9)), 4.14 (d, 1 H, J = 10.1Hz, HC(2)), 4.07 (m, 1 H, HC(6)), 3.78 (s, 3 H, 
HC(12)), 3.55 (dt, 1 H, J = 2.2Hz, J = 12.1Hz, HC(6)), 3.23 (ddd, 1 H, J = 4.0Hz, 
10.2Hz, 12.0Hz, HC(3)), 2.26 (m, 1 H, HC(4)), 1.83 (m, 1 H, HC(5)), 1.67 (m, 2 H, 
HC(4), HC(5)) 
13
C NMR:  (125 MHz, CDCl3) 
  159.39 (C(10)), 133.67 (C(14)), 133.07 (C-aryl), 132.27 (C-aryl), 128.73 (C-aryl), 
128.49 (C-aryl), 127.01 (C(7)), 113.56 (C(9)), 84.56 (C(2)), 68.57 (C(6)), 55.24 
(C(12)). 51.76 (C(3)), 32.21 (C(4)), 27.04 (C(5)) 
 IR: (KBr) 
  2955 (s), 2935 (m), 2914 (m), 2843 (s), 1612 (s), 1583 (m), 1560 (m), 1542 (w), 
1518 (s), 1499 (m), 1491 (m), 1474 (s), 1459 (s), 1450 (m), 1440 (s), 1370 (m), 
1330 (w), 1303 (m), 1267 (m), 1245 (s), 1176 (s), 1115 (m), 1092 (s), 1074 (s), 
1030 (s), 962 (s), 949 (s), 940 (s), 922 (m), 829 (s), 817 (s), 778 (s), 748 (s), 693 (s) 
 MS: (EI) 
  300 (40, M+), 191 (28), 190 (41), 136 (100), 135 (45), 121 (42), 91 (18)  
 TLC: Rf   0.17 (hexanes/EtOAc, 10:1) [CAM] 
 Opt Rot. : [α] D
24 
 -45.5 (c = 0.2, CHCl3) 
 SFC: (2R,3S)-58c, tR 6.28 min (91.4%); (2S,3R)-58c, tR 9.88 min (8.6%) (Chiralpak AD, 
5% MeOH in CO2, 2.5 mL/min, 220 nm, 40 
o
C) 
 Analysis: C18H20O2S (300.41) 
  Calcd:  C, 71.96;  H, 6.71%  
  Found:  C, 71.64;  H, 6.90%  
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Attempted Sulfenofunctionalization of (E)-Methyl 6-hydroxyhex-2-enoate (57d) (Table 9 
Entry 4) [DJK-1-98] 
 
An oven-dried NMR tube was charged with 56 (25.6 mg, 0.1 mmol, 1 equiv), and 57d 
(14.6 mg, 0.1 mmol). To this was added (R)-62b (5.2 mg, 0.01 mmol, 0.1 equiv), CDCl3 (0.7 
mL). MsOH (6.7 µL, 0.1 mmol, 1.0 equiv) was added. After 96 h, only 57d was detectable by 
1
H 
NMR. No further manipulations were done.  
 
Preparation of (5S,6R)-Tetrahydro-2,2-dimethyl-6-phenyl-5-(phenylthio)-2H-pyran (58e) 
and (5S,8R)-Tetrahydro-2,2-dimethyl-5-(phenyl(phenylthio)methyl)furan (59e)  (Table 9 
Entry 5) [DJK-2-45] 
 
Following General Procedure 5, a 5-mL Schlenk flask was charged with 56 (255 mg, 1.0 
mmol, 1.0 equiv), 57e (190 mg, 1.0 mmol), (R)-62b (52 mg, 0.1 mmol, 0.1 equiv) and CH2Cl2 
(2.5 mL). The mixture was cooled to -20 
o
C in a i-PrOH bath. Methanesulfonic acid (65 µL, 1.0 
mmol, 1.0 equiv) was added and the mixture was allowed to stir for 48 h. The reaction was 
worked up following the General Procedure. The product was purified by flash chromatography 
(SiO2, 35 g, 20 mm Ø, hexanes/EtOAc, 100:1) to afford 181.4 mg (61%) of 58e and 70.2 mg 
(24%, combined yield 84%) of a mixture of 58e and 59e as white solids. Partial separation of 
isomers was accomplished by silica gel flash chromatography (SiO2, 3 g, 10 mm Ø, 
hexanes/dichloromethane, 4:1). 
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Data for isomer mixture : 
 IR: 3061 (m), 3028 (m), 2969 (s), 2936 (s), 2860 (s), 1583 (m), 1493 (m), 1471 (s), 
1452 (s), 1437 (s), 1380 (m), 1369 (s), 1354 (s), 1333 (m), 1309 (m), 1259 (m), 
1227 (m), 1180 (s), 1159 (s), 1124 (m), 1072 (s), 1065 (s), 1023 (s), 952 (m), 924 
(m), 911 (s), 892 (s), 819 (w), 784 (m), 757 (s), 744 (s), 701 (s), 628 (m)    
 MS: (EI)  
  298 (M+), 136 (100), 135 (23), 91 (15) 
 TLC:  Rf  58e, 0.39 (hexanes/EtOAc, 10:1) [CAM] 
 Analysis: C19H22OS (298.44) 
  Calcd. : C: 76.46; H: 7.43 
  Found : C: 76.33; H: 7.62 
 
Data for 58e : 
 mp: 58-61 
o
C  
 
1
H NMR: (500 MHz, CDCl3) 
  δ 7.4 (m, 2 H, H(C-aryl)), 7.26 (m, 3 H, H(C-aryl)), 7.13 (m, 5 H, H(C-aryl)), 
4.48 (d, J = 10.2 Hz, 1 H, HC(6)), 3.11 (ddd, J = 12.1, 10.5, 4.3 Hz, 1 H, HC(5)), 
2.08 (ddd, J = 13.5, 7.6, 4.0 Hz, 1 H, HC(4)), 1.87 (m, 1 H, HC(4)), 1.77 – 1.56 
(m, 2 H, HC(3)), 1.32 (s, 3 H, HC(7)), 1.28 (s, 3 H, HC(8)).  
 13
C NMR: (100 MHz, CDCl3) 
  δ 140.6 (C(14)), 133.9 (C(10)), 132.7 (C-aryl), 128.5 (C-aryl), 128.1 (C-aryl), 
128.0 (C-aryl), 127.8 (C-aryl), 126.9 (C-aryl), 77.8 (C(6)), 72.4 (C(2)), 51.2 
(C(5)), 37.2 (C(3)), 31.4 (C(8)), 28.7 (C(4)), 21.7 (C(7)). 
 Opt Rot. : [α] D
24 
 -4.6 (c = 0.56, CHCl3) 
 SFC: (5S,6R)-58e, tR 4.08 min (92.4%); (6S,5R)-58e, tR 4.66 min (7.6%) (Chiralpak 
AD, 5 % MeOH in CO2, 2.5 mL/min, 220 nm, 40 
o
C)  
 
Data for 59e : 
 
1
H NMR: (400 MHz, CDCl3) 
  δ 7.4 (m, 2 H, H(C-aryl)), 7.26 (m, 5 H, H(C-aryl)), 7.13 (m, 3 H, H(C-aryl)), 
4.43 (app q, J = 6.6 Hz, 1 H, HC(5)), 4.25 (d, J = 5.4 Hz, 1 H, HC(8)), 2.08 (m, 1 
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H, HC(4)), 1.87 (m, 1 H, HC(4)), 1.77 – 1.56 (m, 2 H, HC(3)), 1.20 (s, 3 H, 
HC(7)), 1.18 (s, 3 H, HC(6)).  
 
Preparation of (2R,3S)-Tetrahydro-5,5-dimethyl-2-phenyl-3-(phenylthio)-2H-pyran (58f) 
and (2R,6S)-Tetrahydro-4,4-dimethyl-2-(phenyl(phenylthio)methyl)furan (59f) (Table 9 
Entry 6) [DJK-2-46] 
 
Following General Procedure 5, a 5-mL Schlenk flask was charged with 56 (255 mg, 1.0 
mmol, 1.0 equiv), 57f (190 mg, 1.0 mmol), (R)-62b (52 mg, 0.1 mmol, 0.1 equiv) and CH2Cl2 
(2.5 mL). The mixture was cooled to -10 
o
C in a i-PrOH bath. Methanesulfonic acid (65 µL, 1.0 
mmol, 1.0 equiv) was added and the mixture was allowed to stir for 48 h. The reaction was 
worked up following the General Procedure. The product was purified by flash chromatography 
(SiO2, 30 g, 20 mm Ø, hexanes/EtOAc, 40:1) to afford 281 mg (94%) of a 19:1 mixture of 
58f:59f as a pale yellow oil. Further, partial separation of isomers was accomplished by silica gel 
flash chromatography (SiO2, 15 g, 20 mm Ø, hexanes/dichloromethane, 4:1). 
Data for isomer mixture :  
 IR: 3063 (m), 3033 (m), 2942 (s), 2927 (m), 2866 (m), 2842 (m), 1949 (w), 1581 (w), 
1495 (w), 1473 (s), 1455 (m), 1438 (s), 1390 (m), 1372 (m), 1301 (w), 1280 (m), 
1209 (w), 1079 (s), 1026 (s), 993 (s), 963 (m), 921 (w), 894 (m), 814 (m), 759 (s), 
743 (s), 699 (s), 655 (w)    
 MS: (EI) 
  298 (M+), 188 (19), 177 (84), 136 (100), 135 (38), 91 (65)  
 TLC: Rf  58f, 0.42; 59f, 0.35 (hexanes/EtOAc, 10:1) [CAM] 
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 Analysis: C19H22OS (298.44) 
  Calcd. : C: 76.46; H: 7.43 
  Found : C: 76.22; H: 7.49 
 
Data for 58f : 
 1
H NMR:  (500 MHz, CDCl3) 
  7.41 (m, 2 H, H(C-aryl)), 7.29 (m, 3 H, H(C-aryl)), 7.14 (m, 3 H, H(C-aryl)), 7.08 
(m, 2 H, H(C-aryl)), 4.12 (d, J = 10.4 Hz, 1 H, HC(2)), 3.62 (dd, J = 11.1, 2.6 Hz, 1 
H, HC(6)), 3.42 (ddd, J = 12.6, 10.4, 4.2 Hz, 1 H, HC(3)), 3.35 (d, J = 11.2 Hz, 1 H, 
HC(6)), 2.04 (ddd, J = 13.3, 4.1, 2.7 Hz, 1 H, HC(4)), 1.58 (app t, J = 13 Hz, 1 H, 
HC(4)), 1.23 (s, 3 H, HC(16)), 0.92 (s, 3 H, HC(16’)). 
13
C NMR:  (125 MHz, CDCl3) 
  δ 139.9 (C(7)), 133.9 (C(12)), 132.5 (C-aryl), 128.5 (C-aryl), 128.2 (C-aryl), 127.7 
(C-aryl), 126.9 (C-aryl), 85.3 (C(2)), 78.2 (C(6)), 48.0 (C(3)), 45.6 (C(4), 32.6 
(C(5)), 26.8 (C(16’)), 23.8 (C(16)). 
 Opt Rot. : [α] D
24 
 -27.1 (c = 0.35, CHCl3) 
 SFC:  (2R,3S)-58f tR 2.88 min (92.4%); (2S,3R)-58f tR 5.46 min (7.6%) (Chiralpak AD, 
5% MeOH in CO2, 2.5 mL/min, 220 nm, 40 
o
C) 
 
Data for 59f : 
1
H NMR:  (500 MHz, CDCl3) 
  δ 4.52 (dd, J = 16.0, 6.6 Hz, 1 H, HC(2)), 4.25 (d, J = 7.1 Hz, 1 H, HC(5)), 3.51 
(s, 1 H, HC(6)), 1.94 (dd, J = 12.4, 6.3 Hz, 1 H, HC(3)), 1.73 (dd, J = 12.4, 9.2 
Hz, 1 H, HC(3)), 1.12 (s, 3 H, HC(16)), 1.07 (s, 3 H, HC(16’)).  
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Preparation of (2R,3S)-Tetrahydro-2-phenethyl-3-(phenylthio)-2H-pyran (58g) and 
(2S,6R)-Tetrahydro-2-(3-phenyl-1-(phenylthio)propyl)furan (59g) (Table 9 Entry 7) [DJK-
2-48] 
 
Following General Procedure 5, a 5-mL Schlenk flask was charged with 56 (255 mg, 
1.0mmol, 1.0 equiv), 57g (190 mg, 1.0 mmol), (R)-62b (52 mg, 0.1 mmol, 0.1 equiv) and 
CH2Cl2 (2.5 mL). The mixture was cooled to -20 
o
C in a bath. Methanesulfonic acid (65 µL, 1.0 
mmol, 1.0 equiv) was added and the mixture was allowed to stir for 48 h. The reaction was 
worked up following the General Procedure. The product was purified by flash chromatography 
(SiO2, 28 g, 20 mm Ø, hexanes/EtOAc, 50:1) to afford 263.4 mg (88%) of a 5:1 mixture of 
58g:59g as a pale yellow oil. Partial separation of isomers was accomplished by flash 
chromatography (SiO2, 3 g, 10 mm Ø, hexanes/dichloromethane, 2:1, then SiO2, 4 g, 10 mm Ø, 
hexanes/EtOAc, 40:1) 
Data for isomer mixture :  
 IR: 3060 (m), 3025 (s), 2940 (s), 2848 (s), 2729 (w), 1946 (w), 1876 (w), 1804 (w), 
1602 (m), 1583 (m), 1496 (s), 1479 (s), 1454 (s), 1438 (s), 1377 (m), 1344 (m), 
1288 (m), 1256 (m), 1233 (m), 1179 (m), 1118 (s), 1087 (s), 1065 (s), 1038 (s), 
1025 (m), 1010 (m), 982 (m), 931 (m), 869 (m), 844 (w), 804 (w), 777 (w), 743 
(s), 700 (s)   
  MS: (EI) 
  298 (M+), 189 (24), 136 (60), 135 (28), 117 (24), 91 (100), 71 (35) 
  TLC: Rf  58g, 0.30; 59g, 0.24 (hexanes/EtOAc, 20:1)[CAM] 
 Analysis: C19H22OS (298.44) 
  Calcd. : C: 76.46; H: 7.43 
  Found : C: 76.58; H: 7.49 
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Data for 58g: 
 
1
H NMR: (500 MHz, CDCl3) 
  7.46 (d, J = 7.4 Hz, 2 H, H(C-aryl)), 7.26 (m, 5 H, H(C-aryl), 7.18 (t, 3 H, J = 7.4 
Hz, H(C-aryl)) , 4.00 (ddd, J = 9.5, 5.0, 3.1 Hz, 1 H, HC(6)), 3.36 (td, J = 11.8, 
2.5 Hz, 1 H, HC(6)), 3.20 (td, J = 9.5, 2.4 Hz, 1 H, HC(2)), 2.91 (ddd, J = 11.9, 
10.0, 4.1 Hz, 1 H, HC(3)), 2.82 (ddd, J = 14.3, 9.9, 4.8 Hz, 1 H, HC(8)), 2.69 
(ddd, J = 13.6, 9.5, 7.3 Hz, 1 H, HC(8)), 2.46 – 2.31 (m, 1 H, HC(7)), 2.19 – 2.09 
(m, 1 H, HC(5)), 1.87 – 1.77 (ddt, J = 14, 4.8, 9.3 Hz, 1 H, HC(7)), 1.77 – 1.66 
(m, 1 H, HC(4)), 1.66 – 1.58 (m, 1 H, HC(4)), 1.50 (app qd, J = 13.0, 4.2 Hz, 1 H, 
HC(5)). 
 13
C NMR: (126 MHz, CDCl3) 
  142.2 (C(9)), 133.5 (C(14)), 133.2 (C-aryl), 128.8 (C-aryl), 128.6 (C-aryl), 128.2 
(C-aryl), 127.3 (C-aryl), 125.6 (C-aryl), 80.3 (C(2)), 67.9 (C(3)), 49.0 (C(8)), 35.3 
(C(4)), 31.9 (C(8)), 31.3 (C(5)), 27.2 (C(7)), 
 Opt Rot. :  [α] D
24 
 48.9 (c = 0.44, CHCl3) 
 SFC: (2S,3R)-58g, tR 7.42 min (4.1%); (2R,3S)-58g, tR 8.19 min (95.9%) (Chiralcel OJ, 
4 % MeOH in CO2, 2 mL/min, 220 nm, 40 
o
C) 
 
 
Data for 59g: 
 
1
H NMR: (400 MHz, CDCl3) 
  7.43 (m, 2 H, H(C-aryl)), 7.24 (m, 5 H, H(C-aryl)), 7.15 (m, 3 H, H(C-aryl)), 3.94 
(q , J = 7.0 Hz, 1 H, HC(2)), 3.82 (dt, J = 14.0, 6.9 Hz, 1 H, HC(5)), 3.73 (td, J = 
7.7, 5.9 Hz, 1 H, HC(5)), 3.14 – 3.05 (m, 1 H, HC(6)), 3.04 – 2.94 (m, 1 H, 
HC(8)), 2.78 (ddd, J = 13.7, 9.7, 6.8 Hz, 1 H, HC(8)), 2.17 – 2.06 (m, 1 H, 
HC(7)), 2.06 – 1.96 (m, 1 H, HC(7)), 1.93 – 1.64 (m, 4 H, H2C(3) and H2C(4)). 
 13
C NMR: (126 MHz, CDCl3) 
  141.83 (C(14)), 135.56 (C(8)), 132.03 (C-aryl), 128.80 (C-aryl), 128.54 (C-aryl), 
128.30 (C-aryl), 126.75 (C-aryl), 125.79 (C-aryl), 81.77 (C(2)), 68.34 (C(5)), 
53.73 (C(6)), 33.52 (C(3)), 33.00 (C(13)), 29.73(C(4)), 26.01 (C(12)) 
         SFC:  (2R,6S)-59g, tR 6.89 min (4.1%); (2S,6R)-59g, tR 8.16 min (95.9%) (Chiralcel OD, 
5 % MeOH in CO2, 2 mL/min, 220 nm, 40 
o
C) 
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Preparation of (2R,3S)-Tetrahydro-2-isopropyl-3-(phenylthio)-2H-pyran (58h) and 
(2R,6S)-Tetrahydro-2-(2-methyl-1-(phenylthio)propyl)furan (59h) (Table 9 Entry 8) [DJK-
2-66] 
 
Following General Procedure 5 a 5-mL Schlenk flask was charged with 56 (255 mg, 1.0 
mmol, 1.0 equiv), 57h (128 mg, 1.0 mmol), (R)-62b (52 mg, 0.1 mmol, 0.1 equiv) and CH2Cl2 
(2.5 mL). The mixture was cooled to -20 
o
C in an i-PrOH bath. Methanesulfonic acid (65 µL, 1.0 
mmol, 1.0 equiv) was added and the mixture was allowed to stir for 48 h. The reaction was 
worked up following the General Procedure. The product was purified by flash chromatography 
(SiO2, 28 g, 20 mm Ø, hexanes/EtOAc, 40:1) to afford 168 mg (71%) of a 17:1 mixture of 
58h:59h as a pale yellow oil. Further partial separation of isomers was accomplished by silica 
gel flash chromatography (SiO2, 3 g, 10 mm Ø, hexanes/dichloromethane, 4:1)  
Data for isomer mixture : 
 IR: 3073 (m), 2958 (s), 2842 (s), 1949 (m), 1735 (m), 1583 (s), 1474 (s), 1438 (s), 
1378 (s), 1365 (s), 1303 (m), 1264 (s), 1229 (w), 1185 (m), 1085 (s), 1026 (s), 
1001 (s), 925 (s), 873 (m), 853 (w), 805 (m), 775 (s), 744 (s), 691 (s)     
 MS: (EI) 
236 (M+), 193 (61), 175 (57), 136 (100), 127 (29), 109 (35), 91 (29), 83 (26), 71 
(83), 65 (24), 54 (45) 
 TLC: Rf  58h, 0.38; 59h, 0.26 (hexanes/EtOAc, 20:1) [CAM] 
 Analysis: C14H20OS (236.37) 
  Calcd. : C: 71.14; H: 8.53  
  Found : C: 71.42; H: 8.55  
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Data for 58h : 
 
1
H NMR: (500 MHz, CDCl3) 
7.43 (d, 2 H, J = 6.9 Hz, HC(12)), 7.28 (m, 3 H, HC(13,14)), 3.95 (m, 1 H, 
HC(6)), 3.34 (dt, 1 H, J = 3.0, 11.3 Hz, HC(6)), 3.09 (dd, 1 H, J = 2.2, 10.0 Hz, 
HC(2)), 3.02 (ddd, 1 H, J = 3.9, 10.0, 11.0 Hz, HC(3)), 2.34 (dsept, 1 H, J = 2.0, 
7.0 Hz, H C(7)), 2.12 (m, 1 H, HC(4)), 1.59 (m, 3 H, HC(4,5)), 1.00 (d, 3 H, 
J=7.0 Hz, HC(8)) 0.83 (d, 3 H, J= 6.8Hz, H(C9)) 
 13
C NMR: (126 MHz, CDCl3) 
  133.7 (C11)), 133.2 (C(12)), 128.8 (C(13)), 127.3 (C(14)), 85.2 (C(2)), 68.2 
(C6)), 46.9 (C(3)), 32.1 (C(4)), 28.8 (C(7)), 27.2 (C(5)), 20.3 (C(8)), 14.5 (C(9)) 
 Opt Rot. : [α] D
24 
 85.5 (c = 0.14, CHCl3) 
 SFC:  (2R,3S)-4i, tR 3.02 min (96.4%); (2S,3R)-4i, tR 3.49 min (3.6%) (Chiralpak AD, 1 
% MeOH in CO2, 3 mL/min, 220 nm, 40 
o
C), 
Data for 59h : 
 
1
H NMR: (400 MHz, CDCl3)  
7.44 (d, 2 H, J= 7.6 Hz, HC(9)), 7.28 (t, 2 H, J = 8 Hz, HC(10)), 7.18 (d, 2 H, J = 
7.4 Hz, HC(11), 4.05 (app q, J =7.4 Hz, 1 H, HC(2)), 3.84 (app q, 1 H, J= 7.2 Hz, 
HC(5)), 3.76 (app q, 1 H, J= 7.2 Hz, HC(5)), 3.06 (dd, 1 H, J= 3.4, 8.6 Hz, 
HC(6)), 2.31 (m, 1 H, HC(12)), 2.08 (m, 1 H, HC(4,5)), 1.83 (m, 2 H, HC(4,5)), 
1.58 (m, 1 H, HC(4,5), 1.11 (d, 3 H, J= 6.9 Hz, HC(13,14)), 0.99 (d, 3 H, J= 6.9 
Hz, H(C13,14)) 
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Preparation of (2S,3S)-Tetrahydro-2-phenyl-3-(phenylthio)-2H-pyran (58i) (Table 9 Entry 
9) [DJK-1-11] 
 
An oven-dried 5-mm NMR tube was charged with 67 (34 mg, 0.15 mmol, 1.2 equiv), 57i 
(20 mg, 0.12 mmol), (R)-62a (11.5 mg 0.025 mmol, 0.2 equiv) and CDCl3 (0.7 mL). 
Trifluoroacetic acid (9.5 µL, 0.12 mmol, 1.0 equiv) was added and the mixture was allowed to 
stir for 96 h. The product was purified by flash chromatography (SiO2, 27 g, 20 mm Ø, 
hexanes/EtOAc, 40:1) to afford 13.7 mg (41%) of 58i as a pale yellow oil.  
Data for 58i: 
 
1
H NMR: (500 MHz, CDCl3) 
  δ 7.51 (m, 2H, HC(Aryl)), 7.36 (m, 4H HC(Aryl)), 7.25, (m, 1H, HC(Aryl)), 7.14 
(m, 3H, HC(Aryl)), 4.81 (s, 1H, HC(2)), 4.30 (ddt, J = 11.2, 3.5, 1.9 Hz, 1H, 
HC(6)), 3.72 (m, 1H, HC(6’)), 3.61 (s, 1H, HC(3)), 2.32 (m, 1H, HC(4,5)), 2.21 
(m, 1H, HC(4,5)), 2.09 (m, 1H, HC(4,5)), 1.51 (m, 1H, HC(4,5)). 
 SFC: (2S,3S)-58i, tR 9.05 min (47.2%); (2R,3R)-58i, tR 11.86 min (52.8%) (Chiralpak 
AD, 5 % MeOH in CO2, 2 mL/min, 220 nm, 40 
o
C) 
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Preparation of (2R,6R)-Tetrahydro-2-(3-phenyl-1-(phenylthio)propyl)furan (59j) (Table 9 
Entry 10) [DJK-2-73] 
 
Following General Procedure 5, a 5-mL Schlenk flask was charged with 56 (255 mg, 1.0 
mmol, 1.0 equiv), 59j (190 mg, 1.0 mmol), (R)-62b (52 mg, 0.1 mmol, 0.1 equiv) and CH2Cl2 
(2.5 mL). The mixture was cooled to -10 
o
C in an i-PrOH bath. Methanesulfonic acid (65 µL, 1.0 
mmol, 1.0 equiv) was added and the mixture was allowed to stir for 48 h. The reaction was 
worked up following the General Procedure. The product was purified by flash chromatography 
(SiO2, 23 g, 20 mm Ø, hexanes/EtOAc, 70:1) to afford 240 mg (81%) of 59j as a pale yellow oil.  
Data for 59j : 
 
1
H NMR: (400 MHz, CDCl3) 
  7.42 (d, J = 7.1 Hz, 2 H, H(C-aryl)), 7.28 (app t, J = 7.4 Hz, 4 H, H(C-aryl)), 7.24 
– 7.14 (m, 4 H, H(C-aryl)), 4.08 (dt, J = 11.3, 5.6 Hz, 1 H, HC(2)), 3.93 (dd, J = 
14.8, 6.6 Hz, 1 H, HC(5)), 3.78 (dd, J = 14.3, 7.1 Hz, 1 H, HC(5)), 3.23 (dt, J = 
9.1, 4.4 Hz, 1 H, HC(6)), 2.99 (ddd, J = 14.7, 9.9, 5.3 Hz, 1 H, HC(13)), 2.81 
(ddd, J = 13.8, 9.7, 6.7 Hz, 1 H, HC(13)), 2.11 (m, 1 H, HC(12)), 2.04 – 1.96 (m, 
1 H, HC(3)), 1.94 – 1.73 (m, 4 H, HC(12), H(C3), HC(4)). 
 13
C NMR: (126 MHz, CDCl3) 
  141.6 C(14), 135.7 C(8), 131.2 (C-aryl), 128.8 (C-aryl), 128.4 (C-aryl), 128.3 (C-
aryl), 126.4 (C-aryl), 125.8 (C-aryl), 80.7 (C(2)), 68.7 (C(6)), 52.3 (C(5)), 33.3 
(C(13)), 32.8 (C(12)), 28.3 (C(3)), 26.1 (C4)). 
 IR: 3060 (s), 3025 (s), 2945 (s), 2860 (s), 1947 (m), 1873 (w), 1805 (w), 1603 (m), 
1583 (s), 1496 (s), 1480 (s), 1454 (s), 1438 (s), 1357 (m), 1302 (m), 1242 (m), 
1181 (m), 1057 (s), 1025 (s), 925 (m), 869 (w), 741 (s), 699 (s)   
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 MS: (EI) 
  298 (M+), 135 (18), 117 (35), 91 (100), 71 (53), 64 (36)  
 TLC: Rf  0.18 (hexanes/EtOAc, 20:1), [CAM]  
          SFC: (2R,6R)-59j, tR 7.70 min (46.3%); (2S,6S)-59j, tR 8.50 min (53.7%) (Chiralpak 
OD, Gradient 1 % MeOH in CO2 to 10% MeOH in CO2 over 10 min, 2.5 mL/min, 
220 nm, 40 
o
C), 
 Analysis: C19H20OS (298.44) 
  Calcd. : C: 76.47; H: 7.43  
  Found : C: 76.58; H: 7.40  
  
Preparation of (2R)-Tetrahydro-2-((phenylthio)methyl)furan (59k) (Table 9 Entry 11) 
[DJK-2-53] 
 
Following General Procedure 5, a 5-mL Schlenk flask was charged with 56 (255 mg, 1.0 
mmol, 1.0 equiv), 57k (86 mg, 1.0 mmol), (R)-62b (52 mg 0.1 mmol, 0.1 equiv) and CH2Cl2 (2.5 
mL). The mixture was cooled to -10 
o
C in an i-PrOH bath. Methanesulfonic acid (65 µL, 1.0 
mmol, 1.0 equiv) was added and the mixture was allowed to stir for 48 h. The reaction was 
worked up following the General Procedure. The product was purified by flash chromatography 
(SiO2, 27 g, 20 mm Ø, hexanes/EtOAc, 80:1 to 60:1) to afford 140 mg (72%) of 59k as a pale 
yellow oil. The spectroscopic data match those published in the literature.
56a
 
Data for 59k: 
 
1
H NMR: (500 MHz, CDCl3) 
  7.37 (d, J = 7.9 Hz, 2 H, HC(9)), 7.28 (t, J = 7.7 Hz, 2 H HC(10)), 7.17 (t, J = 7.4 
Hz, 1 H, HC(11)), 4.11 – 4.00 (tt, J = 6, 7 Hz, 1 H, HC(2)), 3.91 (dd, J = 14.4, 7.3 
Hz, 1 H, HC(5)), 3.77 (dd, J = 14.4, 7.8 Hz, 1 H, HC(5)), 3.16 (dd, J = 13.0, 5.8 
Hz, 1 H, HC(6)), 2.97 (dd, J = 13.0, 6.8 Hz, 1 H, HC(6)), 2.06 (m, 1 H, HC(3)), 
1.91 (m, 2 H, HC(4)), 1.66 (m, 1 H, HC(3)). 
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 13
C NMR: (101 MHz, CDCl3) 
  136.3 (C(8)), 129.0 (C(9)), 128.7 (C(10)), 125.82 (C(11)), 77.46 (C(2)), 68.19 
(C(5)), 38.71 (C(6)), 30.82 (C(3)), 25.64 (C(4)). 
 Opt Rot. : [α] D
24 
 13.1 (c = 0.89, CHCl3) 
 SFC: (2S)-59k, tR 4.97 min (17.0%); (2R)-59k, tR 6.07 min (83.0%) (Chiralpak AD, 5 
% MeOH in CO2, 2 mL/min, 220 nm, 40 
o
C) 
 
Preparation of (2R)-Tetrahydro-2-phenyl-2-((phenylthio)methyl)furan (59l) (Table 9 Entry 
12) [DJK-2-49] 
 
Following General Procedure 5, a 5-mL Schlenk flask was charged with 56 (255 mg, 1.0 
mmol, 1.0 equiv), 57l (162 mg, 1.0 mmol), (R)-62b (52 mg, 0.1 mmol, 0.1 equiv) and CH2Cl2 
(2.5 mL). The mixture was cooled to -20 
o
C in an i-PrOH bath. Methanesulfonic acid (65 µL 1.0 
mmol, 1.0 equiv) was added and the mixture was allowed to stir for 48 h. The reaction was 
worked up following the General Procedure. The product was purified by flash chromatography 
(SiO2, 24 g, 20 mm Ø, hexanes/EtOAc, 80:1) to afford 228 mg (85%) of 59l as a pale yellow oil.  
Data for 59l : 
 
1
H NMR: (500 MHz, CDCl3) 
  7.47 (d, J = 8.1, 2 H, H(C-aryl)), 7.37 (m, 2 H, H(C-aryl)), 7.32 (m, 2 H, H(C-
aryl)), 7.26 (m, 3 H, H(C-aryl)), 7.16 (t, 1 H, J = 6.7 Hz, H(C-aryl)), 4.08 (dt, J = 
14.4, 7.1 Hz, 1 H, HC(5)), 3.95 (td, J = 8.0, 5.8 Hz, 1 H, HC(5)), 3.48 (d, J = 12.9 
Hz, 1 H, HC(10)), 3.38 (d, J = 12.9 Hz, 1 H, HC(10)), 2.43 (dt, J = 12.3, 8.2 Hz, 1 
H, HC(3)), 2.28 (ddd, J = 12.5, 7.9, 5.1 Hz, 1 H, HC(3)), 2.13 – 2.00 (m, 1 H, 
HC(4)), 1.85 (m, 1 H, HC(4)). 
 13
C NMR: (126 MHz, CDCl3) 
  145.9 (C(6)), 138.0 (C(12)), 129.5 (C-aryl), 128.9 (C-aryl), 128.4 (C-aryl), 127.2 
(C-aryl), 125.9 (C-aryl), 125.6 (C-aryl), 86.4 (C(2)), 68.4 (C(5)), 47.0 (C(10)), 
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37.1 (C(3)), 26.2 (C(4)). 
 IR: 3058 (m), 3023 (m), 2975 (m), 2872 (m), 1952 (w), 1881 (w), 1582 (w), 1480 (s), 
1446 (m), 1439 (m), 1300 (m), 1211 (m), 1120 (m), 1088 (m), 1052 (s), 1026 (s), 
979 (m), 921 (w), 880 (w), 739 (s), 702 (s)   
 MS: (EI) 
  270 (M+), 147 (100), 105 (40), 77 (21) 
 TLC: Rf  0.42 (hexanes/EtOAc, 10:1) [CAM] 
 Opt Rot. : [α] D
24 
 -8.5 (c = 0.51, CHCl3) 
 SFC:  (2R)-59l, tR 5.96 min (61.7%); (2S)-59l, tR 7.25 min (38.3%) (Chiralpak AD, 5 % 
MeOH in CO2, 2.5 mL/min, 220 nm, 40 
o
C) 
 Analysis: C17H18OS (270.11)  
  Calcd. : C: 75.51; H: 6.71 
  Found : C: 75.53; H: 6.52 
 
Preparation of (2R,3S)-Tetrahydro-2-methyl-2-phenyl-3-(phenylthio)-2H-pyran (58m) 
(Table 9 Entry 13) [DJK-3-33] 
 
 Following General Procedure 5, a 5-mL Schlenk flask was charged with 56 (255 mg, 1.0 
mmol, 1.0 equiv), 57m (176 mg, 1.0 mmol), (R)-62b (52 mg, 0.1 mmol, 0.1 equiv) and CH2Cl2 
(2.5 mL). The mixture was cooled to -20 
o
C in a glycol/water bath. Methanesulfonic acid (65 µL 
1.0 mmol, 1.0 equiv) was added at -20 
o
C and the reaction was allowed to stir for 48 h. The 
reaction was worked up following the General Procedure. The product was purified by silica gel 
flash chromatography (SiO2, 18 g, 20 mm Ø, hexanes/EtOAc, 60:1) to afford 233 mg (82%) of 
58m as a white solid. Recrystallization from hot MeOH (5 mL) followed by partial sublimation 
(refluxing ether) yielded 17 mg (6%) of analytically pure needle-like crystals.  
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Data for 58m : 
 mp:  46-48 
o
C (MeOH)  
 1
H NMR:  (500 MHz, CDCl3) 
7.55 (d, 2 H, J = 7.3 Hz, H(C-aryl)), 7.35 (t, 2 H, J = 7.7Hz, H(C-aryl)), 7.25 (t, 1H, 
J = 7.2 Hz, H(C-aryl)), 7.18 (m, 5H, H(C-aryl)), 3.85 (ddd, 1 H, J = 3.7, 8.0, 11.7 
Hz, HC(6)), 3.77 (m, 1 H, HC(6)), 3.57 (dd, 1 H, J = 3.9, 8.7 Hz, HC(3)), 2.05 (m, 
1 H, HC(4)), 1.94 (m, 2 H, HC(4), HC(5)), 1.67 (s, 3 H, HC(7)), 1.57 (m, 1 H, 
HC(5)).   
13
C NMR:  (126 MHz, CDCl3) 
  
145.3 (C(8)), 135.9 (C(13)), 131.7 (C-aryl), 128.8 (C-aryl), 128.1 (C-aryl), 127.1 
(C-aryl), 126.7 (C-aryl), 126.1 (C-aryl), 78.5 (C(2)), 61.8 (C(6)), 55.3 (C(3)), 27.8 
(C(4)), 24.6 (C(5)), 22.5 (C(7)). 
 IR: (KBr) 
  3069 (m), 2994 (m), 2941 (s), 2868 (m), 1578 (m), 1570 (m), 1492 (m), 1479 (s), 
1438 (s), 1377 (s), 1286 (m), 1247 (m), 1155 (m), 1099 (s), 1076 (s), 1059 (s), 1019 
(m), 975 (s), 940 (m), 850 (w), 827 (w), 777 (w), 755 (s), 732 (s), 699 (s), 615 (w) 
 MS: (EI) 
  284 (52, M+), 164 (25), 136 (100), 135 (41), 93 (45), 91 (17) 
   TLC: Rf  0.42 (hexanes/EtOAc, 20:1) [CAM] 
 SFC: (2R,3S)-58m, tR 5.82 min (69.8%); (2S,3R)-58m, tR 6.29 min (30.2%) (Chiralpak 
AD, gradient 1% MeOH to 10% MeOH in CO2 over 10 min, 2.5 mL/min, 220 nm,       
40 
o
C) 
 Analysis:  C18H20OS (284.41) 
   Calcd. : C: 76.01; H: 7.09 
  Found : C: 75.62; H: 7.03 
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Preparation of (2R,6S)-Tetrahydro-2-methyl-2-(phenyl(phenylthio)methyl)furan (59n) 
(Table 9 Entry 14) [DJK-3-56] 
 
 Following General Procedure 5, a 5-mL Schlenk flask was charged with 56 (255 mg, 1.0 
mmol, 1.0 equiv), 57n (176 mg, 1.0 mmol), (R)-62b (52 mg, 0.1 mmol, 0.1 equiv) and CH2Cl2 
(2.5 mL). Methanesulfonic acid (65 µL 1.0 mmol, 1.0 equiv) was added at 23 
o
C and the reaction 
was allowed to stir for 48 h. The reaction was worked up following the General Procedure. The 
product was purified by silica gel flash chromatography (SiO2, 19 g, 20 mm Ø, hexanes/EtOAc, 
40:1 then SiO2, 8 g, 10 mm Ø, hexanes/EtOAc, 60:1) to afford 69 mg (24%) of 59n as a clear 
liquid which solidified at -20 
o
C.  
Data for 59n : 
 bp: 120 
o
C, 0.15 mm Hg 
 mp: 34-36 
o
C 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.42 (d, J = 7.5 Hz, 2 H, H(C-aryl)), 7.30 – 7.20 (m, 5 H, H(C-aryl)), 7.14 (m, 3 
H, H(C-aryl)), 4.29 (s, 1 H, HC(6)), 3.96 – 3.87 (m, 2 H, HC(5)), 2.31 – 2.21 (m, 1 
H, HC(3)), 2.00 – 1.89 (m, 1 H, HC(4)), 1.86 – 1.77 (m, 2 H, HC(3), HC(4)), 1.32 
(s, 3 H, HC(16)). 
13
C NMR:  (125 MHz, CDCl3) 
  δ 140.2 (C(12)), 136.3 (C(8)), 130.8 (C-aryl), 129.6 (C-aryl), 128.6 (C-aryl), 127.8 
(C-aryl), 127.0 (C-aryl), 126.3 (C-aryl), 85.2 (C(2)), 68.3 (C(5)), 63.6 (C(6)), 36.4 
(C(3)), 26.3 (C(4)), 25.4 (C(16)). 
 IR: (KBr) 
  3058 (m), 2987 (s), 2965 (s), 2943 (m), 2924 (m), 2853 (s), 1584 (m), 1570 (m), 
1560 (w), 1491 (m), 1481 (s), 1451 (s), 1372 (m), 1353 (m), 1303 (m), 1252 (m), 
1155 (m), 1095 (s), 1072(m), 1042 (s), 910 (m), 885 (m), 834 (m), 789 (w), 764 
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(m), 746 (m), 733 (s), 703 (s), 686 (s), 650 (w)    
 MS: (EI) 
  284 (4, M+), 199 (5), 105 (6), 85 (100) 
 TLC: Rf  0.34 (hexanes/EtOAc, 20:1) [CAM] 
 SFC: (2R,6S)-59n, tR 6.28 min (60.0%); (2S,6R)-59n, tR 9.68 min (40.0%) (Chiralpak 
OD, 5 % MeOH in CO2, 2 mL/min, 220 nm, 40 
o
C), 
 Analysis: C18H20OS (284.41) 
  Calcd. : C: 76.01; H: 7.09 
  Found : C: 75.95; H: 7.03 
  
Preparation of (5R,6S)-Dihydro-5-(phenyl(phenylthio)methyl)furan-2(3H)-one (59o) (Table 
9 Entry 15) [DJK-2-58] 
 
Following General Procedure 5, a 5-mL Schlenk flask was charged with 56 (255 mg, 1.0 
mmol, 1.0 equiv), 57o (176 mg, 1.0 mmol), (R)-62b (52 mg, 0.1 mmol, 0.1 equiv) and CH2Cl2 
(2.5 mL). The mixture was cooled to -10 
o
C in an i-PrOH bath. Methanesulfonic acid (65 µL 1.0 
mmol, 1.0 equiv) was added and the reaction was allowed to stir for 48 h. The reaction was 
worked up following the General Procedure. The product was purified by flash chromatography 
(SiO2, 21 g, 20 mm Ø, hexanes/EtOAc, 6:1) to afford 237.2 mg (84%) of 59o as a white solid. 
Analytically pure material was obtained by recrystallization from hot hexane.  
Data for 59o : 
 mp: 92-93 
o
C (hexane) 
 
1
H NMR: (500 MHz, CDCl3) 
  δ 7.28 (m, 10 H, H(C-aryl)), 4.89 (dt, J = 6.3, 6.7 Hz, 1 H, HC(5)), 4.27 (d, J = 5.8 
Hz, 1 H, HC(6)), 2.49 – 2.34 (m, 2 H, HC(3), H(C4)), 2.25 (tt, J = 14.0, 6.8 Hz, 1 
H, HC(3)), 2.18 – 2.06 (m, 1 H, HC(4)). 
157 
 
 13
C NMR: (126 MHz, CDCl3) 
  δ 176.5 C(2), 137.3 C(12), 133.5 C(8), 133.0 (C-aryl), 129.0 (C-aryl), 128.8 (C-
aryl), 128.6 (C-aryl), 128 (C-aryl), 127.9 (C-aryl), 81.3 C(6), 58.1 C(5), 28.4 C(3), 
25.9 C(4). 
  IR: (KBr) 
  3071 (w), 3058 (m), 3030 (w), 2989 (w), 2944 (w), 1778 (s), 1470 (m), 1454 (m), 
1439 (m), 1408 (w), 1381 (w), 1346 (m), 1303 (w), 1279 (w), 1253 (w), 1226 (m), 
1184 (s), 1141 (w), 1111 (m), 1055 (m), 1021 (s), 994 (m), 923 (s), 870 (w), 803 
(w), 789 (w), 753 (m), 718 (m), 694 (s), 654 (w)    
 MS: (EI) 
  284 (M+), 199 (100), 175 (16), 91 (34) 
 TLC: Rf  0.12 (hexanes/EtOAc, 4:1) [CAM] 
 Opt Rot. : [α] D
24 
 113.8 (c = 0.46, CHCl3) 
 SFC:  (2R,3S)-59o, tR 11.35 min (90.7%); (2S,3R)-59o, tR 13.86 min (9.3%) (Chiralpak 
AS, 3 % MeOH in CO2, 2.5 mL/min, 220 nm, 40 
o
C) 
 Analysis: C17H16O2S (284.37) 
 Calcd. : C: 71.80 H: 5.67 
 Found : C: 71.83 H: 5.71 
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Attempted Sulfenofunctionalization of (E)-5-Phenylpent-4-enamide (57p) (Table 9 Entry 
16) [DJK-2-55] 
 
An oven-dried 5 mL Schlenk flask was charged with 56 (64.1 mg, 0.25 mmol, 1 equiv), 
and 57p (43.8 mg, 0.25 mmol). To this was added (R)-62b (13 mg, 0.025 mmol, 0.1 equiv), 
CH2Cl2 (0.7 mL). MsOH (17 µL, 0.25 mmol, 1.0 equiv) was added. After 48 h, the reaction was 
quenched with Et3N (50 µL). No desired product was observed. No further manipulations were 
done.  
 
Preparation of (4S,5R)-5-(Methoxyoctan-4-yl)(phenyl)sulfide (89a) (Table 10 Entry 1)  
[DJK-3-74] 
 
 Following General Procedure 5, a 5-mL Schlenk flask was charged with 56 (255 mg, 1.0 
mmol, 1.0 equiv), 4-octene, 88a, (112 mg, 1.0 mmol), (R)-62b (52 mg, 0.1 mmol, 0.1 equiv), 
MeOH (32 mg, 1.0 mmol, 1.0 equiv) and CH2Cl2 (2.5 mL). The mixture was cooled to -20 
o
C in 
an i-PrOH bath. Methanesulfonic acid (65 µL 1.0 mmol, 1.0 equiv) was added and the mixture 
was allowed to stir for 48 h. The reaction was worked up following the General Procedure. The 
product was purified by silica gel flash chromatography (SiO2, 20 g, 20 mm Ø, hexanes/EtOAc, 
40:1) to afford 234.7 mg (93%) of 89a as a pale yellow oil. The spectroscopic data match those 
published in the literature.
63  
Data for 89a : 
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1
H NMR: (500 MHz, CDCl3) 
  7.42 (d, J = 7.3 Hz, 2 H, HC(13)), 7.27 (t, J = 7.3 Hz, 2 H, HC(14)), 7.20 (t, 
J = 7.4 Hz, 1 H, HC(15)), 3.37 (s, 3 H, H3C(10)), 3.29 (dt, J = 8.2, 4.2 Hz, 1 H, 
HC(4)), 3.19 (m, 1 H, HC(5)), 1.57 (m, 8 H, H2C(2), H2C(3), H2C(6) and 
H2C(7)), 0.91 (t, J = 7.2 Hz, 3 H, H3C(1,8)), 0.89 (t, J = 7.2 Hz, 3 H, H3C(1,8)) 
 MS: (EI)  
  252 (M+), 166 (42), 165 (35), 123 (43), 87 (100), 55 (25) 
 Opt Rot. : [α] D
24 
 -13.1 (c = 0.41, CHCl3) 
 SFC: (4R,5S)-89a, tR 6.93 min (8.2%), (4S,5R)-89a, tR 7.72 min (91.8%) (Chiralpak OD, 
1% 95:5 hexanes/i-PrOH in CO2 , 1 mL/min, 220 nm, 40 
o
C)  
 
 
Preparation of ((4S,5S)-5-Methoxyoctan-4-yl)(phenyl)sulfane (Table 10 Entry 2) [DJK-1-
29] 
 
 An oven-dried NMR tube was charged with 1 (30.6 mg, 0.12 mmol, 1.2 equiv), 88b (11.5 
mg, 0.1 mmol), (R)-62b (5.2 mg, 0.01 mmol, 0.1 equiv), MeOH (4.1 µL, 0.1 mmol, 1 equiv) and 
CDCl3. The reaction was cooled to -20 
o
C and MsOH (6.6 µL, 0.1 mmol, 1 equiv) was added. 
The reaction was stirred for 20h and then quenched with Et3N (10 µL). Silica gel flash column 
chromatography (SiO2, 5 g, 10 mm Ø, hexanes/EtOAc 40:1) afforded 5 mg (20%) of 89b as a 
thin film.   
Data for 89b: 
 1
H NMR: (500 MHz, CDCl3) 
  7.41 (d, J = 7.3 Hz, 2 H, HC(13)), 7.27 (t, J = 7.3 Hz, 2 H, HC(14)), 7.20 (t, 
J = 7.4 Hz, 1 H, HC(15)), 3.32 (s, 3 H, H3C(10)), 3.28 (m, 1 H, HC(4)), 3.22 (m, 
1 H, HC(5)), 1.8 – 1.2(m, 8 H, H2C(2), H2C(3), H2C(6) and H2C(7)), 0.94 (m, 6 
H, H3C(1,8)) 
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 SFC: (4R,5R)-89b, tR 4.12 min (47.9%), (4S,5S)-89b, tR 4.45 min (52.1%) (Chiralpak 
OD, 0.8% MeOH in CO2 , 2.3 mL/min, 220 nm, 40 
o
C) 
  
Preparation of (R)-(2-Methoxyoctyl)(phenyl)sulfide (89c) and (S)-(1-Methoxyoctan-2-
yl)(phenyl)sulfide (90c) (Table 10 Entry 3) [DJK-2-74] 
 
Following General Procedure 5, a 5-mL Schlenk flask was charged with 56 (255 mg, 1.0 
mmol, 1.0 equiv), 1-octene, 88c, (112 mg, 1.0 mmol), (R)-62b (52 mg, 0.1 mmol, 0.1 equiv) 
MeOH (32 mg, 1.0 mmol, 1.0 equiv) and CH2Cl2 (2.5 mL). Methanesulfonic acid (65 µL 1.0 
mmol, 1.0 equiv) was added at room temperature and the reaction was allowed to stir for 48 h. 
The reaction was worked up following the General Procedure. The product was purified by flash 
chromatography (SiO2, 20 g, 20 mm Ø, hexanes/t-BuOMe, 60:1) to afford 193 mg (77%) of 89c 
as a pale yellow oil. Kugelrohr distillation (130 
o
C ABT, 3 mm Hg) afforded 123.4 mg (49%) of 
analytically pure 89c as a clear oil. Isomer separation was achieved by flash chromatography 
(SiO2, 5 g, 10 mm Ø, hexanes/dichloromethane, 9:1). 
Data for isomer mixture : 
 bp:  116 
o
C (ABT), 3 mm Hg 
   IR: 3059 (m), 2928 (s), 2859 (s), 1584 (s), 1480 (s), 1461 (s), 1438 (s), 1377 (m), 1185 
(m), 1096 (s), 1025 (s), 738 (s), 690 (s)    
 MS: (EI) 
  252 (M+), 129 (100), 124 (20), 123 (19), 109 (18), 97 (78), 69 (19), 55 (83) 
 TLC: Rf   89c, 0.27; 90c, 0.31 (hexanes/EtOAc, 20:1) [CAM] 
Analysis: C15H24OS (252.42) 
  Calcd. : C: 71.37 H: 9.58 
  Found : C: 71.12 H: 9.32 
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Data for 89c: 
 1
H NMR:  (400 MHz, CDCl3) 
7.37 (d, 2 H, J = 7.2 Hz, HC(11)), 7.28 (t, 2 H, J = 7.3 Hz, HC(12), 7.18 (t, 1 H, J 
=7.3 Hz, HC(13)), 3.34 (s, 3 H, HC(15)), 3.34 (m, 1 H, HC(2)), 3.11 (dd, 1 H, J = 
5.6, 13.1Hz, HC(1)), 2.99 (dd, 1 H, J = 6.1, 13.1 Hz, HC(1)), 1.59 (m, 2 H, H2C(3)), 
1.29 (m, 8 H, H2C(4), H2C(5), H2C(6), H2C(7)), 0.88 (t, 3 H, J = 6.8 Hz, H3C(8)) 
13
C NMR:  (125 MHz, CDCl3) 
  
136.9 (C(10)), 129.2 (C(11)), 128.8 (C(12)), 125.9 (C(13)), 79.9 (C(2)), 57.1 
(C(15)), 37.6 (C(1)), 33.3 (C(3)), 31.7 (C-alkyl), 29.3 (C-alkyl), 25.1 (C-alkyl), 
22.6 (C-alkyl), 14.1 (C(8)) 
 Opt Rot. : [α] D
24 
 5.9 (c = 0.11 , CHCl3) 
 HPLC: (S)-89c, tR 14.13 min (17.8%), (R)-89c, tR 16.92 min (82.2%) (Chiralpak AD-RH, 
45 % MeCN in H2O, 1 mL/min, 220 nm, 40 
o
C) 
Data for 90c: 
 1
H NMR:  (400 MHz, CDCl3) 
  Diagnostic Signals : 7.42 (d, J = 7.2 Hz, HC(11)), 3.51 (m, 1H, HC(1)), 3.23 (m, 
1H, HC(2))  
 
Preparation of (3R,4S)-4-(Methoxy-2-methylheptan-3-yl)(phenyl)sulfide (89d) and (3S,4R)-
3-(Methoxy-2-methylheptan-4-yl)(phenyl)sulfide (90d) (Table 10 Entry 4) [DJK-3-49] 
 
Following General Procedure 5, a 5-mL Schlenk flask was charged with 56 (255 mg, 1.0 
mmol, 1.0 equiv), (E)-2-methyl-3-heptene, 88d, (112 mg, 1.0 mmol), (R)-62b (52 mg, 0.1 mmol, 
0.1 equiv), MeOH (32 mg, 1.0 mmol, 1.0 equiv) and CH2Cl2 (2.5 mL). The mixture was cooled 
to -20 
o
C in a glycol/water bath. Methanesulfonic acid (65 µL 1.0 mmol, 1.0 equiv) was added 
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and the reaction was allowed to stir for 48 h. The reaction was worked up following the General 
Procedure. The product was purified by flash chromatography (SiO2, 20 g, 20 mm Ø, 
hexanes/dichloromethane, 9:1) followed by Kugelrohr distillation to afford 144 mg (58%) of a 
pale yellow oil, determined to be an inseparable 4:1 mixture of 89d:90d. 
Data for mixture : 
 bp:  100 
o
C (ABT, 0.3 mm Hg) 
 IR: 3073 (s), 2959 (s), 2872 (s), 2823 (s), 1583 (s), 1478 (s), 1438 (s), 1383 (s), 1364 
(s), 1329 (m), 1313 (m), 1237 (m), 1179 (s), 1151 (s), 1093 (s), 1025 (s), 983 (m), 
932 (m), 827 (m), 736 (s), 690 (s)     
 MS: (EI)  
  252 (19, M+), 164 (31), 165 (43), 123 (18), 87 (100), 55 (26)  
 TLC: Rf   0.67 (hexanes/EtOAc, 20:1) [CAM] 
  
 Analysis: C15H24OS (252.37) 
  Calcd. : C: 71.37 H: 9.58 
  Found : C: 71.57 H: 9.50 
 
Data for 89d: 
 1
H NMR:  (500 MHz, CDCl3) 
  
7.45 (d, J = 7.2 Hz, 2 H, HC(11)), 7.33 – 7.22 (t, J = 7.6 Hz, 2 H, HC(12)), 7.19 (t, 
J = 7.4 Hz, 2 H, HC(13), 3.42 – 3.35 (m, 1 H, HC(4)), 3.37 (s, 3 H, HC(15)), 3.09 
(dd, J = 6.8, 4.5 Hz, 1 H, HC(3)), 2.25 (dsept, J = 6.7 Hz, 4.4 Hz, 1 H, HC(2)), 1.70 
– 1.62 (m, 2 H, HC(5)), 1.41 – 1.27 (m, 2 H, HC(6)), 1.12 (d, J = 6.8 Hz, 3 H, 
HC(7)), 1.06 (d, J = 6.7 Hz, 3 H, HC(8)), 0.85 (t, J = 7.4 Hz, 3 H, HC(1)).
 
 
13
C NMR:  (126 MHz, CDCl3) 
  
138.0 (C(10)), 131.0 (C(11)), 128.8 (C(12)), 126.1 (C(13)), 82.5 (C(4)), 60.9 
(C(3)), 57.6 (C(15)), 33.5 (C(5)), 29.1 (C(2)), 21.7 (C(7/8)), 18.9 (C(7/8)), 18.6 
(C(6)), 14.1 (C(1))  
 
Data for 90d: 
 1
H NMR:  (500 MHz, CDCl3) 
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7.42 (d, J = 7.2 Hz, 2 H, HC(11)), 7.33 – 7.29 (m, 2 H, HC(12)), 7.24-7.21 (m, 1 H, 
HC(13)), 3.56 (s, 3 H, H(C15)), 3.25 (ddd, J = 11.2, 6.0, 3.4 Hz, 1 H, HC(4), 2.99 
(dd, J = 6.9, 4.2 Hz, 1 H, HC(3), 2.01 (dsept, J = 6.8, 6.8 Hz, 1 H, HC(2)), 1.82 – 
1.70 (m, 1 H, HC(5)), 1.62 – 1.44 (m, 3 H, HC(5)), 0.93 (m, 9 H, HC(7/8), HC(1))  
13
C NMR:  (126 MHz, CDCl3) 
  136.6 (C(10)), 131.4 (C(11)), 128.8 (C(12)), 126.4 (C(13)), 89.4 (C(4)), 61.9 
(C(15)), 52.2 (C(3)), 31.6 (C(2)), 31.3 (C(5)), 20.8 (C(7/8)), 20.0 (C(7/8)), 18.4 
(C(6)), 14.0 (C(1)). 
 
 
Preparation of (3R,4S)-4-(Methoxy-2-methylheptan-3-yl)(phenyl)sulfone (91) and (3S,4R)-
3-(Methoxy-2-methylheptan-4-yl)(phenyl)sulfone (92) (Table 10 Entry 4) [DJK-3-58] 
 
A 5-mL flame-dried Schlenk flask was charged with a 4:1 mixture of 89d:90d (25 mg, 
0.1 mmol), and CH2Cl2 (1.5 mL). m-Chloroperbenzoic acid (48 mg, 0.28 mmol, 2.8 equiv) was 
added portionwise. The reaction was stirred at 23 
o
C for 2 h. Thereupon, the reaction was poured 
into a separatory funnel containing 10 mL of a 4:1 mixture of sat. aq. Na2S2O3:H2O. The reaction 
was diluted with 9 mL CH2Cl2. The layers were separated and the organic layer was poured into 
10 mL of 1 M NaOH. The aqueous layers were then individually extracted with 10 mL CH2Cl2. 
The organic layers were combined, dried over Mg2SO4, filtered and concentrated. Passage 
through a plug of SiO2 (100% EtOAc) gave 27.0 mg (95%) of a 4:1 mixture of 91:92. The crude 
NMR showed no other products. The constitutional isomers were separated by silica gel flash 
chromatography (SiO2, 7 g, 10 mm Ø, hexanes/EtOAc, 25:1).  
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Data for mixture: 
HRMS (ESI):  Calcd. for C12H25O3S (M+H
+
) : 285.1524, found : 285.1524 
 
Data for 91: 
 1
H NMR:  (500 MHz, CDCl3) 
  
7.91 (d, J = 7.2 Hz, 2H, HC(11)), 7.63 (t, J = 7.4 Hz, 1H, HC(13)), 7.55 (t, J = 7.6 
Hz, 2H HC(12)), 3.70 (ddd, J = 7.7, 5.4, 2.5 Hz, 1H, HC(3)), 3.33 (s, 3H, HC(15)), 
3.07 (t, J = 2.7 Hz, 1H, HC(4), 2.37 (septd, J = 6.9, 2.8 Hz, 1H, HC(2)), 1.77 (dddd, 
J = 13.3, 9.9, 7.6, 5.4 Hz, 1H, HC(5)), 1.51 (ddt, J = 14.2, 9.9, 5.7 Hz, 1H, H(C(5)), 
1.37 – 1.23 (m, 2H, HC(6)), 1.21 (d, J = 7.1 Hz, 3H, HC(1)), 1.15 (d, J = 7.1 Hz, 
3H, HC(8)), 0.84 (t, J = 7.4 Hz, 3H, HC(7)). 
13
C NMR:  (126 MHz, CDCl3) 
  
133.2 (C(13)), 128.9 (C-aryl), 128.5 (C-aryl), 78.8 (C(4), 72.1 (C(3)), 58.1 (C(15)), 
35.7 (C-alkyl), 26.9 (C-alkyl), 21.7 (C-alkyl), 20.9 (C-alkyl), 19.3 (C-alkyl), 13.8 
(C-alkyl).  
 SFC:  (3R,4S)-91, tR 6.90 min (84.0%), (3S,4R)-91, tR 7.74 min (16.0%), (Welk-O, 1% 
MeOH in CO2, 3.0 mL/min, 220 nm, 40 
o
C) 
 
Data for 92: 
 1
H NMR:  (500 MHz, CDCl3) 
  
7.91 (d, J = 7.2 Hz, 2H, HC(11)), 7.65 (t, J = 7.4 Hz, 1H, HC(13)), 7.57 (t, J = 7.6 
Hz, 2H, HC(12)), 3.59 (dd, J = 7.7, 1.7 Hz, 1H, HC(3)), 3.44 (s, 3H, HC(15)), 3.06 
(td, J = 5.7, 1.6 Hz, 1H, HC(4)), 1.77 (m, 3H, H-alkyl), 1.38 – 1.26 (m, 1H, H-
alkyl), 1.24 – 1.09 (m, 2H, H-alkyl), 0.95 (d, J = 6.7 Hz, 3H, HC(1)), 0.84 (d, J = 
6.8 Hz, 3H, HC(8)), 0.78 (t, J = 7.3 Hz, 3H, HC(7)). 
 SFC:  (3S,4R)-92, tR 5.64 min (84.0%), (3R,4S)-92, tR 6.56 min (16.0%) (Welk-O, 5% 
hexane:i-PrOH, 95:5 in CO2, 2.0 mL/min, 220 nm, 40 
o
C)  
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Preparation of (4R,5S)-5-(Phenylthio)octan-4-yl acetate (89e) (Table 10 Entry 5) [DJK-2-
65] 
 
Following General Procedure 5, a 5-mL Schlenk flask was charged with 1 (255 mg, 1.0 
mmol, 1.0 equiv), 4-octene, 88a, (112 mg, 1.0 mmol), (R)-62b (52 mg, 0.1 mmol, 0.1 equiv) 
acetic acid (60 mg, 1.0 mmol, 1.0 equiv) and CH2Cl2 (2.5 mL). The mixture was cooled to -20 
o
C 
in an i-PrOH bath. Methanesulfonic acid (65 µL 1.0 mmol, 1.0 equiv) was added and the 
reaction was allowed to stir for 48 h. The reaction was worked up following the General 
Procedure. The product was purified by flash chromatography (SiO2, 24 g, 20 mm Ø, 
hexanes/EtOAc, 40:1) to afford 217 mg (77%) of 89e as a clear liquid. The spectroscopic data 
match those published in the literature.
63a
 
Data for 89e : 
 1
H NMR:  (500 MHz, CDCl3) 
7.44 (d, 2 H, J = 7.5 Hz, H(C14)), 7.29 (t, 2 H, J = 7.4 Hz, HC(15)), 7.22 (t, 1 H, J 
= 7.3 Hz, H(C16)), 5.01 (td, 1 H, J = 3.7, 9.5 Hz, H(C4)), 3.29 (td, 1 H, J = 4.2Hz, 
8.5Hz, HC(5)), 1.84 (s, 3 H, HC(11)), 1.76 (m, 2 H, H(C-alkyl)) 1.63 (m, 1 H, H(C-
alkyl)), 1.52 (m, 3 H, H(C-alkyl)), 1.35 (m, 1 H, H(C-alkyl)), 1.26 (m, 1 H, H(C-
alkyl)), 0.96 (t, 3 H, J =7.1Hz, HC(1,8)), 0.90 (t, 3 H, J =7.4Hz, HC(1,8)) 
13
C NMR: 170.8 (C(10)), 136.1 (C(13)), 132.2 (C(15)), 128.8 (C(14)), 126.8 (C(16)), 75.9 
(C(4)), 53.4 (C(5)), 33.1 (C(3,6)), 32.4 (C(3,6)), 20.8 (C(2,7,11)), 20.7 (C(2,7,11)), 
18.9 (C(2,7,11)), 13.9 (C,1,8)), 13.8 (C(1,8)). 
 MS:
 
(EI) 
  280 (M+), 220 (93), 191 (44), 165 (69), 123 (100), 69 (38), 55 (35) 
 Opt Rot. : [α] D
24
 -13.8 (c = 0.46, CHCl3) 
 HPLC:  (4S, 5R)-89e, tR 5.23 min (8.6%), (4R, 5S)-89e, tR 5.82 min (91.4%) (Chiralpak 
AD-RH, 45 % MeCN in H2O, 1 mL/min, 220 nm, 40 
o
C) 
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Preparation of N-((4R,5S)-5-(Phenylthio)octan-4-yl)acetamide (89f) (Table 10 Entry 6) 
[DJK-2-91] 
 
Following General Procedure 5, a 5-mL Schlenk flask was charged with 56 (255 mg, 1.0 
mmol, 1.0 equiv), 4-octene (112 mg, 1.0 mmol), (R)-62b (52 mg, 0.1 mmol, 0.1 equiv), 
acetonitrile (525 µL, 10.0 mmol, 10 equiv) and CH2Cl2 (2.5 mL). The mixture was cooled to -20 
o
C in an i-PrOH bath. Methanesulfonic acid (65 µL 1.0 mmol, 1.0 equiv) was added and the 
reaction was allowed to stir for 48 h. The reaction was worked up following the General 
Procedure. The product was purified by flash chromatography (SiO2, 24 g, 20 mm Ø, 
hexanes/EtOAc, 3:1) to afford 91 mg (35%) of 89f as a clear liquid. This compound was not 
characterized for publication. 
 
Data for 89f: 
 1
H NMR:  (500 MHz, CDCl3) 
7.39 (m, 2H, HC(15)), 7.27 (m, 2H, HC(14)), 7.19 (m, 1H, HC(16)), 5.50 (d, J = 
9.3 Hz, 1H, HN(9)), 4.20 (m, 1H, HC(4)), 3.39 (m, 1H, HC(5)), 1.73 (s, 3H, 
HC(11), 1.68 – 1.21 (m, 8H, HC(2,3,7,8)), 0.95 (m, 6H, HC(1,8)). 
 SFC:  (3R,4S)-89f, tR 3.08 min (89.1%), (3S,4R)-89f, tR 3.81 min (10.9%), (AD, 5% 
MeOH in CO2, 2.5 mL/min, 220 nm, 40 
o
C) 
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 5.4. Experimental Procedures For Chapter 3. 
 
Preparation of (R)-6-(Azepan-1-yl)-1,5,7,11-tetramethyl-5,7-dihydrodibenzo[d,f][1,3,2]-
diazaphosphepine 6-selenide (100) 
 
 To a dry, 20-mL Schlenk flask under argon was added 6,6-dimethyl-2,2-
di(methylamino)-1,1-biphenyl
134
 (580 mg, 2.45 mmol), THF (9 mL) and Et3N (780 μL, 
5.63 mmol, 2.30 equiv). The solution was cooled to 0 °C. Neat, distilled PCl3 (630 μL, 
7.36 mmol, 3.00 equiv) was added via syringe, and the reaction was allowed to stir for 3 h at 
room temperature. The resulting precipitate was filtered off via cannula with the filtrate being 
transferred to a 100-mL Schlenk flask. The THF was removed by stirring under vacuum. 
Azepane (310 μL, 2.80 mmol, 1.10 equiv), CH2Cl2 (15 mL) and Et3N (500 μL, 3.60 mmol, 
1.48 equiv) were added and the reaction allowed to stir for 16 h. Selenium powder (580 mg, 
7.36 mmol, 3.00 equiv) was added and the reaction stirred at room temperature for 24 h. The 
excess selenium was filtered off through a pad of Celite and the filtrate was concentrated to yield 
an orange foam. The material was dissolved in a minimal amount CH2Cl2 and purified by 
chromatography (SiO2, 140 g, 20 mm 18 cm, hexane/CH2Cl2, 6:1). The resulting off-white 
powder was filtered through a silica plug washing with hexane/Et2O (1:1) to yield 880 mg (82%) 
of (R)-100 (Note: The use of ether is important to remove all traces of selenium). An analytically 
pure sample was obtained by recrystallization from hexane (ca. 10 mL/g). 
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Data for (R)-100: 
 mp:  105–107 °C (hexane) 
 1
H NMR:  (500 MHz, CDCl3) 
   δ 7.27 (t, J = 7.8 Hz, 1H, H(C5)), 7.22 (t, J = 7.7 Hz, 1H, H(C5')), 7.15 (dd, J = 
8.1, 3.1 Hz, 2H, HC(4), HC(4')), 7.09 (d, J = 7.5 Hz, 1H, H(C6)), 7.06 (d, J = 7.6 
Hz, 1H, H(C6')), 3.18 (tt, J = 9.5, 4.6 Hz, 2H, HC(9)), 3.07 (d, J = 12.5 Hz, 3H, 
H(C8)), 2.95 (ddd, J = 14.3, 10.3, 4.6 Hz, 2H, H(C9')), 2.75 (d, J = 13.4 Hz, 3H, 
H(C8')), 2.13 (s, 3H, HC(7)), 2.03 (s, 3H, H(C7')), 1.59 (s, 8H, HC(10), C(11)). 
13
C NMR:  (125 MHz, CDCl3) 
  δ 144.6 (d, J = 5.5 Hz, C(1)), 143.6 (C(1')), 137.4 (C(3)), 136.8 (C(3')), 134.6 
(C(2)), 132.5 (d, J = 2.6 Hz, C(2')), 127.8 (d, J = 2.1 Hz, C(5)), 127.4 (C(5')), 127.2 
(C(6)), 126.9 (d, J = 2.5 Hz, C(6')), 122.0 (C(4)), 120.3 (d, J = 3.6 Hz, C(4')), 49.6 
(d, J = 2.0 Hz, C(9)), 38.7 (d, J = 10.1 Hz, C(8)), 35.5 (d, J = 6.3 Hz, C(8')), 30.3 
(d, J = 4.7 Hz, C(7)), 26.7 (C(7)), 20.0 (C(10)), 19.8 (C(11)) 
 
31
P NMR:  (202 MHz, CDCl3) 
   89.4, JP–Se = 818 Hz 
 IR: (ATR, cm
-1
)  
  2 934 (w), 2858 (w), 1665 (m), 1590 (w), 1510 (w), 1451 (m), 1380 (w), 1278 (s), 
1239 (s), 1223 (s), 1155 (s), 1088 (m), 1055(m), 1027 (s), 1001 (m), 920 (m), 892 
(w), 846 (w), 819 (s), 784 (m), 755 (m), 734 (m), 701 (s), 688 (m), 636 (s), 615 (s) 
 HRMS: calcd for C22H31N3PSe: 448.1425, found: 448.1421  
 TLC: Rf  = 0.52 (hexane/EtOAc, 4:1) 
  Analysis: C22H30N3PSe (446.44) 
  Calcd:  C, 59.19;  H, 6.77; N, 9.41  
  Found: C, 59.50;  H, 6.65; N, 9.12 
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Preparation of (2S,3R)-2-(2-Fluorophenyl)-3-(phenylthio)tetrahydro-2H-pyran (101) and 
(S)-2-((R)-(2-Fluorophenyl)(phenylthio)methyl)tetrahydrofuran (101') [DJK-11-17] 
 
 To a 10-mL Schlenk flask was added 5-(2-fluorophenyl)-pent-4-en-1-ol (99)
3
 (180 mg, 
1.00 mmol), sulfenylating agent 56 (256 mg, 1.00 mmol, 1.00 equiv), (S)-100 (52.2 mg, 
0.100 mmol, 0.100 equiv). To this was added CH2Cl2 (7 mL) and the flask was cooled to 0 °C. 
Neat, dry MsOH (48 μL, 0.75 mmol, 0.75 equiv) was added via syringe. The reaction was stirred 
for 24 h at 0 °C and then was quenched with Et3N (200 μL). The resulting white suspension was 
concentrated in vacuo (20–23 °C, 20 mmHg). The residue was taken up in a minimal amount of 
chloroform and the compound was purified by column chromatography (SiO2, 140 g, 
20 mm,22 cm, hexane/EtOAc, 20:1) to afford 227 mg (79%) of a 20:1 mixture of 101 and 101'. 
An analytically pure sample was obtained by Kugelrohr distillation. 
Data for 101: 
 bp:  130 
o
C (ABT), 0.4 mmHg 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.36 (td, J = 7.4, 1.8 Hz, 1H, HC(11)), 7.25–7.10 (m, 6H, HC(9), HC(13), 
HC(14), HC(15)), 7.05 (td, J = 7.6, 1.2 Hz, 1H, H(C(10)), 6.96 (ddd, J = 9.6, 8.3, 
1.2 Hz, 1H, HC(8)), 4.57 (d, J = 10.3 Hz, 1H, HC(1)), 4.08 (ddt, J = 11.4, 4.8, 1.7 
Hz, 1H, HC(5)), 3.57 (td, J = 11.8, 2.2 Hz, 1H, HC(5)), 3.33 (ddd, J = 12.0, 10.3, 
4.0 Hz, 1H, HC(2)), 2.33 (dtd, J = 12.9, 4.7, 2.7 Hz, 1H, HC(3)), 1.91–1.82 (m, 1H, 
HC(4)), 1.75–1.71 (m, 1H, HC(4)), 1.68 (dd, J = 12.5, 4.1 Hz, 1H, HC(3)) 
13
C NMR:  (125 MHz, CDCl3) 
  δ 160.5 (d, J =247 Hz, C(7)), 133.5 (C(12)), 133.2 (C(14)), 129.6 (d, J = 8.7 Hz, 
HC(11)), 128.8 (d, J = 4.2 Hz, HC(10)), 128.5 (C(13)), 127.3 (d, J = 11.3 Hz, C(6)) 
127.2 (C(15)), 124.0 (d, J = 3.8 Hz, C(9)), 115.3 (d, J = 22.5 Hz, C(8)), 78.4 (C(1)) 
, 68.6 (C(5)) , 50.0 (C(2)) , 32.2 (C(3)) , 27.0 (C(4)) 
19
F  NMR:  (476 MHz, CDCl3) 
   117.4 
170 
 
 IR: (NaCl plate)  
  3059 (w), 2941 (m), 2850 (m), 1619 (w), 1584 (m), 1493 (s), 1453 (m), 1438 (m), 
1371 (w), 1300 (w), 1260 (w), 1232 (s), 1190 (m), 1076 (s), 1025 (s), 970 (m), 959 
(m), 829 (m), 798 (m), 757 (s) 
 HRMS: calcd for C17H18FOS: 289.1062, found: 289.1062 
 TLC: Rf  = 0.46 (hexane/EtOAc, 4:1) 
Opt. Rot. :  []D
24
 +14.2 (c = 0.97, CHCl3) 
  Analysis: C17H17FOS (288.38) 
  Calcd:  C, 70.80;  H, 5.94;   
  Found: C, 70.56;  H, 5.96;  
  
 SFC: (2S,3R)-101, tR 5.88 min (90.4%); (2R,3S)-101, tR 5.33 min (9.6%) (Chiralpak  
  AD, 5% MeOH in CO2, 2 mL/min, 200 bar, 40 °C) 
 
Data for 101':
   
 1
H NMR:   (500 MHz, CDCl3) 
  Diagnostic signals: δ 4.62 (d, J = 6.9 Hz, 1H), 4.38 (dq, J = 0.8, 6.7 Hz, 1H), 3.87–
3.68 (m, 2H), 2.21–2.12(m, 2H), 1.90–1.82 (m, 2H) 
 
19
F  NMR:  (476 MHz, CDCl3) 
   118.90 
 
Crystallization of (R)-62b [DJK-6-5] 
 To a 1-dram vial was added 62b (52 mg, 0.1 mmol). CH2Cl2 (0.5 mL) was added. The 
vial was then placed in a closed container in the presence of a 4-dram vial containing 10 mL of 
pentanes. White spindles were obtained after 48 h which were harvested and submitted for X-ray 
analysis.  
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Reaction of Selenophosphoramide 62b with [PhS(SMe2)]SbCl6 95b [DJK-6-46] 
 
To a solution of 62b (30 mg 0.06 mmol) in DME (200 μL) was added 156 
[PhS(SMe2)]SbCl6 (30 mg, 0.058 mmol). The solution was layered with benzene (1 mL). 
Precipitation was observed. The solids were partially dissolved in CDCl3. A 4:1 ratio of two 
31
P 
NMR resonances at 62.4 ppm and 58.3 ppm respectively was observed.    
 
Disproportionation Upon Attempted Crystallization of Active Species 95b [DJK-6-52] 
 
In a glovebox, 62b (50 mg, 0.098 mmol) and 156 (48 mg, 0.097 mmol) were added to a 
5-mm NMR tube. The material was dissolved in DME (250 μL) and layered with benzene 
(1 mL). Upon standing for 24 h, orange, air-stable crystals of 102 were observed. These were 
harvested and submitted for X-ray analysis.  
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Isomerization Studies of Tetrahydrofuran Products 59 
 
 
General Procedure   
 To an oven dried 5-mm NMR-tube was added substrate, catalyst, electrophile and 
phthalimide as solids. Phthalimide was included to simulate the effect of byproduct formation 
during the reaction. MsOH was added to the side of the NMR tube via syringe. The NMR tube 
was capped with a septa and shaken well. The solution was homogenous. The NMR tube was 
then kept at the appropriate temperature for the specified time. A cryocool bath filled with 2-
propanol and a NESLAB IBC-4A cryocool was used to keep constant temperature for low 
temperature reactions. Furthermore, for low temperature reactions, a Dewar was filled with 2-
propanol and cooled to below -50 
o
C with dry ice. The NMR tube was placed in the cold Dewar 
during transport to and from the NMR spectrometer. The reactions were followed by routine 
1
H 
NMR spectroscopy.  
 
Isomerization of 59k into 58k (Table 11, entry 1) [DJK-3-31] 
 
 Following General Procedure 7, to an oven-dried NMR tube was added 59k (9.7 mg, 0.05 
mmol), 62b (5.3 mg, 0.01 mmol, 0.2 equiv), 56 (12.9 mg, 0.05 mmol, 1 equiv) and CDCl3 (0.7 
mL). Methanesulfonic acid (3.3 µL, 0.05 mmol, 1 equiv) was added at room temperature and the 
mixture was shaken. NMR monitoring revealed no isomerization of 59 k after 3h.  
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Data for 59k: 
 
1
H NMR: (500 MHz, CDCl3) 
  7.37 (d, J = 7.9 Hz, 2 H, HC(9)), 7.28 (t, J = 7.7 Hz, 2 H HC(10)), 7.17 (t, J = 7.4 
Hz, 1 H, HC(11)), 4.11 – 4.00 (tt, J = 6, 7 Hz, 1 H, HC(2)), 3.91 (dd, J = 14.4, 7.3 
Hz, 1 H, HC(5)), 3.77 (dd, J = 14.4, 7.8 Hz, 1 H, HC(5)), 3.16 (dd, J = 13.0, 5.8 
Hz, 1 H, HC(6)), 2.97 (dd, J = 13.0, 6.8 Hz, 1 H, HC(6)), 2.06 (m, 1 H, HC(3)), 
1.91 (m, 2 H, HC(4)), 1.66 (m, 1 H, HC(3)). 
 
Isomerization of 59k (Table 11, entry 2) [DJK-3-36] 
 
 Following General Procedure 7,to an oven-dried NMR tube was added 5k(19 mg, 0.1 
mmol), (R)-62b (5.3 mg, 0.01 mmol, 0.1 equiv), 56 (12.8 mg, 0.05 mmol, 0.5 equiv), 
phthalimide (9.1 mg, 0.06 mmol, 0.6 equiv) and CDCl3 (0.7 mL). The mixture was cooled to -10 
o
C in a glycol/water bath. Methanesulfonic acid (3.3 µL, 0.05 mmol, 1 equiv) was added at -10 
o
C. The mixture was shaken and kept at -10
o
C for 48 h and then quenched with Et3N (5 µl). 
NMR spectroscopy revealed no isomerization of 59k after 48 h. The product was purified by 
passage through a silica plug (hexane/EtOAc, 1:1). 59k was recovered with 100% 
enantiospecificity.  
Data for 59k: 
 1
H NMR: (500 MHz, CDCl3) 
  7.37 (d, J = 7.9 Hz, 2 H, HC(9)), 7.28 (t, J = 7.7 Hz, 2 H HC(10)), 7.17 (t, J = 7.4 
Hz, 1 H, HC(11)), 4.11 – 4.00 (tt, J = 6, 7 Hz, 1 H, HC(2)), 3.91 (dd, J = 14.4, 7.3 
Hz, 1 H, HC(5)), 3.77 (dd, J = 14.4, 7.8 Hz, 1 H, HC(5)), 3.16 (dd, J = 13.0, 5.8 
Hz, 1 H, HC(6)), 2.97 (dd, J = 13.0, 6.8 Hz, 1 H, HC(6)), 2.06 (m, 1 H, HC(3)), 
1.91 (m, 2 H, HC(4)), 1.66 (m, 1 H, HC(3)). 
 SFC:  (2S)-5j, tR 4.97 min (16.6%); (2R)-5j, tR 6.07 min (83.4%) (Chiralpak AD, 5 % 
MeOH in CO2, 2 mL/min, 220 nm, 40 
o
C) 
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Isomerization of 59j at 23 
o
C (Table 11 entry 3) [DJK-3-32] 
 
 Following General Procedure 7, to an oven-dried NMR tube was added 59j (15.1 mg, 
0.05 mmol), (R)-62b (5.3 mg, 0.01 mmol, 0.2 equiv), 56 (12.9 mg, 0.05 mmol, 1 equiv) and 
CDCl3 (0.7 mL). Methanesulfonic acid (3.3 µL, 0.05 mmol, 1 equiv) was added at room 
temperature and the mixture was shaken. After 3h, NMR spectra showed a 3.5:1 ratio of 58j:59j, 
after 4 d at room temperature the ratio was >19:1 58j:59j. 
Data for 59j : 
 
1
H NMR: (400 MHz, CDCl3) 
  7.42 (d, J = 7.1 Hz, 2 H, H(C-aryl)), 7.28 (app t, J = 7.4 Hz, 4 H, H(C-aryl)), 7.24 
– 7.14 (m, 4 H, H(C-aryl)), 4.08 (dt, J = 11.3, 5.6 Hz, 1 H, HC(2)), 3.93 (dd, J = 
14.8, 6.6 Hz, 1 H, HC(5)), 3.78 (dd, J = 14.3, 7.1 Hz, 1 H, HC(5)), 3.23 (dt, J = 
9.1, 4.4 Hz, 1 H, HC(6)), 2.99 (ddd, J = 14.7, 9.9, 5.3 Hz, 1 H, HC(13)), 2.81 
(ddd, J = 13.8, 9.7, 6.7 Hz, 1 H, HC(13)), 2.11 (m, 1 H, HC(12)), 2.04 – 1.96 (m, 
1 H, HC(3)), 1.94 – 1.73 (m, 4 H, HC(12), H(C3), HC(4)). 
Data for 58j: 
 1
H NMR: (500 MHz, CDCl3) 
 4.09 (ddt, J = 11.3, 4.3, 1.9 Hz, 1H), 3.60 (ddd, J = 8.6, 4.8, 2.2 Hz, 1H), 3.51 (td, 
J = 11.6, 2.6 Hz, 1H), 2.83 – 2.71 (m, 1H), 2.67 (ddd, J = 13.7, 9.2, 7.2 Hz, 1H), 
2.27 – 2.13 (m, 2H), 2.09 – 1.99 (m, 1H), 1.95 – 1.81 (m, 2H). 
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Isomerization of 59j at -10 
o
C (Table 11 entry 4) [DJK-3-35] 
 
 Following General Procedure 7, to an oven-dried NMR tube was added 5h (75 mg, 0.25 
mmol), 62b (13.1 mg, 0.025 mmol, 0.1 equiv), 1 (31.7 mg, 0.125 mmol, 0.5 equiv), phthalimide 
(18.5 mg, 0.125 mmol, 0.5 equiv.) and CDCl3 (0.7 mL). Methanesulfonic acid (17 µL, 0.25 
mmol, 1 equiv) was added at -10 
o
C and the mixture was shaken. After 48 h the reaction was 
quenched with Et3N (5 µL). NMR spectroscopy revealed pure 59j. 
Data for 59j : 
 
1
H NMR: (400 MHz, CDCl3) 
  7.42 (d, J = 7.1 Hz, 2 H, H(C-aryl)), 7.28 (app t, J = 7.4 Hz, 4 H, H(C-aryl)), 7.24 
– 7.14 (m, 4 H, H(C-aryl)), 4.08 (dt, J = 11.3, 5.6 Hz, 1 H, HC(2)), 3.93 (dd, J = 
14.8, 6.6 Hz, 1 H, HC(5)), 3.78 (dd, J = 14.3, 7.1 Hz, 1 H, HC(5)), 3.23 (dt, J = 
9.1, 4.4 Hz, 1 H, HC(6)), 2.99 (ddd, J = 14.7, 9.9, 5.3 Hz, 1 H, HC(13)), 2.81 
(ddd, J = 13.8, 9.7, 6.7 Hz, 1 H, HC(13)), 2.11 (m, 1 H, HC(12)), 2.04 – 1.96 (m, 
1 H, HC(3)), 1.94 – 1.73 (m, 4 H, HC(12), H(C3), HC(4)). 
 
Isomerization of 59g at 23 
o
C (Table 11 entry 5) [DJK-3-50] 
 
 Following General Procedure 7, to an oven-dried NMR tube was added 59g (7.3 mg, 
0.025 mmol), 56 (3.3 mg, 0.0125 mmol, 0.5 equiv), (R)-62b (1.2 mg, 0.0025 mmol), phthalimide 
(1.8 mg, 0.0125 mmol, 0.5 equiv.) and CDCl3 (0.7 mL). Methanesulfonic acid (1.6 µL, 0.025 
mmol, 1 equiv) was added at room temperature and the mixture was shaken. After 16 h, NMR 
spectra showed 30:1 ratio of 58g:59g. The reaction was quenched with Et3N (5 µL), and the 
product was purified by flash chromatography (SiO2, 3 g, 10 mm Ø, hexanes:EtOAc, 20:1) to 
yield 3.1 mg (42%) of 58g. 58g was formed with 100% enantiospecificity. 
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Data for 58g: 
 
1
H NMR: (500 MHz, CDCl3) 
  7.46 (d, J = 7.4 Hz, 2 H, H(C-aryl)), 7.26 (m, 5 H, H(C-aryl), 7.18 (t, 3 H, J = 7.4 
Hz, H(C-aryl)) , 4.00 (ddd, J = 9.5, 5.0, 3.1 Hz, 1 H, HC(6)), 3.36 (td, J = 11.8, 
2.5 Hz, 1 H, HC(6)), 3.20 (td, J = 9.5, 2.4 Hz, 1 H, HC(2)), 2.91 (ddd, J = 11.9, 
10.0, 4.1 Hz, 1 H, HC(3)), 2.82 (ddd, J = 14.3, 9.9, 4.8 Hz, 1 H, HC(8)), 2.69 
(ddd, J = 13.6, 9.5, 7.3 Hz, 1 H, HC(8)), 2.46 – 2.31 (m, 1 H, HC(7)), 2.19 – 2.09 
(m, 1 H, HC(5)), 1.87 – 1.77 (ddt, J = 14, 4.8, 9.3 Hz, 1 H, HC(7)), 1.77 – 1.66 
(m, 1 H, HC(4)), 1.66 – 1.58 (m, 1 H, HC(4)), 1.50 (app qd, J = 13.0, 4.2 Hz, 1 H, 
HC(5)). 
 SFC: (2S,3R)-58g, tR 7.42 min (3.9%); (2R,3S)-58g, tR 8.19 min (96.1%) (Chiralcel OJ, 
4 % MeOH in CO2, 2 mL/min, 220 nm, 40 
o
C) 
 
 
Isomerization of 59g at -20 
o
C (Table 11 entry 6) [DJK-3-57] 
 
 Following General Procedure 7, to an oven-dried NMR tube was added a 1:1 mixture of 
58g:59g (15 mg, 0.05 mmol), (R)-62b (2.4 mg, 0.005 mmol), 56 (6.5 mg, 0.025 mmol, 0.5 
equiv), phthalimide (3.7 mg, 0.025 mmol, 0.5 equiv.) and CDCl3 (0.15 mL). The mixture was 
cooled to -20 
o
C in an i-PrOH bath. Methanesulfonic acid (3.2 µL, 0.05 mmol, 1 equiv) was 
added at -20 
o
C, and the mixture was shaken. After 48 h, the reaction was quenched with Et3N (5 
µL) and 0.55 mL of CDCl3 was added. NMR spectroscopy revealed a 5.5:1 mixture of 58g:59g. 
The product was purified by flash chromatography (SiO2, 5 g, 10 mm Ø, hexane/EtOAc, 50:1) to 
afford 8.9 mg of a mixture of 58g and 59g and 4.4 mg of 59g (89% combined recovery).  
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Data for 58g: 
 
1
H NMR: (500 MHz, CDCl3) 
  7.46 (d, J = 7.4 Hz, 2 H, H(C-aryl)), 7.26 (m, 5 H, H(C-aryl), 7.18 (t, 3 H, J = 7.4 
Hz, H(C-aryl)) , 4.00 (ddd, J = 9.5, 5.0, 3.1 Hz, 1 H, HC(6)), 3.36 (td, J = 11.8, 
2.5 Hz, 1 H, HC(6)), 3.20 (td, J = 9.5, 2.4 Hz, 1 H, HC(2)), 2.91 (ddd, J = 11.9, 
10.0, 4.1 Hz, 1 H, HC(3)), 2.82 (ddd, J = 14.3, 9.9, 4.8 Hz, 1 H, HC(8)), 2.69 
(ddd, J = 13.6, 9.5, 7.3 Hz, 1 H, HC(8)), 2.46 – 2.31 (m, 1 H, HC(7)), 2.19 – 2.09 
(m, 1 H, HC(5)), 1.87 – 1.77 (ddt, J = 14, 4.8, 9.3 Hz, 1 H, HC(7)), 1.77 – 1.66 
(m, 1 H, HC(4)), 1.66 – 1.58 (m, 1 H, HC(4)), 1.50 (app qd, J = 13.0, 4.2 Hz, 1 H, 
HC(5)). 
 SFC: (2S,3R)-58g, tR 7.42 min (3.8%); (2R,3S)-58g, tR 8.19 min (96.2%) (Chiralcel OJ, 
4 % MeOH in CO2, 2 mL/min, 220 nm, 40 
o
C) 
 
 
Data for 59g: 
 
1
H NMR: (400 MHz, CDCl3) 
  7.43 (m, 2 H, H(C-aryl)), 7.24 (m, 5 H, H(C-aryl)), 7.15 (m, 3 H, H(C-aryl)), 3.94 
(q , J = 7.0 Hz, 1 H, HC(2)), 3.82 (dt, J = 14.0, 6.9 Hz, 1 H, HC(5)), 3.73 (td, J = 
7.7, 5.9 Hz, 1 H, HC(5)), 3.14 – 3.05 (m, 1 H, HC(6)), 3.04 – 2.94 (m, 1 H, 
HC(8)), 2.78 (ddd, J = 13.7, 9.7, 6.8 Hz, 1 H, HC(8)), 2.17 – 2.06 (m, 1 H, 
HC(7)), 2.06 – 1.96 (m, 1 H, HC(7)), 1.93 – 1.64 (m, 4 H, H2C(3) and H2C(4)). 
 
Determination of Reactant Order in the Sulfenofunctionalization Reaction 
 
General Procedure  
 To a dried 5-mm NMR tube, electrophile 56 and substrate 101 were added. To this was 
added 300 μL of a freshly prepared stock solution of a measured amount of catalyst 100 and 
fluorobenzene standard (1.0 equiv of standard with respect to substrate) in CDCl3, followed by 
400 μL of neat CDCl3. The sample was then inserted into a 400 MHz spectrometer that had been 
pre-cooled to the appropriate temperature and then allowed to equilibrate for 20 minutes. The 
sample was then ejected, the corresponding amount of MsOH was added, the sample was shaken 
for ca. 10 s, reinserted and 
19
F data collection was begun immediately. Data acquisition 
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parameters were as follows:  
 
Spectral Window : –100 ppm to –130 ppm 
pw = 16 μs 
Acquisition Time: 1 s 
Delay Time: 9 s 
Scans per data point: 4 
  
 A delay parameter of 20 s was introduced after each data point such that one data point 
was collected every minute. For brevity, data here is presented in 15 minute intervals. The 
reactions were followed to a minimum of 12% conversion, of which the initial 10% was used to 
determine the initial rate of the reaction.  Each experiment was repeated three times and the rates 
and standard deviations were calculated. Uncertainties are given to one standard deviation. 
 
Determination of Rate for 1.0 equiv. of substrate- Run 1  [DJK-5-20-1] 
 
 Following the General Procedure, 56 (25.5 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.01 mmol, 0.1 equiv) and MsOH (6.5 μL, 0.1 mmol, 1.0 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
8.17E-05 M/min 
 
 [101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
Kinetic Data:  
  
time, min area, IS area, Substrate [Substrate] 
1 19297.7 22228.2 0.142857 
16 19207.5 21687.6 0.140037 
31 19204.7 21577.1 0.139344 
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46 19457.6 21638.5 0.137924 
61 19350.8 21279.1 0.136382 
76 19249.5 21073.9 0.135778 
91 19309.3 20996.3 0.134859 
106 19222 20736.6 0.133796 
121 19094.3 20523.5 0.133306 
136 19488.5 20758.1 0.132103 
151 19192.6 20264.5 0.13095 
166 19402.9 20421.2 0.130532 
181 19366 20080.3 0.128598 
196 19218.4 19945.7 0.128717 
211 19142.7 19666.6 0.127418 
226 19230.4 19610.6 0.126475 
241 19142.6 19375.1 0.12553 
256 19049.9 19154.7 0.124706 
 
 
 
 
Determination of Rate for 1.0 equiv. of substrate- Run 2  [DJK-5-20-2] 
 
 Following the General Procedure, 56 (25.5 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.01 mmol, 0.1 equiv) and MsOH (6.5 μL, 0.1 mmol, 1.0 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
y = -8.17E-05x + 1.40E-01 
R² = 9.87E-01 
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7.81E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
Kinetic Data:  
 
time, min area, IS area, Substrate [Substrate] 
1 17254.8 19621.1 0.140476 
16 17627.1 19905.3 0.139501 
31 17521.1 19509.6 0.137555 
46 17478 19399.4 0.137115 
61 17137.5 18817.2 0.135643 
76 17228.6 18619.6 0.133509 
91 17372.4 18796.3 0.13366 
106 17489.5 18643 0.131682 
121 17126.1 18082.9 0.130436 
136 17331.5 18122 0.129169 
151 17221.4 17742.2 0.127271 
166 17284.2 17785.7 0.127119 
181 17168.8 17528 0.126119 
196 17216.2 17394.9 0.124817 
211 17072.7 17020.5 0.123157 
226 17257.6 17118.6 0.12254 
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Determination of Rate for 1.0 equiv. of substrate- Run 3  [DJK-5-20-3] 
 
 Following the General Procedure, 56 (25.5 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.01 mmol, 0.1 equiv) and MsOH (6.5 μL, 0.1 mmol, 1.0 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at  0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
6.52E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
Kinetic Data:  
 
time, min area, IS area, Substrate [Substrate] 
1 17254.8 19621.1 0.140476 
16 17627.1 19905.3 0.139501 
31 17521.1 19509.6 0.137555 
46 17478 19399.4 0.137115 
61 17137.5 18817.2 0.135643 
76 17228.6 18619.6 0.133509 
y = -7.81E-05x + 1.41E-01 
R² = 9.90E-01 
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91 17372.4 18796.3 0.13366 
106 17489.5 18643 0.131682 
121 17126.1 18082.9 0.130436 
136 17331.5 18122 0.129169 
151 17221.4 17742.2 0.127271 
166 17284.2 17785.7 0.127119 
181 17168.8 17528 0.126119 
196 17216.2 17394.9 0.124817 
211 17072.7 17020.5 0.123157 
226 17257.6 17118.6 0.12254 
 
 
Determination of Rate for 0.2 equiv. of substrate- Run 1  [DJK-5-21-1] 
 
 Following the General Procedure, 56 (25.5 mg, 0.1 mmol, 5.0 equiv), 101 (3.6 mg, 0.02 
mmol), catalyst 100 (4.5 mg, 0.01 mmol, 0.5 equiv) and MsOH (6.5 μL, 0.1 mmol, 5.0 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
1.73E-05 M/min 
 
[101] = 0.028 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
y = -6.52E-05x + 1.41E-01 
R² = 9.73E-01 
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Kinetic Data:  
 
time, min area, IS area, Substrate [Substrate] 
1 10351.8 4602.83 0.030159 
16 10347.9 4628.25 0.030337 
31 10308.4 4578 0.030122 
46 10243.3 4513.6 0.029887 
61 10301.3 4431.66 0.02918 
76 10200 4389.33 0.029188 
91 10272.8 4376.3 0.028895 
106 10219.4 4384.53 0.029101 
121 10361.6 4209.74 0.027557 
136 10334.6 4298.13 0.028209 
151 10249.2 4179.5 0.027659 
166 10229.7 4173.67 0.027673 
181 10229 4145.93 0.027491 
196 10300.4 4053.65 0.026693 
211 10132.1 4035.01 0.027012 
226 10247.7 4022.88 0.026627 
241 10193.8 3974.25 0.026444 
256 10243.5 3950.94 0.026161 
271 10223.1 3927.23 0.026056 
286 10221.9 3774.96 0.025049 
301 10171.7 3745.46 0.024976 
316 10224.6 3739.16 0.024805 
331 10264.8 3749.75 0.024777 
346 10191.5 3756.95 0.025004 
361 10256.3 3681.87 0.024349 
376 10126.2 3588.08 0.024034 
391 10229.7 3627 0.024049 
406 10238.9 3533.67 0.023409 
421 10141.7 3532.63 0.023626 
436 10177.5 3470.67 0.02313 
451 10193.3 3532.63 0.023506 
466 10248.4 3416.93 0.022614 
481 10249.9 3301.25 0.021846 
496 10369.6 3473.14 0.022718 
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Determination of Rate for 0.2 equiv. of substrate- Run 2  [DJK-5-21-2] 
 
 Following the General Procedure, 56 (25.5 mg, 0.1 mmol, 5.0 equiv), 101 (3.6 mg, 0.02 
mmol), catalyst 100 (4.5 mg, 0.01 mmol, 0.5 equiv) and MsOH (6.5 μL, 0.1 mmol, 5.0 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
1.93E-05 M/min 
 
[101] = 0.028 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
Kinetic Data:  
 
time, min area, IS area, Substrate [Substrate] 
1 9026.41 4012.4 0.02619 
16 8988.09 3946.27 0.025869 
31 9064.36 3894.25 0.025313 
46 9081.38 3946.81 0.025606 
61 9039.12 3848.57 0.025086 
76 8990.63 3807.15 0.02495 
y = -1.73E-05x + 3.04E-02 
R² = 9.11E-01 
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91 9027.9 3817.54 0.024914 
106 8988.36 3697.96 0.02424 
121 9046.63 3627.46 0.023625 
136 8943.41 3652.61 0.024063 
151 8969.39 3540.14 0.023255 
166 8944.07 3416.44 0.022506 
181 8923.69 3454.11 0.022806 
196 8950.07 3438.87 0.022638 
211 9054.26 3453.97 0.022476 
226 8935.37 3377.87 0.022273 
241 9026.12 3383.39 0.022085 
256 8934.23 3213.64 0.021193 
271 8989.68 3221.75 0.021116 
286 8848.51 3147.9 0.020961 
301 8939.57 3142.65 0.020713 
316 9081.41 3135.43 0.020342 
331 8974.48 3018.45 0.019817 
346 9018.71 2973.68 0.019427 
361 8946.08 2930.68 0.019301 
376 8957.99 2915.54 0.019176 
391 8922.59 2833.7 0.018712 
406 8983.35 2776.98 0.018213 
421 9032.4 2798.19 0.018253 
436 8926.65 2745.64 0.018122 
451 8972.7 2690.03 0.017664 
466 8897.56 2540.26 0.016821 
481 8920.09 2583.62 0.017065 
496 8940.66 2667.57 0.017579 
511 8833.85 2524.29 0.016836 
526 8936.04 2444.12 0.016115 
 
186 
 
 
 
Determination of Rate for 0.2 equiv. of substrate- Run 3  [DJK-5-21-3] 
 
 Following the General Procedure, 56 (25.5 mg, 0.1 mmol, 5.0 equiv), 101 (3.6 mg, 0.02 
mmol), catalyst 100 (4.5 mg, 0.01 mmol, 0.5 equiv) and MsOH (6.5 μL, 0.1 mmol, 5.0 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
1.65E-05 M/min 
 
[101] = 0.028 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
Kinetic Data:  
 
time, min area, IS area, Substrate [Substrate] 
1 10433.8 3247.82 0.027778 
16 10269.2 3198.37 0.027793 
31 10342.2 3138.71 0.027082 
46 10391.1 3180.31 0.027312 
61 10409.4 3069.53 0.026314 
76 10333.8 3150.39 0.027205 
y = -1.93E-05x + 2.63E-02 
R² = 9.18E-01 
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91 10257.2 3061.27 0.026633 
106 10340.2 3017.41 0.026041 
121 10450.2 3026.2 0.025842 
136 10327.7 2981.53 0.025762 
151 10388.7 2967.07 0.025487 
166 10342 2878.88 0.024841 
181 10316.7 2897.85 0.025066 
196 10295.4 2771.8 0.024025 
211 10254.7 2739.3 0.023838 
226 10390 2785.99 0.023928 
241 10316.9 2793.42 0.024162 
256 10336.5 2778.54 0.023988 
271 10298.7 2721.48 0.023581 
286 10457.2 2708.39 0.023112 
301 10284.8 2612.9 0.022671 
316 10360.6 2659.21 0.022904 
331 10285.2 2534.92 0.021994 
346 10405.1 2559.95 0.021955 
361 10294.9 2501.15 0.02168 
376 10305.8 2450.44 0.021218 
391 10263.7 2408.26 0.020939 
406 10265.2 2390.41 0.02078 
421 10241.1 2438.83 0.021251 
436 10300.7 2369.27 0.020526 
451 10249 2329.19 0.02028 
466 10250 2156.45 0.018774 
481 10277 2253.95 0.019572 
496 10250.7 2188.88 0.019055 
511 10236.6 2075.83 0.018096 
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Determination of Rate for 0.33 equiv. of substrate- Run 1 [DJK-5-24-1]  
 
 Following the General Procedure, 56 (25.5 mg, 0.1 mmol, 3.0 equiv), 101 (6 mg, 0.033 
mmol), catalyst 100 (4.5 mg, 0.01 mmol, 0.3 equiv) and MsOH (6.5 μL, 0.1 mmol, 3.0 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
2.3E-05 M/min 
 
[101] = 0.045 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
Kinetic Data:  
 
time, min area, IS area, Substrate [Substrate] 
1 10275.6 7687.94 0.004762 
16 10225.2 7581.16 0.004719 
31 10331.5 7527.74 0.004637 
46 10398.8 7468.9 0.004571 
61 10360.5 7553.31 0.00464 
76 10316.8 7469.57 0.004608 
91 10366.1 7246.15 0.004449 
y = -1.65E-05x + 2.79E-02 
R² = 8.65E-01 
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106 10356.8 7107.42 0.004368 
121 10263.7 7226.15 0.004481 
136 10420.5 7183.87 0.004388 
151 10357.8 7154.04 0.004396 
166 10288.5 7002.15 0.004332 
181 10185.6 6974.49 0.004358 
196 10254.3 6961.55 0.004321 
211 10134.5 6782.09 0.004259 
226 10264.4 6822.62 0.004231 
241 10237.2 6769.8 0.004209 
256 10256.8 6766.76 0.004199 
 
 
 
Determination of Rate for 0.33 equiv. of substrate- Run 2 [DJK-5-24-2] 
 
 Following the General Procedure, 56 (25.5 mg, 0.1 mmol, 3.0 equiv), 101 (6 mg, 0.033 
mmol), catalyst 100 (4.5 mg, 0.01 mmol, 0.3 equiv) and MsOH (6.5 μL, 0.1 mmol, 3.0 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
2.41E-05 M/min 
 
[101] = 0.045 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
y = -2.30E-06x + 4.71E-03 
R² = 8.91E-01 
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Kinetic Data:  
 
time, min area, IS area, Substrate [Substrate] 
1 9993.4 8446.41 0.047619 
16 10033.9 8251.56 0.046333 
31 10007.2 8158.9 0.045935 
46 9920.41 8172.94 0.046416 
61 9959.23 7992.45 0.045214 
76 9936.76 7928.88 0.044956 
91 10019.5 7933.09 0.044609 
106 9923.51 7837.48 0.044497 
121 10015 7787.27 0.043808 
136 9995.63 7683.35 0.043307 
151 9955.83 7682.62 0.043476 
166 9931.44 7648.62 0.04339 
181 9911.4 7502.03 0.042645 
196 9917.41 7481.08 0.0425 
211 9961.64 7479.11 0.0423 
226 10004.9 7475.35 0.042096 
241 9914.63 7260.81 0.04126 
256 9912.3 7195.83 0.0409 
271 9979.76 7220.15 0.040761 
286 9912.9 7163.52 0.040714 
301 9955.09 7123.25 0.040314 
316 9964.23 7024.42 0.039718 
331 9973.77 7038.52 0.03976 
346 9887.14 6979.61 0.039772 
361 9965.61 6873.82 0.038861 
376 9929.93 6851.09 0.038872 
391 9833.89 6797.05 0.038942 
406 9818.74 6651.6 0.038167 
421 9910.96 6645.56 0.037778 
436 9802.82 6611.23 0.037997 
451 9845.6 6472.2 0.037037 
466 9799.86 6486.67 0.037293 
481 9801.99 6379.07 0.036666 
496 9958.57 6471.34 0.036612 
511 9987.07 6342.19 0.035779 
526 9893.13 6308.6 0.035927 
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Determination of Rate for 0.33 equiv. of substrate- Run 3 [DJK-5-24-3] 
 
 Following the General Procedure, 56 (25.5 mg, 0.1 mmol, 3.0 equiv), 101 (6 mg, 0.033 
mmol), catalyst 100 (4.5 mg, 0.01 mmol, 0.3 equiv) and MsOH (6.5 μL, 0.1 mmol, 3.0 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
2.68E-05 M/min 
 
[101] = 0.045 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
Kinetic Data:  
 
time, min area, IS area, Substrate [Substrate] 
1 9856.83 7077.35 0.047619 
16 9821.55 7012.79 0.047354 
31 9800.34 6837.27 0.046269 
46 9894.93 6774.54 0.045406 
61 9811.66 6697.89 0.045273 
76 9868.1 6637.3 0.044607 
91 9902.04 6677.22 0.044722 
106 9883.71 6593.63 0.044244 
y = -2.41E-05x + 4.70E-02 
R² = 9.21E-01 
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121 9932.07 6621.58 0.044215 
136 9871.09 6595.42 0.044312 
151 9867.38 6372.14 0.042828 
166 9813.94 6246.19 0.04221 
181 9779.49 6326.62 0.042905 
196 9767.99 6172.65 0.04191 
211 9982.19 6196.44 0.041168 
226 9925.37 6203.28 0.04145 
241 9941.44 6070.14 0.040495 
256 9904.36 6061.91 0.040591 
 
 
 
Determination of Rate for 0.6 equiv. of substrate- Run 1 [DJK-5-26-1] 
 
 Following the General Procedure, 56 (25.5 mg, 0.1 mmol, 1.7 equiv), 101 (10.8 mg, 0.06 
mmol), catalyst 100 (4.5 mg, 0.01 mmol, 0.017 equiv) and MsOH (6.5 μL, 0.1 mmol, 1.7 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
5.53E-05 M/min 
 
[101] = 0.085 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
y = -2.68E-05x + 4.69E-02 
R² = 9.43E-01 
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Kinetic Data:  
 
time, min area, IS area, Substrate [Substrate] 
1 13257.5 12996.8 0.084921 
16 13179.1 12774.6 0.083965 
31 13211.7 12586.3 0.082524 
46 13149.4 12435.7 0.081922 
61 13228.4 12388.8 0.081126 
76 13248.3 12307.1 0.08047 
91 13199.4 12108.2 0.079463 
106 13221.2 12033.5 0.078842 
121 13163 11812 0.077733 
136 13156.6 11686.5 0.076945 
151 13078.4 11564.1 0.076594 
166 13145.7 11512.4 0.075861 
181 13173 11398.6 0.074956 
196 13142 11329.9 0.07468 
211 13105.6 11097.4 0.07335 
226 13074.4 11109.1 0.073603 
 
 
 
Determination of Rate for 0.6 equiv. of substrate- Run 2 [DJK-5-26-2] 
 
 Following the General Procedure, 56 (25.5 mg, 0.1 mmol, 1.7 equiv), 101 (10.8 mg, 0.06 
mmol), catalyst 100 (4.5 mg, 0.01 mmol, 0.017 equiv) and MsOH (6.5 μL, 0.1 mmol, 1.7 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
y = -5.53E-05x + 8.47E-02 
R² = 9.79E-01 
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NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
5.05E-05 M/min 
 
[101] = 0.085 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
Kinetic Data:  
 
time, min area, IS area, Substrate [Substrate] 
1 11883.6 12266.3 0.084921 
16 11937.4 12366.8 0.085231 
31 11926.4 12172.7 0.08397 
46 11792.9 11919.2 0.083152 
61 11841.9 11758.3 0.08169 
76 11984.6 11798.1 0.080991 
91 11768.8 11521.6 0.080543 
106 11987.7 11600.6 0.079615 
121 11774.5 11380.8 0.07952 
136 11738.5 11220.4 0.07864 
151 11780.7 11168.9 0.077999 
166 11778.4 11109.4 0.077598 
181 11813.1 10967.1 0.076379 
196 11827.6 10720.7 0.074572 
211 11782.3 10807.9 0.075467 
226 11745.1 10505 0.073585 
241 11694.9 10509.6 0.073933 
256 11733.1 10320 0.072363 
271 11677.2 10371.6 0.073073 
286 11805.3 10175.3 0.070912 
301 11815.1 10109.7 0.070396 
316 11668.2 10047 0.07084 
331 11652.6 9793.79 0.069147 
346 11739.6 9817.01 0.068798 
361 11818.6 9856.03 0.068609 
376 11657.3 9648.64 0.068095 
391 11692.5 9552.7 0.067215 
406 11714.4 9670.85 0.067919 
421 11726.2 9443.92 0.066259 
436 11653.9 9323.91 0.065823 
451 11731.4 9207.34 0.06457 
466 11792.9 9198.6 0.064172 
195 
 
481 11720.4 9078.99 0.06373 
496 11676.2 8937.52 0.062974 
511 11720.9 8899.81 0.062469 
 
 
 
Determination of Rate for 0.6 equiv. of substrate- Run 3 [DJK-5-26-3]  
 
 Following the General Procedure, 56 (25.5 mg, 0.1 mmol, 1.7 equiv), 101 (10.8 mg, 0.06 
mmol), catalyst 100 (4.5 mg, 0.01 mmol, 0.017 equiv) and MsOH (6.5 μL, 0.1 mmol, 1.7 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
5.12E-05 M/min 
 
[101] = 0.085 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
Kinetic Data:  
 
time, min area, IS area, Substrate [Substrate] 
1 433.599 424.951 0.084921 
16 435.414 421.24 0.083828 
y = -5.05E-05x + 8.55E-02 
R² = 9.65E-01 
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31 435.183 416.971 0.083023 
46 432.401 411.786 0.082518 
61 432.667 409.197 0.081949 
76 435.503 404.114 0.080404 
91 431.978 398.054 0.079844 
106 428.372 395.296 0.079958 
121 431.857 389.041 0.078058 
136 428.547 384.8 0.077804 
151 432.99 383.905 0.076826 
166 432.059 384.416 0.077094 
181 430.659 378.087 0.076071 
196 430.673 376.276 0.075704 
211 427.165 365.308 0.074101 
226 430.099 369.489 0.074438 
241 431.305 361.696 0.072664 
256 430.016 360.771 0.072696 
 
 
 
Determination of Rate for 2.0 equiv. of substrate- Run 1 [DJK-5-48-1] 
 
 Following the General Procedure, 56 (25.5 mg, 0.1 mmol, 0.5 equiv), 101 (36 mg, 0.2 
mmol), catalyst 100 (4.5 mg, 0.01 mmol, 0.05 equiv) and MsOH (6.5 μL, 0.1 mmol, 0.5 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
1.11E-04 M/min 
 
y = -5.12E-05x + 8.48E-02 
R² = 9.72E-01 
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[101] = 0.28 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
Kinetic Data:  
 
time, min area, IS area, Substrate [Substrate] 
1 16554.9 20355.8 0.285714 
16 16540.5 20302 0.285207 
31 16457.9 20034.2 0.282858 
46 16374.6 19828.3 0.281375 
61 16434.3 19713.8 0.278734 
76 16514.2 19758.2 0.27801 
91 16540.2 19749.2 0.277446 
106 16507.2 19520.8 0.274786 
121 16457.1 19297 0.272463 
136 16469.3 19227 0.271273 
151 16376.4 18979.8 0.269304 
166 16452.6 18953 0.267679 
181 16448.4 18747.3 0.264841 
196 16426.5 18753.3 0.265279 
211 16341.3 18499.2 0.263049 
226 16325 18387.9 0.261727 
241 16398.7 18322.6 0.259626 
256 16474.4 18349.2 0.258808 
271 16301 18006.8 0.25668 
286 16400.6 17925.6 0.253971 
301 16495.5 17935.2 0.252645 
316 16406.4 17787.2 0.251921 
331 16371.6 17630.2 0.250228 
346 16354 17542.9 0.249257 
361 16353 17390.3 0.247104 
376 16370.3 17321.7 0.245869 
391 16288.3 17148.4 0.244635 
406 16358.4 17050.3 0.242193 
421 16401.4 17117.6 0.242511 
436 16165 16736.8 0.240584 
451 16314.2 16761.7 0.238739 
466 16288.2 16564 0.236299 
481 16327.1 16613 0.236434 
496 16147.3 16238.8 0.233682 
511 16287.4 16361.5 0.233422 
526 16245.1 16178.2 0.231408 
198 
 
 
 
 
Determination of Rate for 2.0 equiv. of substrate- Run 2 [DJK-5-48-2] 
 
 Following the General Procedure, 56 (25.5 mg, 0.1 mmol, 0.5 equiv), 101 (36 mg, 0.2 
mmol), catalyst 100 (4.5 mg, 0.01 mmol, 0.05 equiv) and MsOH (6.5 μL, 0.1 mmol, 0.5 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
1.17E-04 M/min 
 
[101] = 0.28 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
Kinetic Data:  
 
time, min area, IS area, Substrate [Substrate] 
1 17650.1 20153.7 0.285714 
16 17810.7 20279.4 0.284904 
31 17467.1 19710.4 0.282357 
46 17486.1 19639.8 0.28104 
61 17727 19738.4 0.278613 
y = -1.11E-04x + 2.86E-01 
R² = 9.93E-01 
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76 17491 19368.8 0.277085 
91 17636.7 19463 0.276132 
106 17575.6 19281.6 0.274509 
121 17517.7 19059.8 0.272249 
136 17341.5 18707.2 0.269927 
151 17749.7 19064.6 0.268758 
166 17512.4 18713.5 0.267383 
181 17608 18642.6 0.264924 
196 17600.4 18561.9 0.263891 
211 17363.4 18067.8 0.260372 
226 17331.1 18015.6 0.260104 
 
 
 
Determination of Rate for 2.0 equiv. of substrate- Run 3 [DJK-5-48-3] 
 
 Following the General Procedure, 56 (25.5 mg, 0.1 mmol, 0.5 equiv), 101 (36 mg, 0.2 
mmol), catalyst 100 (4.5 mg, 0.01 mmol, 0.05 equiv) and MsOH (6.5 μL, 0.1 mmol, 0.5 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
1.16E-04 M/min 
 
[101] = 0.28 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
y = -1.17E-04x + 2.87E-01 
R² = 9.94E-01 
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Kinetic Data:  
 
time, min area, IS area, Substrate [Substrate] 
1 18958.3 21815.2 0.285714 
16 18826.9 21599.7 0.284866 
31 18669.7 21211.6 0.282103 
46 18744.3 21140.8 0.280043 
61 18733.9 21129.5 0.280048 
76 18802.1 21011.1 0.277469 
91 18671.9 20685.8 0.275078 
106 18745.3 20750.6 0.274859 
121 18619.1 20293.7 0.270629 
136 18629.1 20323.4 0.27088 
151 18575 20085.2 0.268485 
166 18548.5 20007 0.267821 
181 18648.1 19879.9 0.264699 
196 18658 19844.6 0.264088 
211 18668.9 19701.4 0.26203 
 
 
 
Determination of Rate for 0.3 equiv. of electrophile- Run 1 [DJK-5-34-1] 
 
 Following the General Procedure, 56 (7.6 mg, 0.03 mmol, 0.3 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.01 mmol, 0.1 equiv) and MsOH (6.5 μL, 0.1 mmol, 0.1 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
y = -1.16E-04x + 2.86E-01 
R² = 9.91E-01 
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NMR spectrometer at room 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. 
Kobs = 6.43E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.042 M 
[MsOH] = 0.14 M 
 
Kinetic Data:  
 
time, min area, IS area, Substrate [Substrate] 
1 20577.1 22405 0.142857 
16 20451.8 22223.6 0.142569 
31 20632 22108.3 0.14059 
46 20439.7 21790.5 0.139873 
61 20543.8 21580.2 0.137821 
76 20544 21498.4 0.137297 
91 20513.3 21199.4 0.13559 
106 20393.1 21046.7 0.135407 
121 20355.9 20951.5 0.135041 
136 20422.4 20810.9 0.133698 
151 20516.2 20833.3 0.13323 
166 20420 20483.3 0.131609 
181 20357.8 20210 0.13025 
196 20359.4 20316.1 0.130923 
211 20345.2 19920.7 0.128465 
226 20414.4 19900.7 0.127901 
241 20344.7 19739.9 0.127302 
256 20409.1 19867.6 0.127721 
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Determination of Rate for 0.3 equiv. of electrophile- Run 2 [DJK-5-34-2] 
 
 Following the General Procedure, 56 (7.6 mg, 0.03 mmol, 0.3 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.01 mmol, 0.1 equiv) and MsOH (6.5 μL, 0.1 mmol, 0.1 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
5.30E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.042 M 
[MsOH] = 0.14 M 
 
Kinetic Data:  
 
time, min area, IS area, Substrate [Substrate] 
1 19785.3 20881.9 0.142857 
16 19979.1 21021.1 0.142414 
31 19736.8 20538.7 0.140855 
46 19740.7 20508.6 0.14062 
61 20111.2 20733.6 0.139544 
76 19575.2 19967 0.138064 
91 19730.4 20124.8 0.138061 
y = -6.43E-05x + 1.42E-01 
R² = 9.87E-01 
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106 19575 19598.8 0.13552 
121 19689.1 19646.3 0.135061 
136 19554.2 19401 0.134295 
151 19698.1 19378.7 0.13316 
166 19784.3 19467.9 0.13319 
181 19663.9 19074.8 0.1313 
196 19479.9 18792.6 0.130579 
211 19461.9 18875.1 0.131274 
226 19626.3 18781.7 0.12953 
241 19601.2 18774.1 0.129644 
256 19529.4 18360.4 0.127253 
271 19472.4 18230.9 0.126725 
286 19574.7 18191.9 0.125793 
301 19494.8 17933.2 0.124513 
316 19612 18079.1 0.124776 
331 19463.2 17807.1 0.123838 
346 19365.8 17578.2 0.122861 
361 19564.1 17590 0.121697 
376 19560.8 17613 0.121877 
391 19542.6 17303.7 0.119848 
406 19444.6 17112.2 0.119119 
421 19768.3 17625.8 0.120685 
436 19343.4 16921.3 0.118406 
451 19482.6 17013.4 0.1182 
466 19578 16926.9 0.117026 
481 19537.7 16813.5 0.116482 
496 19473.3 16702.3 0.116094 
511 19229.2 16365.2 0.115195 
526 19414.4 16431 0.114555 
541 19352.1 16226.4 0.113493 
556 19312.4 16127.3 0.113032 
571 19464.3 16282.7 0.11323 
586 19464.2 16056.3 0.111656 
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Determination of Rate for 0.3 equiv. of electrophile- Run 3 [DJK-5-34-3] 
 
 Following the General Procedure, 56 (7.6 mg, 0.03 mmol, 0.3 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.01 mmol, 0.1 equiv) and MsOH (6.5 μL, 0.1 mmol, 0.1 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
7.13E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.042 M 
[MsOH] = 0.14 M 
 
Kinetic Data:  
 
time, min area, IS area, Substrate [Substrate] 
1 18383.4 21323.6 0.142857 
16 18718.9 21614 0.142207 
31 18368.3 20982.2 0.140685 
46 18225.9 20718.4 0.140002 
61 18280 20513.7 0.138209 
76 18383.7 20495.1 0.137304 
91 18464.1 20464.6 0.136503 
y = -5.30E-05x + 1.42E-01 
R² = 9.87E-01 
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106 18215.4 19905.5 0.134587 
121 18276.6 19804 0.133452 
136 18154.6 19461.7 0.132027 
151 18184.5 19492.8 0.13202 
166 18134.3 19251.8 0.130749 
181 18076.8 19048.7 0.129781 
196 18256.7 19079.8 0.128712 
211 18126.9 18818.6 0.127859 
226 18231.8 18936.8 0.127922 
 
 
 
Determination of Rate for 0.5 equiv. of electrophile- Run 1 [DJK-5-33-1] 
 
 Following the General Procedure, 56 (12.8 mg, 0.05 mmol, 0.5 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.01 mmol, 0.1 equiv) and MsOH (6.5 μL, 0.1 mmol, 0.1 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
7.22E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.07 M 
[MsOH] = 0.14 M 
 
y = -7.13E-05x + 1.43E-01 
R² = 9.85E-01 
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Kinetic Data:  
 
time, min area, IS area, Substrate [Substrate] 
1 19863 22121.4 0.142857 
16 19694.2 21807.8 0.142039 
31 19638.1 21692.6 0.141692 
46 19720 21369.2 0.139 
61 19776.3 21240 0.137767 
76 19669.1 21137 0.137846 
91 19658.7 20937.7 0.136618 
106 19629.3 20689.6 0.135201 
121 19548 20462.8 0.134276 
136 19702.6 20354 0.132514 
151 19631.7 20234.2 0.132209 
166 19614.1 20066.1 0.131229 
181 19517.3 19777 0.12998 
196 19564 19670.2 0.128969 
211 19660.8 19599.7 0.127874 
226 19579.3 19392.2 0.127047 
 
 
 
Determination of Rate for 0.5 equiv. of electrophile- Run 2 [DJK-5-33-2] 
 
 Following the General Procedure, 56 (12.8 mg, 0.05 mmol, 0.5 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.01 mmol, 0.1 equiv) and MsOH (6.5 μL, 0.1 mmol, 0.1 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
y = -7.22E-05x + 1.43E-01 
R² = 9.87E-01 
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NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
7.04E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.07 M 
[MsOH] = 0.14 M 
 
Kinetic Data:  
 
time, min area, IS area, Substrate [Substrate] 
1 14342.6 16649.4 0.142857 
16 14429 16677.6 0.142242 
31 14233.1 16226.6 0.140301 
46 14475.9 16302.7 0.138594 
61 14284.6 16014.9 0.137971 
76 14379.4 15897.5 0.136057 
91 14306.4 15807 0.135972 
106 14331.2 15745.7 0.135211 
121 14135 15334.4 0.133506 
136 14560.9 15768.2 0.133268 
151 14344.5 15457.8 0.132615 
166 14267 15130.4 0.130512 
181 14311 15070.4 0.129594 
196 14249.9 15026.5 0.129771 
211 14415.2 15123.1 0.129107 
226 14310.9 14809.4 0.127351 
 
208 
 
 
 
Determination of Rate for 0.5 equiv. of electrophile- Run 3 [DJK-5-33-3] 
 
 Following the General Procedure, 56 (12.8 mg, 0.05 mmol, 0.5 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.01 mmol, 0.1 equiv) and MsOH (6.5 μL, 0.1 mmol, 0.1 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
7.96E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.07 M 
[MsOH] = 0.14 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 19273.8 21606.7 0.142857 
16 19354.2 21560.9 0.141962 
31 19389.8 21212.1 0.139409 
46 19292.2 20934.5 0.138281 
61 19268 20723.8 0.137061 
76 19325.1 20707.1 0.136546 
91 19371 20546.9 0.135168 
y = -7.04E-05x + 1.43E-01 
R² = 9.74E-01 
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106 19396.8 20322.6 0.133515 
121 19209.8 19929 0.132204 
136 19406 20127.3 0.132169 
151 19308.1 19883.8 0.131232 
166 19370.7 19707.7 0.12965 
181 19349.4 19570.2 0.128887 
196 19360.8 19365.4 0.127463 
211 19419.5 19327.3 0.126828 
226 19278.3 19007.6 0.125643 
241 19300.5 18797.4 0.124111 
256 19361.4 18680.5 0.122951 
271 19309.9 18604.3 0.122776 
286 19438.2 18533.8 0.121504 
301 19394.1 18343.2 0.120528 
316 19490.1 18350.5 0.119982 
331 19324.3 17978.6 0.118559 
346 19505.9 18070.1 0.118053 
361 19626.9 18119.3 0.117644 
376 19391.7 17794.7 0.116938 
391 19310 17575.7 0.115988 
406 19409.3 17413.9 0.114332 
421 19220.2 17137.2 0.113622 
436 19402.5 17179.4 0.112832 
451 19488.2 17041.4 0.111433 
466 19364.1 16986.4 0.111785 
481 19374.3 16748.6 0.110162 
496 19489.2 16868.8 0.110299 
511 19418.1 16610 0.109004 
526 19258.9 16362.5 0.108268 
541 19534.6 16388.8 0.106911 
556 19399.4 16224.9 0.10658 
571 19506.6 16159.8 0.105569 
586 19447.8 16063.4 0.105256 
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Determination of Rate for 1.8 equiv. of electrophile- Run 1 [DJK-5-27-1] 
 
 Following the General Procedure, 56 (46 mg, 0.18 mmol, 1.8 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.01 mmol, 0.1 equiv) and MsOH (6.5 μL, 0.1 mmol, 0.1 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
7.78E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.26 M 
[MsOH] = 0.14  
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 19445.7 23603.9 0.142857 
16 19345 23274.1 0.141594 
31 19170.7 22827.2 0.140138 
46 19251 22710.5 0.13884 
61 19235.8 22450.1 0.137357 
76 19221.2 22338.7 0.136779 
91 19294.7 22273.1 0.135858 
y = -7.96E-05x + 1.43E-01 
R² = 9.82E-01 
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106 19341 22090.1 0.134419 
121 19151.3 21761.4 0.13373 
136 19289 21740.5 0.132648 
151 19271.5 21409.8 0.130749 
166 19244.8 21240.1 0.129893 
181 19209.2 21038.2 0.128896 
196 19198.3 20800.3 0.127511 
211 19261.9 20837.3 0.127316 
226 19106.8 20503 0.126291 
241 19208.5 20343.1 0.124642 
256 19147 20268 0.124581 
271 19152.1 19971.5 0.122726 
286 19121.1 19808.5 0.121922 
301 19033.1 19598 0.121184 
316 19150.4 19615.9 0.120551 
331 19267.4 19579.5 0.119597 
346 19302.5 19299.4 0.117672 
361 19186.2 19142 0.117419 
376 19038.1 18842.2 0.11648 
391 19110 18882.8 0.116291 
406 19128.4 18684.9 0.114962 
421 19080.5 18483.1 0.114006 
436 19082.7 18476.7 0.113953 
451 19185.2 18215.7 0.111743 
466 19106.6 18047.3 0.111166 
481 19092.3 17859.6 0.110092 
496 19068.8 17650.1 0.108935 
511 19157.6 17674 0.108576 
 
 
 
y = -7.78E-05x + 1.43E-01 
R² = 9.87E-01 
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Determination of Rate for 1.8 equiv. of electrophile- Run 2 [DJK-5-27-2] 
 
 Following the General Procedure, 56 (46 mg, 0.18 mmol, 1.8 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.01 mmol, 0.1 equiv) and MsOH (6.5 μL, 0.1 mmol, 0.1 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
7.92E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.26 M 
[MsOH] = 0.14  
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 18351.5 21274 0.142857 
16 18046.1 20808.6 0.142097 
31 17982.8 20414.2 0.139894 
46 18299.6 20546.5 0.138363 
61 18111 20105.8 0.136805 
76 18304.6 20209.6 0.136057 
91 18119.8 19698.1 0.133966 
106 18062 19634.9 0.133964 
121 17999.1 19408.3 0.13288 
136 18032.2 19258.5 0.131613 
151 17809.2 18801.6 0.130099 
166 17846.6 18862.8 0.130249 
181 17844.9 18648.2 0.12878 
196 18347.4 18822.8 0.126425 
211 17749.9 18153.3 0.126033 
226 18137.2 18365.5 0.124783 
241 18035.4 18108.9 0.123734 
256 17961.2 18050.3 0.123844 
271 18068.2 17841.5 0.121686 
286 18086.6 17762.2 0.121022 
301 18075.3 17531.2 0.119523 
316 18043.5 17488.4 0.119441 
331 17848.9 17181.3 0.118623 
346 18224.1 17332.1 0.117201 
213 
 
361 18116 17047 0.11596 
376 17977.5 16740.2 0.114751 
391 17911.1 16587.7 0.114127 
406 18222.2 16703 0.112958 
421 17929 16392.4 0.112671 
436 18214.3 16340.3 0.110553 
451 18108 16204.8 0.11028 
466 17854.9 15812.3 0.109134 
481 17968.3 15925.2 0.10922 
496 18020.7 15669.4 0.107153 
511 18104.5 15681.8 0.106742 
526 17814.7 15283.4 0.105722 
 
 
 
Determination of Rate for 1.8 equiv. of electrophile- Run 3 [DJK-5-27-3] 
 
 Following the General Procedure, 56 (46 mg, 0.18 mmol, 1.8 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.01 mmol, 0.1 equiv) and MsOH (6.5 μL, 0.1 mmol, 0.1 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
8.21E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.26 M 
y = -7.92E-05x + 1.42E-01 
R² = 9.77E-01 
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[MsOH] = 0.14  
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 17815.6 21628.9 0.142857 
16 17686.6 21177.4 0.140895 
31 17868.8 21198.9 0.1396 
46 17670.5 20799.4 0.138506 
61 17697.8 20610.7 0.137038 
76 17709.2 20398.1 0.135537 
91 17663.4 20205.7 0.134607 
106 17692.1 19970.3 0.132823 
121 17664.5 19861.2 0.132304 
136 17607.6 19625.5 0.131156 
151 17682.2 19444.5 0.129398 
166 17689.6 19226 0.127891 
181 17691.5 19179.7 0.127569 
196 17753.5 19036.1 0.126172 
211 17692.8 18787.1 0.124949 
226 17594.1 18559 0.124124 
241 17636.4 18347.2 0.122413 
256 17567.6 18266.7 0.122353 
271 17618.3 18050.1 0.120555 
286 17580.2 17895.3 0.11978 
301 17677.3 17760.1 0.118222 
316 17511.9 17619.1 0.118391 
331 17495.9 17456.9 0.117408 
346 17462.1 17192.2 0.115852 
361 17608.3 17109.6 0.114338 
376 17494.4 16867 0.113451 
391 17689.4 16759.6 0.111486 
406 17584.3 16497.7 0.110399 
421 17521.9 16495.3 0.110776 
436 17479.9 16270.6 0.10953 
451 17596.9 16243.8 0.108622 
466 17512.8 16011.8 0.107585 
481 17542.4 15880 0.10652 
496 17552.4 15790.4 0.105858 
511 17575.3 15721.3 0.105258 
526 17498.5 15485 0.104131 
541 17523.2 15280.2 0.102609 
556 17582.9 15194.3 0.101685 
571 17526.4 15045 0.101011 
215 
 
586 17561 14997.6 0.100494 
 
 
 
 
Determination of Rate for 3.0 equiv. of electrophile- Run 1 [DJK-5-29-1] 
 
 Following the General Procedure, 56 (76.6 mg, 0.3 mmol, 3.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.01 mmol, 0.1 equiv) and MsOH (6.5 μL, 0.1 mmol, 0.1 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
8.26E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.42 M 
[MsOH] = 0.14  
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 18605.1 19509.4 0.142857 
16 18481.4 19098 0.140781 
31 18469.7 18806.8 0.138722 
y = -8.21E-05x + 1.42E-01 
R² = 9.84E-01 
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46 18214.1 18483.7 0.138252 
61 18402.3 18501.9 0.136973 
76 18297.8 18209.1 0.135575 
91 18469.4 18241.6 0.134555 
106 18456 18069.8 0.133385 
121 18658.4 18113.4 0.132256 
136 18256.8 17580.5 0.131189 
151 18119.8 17385.1 0.130712 
166 18346.3 17330.9 0.128695 
181 18352.5 17342.9 0.128741 
196 18285.1 17048.3 0.12702 
211 18554.4 17153.2 0.125947 
226 18933.8 17366.7 0.12496 
 
 
 
Determination of Rate for 3.0 equiv. of electrophile- Run 2 [DJK-5-29-2] 
 
 Following the General Procedure, 56 (76.6 mg, 0.3 mmol, 3.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.01 mmol, 0.1 equiv) and MsOH (6.5 μL, 0.1 mmol, 0.1 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
8.58E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.42 M 
y = -8.26E-05x + 1.42E-01 
R² = 9.82E-01 
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[MsOH] = 0.14  
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 18060.7 19782.1 0.142857 
16 18220.6 19721 0.141166 
31 18231.3 19568.8 0.139994 
46 18118 19237 0.138481 
61 18227.7 19183 0.137262 
76 18065 18989.7 0.137102 
91 18247.9 18931.3 0.135311 
106 18154.8 18704.1 0.134372 
121 18196 18415 0.131996 
136 18146 18208.8 0.130877 
151 18166.6 18087.9 0.129861 
166 18181.6 17910 0.128478 
181 18159.7 17799.3 0.127838 
196 18107.5 17562.3 0.126499 
211 18277.5 17562.9 0.125327 
226 18203.3 17386.2 0.124571 
241 18342 17326.6 0.123206 
256 18150.7 16957 0.121848 
271 17924.6 16901.2 0.122979 
286 18230.7 16798 0.120176 
301 17946.4 16553.3 0.120302 
316 18128.5 16361.9 0.117716 
331 18133.1 16276.6 0.117073 
346 18174.8 16042.4 0.115123 
361 18080.8 15872.4 0.114496 
376 18202.9 15916.8 0.114046 
391 18185.2 15752.9 0.112981 
406 18199.1 15672.6 0.11232 
421 18085.6 15437.5 0.111329 
436 18135.4 15366 0.110509 
451 18073.3 15116.1 0.109085 
466 18185.1 15063.3 0.108036 
481 18164.4 15020.9 0.107855 
496 18116.7 14784.5 0.106437 
511 18296.9 14803 0.10552 
526 18093.7 14567.5 0.105008 
541 18122 14456.7 0.104046 
556 18149.8 14315 0.102869 
571 18155.3 14187.3 0.10192 
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Determination of Rate for 3.0 equiv. of electrophile- Run 3 [DJK-5-29-3] 
 
 Following the General Procedure, 56 (76.6 mg, 0.3 mmol, 3.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.01 mmol, 0.1 equiv) and MsOH (6.5 μL, 0.1 mmol, 0.1 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
8.06E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.42 M 
[MsOH] = 0.14  
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 15007.5 19915.5 0.142857 
16 14861.2 19527.9 0.141456 
31 14996.9 19408.1 0.139316 
46 14946.9 19151.8 0.137936 
61 15053.5 19182.7 0.13718 
y = -8.58E-05x + 1.43E-01 
R² = 9.79E-01 
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76 15028.8 18944.2 0.135697 
91 15085.7 18894 0.134827 
106 14882.2 18526 0.134009 
121 14957.2 18463 0.132884 
136 15164.9 18517.1 0.131448 
151 14971.4 18077.5 0.129986 
166 14924.6 17946.9 0.129451 
181 15064.5 17890 0.127842 
196 14894.8 17619.6 0.127345 
211 14877.1 17446.3 0.126242 
226 14952.4 17519.6 0.126134 
 
 
 
Determination of Rate for 0.03 equiv. of catalyst- Run 1 [DJK-5-43-1] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (1.4 mg, 0.01 mmol, 0.03  equiv) and MsOH (6.5 μL, 0.1 mmol, 0.1 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
2.04E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.14 M   
y = -8.06E-05x + 1.42E-01 
R² = 9.75E-01 
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Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 17522.5 21089.3 0.142857 
16 17528.6 20860.1 0.141255 
31 17485.9 20686.1 0.140419 
46 17471.3 20553.7 0.139637 
61 17302.8 20444.8 0.14025 
76 17523 20524.4 0.139027 
91 17461 20486.3 0.139261 
106 17420.1 20493.7 0.139639 
121 17457.3 20301.2 0.138032 
136 17513.5 20240.9 0.137181 
151 17435.2 20236.9 0.137769 
166 17428.5 20172.5 0.137384 
181 17536.4 20242.8 0.137014 
196 17446.1 20202.1 0.137447 
211 17408.1 20027.9 0.136559 
226 17517.4 20167.6 0.136653 
241 17559 20046.9 0.135514 
256 17455.2 19974.5 0.135827 
271 17412.3 19880.4 0.13552 
286 17398 19809.4 0.135147 
301 17384.3 19807.3 0.13524 
316 17544.2 20097.1 0.135968 
331 17261.2 19577.6 0.134625 
346 17398.7 19573.3 0.133531 
361 17359 19494.2 0.133296 
376 17365.8 19476.8 0.133125 
391 17312.2 19426.7 0.133193 
406 17399.9 19466.2 0.132792 
421 17394.5 19308.6 0.131757 
436 17592.8 19664.7 0.132675 
451 17368.7 19232.6 0.131434 
466 17341.2 19196 0.131392 
481 17401.4 19275.9 0.131482 
496 17303.1 19046.4 0.130655 
511 17394 19176.1 0.130857 
526 17436.8 19021.2 0.129481 
541 17381.2 19043.2 0.130046 
556 17423.9 19177.7 0.130643 
571 17287 18943.4 0.130069 
586 17435.9 18942.8 0.128954 
601 17394.7 18873.8 0.128789 
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616 17433.7 18937 0.128931 
631 17221.3 18648.2 0.128531 
646 17326.4 18676.5 0.127945 
661 17379.6 18652 0.127386 
676 17295.7 18562.9 0.127392 
691 17351.2 18521.6 0.126702 
 
 
 
Determination of Rate for 0.03 equiv. of catalyst- Run 2 [DJK-5-43-2] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (1.4 mg, 0.01 mmol, 0.03  equiv) and MsOH (6.5 μL, 0.1 mmol, 0.1 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
2.04E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
  
y = -2.04E-05x + 1.41E-01 
R² = 9.72E-01 
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Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 17393.3 22103.9 0.142857 
16 17243.3 21780.9 0.141994 
31 17193.1 21824.6 0.142694 
46 17144.9 21593.9 0.141583 
61 17234.6 21665.1 0.141311 
76 17396.6 21872.6 0.141335 
91 17227.9 21528.1 0.140472 
106 17156.6 21483.6 0.140764 
121 17218.2 21403 0.139734 
136 17135.6 21244.4 0.139367 
151 17518.2 21693.1 0.139203 
166 17415.3 21499.6 0.138776 
181 17310.6 21260.3 0.138061 
196 17205.2 21151.6 0.138197 
211 17159.5 21066.2 0.138006 
226 17355.9 21319.4 0.138084 
241 16978.9 20970.3 0.138839 
256 17161.6 20949.5 0.137224 
271 17134.5 20933.6 0.137337 
286 17216.5 20872 0.136281 
301 17008.4 20597.3 0.136133 
316 17146.1 20787.7 0.136288 
331 17325.3 20931.2 0.135809 
346 17160.2 20577.8 0.134801 
361 17222.5 20693.2 0.135066 
376 17225.4 20513.5 0.133871 
391 17059.1 20369.4 0.134226 
406 17110 20422.2 0.134174 
421 17159.3 20394.3 0.133605 
436 17260.3 20520.5 0.133646 
451 17097.4 20293.6 0.133427 
466 17040.8 20117.3 0.132707 
481 17208.6 20074 0.13113 
496 17157.6 20161.1 0.132091 
511 17088.8 20029.1 0.131754 
526 17087.6 19975 0.131408 
541 17069.7 20082.7 0.132255 
556 17115.9 19968.7 0.131149 
571 17051.4 20002.1 0.131865 
586 17090.9 19791.1 0.130173 
601 17079.4 19705.9 0.1297 
616 17106.5 19782.3 0.129996 
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631 17105.5 19834.4 0.130346 
646 17074.1 19696.1 0.129675 
661 17049 19620.2 0.129366 
676 17150.3 19529 0.128004 
691 17102.2 19563.7 0.128592 
706 17021.9 19346 0.127761 
721 17159.1 19563.6 0.128165 
736 17062.2 19442.7 0.128096 
751 17035.5 19304.3 0.127384 
766 17158.1 19408.4 0.127156 
781 17183.3 19371.8 0.12673 
796 17076.6 19349.6 0.127375 
811 17155.4 19450.2 0.12745 
826 16876.6 19015 0.126656 
841 17038.9 19098.8 0.126003 
856 16942.4 18891.4 0.125344 
 
 
 
Determination of Rate for 0.03 equiv. of catalyst- Run 3 [DJK-5-43-3] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (1.4 mg, 0.01 mmol, 0.03  equiv) and MsOH (6.5 μL, 0.1 mmol, 0.1 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
1.90E-05 M/min 
 
y = -2.04E-05x + 1.42E-01 
R² = 9.82E-01 
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[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 19753.4 22001.6 0.142857 
16 19604.9 21904.2 0.143302 
31 19806.4 21976 0.142309 
46 19746.4 21775.8 0.141441 
61 19817 21834.7 0.141318 
76 19717.5 21713 0.14124 
91 19704.1 21674.9 0.141088 
106 19782.8 21485.5 0.139299 
121 19663.9 21472.9 0.140059 
136 19768.4 21766.5 0.141223 
151 19790.6 21507 0.139383 
166 19829.2 21471 0.138879 
181 19857.8 21405.7 0.138257 
196 19843.2 21530.2 0.139164 
211 19645.7 21237.6 0.138652 
226 19658.6 21164.1 0.138082 
241 19697.5 21266.4 0.138475 
256 19699 21060.6 0.137125 
271 19626.4 20893.2 0.136538 
286 19516 20830.6 0.136899 
301 19568.1 20905.3 0.137024 
316 19598.1 20850.6 0.136456 
331 19594.1 20835.6 0.136386 
346 19654.6 20906.7 0.13643 
361 19674 20793.9 0.13556 
376 19583.5 20663.5 0.135333 
391 19592.4 20645.4 0.135153 
406 19732.8 20776.4 0.135043 
421 19566.3 20625.7 0.135204 
436 19782.5 20753.5 0.134555 
451 19559.3 20538.1 0.134678 
466 19655.2 20490.6 0.133711 
481 19688.5 20516.5 0.133653 
496 19716.7 20442.7 0.132982 
511 19644.9 20265.5 0.132311 
526 19569.2 20269.1 0.132847 
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541 19634 20261.1 0.132356 
556 19696.4 20411.4 0.132915 
571 19568.8 20086.2 0.131651 
586 19633.7 20070.2 0.131111 
601 19721.9 20089 0.130647 
616 19666 20084.6 0.13099 
631 19531.3 19958.5 0.131065 
646 19640 19881.1 0.129834 
661 19543.2 19866 0.130378 
676 19570.4 19791.8 0.129711 
691 19594.4 19824.9 0.129768 
706 19518.7 19701.9 0.129463 
 
 
 
Determination of Rate for 0.05 equiv. of catalyst- Run 1 [DJK-5-36-1] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (2.3 mg, 0.01 mmol, 0.05  equiv) and MsOH (6.5 μL, 0.1 mmol, 0.1 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
3.72E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
y = -1.90E-05x + 1.43E-01 
R² = 9.82E-01 
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[MsOH] = 0.14 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 19390.9 20728.4 0.142857 
16 19437.9 20621 0.141773 
31 19492.6 20474.5 0.140371 
46 19489.5 20460 0.140294 
61 19617.2 20555 0.140028 
76 19646 20311.9 0.138169 
91 19335.5 20034.3 0.138469 
106 19437 19998 0.137496 
121 19337.5 19882.9 0.137408 
136 19368.3 19716.2 0.13604 
151 19414.2 19667.5 0.135383 
166 19432.1 19748.2 0.135813 
181 19456.2 19711.5 0.135393 
196 19408.3 19572.6 0.134771 
211 19623.9 19433.2 0.132341 
226 19514.9 19534.7 0.133775 
241 19418.7 19374 0.133332 
256 19338.4 19277.2 0.133216 
271 19439.6 19278 0.132528 
286 19441.4 19114.3 0.131391 
301 19326.5 18901.4 0.1307 
316 19538.6 19092.3 0.130587 
331 19405 18792 0.129418 
346 19288.3 18683.6 0.12945 
361 19366.2 18733.3 0.129272 
376 19347 18635.9 0.128727 
391 19397.3 18575.2 0.127975 
406 19333.1 18440.1 0.127466 
421 19327 18414.1 0.127327 
436 19424 18302.2 0.125921 
451 19325.3 18198.9 0.12585 
466 19451.5 18246.7 0.125362 
481 19501.3 18352.8 0.125769 
496 19404.2 18050.2 0.124314 
511 19359.6 17945.1 0.123875 
526 19489.4 17914 0.122837 
541 19445.8 17796.6 0.122305 
556 19440.3 17886.3 0.122957 
571 19382.3 17746.9 0.122363 
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Determination of Rate for 0.05 equiv. of catalyst- Run 2 [DJK-5-36-2] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (2.3 mg, 0.01 mmol, 0.05  equiv) and MsOH (6.5 μL, 0.1 mmol, 0.1 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
3.72E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 18509.5 20850.5 0.142857 
16 18454.7 20723.3 0.142407 
31 18155.6 20410.6 0.142569 
46 18596.3 20860 0.142255 
61 18377 20451.9 0.141136 
y = -3.72E-05x + 1.42E-01 
R² = 9.84E-01 
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76 18248.9 20288.8 0.140994 
91 18159.4 20035.2 0.139918 
106 18302.5 20271.9 0.140464 
121 18558.1 20368.2 0.139187 
136 18651.4 20428 0.138898 
151 18330.2 19818.5 0.137115 
166 18126.8 19464.1 0.136174 
181 18244 19708.7 0.136999 
196 18243.1 19561.2 0.135981 
211 18159.2 19409.4 0.135549 
226 18394.1 19569.9 0.134924 
241 18245.7 19390.9 0.134778 
256 18459.8 19421.4 0.133424 
271 18143.2 19279.3 0.134759 
286 18113.8 18968.8 0.132804 
301 18151.2 18766.8 0.131119 
316 18035.8 18638.8 0.131058 
331 18357.6 18854.3 0.130249 
346 18191.9 18611.4 0.129742 
361 18122.5 18438.9 0.129032 
376 17810.3 18055.2 0.128562 
391 17871.2 18168.4 0.128927 
406 18383.9 18781.2 0.129558 
421 18377 18682.7 0.128927 
436 17945.8 18128.3 0.128107 
451 18062.8 18193.1 0.127733 
466 18167.6 18199.8 0.127043 
481 18088 17792.6 0.124747 
496 18170.5 18020.7 0.125772 
511 18238 17815.3 0.123879 
526 18531.6 18273.8 0.125054 
541 18241.7 17680.7 0.122918 
556 18374.8 17858.1 0.123252 
571 18051.4 17424.4 0.122413 
586 18059.4 17492.4 0.122836 
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Determination of Rate for 0.05 equiv. of catalyst- Run 3 [DJK-5-36-3] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (2.3 mg, 0.01 mmol, 0.05  equiv) and MsOH (6.5 μL, 0.1 mmol, 0.1 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
4.07E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 19009.1 20905.4 0.142857 
16 18968.1 20752 0.142115 
31 18936.6 20688.7 0.141918 
46 18974.2 20527.1 0.14053 
61 18996.8 20466.7 0.13995 
76 18994.6 20398.1 0.139497 
91 18910.1 20179.3 0.138617 
y = -3.72E-05x + 1.43E-01 
R² = 9.70E-01 
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106 18960 20098.6 0.1377 
121 18960.3 20031.2 0.137236 
136 18886.3 19879.4 0.136729 
151 18945.8 19732.2 0.135291 
166 18939.9 19635.5 0.13467 
181 18766.8 19496.6 0.13495 
196 18794.4 19398.4 0.134073 
211 18920.9 19428.1 0.133381 
226 18892.8 19365.7 0.13315 
241 18893.4 19236.7 0.132259 
256 18832.7 19131.5 0.13196 
271 18856.3 19063.3 0.131325 
286 18891.9 18955.9 0.130339 
301 18795.8 18840.5 0.130208 
316 18770.2 18739.9 0.129689 
331 18670.4 18589.1 0.129333 
346 18771.9 18621.7 0.128859 
361 18641.8 18435.1 0.128458 
376 18654.4 18369.1 0.127912 
391 18805.6 18314.3 0.126505 
406 18868.6 18269.1 0.125772 
421 18860.6 18256.8 0.12574 
436 18853.1 18013.3 0.124113 
451 18840.3 18045 0.124415 
466 18784.6 17953.8 0.124154 
481 18640.5 17815.8 0.124152 
496 18683.9 17687.2 0.122969 
511 18709.4 17634.9 0.122439 
526 18824.5 17687.1 0.12205 
541 18741.3 17465 0.121053 
556 18755.7 17406.4 0.120554 
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Determination of Rate for 0.18 equiv. of catalyst- Run 1 [DJK-5-39-1] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (8 mg, 0.018 mmol, 0.18  equiv) and MsOH (6.5 μL, 0.1 mmol, 0.1 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
1.50E-04 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 17696.8 21730.4 0.142857 
16 17770.7 21602.1 0.141423 
31 17428.9 20788.7 0.138767 
46 17368.2 20425.4 0.136818 
61 17420.1 19985.1 0.13347 
76 17477.7 19832.9 0.132017 
91 17427.9 19370.6 0.129308 
y = -4.07E-05x + 1.42E-01 
R² = 9.85E-01 
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106 17619.3 19101.5 0.126127 
121 17327.1 18721.6 0.125703 
136 17401.7 18501.1 0.12369 
151 17470.6 18264.2 0.121625 
166 17653.2 17984.8 0.118525 
 
 
 
Determination of Rate for 0.18 equiv. of catalyst- Run 2 [DJK-5-39-2] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (8 mg, 0.018 mmol, 0.18  equiv) and MsOH (6.5 μL, 0.1 mmol, 0.1 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
1.71E-04 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
  
y = -1.50E-04x + 1.43E-01 
R² = 9.82E-01 
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Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 18995.9 20420.1 0.142857 
16 19208.1 20114.4 0.139164 
31 19001.2 19467.9 0.136158 
46 18763.3 19003.4 0.134594 
61 18926.6 18734.1 0.131542 
76 19034.5 18523.6 0.129327 
91 19190 18290.1 0.126662 
106 19117.4 17887.2 0.124342 
121 19141.4 17619.3 0.122326 
136 19031.8 17258.9 0.120514 
151 19046.8 16996.8 0.11859 
166 18883.9 16532.4 0.116345 
 
 
 
Determination of Rate for 0.18 equiv. of catalyst- Run 3 [DJK-5-39-3] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (8 mg, 0.018 mmol, 0.18  equiv) and MsOH (6.5 μL, 0.1 mmol, 0.1 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
1.38E-04 M/min 
 
y = -1.71E-04x + 1.42E-01 
R² = 9.84E-01 
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[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 19088 22538.6 0.142857 
16 18883.6 22120.5 0.141725 
31 18832.2 21603.9 0.138793 
46 18896.3 21325.8 0.136541 
61 19203.5 21345 0.134478 
76 18946 20722.8 0.132332 
91 18920.7 20292.1 0.129755 
106 18898.3 20000.4 0.128042 
121 18888.8 19845.4 0.127113 
136 18930.8 19441.4 0.124249 
151 18862.1 19120.8 0.122645 
166 18977.6 18983.6 0.121024 
 
 
 
Determination of Rate for 0.3 equiv. of catalyst- Run 1 [DJK-5-79-1] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (13.2 mg, 0.3 mmol, 0.3  equiv) and MsOH (6.5 μL, 0.1 mmol, 0.1 equiv) 
y = -1.38E-04x + 1.43E-01 
R² = 9.84E-01 
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were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
2.05E-04 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 19078.3 21697.3 0.142857 
16 18989.6 21081.1 0.139448 
31 18886.4 20603.9 0.137036 
46 18918.3 20096.3 0.133435 
61 18953.1 19712.8 0.130648 
76 19027.1 19317.9 0.127533 
91 18856.4 18686.4 0.124481 
106 18937.7 18288.2 0.121305 
121 18972 17884.5 0.118413 
  
 
 
  
y = -2.05E-04x + 1.43E-01 
R² = 9.91E-01 
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Determination of Rate for 0.3 equiv. of catalyst- Run 2 [DJK-5-79-2] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (13.2 mg, 0.3 mmol, 0.3  equiv) and MsOH (6.5 μL, 0.1 mmol, 0.1 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
2.04E-04 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 19107.6 21243.4 0.142857 
16 18980.5 20801.5 0.140822 
31 18989.7 20256.3 0.137065 
46 18614.1 19484 0.134499 
61 19040.3 19446.4 0.131235 
76 18537.8 18633.6 0.129158 
91 18804.9 18230.4 0.124569 
106 18672.7 17882.2 0.123055 
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Determination of Rate for 0.3 equiv. of catalyst- Run 3 [DJK-5-79-3] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (13.2 mg, 0.3 mmol, 0.3  equiv) and MsOH (6.5 μL, 0.1 mmol, 1.0 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
1.93E-04 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 17635.7 20259.8 0.142857 
16 17740 19923.2 0.139658 
31 17606.3 19444.2 0.137335 
46 17479.4 18785.1 0.133643 
61 17329.6 18424.4 0.13221 
76 17397.4 17884.5 0.127836 
91 17494.6 17864.8 0.126985 
y = -2.04E-04x + 1.44E-01 
R² = 9.86E-01 
0.128 
0.13 
0.132 
0.134 
0.136 
0.138 
0.14 
0.142 
0.144 
0.146 
0 20 40 60 80 
C
o
n
ce
n
tr
at
io
n
, M
 
Time, min 
0.3 Catalyst Run 2 
Series1 
Linear (Series1) 
238 
 
106 17642.2 17634.6 0.1243 
121 17119.8 16714.2 0.121408 
 
 
 
Determination of Rate for 0.1 equiv. of acid - Run 1 [DJK-5-59-1] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.1 mmol, 0.1  equiv) and MsOH (0.7 μL, 0.01 mmol, 0.1 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
2.16E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.014 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 627.378 666.39 0.142857 
16 623.49 667.361 0.143957 
31 627.327 660.121 0.141525 
y = -1.93E-04x + 1.43E-01 
R² = 9.76E-01 
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46 618.85 659.277 0.14328 
61 627.972 658.727 0.141081 
76 623.293 658.158 0.142017 
91 621.958 655.155 0.141673 
106 625.505 650.303 0.139826 
121 624.075 650.722 0.140237 
136 623.127 648.864 0.140049 
151 621.72 647.686 0.140111 
166 621.306 645.462 0.139723 
181 626.197 644.926 0.138517 
196 627.882 644.217 0.137993 
211 621.169 638.252 0.138193 
226 623.732 640.212 0.138048 
241 621.689 633.261 0.136997 
256 623.963 634.79 0.136828 
271 615.936 632.762 0.138168 
286 623.924 631.39 0.136103 
301 619.433 626.694 0.13607 
316 617.34 629.259 0.137091 
331 620.466 629.077 0.136361 
346 613.274 622.005 0.136409 
361 622.464 624.745 0.134987 
376 619.61 622.861 0.1352 
391 618.982 618.543 0.134399 
406 619.987 618.123 0.13409 
421 619.418 612.943 0.133088 
436 619.115 615.621 0.133735 
451 621.744 616.133 0.13328 
466 616.497 611.883 0.133487 
481 616.854 609.047 0.132792 
496 619.44 609.228 0.132277 
511 621.426 608.868 0.131776 
526 619.459 607.164 0.131825 
541 621.997 605.456 0.130917 
556 617.626 601.592 0.131002 
571 617.96 598.489 0.130256 
586 617.963 597.603 0.130063 
601 619.541 600.27 0.13031 
616 614.048 594.107 0.130126 
631 616.909 592.507 0.129174 
646 614.421 591.115 0.129392 
661 614.28 589.645 0.1291 
676 618.188 587.988 0.127924 
691 614.95 585.781 0.128114 
706 614.193 585.697 0.128254 
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Determination of Rate for 0.1 equiv. of acid - Run 2 [DJK-5-59-2] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.1 mmol, 0.1  equiv) and MsOH (0.7 μL, 0.01 mmol, 0.1 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
1.92E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.014 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 17787.2 21886.2 0.142857 
16 17983.8 22191.1 0.143264 
31 18084.7 22172.2 0.142343 
46 18025.4 21945.8 0.141353 
61 18151.1 22097.8 0.141347 
76 17879.4 21764.9 0.141333 
91 17956.9 21891.1 0.141539 
y = -2.16E-05x + 1.43E-01 
R² = 9.82E-01 
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106 17882.3 21765.6 0.141314 
121 17834.2 21693.1 0.141224 
136 17645.3 21403.1 0.140827 
151 17846.4 21632.3 0.140731 
166 17892.2 21533 0.139727 
181 17913.5 21543 0.139626 
196 17885.5 21364.3 0.138684 
211 17772.1 21405 0.139835 
226 17845.6 21370.1 0.139032 
241 17842.1 21343.2 0.138884 
256 17757 21170.2 0.138419 
271 17809.4 21152.2 0.137894 
286 17772.5 21229.9 0.138688 
301 17876.8 21185.4 0.13759 
316 17751.5 21033.3 0.137566 
331 17830.1 20991.1 0.136685 
346 17907.1 21049 0.136473 
361 17689 20817.2 0.136634 
376 17800.9 20933.5 0.136533 
391 17690.2 20764.9 0.136281 
406 17656.6 20680 0.135982 
421 17832.6 20738.9 0.135024 
436 17885.8 20792.2 0.134968 
451 17609.7 20474.3 0.134988 
466 17730.1 20633.7 0.135115 
481 17653.9 20478.2 0.134676 
496 17647 20449.4 0.134539 
511 17695.3 20308.5 0.133248 
526 17779 20372.4 0.133037 
541 17619.4 20208.4 0.133162 
556 17592.8 20178.8 0.133168 
571 17691.4 20113.3 0.131996 
586 17678.5 20023.5 0.131502 
601 17835.6 20083.8 0.130737 
616 17695.4 20129.1 0.13207 
631 17636.7 19976.8 0.131507 
646 17513.2 19851.7 0.131605 
661 17556.4 19855.4 0.131305 
676 17771.9 19987.5 0.130576 
691 17648 19813.3 0.130347 
706 17704.3 19800.6 0.129849 
721 17643.4 19725.3 0.129802 
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Determination of Rate for 0.1 equiv. of acid - Run 3 [DJK-5-59-3] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.1 mmol, 0.1  equiv) and MsOH (0.7 μL, 0.01 mmol, 0.1 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
1.85E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.014 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 19261.1 22082.3 0.142857 
16 19156.3 21998.2 0.143092 
31 19164.2 21882.2 0.142278 
46 18933.3 21714.1 0.142907 
61 18978.2 21775.5 0.142972 
76 19082.9 21780.3 0.142219 
91 18908.8 21650.4 0.142673 
y = -1.92E-05x + 1.43E-01 
R² = 9.84E-01 
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106 19031.6 21746.7 0.142383 
121 19056.1 21545.6 0.140885 
136 19059.5 21562.3 0.140969 
151 19029 21452.7 0.140477 
166 19019.2 21480.9 0.140734 
181 18823.5 21321.9 0.141145 
196 19087.3 21350.2 0.139379 
211 18915.5 21235.1 0.139886 
226 18882.4 21171.6 0.139712 
241 19071.5 21328.2 0.13935 
256 18866.8 21153.3 0.139707 
271 18865.9 21027.8 0.138885 
286 18827.8 20923.5 0.138476 
301 18885.8 20996.1 0.138529 
316 18916 20939.5 0.137935 
331 19005.6 21026.4 0.137855 
346 19000.8 20884.2 0.136957 
361 18890.3 20721.7 0.136686 
376 18922.2 20905.1 0.137664 
391 18745.1 20586.2 0.136844 
406 18856.6 20688 0.136708 
421 18872.7 20548.8 0.135672 
436 18817.6 20476 0.135587 
451 18789.7 20440.3 0.135552 
466 18700 20341.7 0.135545 
481 18754.2 20339.3 0.135138 
496 18903.1 20458.6 0.13486 
511 18739.2 20224.7 0.134484 
526 18733.7 20097.5 0.133677 
541 18862.7 20218 0.133559 
556 18865.2 20176.5 0.133267 
571 18887.4 20154.6 0.132966 
586 18824.8 20021.9 0.13253 
601 18783 19915.8 0.132121 
616 18705.6 19850.6 0.132233 
631 18742 19822.7 0.131791 
646 18866.8 20001.7 0.132101 
661 18675.2 19728.5 0.131634 
676 18856.4 19714.1 0.130274 
691 18735.3 19770.4 0.13149 
706 18671.2 19560.2 0.130539 
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Determination of Rate for 0.2 equiv. of acid - Run 1 [DJK-5-56-1] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.1 mmol, 0.1  equiv) and MsOH (1.3 μL, 0.02 mmol, 0.2 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
3.87E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.028 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 18989.4 21949.5 0.142857 
16 19132.4 22082.6 0.142649 
31 18808.5 21675.7 0.142432 
46 19085.5 21813.6 0.141258 
61 19028.4 21729.8 0.141137 
76 18921.9 21409.9 0.139842 
91 19005.1 21428.2 0.139349 
y = -1.85E-05x + 1.44E-01 
R² = 9.85E-01 
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106 18973.3 21365.3 0.139173 
121 18849.8 21158.5 0.138729 
136 18881.7 21148.7 0.13843 
151 18941.1 21040.2 0.137288 
166 18744.6 20809.6 0.137207 
181 18890.7 20833.6 0.136303 
196 18873.4 20713 0.135638 
211 18833.6 20514.3 0.134621 
226 18859.8 20589.6 0.134927 
241 18858.7 20464.8 0.134117 
256 18896.8 20280.9 0.132644 
271 18846.9 20172.2 0.132282 
286 18815.5 20075 0.131865 
301 18739.4 20014.9 0.132004 
316 18649 19874.3 0.131712 
331 18821.3 19782.9 0.129906 
346 18777.1 19695.5 0.129636 
361 18810.3 19664.7 0.129205 
376 18765.2 19570.4 0.128895 
391 18917.7 19479 0.127259 
406 18761.5 19375.2 0.127634 
421 18757.2 19292.3 0.127117 
436 18803.5 19254.8 0.126558 
451 18723.8 19013.8 0.125506 
466 18826.1 19096 0.125363 
481 18696.5 18860.7 0.124677 
496 18685.7 18856.7 0.124723 
511 18745.6 18829.2 0.124143 
526 18725.6 18615.3 0.122863 
541 18764.8 18605.4 0.122542 
556 18645.5 18347.8 0.121618 
571 18817.6 18363.6 0.12061 
586 18813.5 18276.8 0.120066 
601 18759.2 18185.6 0.119812 
616 18676.5 18187.3 0.120354 
631 18735.1 18004.7 0.118773 
646 18577 17815.8 0.118527 
661 18772.9 17817 0.117298 
676 18778.2 17764.8 0.116922 
691 18668.2 17522.5 0.116006 
706 18731.9 17611.5 0.116199 
721 18714.2 17416.3 0.11502 
736 18765.2 17369.9 0.114402 
751 18685.4 17283.4 0.114318 
766 18755.7 17248.7 0.113661 
781 18650.1 16925.1 0.11216 
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Determination of Rate for 0.2 equiv. of acid - Run 2 [DJK-5-56-2] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.1 mmol, 0.1  equiv) and MsOH (1.3 μL, 0.02 mmol, 0.2 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
3.31E-05 M/min 
 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.028 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 18590.2 22080.8 0.142857 
16 18453.5 21978.6 0.143249 
31 18332 21864.7 0.143451 
46 18359.6 21731.2 0.142361 
y = -3.87E-05x + 1.43E-01 
R² = 9.87E-01 
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61 18364.9 21634.9 0.141689 
76 18306.9 21568.2 0.1417 
91 18420.1 21506.3 0.140425 
106 18236.8 21389.5 0.141066 
121 18362.3 21315.7 0.139619 
136 18333.3 21155.3 0.138787 
151 18365.2 21122.7 0.138333 
166 18282.3 21056 0.138521 
181 18429.6 21044.6 0.13734 
196 18273.1 20795.1 0.136874 
211 18348.7 20768.5 0.136135 
226 18282.3 20766.4 0.136616 
241 18309.5 20603.7 0.135344 
256 18366 20541 0.134517 
271 18138.2 20286.9 0.134522 
286 18182.5 20308.1 0.134334 
301 18249 20400 0.13445 
316 18183.2 20187.2 0.133529 
331 18299.1 20131.9 0.13232 
346 18117.6 19879 0.131967 
361 18259.9 19985.3 0.131639 
376 18131 19811 0.131418 
391 18242.2 19860.3 0.130942 
406 18118.9 19664.1 0.130531 
421 18221.1 19605.1 0.129409 
436 18300.4 19664.9 0.129242 
451 18201.3 19461.4 0.128601 
466 18242.5 19403.2 0.127926 
481 18264.9 19135.8 0.126009 
496 18207.2 19198.7 0.126824 
511 18213.7 19130.9 0.126331 
526 18165.6 19105.7 0.126498 
541 18218 19034 0.125661 
556 18140.5 18980.2 0.125841 
571 18063.2 18832.5 0.125396 
586 18155.6 18762.6 0.124295 
601 18074.4 18788.7 0.125027 
616 18084.7 18543.8 0.123327 
631 18125.6 18446.6 0.122404 
646 18002.3 18413 0.123018 
661 18255.4 18407.6 0.121277 
676 18063.5 18291.5 0.121792 
691 18133.8 18238.9 0.120971 
706 18160.9 18130.2 0.120071 
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Determination of Rate for 0.2 equiv. of acid - Run 3 [DJK-5-56-3] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.1 mmol, 0.1  equiv) and MsOH (1.3 μL, 0.02 mmol, 0.2 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
3.62E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.028 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 16700.8 19326.7 0.142857 
16 16585.2 19183.5 0.142787 
31 16644.4 19277.8 0.142979 
46 16664.8 19300.1 0.142969 
61 16618.4 18995.9 0.141108 
76 16741.2 18954.4 0.139767 
91 16682.3 18944 0.140184 
y = -3.31E-05x + 1.44E-01 
R² = 9.83E-01 
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106 16621.9 18806.9 0.139675 
121 16763.2 18903.9 0.139212 
136 16579.5 18603.6 0.138518 
151 16643.9 18573 0.137755 
166 16524.5 18465 0.137944 
181 16710 18380.6 0.135789 
196 16591.8 18360.7 0.136608 
211 16447.8 18132.6 0.136092 
226 16578.1 18106.1 0.134825 
241 16633.8 18047.4 0.133938 
256 16547.2 17957.1 0.133966 
271 16599.7 17926.9 0.133317 
286 16569.7 17827.7 0.13282 
301 16614.6 17742.4 0.131827 
316 16517.7 17683.4 0.132159 
331 16461.9 17553 0.131629 
346 16498.5 17581.4 0.13155 
361 16481 17534.3 0.131337 
376 16458.7 17349.4 0.130128 
391 16588 17374.4 0.1293 
406 16459.5 17182.7 0.128871 
421 16518.9 17161.1 0.128247 
436 16520.5 17055.5 0.127445 
451 16498.9 16978.8 0.127038 
466 16545.7 16802.7 0.125365 
481 16612.5 16910.3 0.12566 
496 16497.2 16706.3 0.125012 
511 16423.3 16708.7 0.125593 
526 16500.4 16553.6 0.123845 
541 16505.9 16584.5 0.124035 
556 16401 16439.5 0.123737 
571 16463.6 16406.5 0.123019 
586 16543.5 16400.2 0.122378 
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Determination of Rate for 0.35 equiv. of acid - Run 1 [DJK-5-61-1] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.1 mmol, 0.1  equiv) and MsOH  (2.2 μL, 0.035 mmol, 0.35 
equiv) were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into 
an NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
5.87E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.05 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 17621.8 20620.4 0.142857 
16 17504.6 20335.1 0.141824 
31 17596.9 20350.1 0.141184 
46 17526.4 20171.5 0.140508 
61 17526.3 20031.4 0.139533 
76 17512.6 20027.4 0.139614 
91 17349.8 19570.6 0.13771 
y = -3.62E-05x + 1.43E-01 
R² = 9.81E-01 
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106 17390.9 19587.3 0.137502 
121 17346.5 19417.6 0.136659 
136 17259.6 19101.3 0.13511 
151 17419.9 19177.3 0.134399 
166 17131.7 18814.9 0.134078 
181 17384.4 18842.3 0.132321 
196 17274.9 18665.5 0.13191 
211 17337.1 18569.7 0.130763 
226 17283.4 18326.7 0.129452 
241 17251 18245.4 0.12912 
256 17177.9 18090.7 0.12857 
271 17289.3 18073.6 0.127621 
286 17143.6 17757.7 0.126456 
301 17454.7 17938.4 0.125466 
316 17243.8 17683.7 0.125197 
331 17260 17542.9 0.124084 
346 17228.5 17325.9 0.122773 
361 17252.7 17227.8 0.121907 
376 17046.8 16931.9 0.12126 
391 17057.7 16869.4 0.120735 
406 17243.7 16818.8 0.119075 
421 17077.4 16656.6 0.119075 
436 17103.8 16431.3 0.117283 
451 17088.3 16405.4 0.117204 
466 17099.9 16252.8 0.116035 
481 17173.3 16260.3 0.115593 
496 17220.3 16134.9 0.114388 
511 17126.8 15862.5 0.113071 
526 17017.8 15823.5 0.113515 
541 17155.6 15723.8 0.111894 
556 17239 15731.3 0.111406 
571 16991.3 15361.8 0.110375 
586 17132.7 15328.9 0.10923 
601 17280.1 15423.8 0.108968 
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Determination of Rate for 0.35 equiv. of acid - Run 2 [DJK-5-61-2] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.1 mmol, 0.1  equiv) and MsOH  (2.2 μL, 0.035 mmol, 0.35 
equiv) were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into 
an NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
6.18E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.05 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 19532.9 22364.4 0.142857 
16 19865.1 22686.6 0.142492 
31 19604.2 22291.3 0.141872 
46 19498.9 22224.3 0.14221 
61 19505.3 22121 0.141502 
76 19793.3 22353.2 0.140907 
91 19489.3 22058 0.141215 
y = -5.87E-05x + 1.43E-01 
R² = 9.84E-01 
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106 19332.2 21803 0.140717 
121 19327.1 21876 0.141225 
136 19425.6 21710.7 0.139448 
151 19501.3 21825.3 0.139639 
166 19519.5 21673 0.138536 
181 19373.7 21561.9 0.138863 
196 19475.1 21709.3 0.139084 
211 19618.7 21913 0.139362 
226 19254.9 21401 0.138677 
241 19452.1 21465.3 0.137684 
256 19571.7 21513.4 0.137149 
271 19390.1 21261.5 0.136812 
286 19269.3 21199.7 0.13727 
301 19442.4 21124 0.135562 
316 19314.7 21200.6 0.136953 
331 19439.7 21191.5 0.136014 
346 19310.6 20906.6 0.135082 
361 19546.7 21065.7 0.134466 
376 19443.9 21081 0.135276 
391 19360.3 20899.7 0.134691 
406 19194.6 20687.7 0.134476 
421 19249.5 20807.9 0.134872 
436 19252.6 20709.2 0.13421 
451 19227.5 20699.3 0.134321 
466 19153.1 20500 0.133545 
481 19289.4 20623.1 0.133397 
496 19301.4 20521.3 0.132656 
511 19385.9 20642.7 0.132859 
526 19249.9 20406.4 0.132266 
541 19190.9 20275.9 0.131825 
556 19386.6 20447.4 0.131598 
571 19214.4 20292.9 0.131774 
586 19277.1 20237 0.130983 
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Determination of Rate for 0.35 equiv. of acid - Run 3 [DJK-5-61-3] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.1 mmol, 0.1  equiv) and MsOH  (2.2 μL, 0.035 mmol, 0.35 
equiv) were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into 
an NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
6.23E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.05 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 19398.7 23024 0.142857 
16 19619.6 23054.8 0.141438 
31 19541.3 22783.8 0.140335 
46 19505.9 22719.6 0.140194 
61 19355.2 22395.9 0.139272 
76 19682.2 22635.8 0.138425 
91 19462.1 22188.9 0.137227 
y = -6.18E-05x + 1.42E-01 
R² = 9.84E-01 
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106 19263.5 21723.2 0.135732 
121 19322.8 21687.7 0.135094 
136 19270.1 21456 0.134017 
151 19113.4 21280.9 0.134013 
166 19179.9 21146.5 0.132705 
181 19430.5 21271.1 0.131765 
196 19572.6 21087.7 0.12968 
211 19361.9 20821.1 0.129434 
226 19376.2 20690.6 0.128528 
241 19340.8 20416.1 0.127055 
256 19323.7 20246.9 0.126114 
271 19214.3 20043.9 0.12556 
286 19234.3 19981.8 0.125041 
301 19118.9 19587.8 0.123315 
316 19292.9 19557.9 0.122016 
331 19154.1 19454.1 0.122248 
346 19220.1 19474.4 0.121956 
361 19190 19104.2 0.119825 
376 19158.8 19068.6 0.119797 
391 19127.6 18926.7 0.119099 
406 19040.9 18625.3 0.117736 
421 19306.1 18800.2 0.117209 
436 19387.4 18739.2 0.116339 
451 19188.5 18342.4 0.115056 
466 19143.4 18331.1 0.115256 
481 19104.6 18072.4 0.11386 
496 19244.2 18061.9 0.112969 
511 19108 17783.8 0.112022 
526 19219.4 17705.7 0.110884 
541 19268.2 17685.9 0.110479 
556 19179.1 17437.8 0.109435 
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Determination of Rate for 0.6 equiv. of acid - Run 1 [DJK-5-68-1] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.1 mmol, 0.1  equiv) and MsOH  (3.9 μL, 0.06 mmol, 0.6 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
8.65E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.085 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 18121.2 18480.9 0.142857 
16 18084.7 18422.3 0.142692 
31 18147.7 18200.3 0.140483 
46 18085.7 17973 0.139204 
61 18175 17930.1 0.138189 
76 18074.2 17721.5 0.137343 
91 18051.4 17496.2 0.135768 
y = -6.23E-05x + 1.43E-01 
R² = 9.84E-01 
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106 18048 17258.7 0.133951 
121 18050 17127.2 0.132915 
136 18030.4 17034.8 0.132342 
151 17927.2 16663.4 0.130202 
166 17958.6 16472.5 0.128485 
181 18057.7 16567.3 0.128515 
196 18035.6 16304.2 0.126629 
211 17919.1 16121.4 0.126024 
 
 
 
Determination of Rate for 0.6 equiv. of acid - Run 2 [DJK-5-68-2] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.1 mmol, 0.1  equiv) and MsOH  (3.9 μL, 0.06 mmol, 0.6 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
7.79E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.085 M 
 
  
y = -8.65E-05x + 1.43E-01 
R² = 9.87E-01 
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Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 18908.7 21360.4 0.142857 
16 18977 21259.7 0.141672 
31 19027.3 20921.9 0.139052 
46 19021.5 20786.2 0.138193 
61 19065.6 20716.1 0.137408 
76 18866.5 20319.5 0.1362 
91 18865.1 20150.4 0.135076 
106 18992.4 20114.5 0.133932 
121 18833.9 19850.1 0.133284 
136 18953.5 19562.5 0.130524 
151 18807.9 19340.1 0.130039 
166 18898.3 19319.4 0.129278 
181 18826.8 18973 0.127442 
196 18769.7 18904.5 0.127369 
211 18971.1 18709.3 0.124715 
226 18819.4 18540.2 0.124584 
241 18710 18424.2 0.124529 
256 18830.1 18299 0.122894 
 
 
 
Determination of Rate for 0.6 equiv. of acid - Run 3 [DJK-5-68-3] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.1 mmol, 0.1  equiv) and MsOH  (3.9 μL, 0.06 mmol, 0.6 equiv) 
y = -7.79E-05x + 1.42E-01 
R² = 9.79E-01 
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were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
8.11E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.085 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 15095.7 18451.9 0.142857 
16 15253.6 18229.2 0.139672 
31 15253.7 18086.7 0.138579 
46 15417.1 18021.2 0.136614 
61 15213.1 17770.8 0.136522 
76 15144.6 17579.8 0.135666 
91 15395.7 17513.4 0.132949 
106 15202.6 17250.2 0.132614 
121 15100 16957.2 0.131248 
136 15194.1 16953.8 0.130409 
151 14938.4 16553.4 0.129508 
166 15066.2 16533.8 0.128258 
181 15053.3 16375.1 0.127135 
196 15015.8 16232.8 0.126345 
211 14923.1 15912.5 0.124622 
226 15005.5 15808.1 0.123124 
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Determination of Rate for 1.8 equiv. of acid - Run 1 [DJK-5-54-1] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.1 mmol, 0.1  equiv) and MsOH  (11.7 μL, 0.18 mmol, 1.8 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
5.80E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.26 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 19053.2 21171.4 0.142857 
16 19263.7 21096.3 0.140795 
31 19437.3 21305.6 0.140922 
46 19110.6 20753.6 0.139617 
61 19247.1 20686.4 0.138178 
76 19372.3 20795.3 0.138008 
91 19121.6 20365.2 0.136926 
y = -8.11E-05x + 1.41E-01 
R² = 9.80E-01 
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106 19211.7 20294.1 0.135808 
121 19270.6 20198.7 0.134756 
136 18852.8 19627.4 0.133847 
151 19284.6 20068.2 0.133788 
166 18881.1 19462.8 0.132525 
181 18866.7 19440.4 0.132474 
196 19128.4 19522.6 0.131214 
211 19188.3 19491.5 0.130596 
226 19352.4 19710.9 0.130946 
241 18965.1 18963.5 0.128553 
256 19021 18939.3 0.128012 
271 19041.3 18806.3 0.126978 
286 19064 18730 0.126312 
301 19068.6 18590.8 0.125343 
316 19050 18380.4 0.124045 
331 19043.5 18351.7 0.123894 
346 19088.8 18069.9 0.121702 
361 18896.7 17771.2 0.120907 
376 18986.7 17971 0.121687 
391 19042.3 17783.9 0.120068 
406 19034.5 17542.4 0.118486 
421 19131.3 17572.4 0.118088 
436 18915 17299.9 0.117587 
451 18978.3 17207.5 0.116568 
466 19009.8 16920.9 0.114437 
481 18998.8 16971.3 0.114844 
496 18989.5 16621.3 0.112531 
511 18968.1 16626.5 0.112693 
526 18926.6 16446.6 0.111718 
541 18886.5 16179.8 0.110139 
556 18788.7 15992.9 0.109434 
571 18855.9 15964.9 0.108853 
586 18893.8 15852.7 0.107871 
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Determination of Rate for 1.8 equiv. of acid - Run 2 [DJK-5-54-2] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.1 mmol, 0.1  equiv) and MsOH  (11.7 μL, 0.18 mmol, 1.8 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
5.85E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.26 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 18016 20748.4 0.142857 
16 17926.9 20445.4 0.141471 
31 17834.5 20196.2 0.14047 
46 17921.4 20188 0.139732 
61 17854.6 19950.6 0.138606 
76 18081.8 20386 0.139851 
91 17902.1 19793.2 0.137147 
y = -5.80E-05x + 1.42E-01 
R² = 9.80E-01 
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106 17798.9 19569.1 0.136381 
121 17852.6 19510.4 0.135563 
136 17854.6 19281.5 0.133957 
151 17658.2 19071.4 0.133971 
166 17725.9 19037.4 0.133222 
181 17833.3 18851.2 0.131124 
196 17794.1 18855.5 0.131443 
211 17791.5 18725.8 0.130558 
226 17706 18389.2 0.12883 
241 17772 18425.8 0.128607 
256 17764.8 18250.1 0.127433 
 
 
 
Determination of Rate for 1.8 equiv. of acid - Run 3 [DJK-5-54-3] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.1 mmol, 0.1  equiv) and MsOH  (11.7 μL, 0.18 mmol, 1.8 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 0 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
5.19E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.26 M 
y = -5.85E-05x + 1.42E-01 
R² = 9.80E-01 
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Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 16601.5 17900.1 0.142857 
16 16444 17590.9 0.141734 
31 16549.9 17659.4 0.141376 
46 16543.6 17434.1 0.139625 
61 16678.4 17489.2 0.138934 
76 16569.1 17257.8 0.138 
91 16476 17224.5 0.138512 
106 16426.9 16964 0.136825 
121 16389.9 16827 0.136027 
136 16672.5 17104.7 0.135928 
151 16549.7 16861.7 0.134991 
166 16436.6 16597.2 0.133788 
181 16400.6 16478.9 0.133126 
196 16461.4 16374.5 0.131794 
211 16404.3 16441.3 0.132792 
226 16463.9 16243.6 0.13072 
 
 
 
Determination of Rate at 10 
o
C - Run 1 [DJK-11-56] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.1 mmol, 0.1  equiv) and MsOH  (6.5 μL, 0.1 mmol, 1.0 equiv) 
y = -5.19E-05x + 1.42E-01 
R² = 9.83E-01 
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were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 10 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
1.69E-04 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 2559.74 3354.43 0.140476 
16 2571.18 3308.79 0.137948 
31 2543.22 3232.63 0.136255 
46 2529.03 3153.45 0.133663 
61 2532.07 3078.15 0.130315 
76 2508.46 2984.49 0.127539 
91 2492.61 2914.93 0.125358 
106 2488.31 2857.75 0.123112 
121 2487.11 2795.62 0.120493 
136 2474.38 2728.95 0.118225 
151 2468.5 2654.88 0.11529 
166 2468.76 2604.86 0.113106 
181 2472.42 2539.98 0.110126 
196 2467.17 2477.84 0.10766 
211 2457.99 2422.17 0.105634 
226 2499.78 2399.79 0.102909 
241 2489.23 2336.73 0.100629 
256 2471.02 2284.59 0.099109 
271 2482.83 2231.52 0.096346 
286 2477.38 2184.11 0.094507 
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Determination of Rate at 10 
o
C - Run 2 [DJK-11-57] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.1 mmol, 0.1  equiv) and MsOH  (6.5 μL, 0.1 mmol, 1.0 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 10 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
1.71E-04 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 2558.85 3354.59 0.142063 
16 2569.87 3308.73 0.139521 
31 2541.85 3232.96 0.137828 
46 2527.21 3153.2 0.135207 
61 2530.53 3078.32 0.131823 
76 2506.99 2984.56 0.129008 
91 2490.83 2915.02 0.126819 
y = -1.69E-04x + 1.41E-01 
R² = 9.96E-01 
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106 2485.98 2857.4 0.124555 
121 2485.79 2795.54 0.121868 
136 2472.38 2728.46 0.119589 
151 2466.55 2654.34 0.116615 
166 2467.25 2604.34 0.114386 
181 2470.3 2539.66 0.111407 
196 2465.64 2477.34 0.108879 
211 2456.4 2421.76 0.106837 
226 2497.99 2399.64 0.104098 
241 2487.62 2336.39 0.101777 
256 2469 2284.25 0.100256 
271 2480.55 2230.93 0.09746 
286 2475.34 2183.03 0.095568 
 
 
 
Determination of Rate at 10 
o
C - Run 3 [DJK-11-58] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.1 mmol, 0.1  equiv) and MsOH  (6.5 μL, 0.1 mmol, 1.0 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 10 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
1.91E-04 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
y = -1.71E-04x + 1.43E-01 
R² = 9.95E-01 
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[MsOH] = 0.14 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 2632.63 3389.63 0.140476 
16 2669.72 3357.12 0.137196 
31 2664.27 3277.61 0.134221 
46 2667.96 3198.62 0.130805 
61 2658.73 3125.25 0.128248 
76 2649.64 3047.51 0.125487 
91 2660.1 2978.35 0.122157 
106 2654.94 2911.53 0.119648 
121 2649.79 2840.85 0.116971 
136 2656.62 2785.71 0.114405 
151 2633.86 2727.25 0.112972 
166 2646.5 2658.12 0.109583 
181 2629.75 2587.83 0.107365 
196 2627.55 2528.64 0.104997 
211 2620.84 2480.77 0.103273 
226 2631.92 2431.46 0.100794 
241 2622.41 2368.77 0.098551 
256 2644.87 2327.53 0.096013 
271 2628.87 2260.78 0.093827 
286 2630.9 2215.19 0.091864 
301 2637.68 2157.74 0.089252 
316 2635.36 2119.19 0.087734 
331 2622.84 2067 0.085982 
346 2618.82 2011.07 0.083784 
361 2610.2 1967.17 0.082226 
376 2590.29 1913.78 0.080609 
391 2594.44 1865.7 0.078458 
406 2580.81 1823.22 0.077077 
421 2575.34 1780.13 0.075415 
436 2563.59 1738.65 0.073995 
451 2561.28 1685.78 0.07181 
466 2562.64 1661.87 0.070754 
481 2551.46 1609.84 0.068839 
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Determination of Rate at 20 
o
C - Run 1 [DJK-11-53] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.1 mmol, 0.1  equiv) and MsOH  (6.5 μL, 0.1 mmol, 1.0 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at 20 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
2.45E-04 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 14353.4 15176.3 0.134921 
16 14328.3 14807.1 0.131869 
31 14251.9 14313.2 0.128154 
46 14252.9 13885.2 0.124313 
61 14138.8 13383.7 0.12079 
76 14124.8 12982.9 0.117289 
91 14107.4 12570 0.113699 
y = -1.91E-04x + 1.40E-01 
R² = 9.97E-01 
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106 14007.3 12178.6 0.110946 
121 14013.1 11779.8 0.107268 
136 14004 11418.2 0.104043 
151 13967.1 11067.5 0.101114 
166 13877.9 10705 0.098431 
181 13892.8 10435.1 0.095846 
196 13941.7 10121.2 0.092637 
211 13882.7 9813.19 0.090199 
226 13887.1 9526.65 0.087538 
241 13864.6 9245.34 0.085091 
256 13884.8 8969.75 0.082434 
271 13859 8711.64 0.080211 
286 13882.3 8462.98 0.077791 
301 13813.6 8202.65 0.075773 
316 13818.3 8005.72 0.073929 
331 13783.3 7743.26 0.071687 
346 13775.8 7513.42 0.069597 
361 13774.7 7317.23 0.067785 
376 13751.1 7091.38 0.065805 
391 13769.3 6937.72 0.064294 
406 13812.3 6741.33 0.06228 
421 13776.9 6554.02 0.060705 
436 13682.1 6320.11 0.058944 
451 13682.9 6138.33 0.057245 
466 13460.8 5870.27 0.055649 
481 13429.3 5684.86 0.054017 
496 13405.7 5509.02 0.052439 
511 13409.6 5385.85 0.051251 
526 13370 5204.31 0.049671 
541 13378.6 5032.66 0.048001 
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Determination of Rate at 20 
o
C - Run 2 [DJK-11-54] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.1 mmol, 0.1  equiv) and MsOH  (6.5 μL, 0.1 mmol, 1.0 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at  20 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
2.67E-04 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 11378 13502.4 0.137302 
16 11276.8 13044.4 0.133835 
31 11374.6 12739.4 0.129582 
46 11225 12183.7 0.125581 
61 11169.1 11751.5 0.121732 
76 11184.6 11410.8 0.118039 
 
y = -2.45E-04x + 1.36E-01 
R² = 9.99E-01 
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Determination of Rate at 20 
o
C - Run 3 [DJK-11-55] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.1 mmol, 0.1  equiv) and MsOH  (6.5 μL, 0.1 mmol, 1.0 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at  20 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
2.54E-04 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 14353.4 15176.3 0.140476 
16 14328.3 14807.1 0.137299 
31 14251.9 14313.2 0.133431 
46 14252.9 13885.2 0.129432 
61 14138.8 13383.7 0.125764 
76 14124.8 12982.9 0.122118 
91 14107.4 12570 0.11838 
y = -2.67E-04x + 1.38E-01 
R² = 9.99E-01 
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106 14007.3 12178.6 0.115514 
121 14013.1 11779.8 0.111685 
136 14004 11418.2 0.108327 
151 13967.1 11067.5 0.105277 
166 13877.9 10705 0.102484 
181 13892.8 10435.1 0.099793 
196 13941.7 10121.2 0.096451 
211 13882.7 9813.19 0.093913 
226 13887.1 9526.65 0.091142 
241 13864.6 9245.34 0.088595 
256 13884.8 8969.75 0.085829 
271 13859 8711.64 0.083514 
286 13882.3 8462.98 0.080994 
301 13813.6 8202.65 0.078893 
316 13818.3 8005.72 0.076973 
331 13783.3 7743.26 0.074638 
346 13775.8 7513.42 0.072462 
361 13774.7 7317.23 0.070576 
376 13751.1 7091.38 0.068515 
391 13769.3 6937.72 0.066942 
406 13812.3 6741.33 0.064844 
421 13776.9 6554.02 0.063204 
436 13682.1 6320.11 0.061371 
451 13682.9 6138.33 0.059602 
466 13460.8 5870.27 0.05794 
481 13429.3 5684.86 0.056242 
496 13405.7 5509.02 0.054598 
511 13409.6 5385.85 0.053362 
526 13370 5204.31 0.051716 
541 13378.6 5032.66 0.049978 
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Determination of Rate at -20 
o
C - Run 1 [DJK-11-59] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.1 mmol, 0.1  equiv) and MsOH  (6.5 μL, 0.1 mmol, 1.0 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at  -20 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
2.66E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 3072.85 3278.18 0.140872 
16 3201.49 3330.23 0.13852 
31 3199.57 3269.13 0.13606 
46 3189.11 3237.39 0.135181 
61 3144.89 3249.5 0.137595 
76 3127.28 3241.89 0.138046 
91 3124.69 3210.11 0.136806 
y = -2.55E-04x + 1.41E-01 
R² = 9.99E-01 
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106 3123.43 3215.04 0.137071 
121 3120.54 3191.67 0.136201 
136 3116.21 3172.01 0.13555 
151 3120.83 3156.89 0.134704 
166 3117.93 3141 0.134151 
181 3117.13 3152.31 0.134668 
196 3103.8 3137.9 0.134628 
211 3110.64 3115.08 0.133355 
226 3123.45 3111.12 0.13264 
241 3103.81 3096.87 0.132868 
256 3118.69 3077.45 0.131404 
271 3106.48 3073.1 0.131734 
286 3118.99 3050.78 0.130253 
301 3116.97 3046.42 0.130151 
316 3108.74 3051.92 0.130731 
331 3119.85 3024.05 0.129076 
346 3106.33 3030.07 0.129896 
361 3106.64 3023.3 0.129593 
376 3113.74 3010.44 0.128747 
391 3113.87 2986.74 0.127729 
406 3114.37 2976.37 0.127265 
421 3104.63 2973.27 0.127531 
436 3110.26 2966.8 0.127023 
451 3112.94 2971.07 0.127096 
466 3106.91 2941.07 0.126057 
481 3104.05 2947.18 0.126435 
496 3115.18 2923.1 0.124954 
511 3106.99 2926.53 0.125431 
526 3111.69 2914.94 0.124745 
541 3119.34 2909.71 0.124216 
556 3102 2881.13 0.123684 
571 3112.39 2891.51 0.123715 
586 3092.53 2880.81 0.124049 
601 797.858 714.839 0.119309 
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Determination of Rate at -20 
o
C - Run 2 [DJK-11-60] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.1 mmol, 0.1  equiv) and MsOH  (6.5 μL, 0.1 mmol, 1.0 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at  -20 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
2.16E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 3000.29 2245.43 0.142063 
16 3074.59 2355.43 0.145422 
31 3050.52 2362.15 0.146987 
46 3014.57 2389.47 0.15046 
61 3009.69 2348.89 0.148145 
76 2999.84 2282.54 0.144433 
91 3049.22 2280.68 0.141978 
y = -2.66E-05x + 1.39E-01 
R² = 9.78E-01 
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106 3062.9 2274.73 0.140975 
121 3066.95 2324.77 0.143886 
136 3109.79 2324.62 0.141895 
151 3091.02 2345.01 0.144009 
166 3084.93 2342.46 0.144136 
181 3089.54 2342.91 0.143949 
196 3084.75 2339.35 0.143953 
211 3095.88 2346.75 0.143889 
226 3085.61 2319.04 0.142664 
241 3073.67 2303.72 0.142272 
256 3067.56 2320.48 0.143592 
271 3117.28 2321.65 0.141373 
286 3111.9 2295.67 0.140033 
301 3111.6 2302.73 0.140477 
316 3122.38 2290.04 0.139221 
331 3072.42 2292.11 0.141612 
346 3066.96 2295.82 0.142094 
361 3066.97 2257.95 0.13975 
376 3059.94 2266.25 0.140586 
391 3061.15 2234.84 0.138582 
406 3054.38 2266.19 0.140838 
421 3056.57 2223.61 0.138093 
436 3054.99 2214.08 0.137572 
451 3045.6 2248.44 0.140138 
466 3066.41 2208.28 0.136701 
481 3053.82 2196.73 0.136546 
496 3051.94 2189.68 0.136192 
511 3057.08 2188.18 0.13587 
526 3050.59 2179.59 0.135624 
541 3052.08 2161.86 0.134455 
556 3052.65 2171.2 0.135011 
571 3046.2 2176.3 0.135615 
586 3052.43 2161.43 0.134413 
601 3051.27 2167.67 0.134852 
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Determination of Rate at -20 
o
C - Run 3 [DJK-11-61] 
 
 Following the General Procedure, 56 (25.6 mg, 0.1 mmol, 1.0 equiv), 101 (18 mg, 0.1 
mmol), catalyst 100 (4.5 mg, 0.1 mmol, 0.1  equiv) and MsOH  (6.5 μL, 0.1 mmol, 1.0 equiv) 
were combined in an NMR tube containing 0.7 mL of CDCl3. The tube was inserted into an 
NMR spectrometer at  -20 
o
C. The reaction was then followed by 
19
F NMR spectroscopy. Kobs = 
2.23E-05 M/min 
 
[101] = 0.14 M 
[56] = 0.14 M 
[MsOH] = 0.14 M 
 
Kinetic Data: 
 
time, min area, IS area, Substrate [Substrate] 
1 3344.53 2336.24 0.14127 
16 3396.27 2494.94 0.148568 
31 3384.9 2461.68 0.14708 
46 3376.97 2397.4 0.143576 
61 3359.76 2411.87 0.145182 
76 3329.52 2423.51 0.147208 
91 3323.64 2410.83 0.146696 
y = -2.16E-05x + 1.48E-01 
R² = 8.54E-01 
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106 3303.49 2410.84 0.147592 
121 3286.15 2406.52 0.148105 
136 3284.41 2393.13 0.147359 
151 3279.11 2381.04 0.146851 
166 3282.1 2380.78 0.146702 
181 3277.23 2327.96 0.14366 
196 3292.09 2351.89 0.144482 
211 3279.72 2343.34 0.144499 
226 3272.9 2330.61 0.144014 
241 3276.72 2318.65 0.143108 
256 3256.73 2345.05 0.145626 
271 3264.34 2326.84 0.144158 
286 3276.35 2319.28 0.143163 
301 3260.15 2287.67 0.141913 
316 3273.86 2277.21 0.140673 
331 3267.62 2299.12 0.142297 
346 3268.15 2249.36 0.139195 
361 3255.88 2251.15 0.139831 
376 3266.07 2239.36 0.138665 
391 3259.24 2263.85 0.140475 
406 3256.42 2252.5 0.139892 
421 3254.38 2251.24 0.139901 
436 3254.91 2272 0.141168 
451 3263 2239.05 0.138776 
466 3246.81 2251.52 0.140245 
481 3261.84 2265.61 0.140472 
496 3250.91 2208.75 0.137407 
511 3266.25 2181.16 0.135053 
526 3264.14 2175.69 0.134802 
541 3253.59 2179.5 0.135476 
556 3261.75 2152.8 0.133481 
571 3259.47 2188.94 0.135817 
586 3244.85 2178.5 0.135778 
601 3260.3 2180.96 0.135287 
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 5.5. Experimental Procedures for Chapter 4. 
 
Optimization of Phenol Cinnamylation  
 
General Procedure  
 To an oven dried Schlenk flask was added washed, dry NaH (1.05 equiv) in a glovebox. 
For alkali metals, the metal was weighed in hexanes outside the glovebox and dried before 
addition to the reaction flask. The flask was transferred to a Schlenk line. Solvent (0.5M) was 
added to afford a cloudy mixture. The mixture was placed in an ice bath and the corresponding 
phenol (1 equiv) was added portionwise. During this phase, substantial gas evolution was 
observed. The insoluble material appeared to change in texture from an amorphous, cloudy 
particulate matter to a finely distributed crystallized solid. The reaction was removed from the 
ice bath and then allowed to stir at rt for 30 min. Subsequently, cinnamyl chloride (1.1 equiv) 
was added dropwise via syringe. After the addition was complete, the reaction was placed in an 
oil bath and then heated to reflux for the specified amount of time. After completion of the 
reaction as adjudged by TLC, the flask was removed from the heat source and allowed to cool to 
rt. The mixture was then transferred to a separatory funnel, diluted with water (5 mL) and 
dichloromethane (10 mL), and then acidified to pH <1 with slow addition of a 6 M HCl solution. 
The aqueous layer was separated and then back extracted with a further 10 mL of 
y = -2.24E-05x + 1.49E-01 
R² = 8.22E-01 
0.132 
0.134 
0.136 
0.138 
0.14 
0.142 
0.144 
0.146 
0.148 
0.15 
0.152 
0 200 400 600 800 
C
o
n
ce
n
tr
at
io
n
, M
 
Time, min 
-20 C Run 3 
Series1 
Linear (Series1) 
281 
 
dichloromethane. The combined organic layers were then washed with brine, dried over MgSO4, 
and then filtered through glass wool. The filtrate was dried by rotary evaporation (3 mm Hg, 30 
o
C). The residue was then taken up in 10 mL dichloromethane. 
1
H NMR of the crude material 
was taken at this point. Celite was added and the mixture was concentrated to afford a white 
powder, which was then subjected to flash column chromatography.  
 
Cinnamylation of Phenol with Na in Tetrahydrofuran (Table 14 Entry 1) [DJK-18-46] 
 
 
 
 Following General Procedure 8, Na (24 mg, 1.05 mmol), THF (2 mL), phenol (94 mg, 1 
mmol) and cinnamyl chloride (153 μL, 1.1 mmol) were combined in a 10-mL Schlenk flask. The 
reaction was stirred at 22 
o
C  for 16 h. The reaction was then worked up according to the General 
Procedure with the following modification: diethyl ether was used as the extraction solvent 
instead of dichloromethane. Silica gel flash column chromatography (12:1, hexanes/ethyl 
acetate, 20 mm diameter, 16 cm SiO2) afforded 25 mg (12%) of a >9:1 mixture of 114 and 115 
as a pale oil. 
Data for 114: 
 1
H NMR:  (500 MHz, CDCl3)  
 7.39 – 7.35 (m, 2H), 7.33 – 7.28 (m, 2H), 7.25 – 7.14 (m, 3H), 6.92 (td, J = 7.4, 
1.2 Hz, 1H), 6.83 (dd, J = 7.9, 1.2 Hz, 1H), 6.52 (d, J = 15.9 Hz, 1H), 6.40 (dt, J = 
15.9, 6.5 Hz, 1H), 3.59 (d, J = 6.0 Hz, 1H). 
  
Diagnostic for 115: 
 1
H NMR:  (500 MHz, CDCl3)  
  6.29 (ddd, J = 17.2, 10.2, 7.3 Hz, 1H), 5.21 (d, J = 10.2 Hz, 1H), 5.02 – 4.97 (m, 
2H) 
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Diagnostic for 116: 
 1
H NMR:  (500 MHz, CDCl3)  
 6.74 (dt, J = 15.9, 1.7 Hz, 1H), 6.49 – 6.38 (m, 1H), 4.71 (dd, J = 5.8, 1.5 Hz, 1H). 
 
Cinnamylation of Phenol with Na in Et2O (Table 14 Entry 2) [DJK-18-47] 
 
 Following General Procedure 8, Na (24 mg, 1.05 mmol), ether (2 mL), phenol (94 mg, 1 
mmol) and cinnamyl chloride (153 μL, 1.1 mmol) were combined in a 10-mL Schlenk flask. The 
reaction was stirred at 22 
o
C  for 16 h. The reaction was then worked up according to the General 
Procedure with the following modification: diethyl ether was used as the extraction solvent. 
Silica gel flash column chromatography (12:1, hexanes/ethyl acetate, 20 mm diameter, 16 cm 
SiO2) afforded 137 mg (65%) of a 4.5:1 mixture of 114 and 115 as a pale oil.  
 
Cinnamylation of Phenol with Na in CH2Cl2 (Table 14, Entry 3) [DJK-18-48] 
 
 Following General Procedure 8, Na (24 mg, 1.05 mmol), CH2Cl2 (2 mL), phenol (94 mg, 
1 mmol) and cinnamyl chloride (153 μL, 1.1 mmol) were combined in a 10-mL Schlenk flask. 
The reaction was stirred at 22 
o
C  for 16 h. The reaction was then worked up according to the 
General Procedure. Silica gel flash column chromatography (12:1, hexanes/ethyl acetate, 20 mm 
diameter, 16 cm SiO2) afforded 78 mg (37%) of a 4:1 mixture of 114 and 115 as a pale oil.  
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Cinnamylation of Phenol with Li in CH2Cl2 (Table 14, Entry 4) [DJK-18-49] 
 
 Following General Procedure 8, washed lithium (8 mg, 1.1 mmol), CH2Cl2 (2 mL), 
phenol (94 mg, 1 mmol) and cinnamyl chloride (153 μL, 1.1 mmol) were combined in a 10-mL 
Schlenk flask. The reaction was stirred at 22 
o
C  for 16 h. The reaction was then worked up 
according to the General Procedure. The crude NMR did not show appreciable amounts of 
product and the material was not purified further  
  
Cinnamylation of Phenol with K in CH2Cl2 (Table 14, Entry 5) [DJK-18-50] 
 
 Following General Procedure 8, washed potassium (42 mg, 1.05 mmol), CH2Cl2 (2 mL), 
phenol (94 mg, 1 mmol) and cinnamyl chloride (153 μL, 1.1 mmol) were combined in a 10-mL 
Schlenk flask. The reaction was stirred at 22 
o
C  for 16 h. The reaction was then worked up 
according to the General Procedure.Silica gel flash column chromatography (12:1, hexanes/ethyl 
acetate, 20 mm diameter, 16 cm SiO2) afforded 61 mg (29%) of a 2:1 mixture of 114 and 115 as 
a pale oil.  
 
Cinnamylation of Phenol with NaH in CH2Cl2 (Table 14 Entry 6) [DJK-18-51] 
 
 Following General Procedure 8, NaH (25 mg, 1.05 mmol), CH2Cl2 (2 mL), phenol (94 
mg, 1 mmol) and cinnamyl chloride (153 μL, 1.1 mmol) were combined in a 10-mL Schlenk 
flask. The reaction was stirred at reflux for 16 h. The reaction was then worked up according to 
the General Procedure. Silica gel flash column chromatography (12:1, hexanes/ethyl acetate, 20 
mm diameter, 16 cm SiO2) afforded 139 mg (66%) of a 7:1 mixture of 114 and 115 as a pale oil.  
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Cinnamylation of Phenol with NaH in CCl4 (Table 14 Entry 7) [DJK-18-52] 
 
 Following General Procedure 8, NaH (25 mg, 1.05 mmol), CCl4 (2 mL), phenol (94 mg, 
1 mmol) and cinnamyl chloride (153 μL, 1.1 mmol) were combined in a 10-mL Schlenk flask. 
The reaction was stirred at reflux for 16 h. The reaction was then worked up according to the 
General Procedure. Silica gel flash column chromatography (12:1, hexanes/ethyl acetate, 20 mm 
diameter, 16 cm SiO2) afforded 143 mg (68%) of a 9.5:1 mixture of 114 and 115 as a pale oil.  
 
Cinnamylation of Phenol with NaH in Benzene  (Table 14 Entry 8) [DJK-18-53] 
 
 Following General Procedure 8, NaH (25 mg, 1.05 mmol), benzene (2 mL), phenol (94 
mg, 1 mmol) and cinnamyl chloride (153 μL, 1.1 mmol) were combined in a 10-mL Schlenk 
flask. The reaction was stirred at reflux for 16 h. The reaction was then worked up according to 
the General Procedure with the following modification: diethyl ether was used as the extraction 
solvent. Silica gel flash column chromatography (12:1, hexanes/ethyl acetate, 20 mm diameter, 
16 cm SiO2) afforded 155 mg (74%) of a 9:1 mixture of 114 and 115 as a pale oil. 
 
Preparation of cinnamyl-substituted Phenols (Table 15) 
 
General Procedure  
 To a 50-mL oven dried Schlenk flask was added washed, dry NaH (1.05 equiv) in a 
glovebox. The flask was transferred to a Schlenk line. Solvent (0.5M) was added to afford a 
cloudy mixture. The mixture was placed in an ice bath and the corresponding phenol (1 equiv) 
was added portionwise. During this phase, substantial gas evolution was observed. The insoluble 
material appeared to change in texture from an amorphous, cloudy particulate matter to a finely 
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distributed crystallized solid. The reaction was removed from the ice bath and then allowed to 
stir at rt for 30 min. Subsequently, cinnamyl chloride (1.1 equiv) was added dropwise via 
syringe. After the addition was complete, the reaction was placed in an oil bath and then heated 
to reflux for the specified amount of time. After completion of the reaction as adjudged by TLC, 
the flask was removed from the heat source and allowed to cool to rt. The mixture was then 
transferred to a separatory funnel, diluted with water (20 mL) and dichloromethane (20 mL), and 
then acidified to pH <1 with slow addition of a 6M HCl solution. The aqueous layer was 
separated and then back extracted with a further 30 mL of dichloromethane. The combined 
organic layers were then washed with brine, dried over MgSO4, and then filtered through glass 
wool. The filtrate was dried under reduced pressure (~3 mm Hg, rotary evaporator). The residue 
was then taken up in 10 mL dichloromethane. Celite was added and the mixture was 
concentrated to afford a white powder, which was then subjected to flash column 
chromatography. If necessary, a second flash column chromatography operation was performed 
using silica impregnated with 10% AgNO3 (w/w). 
 
Preparation of (E)-2-(3-Phenyl-2-propen-1-yl)phenol (114) [DJK-11-24] 
 
 Following General Procedure 9, NaH (252 mg, 10.5 mmol), CCl4 (20 mL), phenol (0.94 
g, 10 mmol) and cinnamyl chloride (1.53 mL, 11 mmol) were combined in a 50-mL Schlenk 
flask. The reaction was worked up according to the General Procedure. Silica gel flash column 
chromatography (3:1 hexanes/toluene, 30 mm diameter, 14 cm SiO2) followed by a second silica 
gel flash column chromatography (9:1, hexanes/ethyl acetate, 30 mm diameter, 50 g SiO2 (10% 
AgNO3 w/w)) afforded a pale oil. Distillation afforded 1.49 g of 114 (71%) as a pale oil that 
solidifed upon standing. The spectroscopic data matched those reported in the literature.
161
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Data for 114: 
 1
H NMR:  (500 MHz, CDCl3)  
 δ 7.39 – 7.35 (m, 2H), 7.33 – 7.28 (m, 2H), 7.25 – 7.14 (m, 3H), 6.92 (td, J = 7.4, 
1.2 Hz, 1H), 6.83 (dd, J = 7.9, 1.2 Hz, 1H), 6.52 (d, J = 15.9 Hz, 1H), 6.40 (dt, J = 
15.9, 6.5 Hz, 1H), 3.59 (d, J = 6.0 Hz, 1H). 
 13
C NMR: (126 MHz,CDCl3) 
  δ 154.2, 137.3, 131.8, 130.7, 128.8, 128.2, 128.1, 127.6, 126.5, 125.9, 121.3, 
116.0, 34.4. 
 MS: (EI, 70 eV, m/z) 
  210 (100, M
+
), 119 (33), 115 (38),  104 (66), 91 (82), 69 (45). 
 
Preparation of (E)-2-(3-Phenyl-2-propen-1-yl)-4-methylphenol (114b) [DJK-9-67] 
 
 Following General Procedure 9, NaH (252 mg, 10.5 mmol), CCl4 (20 mL), p-cresol (1.08 
g, 10 mmol) and cinnamyl chloride (1.53 mL, 11 mmol) were combined in a 50-mL Schlenk 
flask. The reaction was worked up according to the General Procedure. Silica gel flash column 
chromatography (3:1 hexanes/toluene, 30 mm diameter, 16 cm SiO2) followed by a second silica 
gel flash column chromatography (9:1, hexanes/ethyl acetate, 50 g SiO2 (10% AgNO3 w/w)) 
afforded a pale oil. Distillation afforded 1.05 g of 114b (47%) as a pale oil that solidified upon 
standing. The spectral data matched those reported in the literature.
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Data for 114b: 
 1
H NMR:  (500 MHz, CDCl3)  
 δ 7.40 – 7.35 (m, 2H), 7.32 (td, J = 7.6, 1.1 Hz, 2H), 7.26 – 7.21 (m, 1H), 7.06 (t, J 
= 8.3 Hz, 1H), 6.84 (t, J = 7.5 Hz, 1H), 6.56 (d, J = 16.0 Hz, 0H), 6.41 (dtd, J = 
15.8, 6.6, 1.0 Hz, 1H), 4.96 (s, 1H), 3.59 (dd, J = 6.7, 1.6 Hz, 2H), 2.28 (s, 3H) 
 13
C NMR: (126 MHz,CDCl3) 
 δ 149.7, 135.1, 129.3, 128.9, 128.2, 126.5, 126.2, 126.1, 125.2, 124.2, 124.1, 
123.4, 113.6, 32.1, 18.5. 
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 MS: (EI, 70 eV, m/z) 
  224 (100, M
+
), 209 (30), 133 (55), 115 (30), 104 (35), 91 (69), 77 (22) 
 
Preparation of (E)-2-(3-Phenyl-2-propen-1-yl)-6-methylphenol  (114c) [DJK-11-20] 
 
 Following General Procedure 9, NaH (252 mg, 10.5 mmol), CCl4 (20 mL), o-cresol (1.08 
g, 10 mmol) and cinnamyl chloride (1.53 mL, 11 mmol) were combined in a 50-mL Schlenk 
flask. The reaction was worked up according to the General Procedure. Silica gel flash column 
chromatography (3:1 hexanes/toluene, 30 mm diameter, 14 cm SiO2) followed by a second silica 
gel flash column chromatography (9:1, hexanes/ethyl acetate, 30 mm diameter 50 g SiO2 (10% 
AgNO3 w/w)) afforded a pale oil. Distillation afforded 1.38 g of 114c (62%) as a pale oil that 
solidified upon standing. The spectral data matched those reported in the literature.
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Data for 114c: 
 1
H NMR:  (500 MHz, CDCl3)  
  δ 7.41 – 7.35 (m, 2H), 7.34 – 7.30 (m, 2H), 7.23 (ddd, J = 12.8, 6.5, 1.7 Hz, 1H), 
7.06 (t, J = 8.7 Hz, 1H), 6.90 – 6.80 (m, 1H), 6.56 (d, J = 16.0 Hz, 0H), 6.41 (ddd, 
J = 15.9, 8.0, 5.6 Hz, 1H), 3.59 (dd, J = 6.6, 1.7 Hz, 2H). 
 13
C NMR: (126 MHz,CDCl3) 
  δ 152.5, 136.9, 131.6, 129.4, 128.5, 128.1, 127.9, 127.4, 126.2, 124.9, 124.0, 
120.4, 34.6, 15.9. 
 MS: (EI, 70 eV, m/z) 
  224 (100, M
+
), 209 (33), 168 (26), 141 (28), 120 (29), 115 (52), 105 (47), 91 (71), 
77 (76), 69 (41). 
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Preparation of (E)-2-(3-Phenyl-2-propen-1-yl)-4-methoxyphenol (114d) [DJK-10-26] 
 
 Following General Procedure 9, NaH (252 mg, 10.5 mmol), CCl4 (20 mL), 4-
methoxyphenol (1.24 g, 10 mmol) and cinnamyl chloride (1.53 mL, 11 mmol) were combined in 
a 50-mL Schlenk flask. The reaction was worked up according to the General Procedure. Silica 
gel flash column chromatography (3:1, hexanes/toluene, 30 mm diameter, 14 cm SiO2) followed 
by a second silica gel flash column chromatography (9:1 hexanes/ethyl acetate, 30 mm diameter, 
50 g SiO2 (10% AgNO3 w/w)) afforded a pale oil. Distillation afforded 1.17 g of 114d (49%) as a 
pale oil that solidified upon standing. The spectral data matched those reported in the 
literature.
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Data for 114d: 
 
1
H NMR: (500 MHz, CDCl3) 
  δ 7.39 – 7.14 (m, 5H), 6.81 – 6.65 (m, 3H), 6.48 (d, 1H, J = 15.9 Hz), 6.35 (dt, J = 
15.9, 6.5 Hz, 1H), 3.74 (s, 3H), 3.52 (d, J = 5.7 Hz, 1H). 
 13
C NMR: (126 MHz,CDCl3) 
  δ 153.8, 147.9, 137.0, 131.5, 128.5, 127.7, 127.3, 126.8, 126.2, 116.4, 116.0, 
112.6, 55.7, 34.3. 
 MS: (EI, 70 eV, m/z) 
  240 (100, M
+
), 149 (66), 136 (99), 121 (25), 115 (31), 108 (44), 91 (79), 77 (21).  
 
Preparation of (E)- 2-(3-Phenyl-2-propen-1-yl)-4-fluorophenol  (114e) [DJK-18-44] 
 
 Following General Procedure 9, NaH (252 mg, 10.5 mmol), CCl4 (20 mL), 4-
fluorophenol (1.12 g, 10 mmol) and cinnamyl chloride (1.53 mL, 11 mmol) were combined in a 
50-mL Schlenk flask. The reaction was worked up according to the General Procedure. Silica gel 
flash column chromatography (3:1 hexanes/toluene, 30 mm diameter, 16 cm SiO2) followed by a 
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second silica gel flash column chromatography (9:1, hexanes/ethyl acetate, 30 mm diameter, 50 
g SiO2 (10% AgNO3 w/w)) afforded a pale oil. Distillation afforded 1.73 g of 114e (76%) as a 
yellow oil that solidified upon standing.
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Data for 114e: 
 bp: 100 
o
C  (ABT, 3*10
-5
 T) 
 
1
H NMR: (500 MHz, CDCl3) 
  δ 7.40 – 7.32 (m, 2H), 7.29 (ddd, J = 7.9, 6.2, 1.3 Hz, 2H), 7.24 – 7.18 (m, 1H), 
6.88 (dd, J = 9.0, 3.0 Hz, 1H), 6.82 (td, J = 8.3, 3.1 Hz, 1H), 6.74 (dd, J = 8.7, 4.7 
Hz, 1H), 6.49 (dt, J = 15.7, 1.6 Hz, 1H), 6.33 (dt, J = 15.9, 6.6 Hz, 1H), 3.52 (dd, 
J = 6.6, 1.5 Hz, 2H). 
 13
C NMR: (126 MHz,CDCl3) 
  δ 157.2 (d, J = 232 Hz) , 149.8, 136.9, 132.0, 128.6, 127.5, 127.3 (d, J = 7 Hz), 
126.9, 126.2, 116.6 (d,  J = 23 Hz), 116.5 (d, J = 8.5 Hz), 113.9 (d, J = 25 Hz),  
34.0. 
 19
F NMR: (476 MHz,CDCl3) 
  δ -123.9 (m) 
 IR: (ATR, cm
-1
) 
  3429 (br), 3027 (w), 1619 (w), 1598 (w), 1494 (s), 1438 (s), 1327 (w), 1254 (w), 
1176 (s), 1141 (m), 1090 (w), 1028 (w), 958 (m), 928 (w), 872 (w), 809 (m), 748 (s), 
731 (m), 716 (w), 692 (s). 
 MS: (EI, 70 eV, m/z) 
  228 (100, M
+
), 137 (46), 115 (21), 109 (21), 104 (85), 91 (57) 
 HRMS: Calcd for C15H13OF 200.0950, found 200.0952, error  0.7  
 TLC: Rf 0.30 (4:1, hexanes/ethyl acetate) [UV,CAM] 
  
Preparation of (E)- 2-(3-Phenyl-2-propen-1-yl)-4-chlorophenol  (114f) [DJK-11-32] 
 
 Following General Procedure 9, NaH (252 mg, 10.5 mmol), CCl4 (20 mL), 4-
chlorophenol (1.28 g, 10 mmol) and cinnamyl chloride (1.53 mL, 11 mmol) were combined in a 
290 
 
50-mL Schlenk flask. The reaction was worked up according to the General Procedure. Silica gel 
flash column chromatography (3:1 hexanes/toluene, 30 mm diameter, 16 cm SiO2) followed by a 
second silica gel flash column chromatography (9:1, hexanes/ethyl acetate, 50 g SiO2 (10% 
AgNO3 w/w)) afforded a pale oil. Distillation afforded 1.49 g of 114f (61%) as a yellow oil that 
solidified upon standing. The spectroscopic data matched those reported in the literature.
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Data for 114f: 
 
1
H NMR: (500 MHz, CDCl3) 
  δ 7.43 – 7.07 (m, 5H), 6.77 (d, J = 8.5 Hz, 1H), 6.57 – 6.49 (m, 1H), 6.36 (dt, J = 
15.9, 6.6 Hz, 1H), 4.97 (s, 1H), 3.60 – 3.47 (m, 2H). 
 13
C NMR: (126 MHz,CDCl3) 
  δ 159.4, 152.8, 137.1, 132.4, 130.3, 128.8, 127.8, 127.7, 127.1, 126.5, 117.2,  
34.1. 
 MS: (EI, 70 eV, m/z) 
  246 (33, M
+
+2), 244 (96, M
+
), 209 (75), 165 (19), 153 (42), 115 (42), 105 (60), 
104 (100), 91 (87), 81 (40), 77 (59), 69 (81)  
 
Preparation of (E)-2-(3-Phenyl-2-propen-1-yl)-4-bromophenol (114g) [DJK-11-31] 
 
 Following General Procedure 9, NaH (252 mg, 10.5 mmol), CCl4 (20 mL), 4-
bromophenol (1.73 g, 10 mmol) and cinnamyl chloride (1.53 mL, 11 mmol) were combined in a 
50-mL Schlenk flask. The reaction was worked up according to the General Procedure. Silica gel 
flash column chromatography (3:1 hexanes/toluene, 30 mm diameter, 16 cm SiO2) followed by a 
second silica gel flash column chromatography (9:1, hexanes/ethyl acetate, 30 mm diameter 50 g 
SiO2 (10% AgNO3 w/w)) afforded a pale oil. Distillation afforded 1.62 g of 114g (56%) as a pale 
oil that solidified upon standing. The spectroscopic data matched those reported in the 
literature.
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Data for 114g: 
 
1
H NMR: (500 MHz, CDCl3) 
  δ 7.42 – 7.19 (m, 5H), 6.74 (ddd, J = 9.9, 8.5, 1.3 Hz, 1H), 6.53 (dd, J = 15.9, 1.7 
Hz, 1H), 6.36 (dt, J = 15.9, 6.6 Hz, 0H), 4.99 (d, J = 1.3 Hz, 0H), 3.55 (dd, J = 
6.6, 1.6 Hz, 2H). 
 13
C NMR: (126 MHz,CDCl3) 
  δ 153.4, 150.1, 137.1, 133.2, 132.4, 130.8, 128.8, 128.3, 127.8, 127.1, 126.5, 
117.7, 113.2, 34.1. 
 MS: (EI, 70 eV, m/z) 
  290 (71, M
+
+2), 288 (76, M
+
), 209 (93), 131 (24), 118 (39), 115 (45), 104 (100), 
91 (82), 77 (41). 
 
Preparation of (E)- 2-(3-Phenyl-2-propen-1-yl)-4-trifluoromethylphenol (114h)  [DJK-17-
46] 
 
 Following General Procedure 9, NaH (126 mg, 5.25 mmol), toluene (10 mL), 4-
trifluoromethylphenol (810 mg, 5 mmol) and cinnamyl chloride (715 μL, 5.5 mmol) were 
combined in a 50-mL Schlenk flask. The reaction was worked up according to the General 
Procedure. Silica gel flash column chromatography (3:1 hexanes/toluene, 30 mm diameter, 16 
cm SiO2) followed by a second silica gel flash column chromatography (9:1, hexanes/ethyl 
acetate, 30 mm diameter 50 g SiO2 (10% AgNO3 w/w)) afforded a pale oil. Distillation afforded  
885 mg of 114h (64%) as a clear oil that solidified upon standing.  
Data for 114h: 
 bp: 120 
o
C (ABT, 3.2 * 10
-5
 T) 
 
1
H NMR: (500 MHz, CDCl3) 
  δ 7.47 – 7.28 (m, 6H), 7.24 (dd, J = 8.6, 6.2 Hz, 1H), 6.88 (d, J = 8.2 Hz, 1H), 
6.54 (dt, J = 15.8, 1.6 Hz, 1H), 6.36 (dt, J = 15.9, 6.6 Hz, 1H), 5.26 (s, 1H), 3.64 – 
3.57 (m, 2H). 
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 13
C NMR: (126 MHz,CDCl3) 
 δ 156.95, 136.96, 132.57, 129.13, 129.05, 128.91, 128.85, 128.75, 127.93, 127.90, 
127.87, 127.85, 126.86, 126.50, 126.46, 126.37, 125.98, 125.69, 125.59, 125.56, 
125.53, 125.50, 116.04, 77.51, 77.46, 77.26, 77.01, 34.26. 
 19
F NMR: (500 MHz, CDCl3) 
 -61.56 
 IR: (ATR, cm
-1
) 
  3498 (br), 3027 (w), 2923 (w), 1614 (w), 1496 (w), 1485 (w), 1448 (w), 1355 (s), 
1335 (s), 1250 (w), 1201 (s), 1152 (s), 1114 (s), 1028 (w), 967 (m), 928 (w), 889 
(w), 805 (w), 743 (m), 692 (s). 
 MS: (EI, 70 eV, m/z) 
  278 (4, M
+
), 260 (83), 223 (30),  184 (23), 168 (60), 156 (35), 149 (40), 141 (60), 
128 (51), 115 (74), 104 (40), 91 (69), 77 (100).. 
 HRMS: Calcd for C16H13OF3 278.0919, found 278.0912, error  -2.4 
 TLC: Rf  0.33 (4:1, hexanes/ethyl acetate) [UV,CAM] 
 
Preparation of (E)-2-(5-Phenylpent-2-en-1-yl)phenol (114i) [DJK-9-87] 
 
 Following General Procedure 9, NaH (126 mg, 5.25 mmol), toluene (10 mL), 4-
trifluoromethylphenol (810 mg, 5 mmol) and phenethyl allyl chloride (990 mg, 5.5 mmol) were 
combined in a 50-mL Schlenk flask. The reaction was worked up according to the General 
Procedure. Silica gel flash column chromatography (3:1, hexanes/toluene, 30 mm diameter, 16 
cm SiO2) followed by a second silica gel flash column chromatography (9:1, hexanes/ethyl 
acetate, 30 mm diameter SiO2 (10% AgNO3 w/w)) afforded a pale oil. Distillation afforded 940 
mg of 114i (79%) as a clear oil.  
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Data for 114i: 
 bp: 160 
o
C (ABT, 0.05 T) 
 
1
H NMR: (500 MHz, CDCl3) 
  δ 7.30 – 7.26 (m, 2H), 7.21 – 7.10 (m, 5H), 7.05 (dd, J = 7.5, 1.7 Hz, 1H), 6.87 
(td, J = 7.4, 1.2 Hz, 1H), 6.82 (dd, J = 8.0, 1.2 Hz, 1H), 5.64 (ddd, J = 5.5, 3.9, 1.7 
Hz, 2H), 5.01 (s, 1H), 3.35 (dd, J = 4.5, 1.8 Hz, 3H), 2.70 (dd, J = 8.8, 6.7 Hz, 
3H), 2.42 – 2.32 (m, 3H). 
 13
C NMR: (126 MHz,CDCl3) 
  δ 154.2, 141.7, 131.9, 130.2, 128.4, 128.3, 128.2, 127.8, 125.8, 120.8, 115.8, 35.7, 
34.2, 34.0. 
 IR: (ATR, cm
-1
) 
  3498 (br), 3027 (w), 2923 (w), 1614 (w), 1496 (w), 1485 (w), 1448 (w), 1355 (s), 
1335 (s), 1250 (w), 1201 (s), 1152 (s), 1114 (s), 1028 (w), 967 (m), 928 (w), 889 
(w), 805 (w), 743 (m), 692 (s). 
 MS: (EI, 70 eV, m/z) 
  238 (95, M
+
), 147 (100), 131 (21), 107 (42), 91 (62)    
 TLC: Rf  0.27 (4:1, hexanes/ethyl acetate) [UV,CAM] 
 Analysis: C17H18O (238.33) 
 Calcd: C,   85.67; H,  7.61%  
 Found: C,   85.31; H,  7.63% 
  
Preparation of (E)-1-(3-Phenyl-2-propen-1-yl)naphthalen-2-ol (114j) [DJK-12-54] 
 
 Following General Procedure 9, NaH (252 mg, 10.5 mmol), CCl4 (20 mL), 2-naphthol 
(1.44g, 10 mmol) and cinnamyl chloride (1.53 mL, 11 mmol) were combined in a 50-mL 
Schlenk flask. The reaction was worked up according to the General Procedure. Silica gel flash 
column chromatography (3:1 hexanes/toluene, 30 mm diameter, 16 cm SiO2) followed by a 
second silica gel flash column chromatography (9:1, hexanes/ethyl acetate, 30 mm diameter 50 g 
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SiO2 (10% AgNO3 w/w)) afforded a pale pink solid. The spectroscopic data matched those 
reported in the literature.
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Data for 114j: 
 mp: 62-64 
o
C (hexanes) 
 
1
H NMR: (500 MHz, CDCl3) 
  8.00 (d, J = 8.6 Hz, 1H), 7.82 (d, J = 8.1 Hz, 1H), 7.72 (d, J = 8.8 Hz, 1H), 7.52 
(ddt, J = 8.2, 6.9, 1.3 Hz, 1H), 7.39 – 7.35 (m, 1H), 7.34 – 7.29 (m, 2H), 7.30 – 
7.24 (m, 2H), 7.22 – 7.18 (m, 1H), 7.16 – 7.09 (m, 2H), 6.47 (p, J = 1.9 Hz, 2H), 
4.01 (dd, J = 3.1, 1.4 Hz, 2H). 
 13
C NMR: (126 MHz,CDCl3) 
 δ 151.1, 137.2, 133.3, 130.9, 129.4, 128.6, 128.4, 128.3, 127.6, 127.1, 126.6, 
126.1, 126.0, 123.2, 123.1, 117.9, 117.1, 28.43. 
 MS: (EI, 70 eV, m/z) 
  260 (100, M
+
), 169 (59), 156 (36), 128 (38), 117 (25), 115 (24), 104 (44), 91 (38). 
 
Preparation of 2-(3-Methylbut-2-en-1-yl)phenol (114k) [DJK-14-83] 
 
 Following General Procedure 9, NaH (126 mg, 5.25 mmol), CCl4 (10 mL), phenol (470 
mg, 5 mmol) and prenyl chloride (605 μL, 5.5 mmol) were combined in a 50-mL Schlenk flask. 
The reaction was worked up according to the General Procedure. Silica gel flash column 
chromatography (3:1, hexanes/toluene, 30 mm diameter, 16 cm SiO2) followed by a second silica 
gel flash column chromatography (9:1, hexanes/ethyl acetate, 30 mm diameter 50 g SiO2 (10% 
AgNO3 w/w)) afforded a pale oil. Distillation afforded 525 mg (65%) of 114k as a clear oil. The 
spectroscopic data matched those reported in the literature.
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Data for 114k: 
 
1
H NMR: (500 MHz, CDCl3) 
  δ 7.14 (t, J = 7.4 Hz, 1H), 6.89 (td, J = 7.5, 1.2 Hz, 1H), 6.83 (dt, J = 7.6, 1.3 Hz, 
1H), 5.35 (dddd, J = 7.3, 5.8, 2.9, 1.5 Hz, 1H), 5.09 (s, 1H), 3.38 (d, J = 7.2 Hz, 
2H), 1.80 (dd, J = 5.1, 1.4 Hz, 6H). 
 13
C NMR: (126 MHz,CDCl3) 
 δ 154.1, 129.8, 127.3, 121.8, 120.6, 115.5, 29.4, 25.7, 17.7. 
 MS: (EI, 70 eV, m/z) 
  162 (21, M
+
), 145 (39), 133 (38), 115 (33), 107 (100), 91 (77), 77 (47) 
 
Preparation of (E)-2-(3-(Furan-2-yl)allyl)phenol (119b) [DJK-17-70] 
 
 To a 5-mL Schlenk flask equipped with a stir bar was added, under argon, (E)-3-(furan-2-
yl)-1-(2-hydroxyphenyl)prop-2-en-1-one 118b (749 mg, 3.5 mmol), THF (3.5 mL) and 
triethylamine (535 μL, 3.85 mmol, 1.1 equiv). To this solution was added with vigorous stirring 
ethyl chloroformate  (370 μL, 3.85 mmol, 1.1 equiv). The color of the solution changed from 
dark brown to light gold with concomitant precipitation of solid triethylammonium chloride. The 
mixture was stirred for a further 30 min and the reaction was assayed for completion by TLC. To 
a separate 50-mL flask, under argon and equipped with a stir bar, was added ethanol (15 mL) and 
cerium chloride heptahydrate (1.56 g, 4.2 mmol, 1.2 equiv) and the resulting clear solution was 
stirred for 20 min. The solution containing the ethyl carbonate of the starting material was then 
filtered into the second flask through glass wool. THF (2x 5mL) was used to wash the flask and 
filter cake. To the resulting light yellow solution was added NaBH4 (160 mg, 4.2 mmol, 1.2 
equiv) and the solution was stirred for a further 1 h. Water (1 mL) was added to quench the 
reaction, and the solution was then stirred a further 15 min. The resulting heterogenous mixture 
was transferred to a 125-mL separatory funnel and diluted with water (15 mL) and CH2Cl2 (30 
mL). The layers were separated and the aq. layer was extracted with CH2Cl2 (2x 30 mL). The 
organic layers were combined, dried over MgSO4 and concentrated by rotary evaporation (30 
o
C, 
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3 mm Hg). The crude material thus obtained was redissolved in 10 mL of CH2Cl2 and adsorbed 
onto Celite. Purification by silica gel flash column chromatography (12:1, hexanes/ethyl acetate, 
20 mm diameter, 18 cm SiO2) followed by bulb-to-bulb diffusion pump distillation afforded 112 
mg (16%) of 119b as a pale yellow oil .    
Data for 119b: 
 bp:  70 
o
C, 2 x 10
-4
 mm Hg 
 
1
H NMR: (500 MHz,CDCl3) 
   δ 7.33 (d, J = 1.8 Hz, 1H, HC(11)), 7.17 (m, 2H, HC(3), HC(5)), 6.93 (t, J = 7.5 
Hz, 1H, HC(4)), 6.83 (d, J = 7.9 Hz, 1H, HC(6)), 6.41–6.31 (m, 2H, HC(8), 
HC(12)), 6.28 (d, J = 15.9 Hz, 1H, HC(9)), 6.18 (d, J = 3.3 Hz, 1H, HC(13)), 4.87 
(s, 1H, OH), 3.55 (d, J = 6.3 Hz, 2H, HC(7)). 
 
13
C NMR: (126 MHz,CDCl3) 
  δ 154.1 (C1), 141.9 (C2), 130.8 (C3), 128.2 (C5), 127.0 (C8), 121.3 (C9), 120.2 
(C4), 115.9 (C6), 111.4, 107.3 (C13), 33.9 (C7). 
 IR: (ATR, cm
-1
) 
  3409 (br), 1593 (w), 1489 (m), 1455 (s), 1232 (m), 1095 (w), 1012 (m), 964 (m), 
753 (s) 
 MS: (EI, 70 eV, m/z) 
  200 (100, M
+
), 171 (16), 131 (19), 107 (16), 94 (54), 81 (24)  
 HRMS: Calcd for C13H12O2 200.0837, found 200.0842, error 2.3  
 TLC: Rf 0.36 (4:1, hexanes/ethyl acetate) [UV, CAM] 
 
Preparation of (E)-2-(4-Phenylbut-3-en-1-yl)phenol 120 [DJK-12-69] 
 
 To a 5 mL oven-dried Schlenk flask was added Grubbs-I-indenylidene (92 mg, 0.1 mmol, 
0.05 equiv.) in a glovebox. The flask was transferred to a Schlenk line and CH2Cl2 (4 mL) was 
added. To this stirring solution was added styrene (1.15 mL, 10.0 mmol, 5 equiv) and 2-(but-3-
en-1-yl)phenol (296 mg, 2.0 mmol). The solution was stirred at rt for 24 h. The volatiles were 
then removed by rotary evaporation (30 
o
C, 3 mm Hg). Purification by silica gel flash column 
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chromatography (12:1, hexanes/ethyl acetate, 20 mm diameter, 18 cm SiO2) afforded 274 mg 
(62%) of 120 as a pale oil. The spectral data matched those reported in the literature.
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Data for 120: 
 1
H NMR:  (400 MHz, CDCl3)  
  δ 7.38 (d, J = 6.9 Hz, 2H, HC(12)), 7.33 (t, J = 7.7 Hz, 2H, HC(13)), 7.24 (t, J = 
7.2 Hz, 1H, HC(14)), 7.20 (dd, J = 7.5, 1.6 Hz, 1H, HC(3)), 7.14 (td, J = 7.7, 1.7 
Hz, 1H, HC(5)), 6.93 (td, J = 7.4, 1.1 Hz, 1H, HC(4)), 6.81 (dd, J = 8.0, 1.2 Hz, 
1H, HC(6)), 6.48 (dt, J = 15.9, 1.4 Hz, 1H, HC(10)), 6.33 (dt, J = 15.8, 6.9 Hz, 
1H, HC(9)), 4.69 (s, 1H, OH), 2.84 (dd, J = 8.8, 6.6 Hz, 2H, HC(7)), 2.62–2.54 
(app q,  J = 7.5 Hz, 2H, HC(8)). 
 
Preparation of (E)-2-(4-Phenylbut-3-en-1-yl)phenol methyl ether 130a [DJK-17-14] 
 
 To a 5 mL oven-dried Schlenk flask was added Grubbs-I-indenylidene (24 mg, 0.026 
mmol, 0.03 equiv.) in a glovebox. The flask was transferred to a Schlenk line and CH2Cl2 (3 mL) 
was added. To this stirring solution was added styrene (745 μL, 6.5 mmol, 5 equiv) and 2-(but-3-
en-1-yl)phenol methyl ether (211 mg, 1.3 mmol). The solution was stirred at rt for 24 h. After 24 
h, 8 mg of indeylidene catalyst (0.008 mmol, 0.01 equiv) was added and the reaction was stirred 
a further 12 h. The volatiles were then removed by rotary evaporation (30 
o
C, 3 mm Hg). 
Purification by silica gel flash column chromatography (40:1, hexanes/ethyl acetate, 20 mm 
diameter, 18 cm SiO2) afforded 213 mg (69%) of 130a as a pale oil. 
Data for 130a: 
 1
H NMR:  (400 MHz, CDCl3)  
  δ 7.38 (d, J = 6.9 Hz, 2H, HC(12)), 7.33 (t, J = 7.7 Hz, 2H, HC(13)), 7.24 (t, J = 
7.2 Hz, 1H, HC(14)), 7.20 (dd, J = 7.5, 1.6 Hz, 1H, HC(3)), 7.14 (td, J = 7.7, 1.7 
Hz, 1H, HC(5)), 6.93 (td, J = 7.4, 1.1 Hz, 1H, HC(4)), 6.81 (dd, J = 8.0, 1.2 Hz, 
1H, HC(6)), 6.48 (dt, J = 15.9, 1.4 Hz, 1H, HC(10)), 6.33 (dt, J = 15.8, 6.9 Hz, 
1H, HC(9)), 4.69 (s, 1H, OH), 2.84 (dd, J = 8.8, 6.6 Hz, 2H, HC(7)), 2.62–2.54 
(app q,  J = 7.5 Hz, 2H, HC(8)). 
 
298 
 
Preparation of (E)-2-(4-Phenylbut-3-en-1-yl)phenol  (120) [DJK-17-16] 
 
 Following the procedure of Ammann and White
96b
, to a 50-mL oven-dried Schlenk flask  
was added NaH (48 mg, 2.0 mmol, 2.2 equiv). The flask was transferred to a Schlenk line and 
DMF (1.5 mL) was added. The flask was placed in an ice bath and ethanethiol (155 μL) was 
added dropwise. In the process of addition the solution turned homogenous. Methyl ether 131b 
(238 mg, 1 mmol) was dissolved in DMF (1.5 mL) and added to the mixture. The solution was 
then heated to reflux for 3 h. After this time, the solution was cooled down to rt, and then 
transferred to a 60-mL separatory funnel. The mixture was diluted with water (5 mL) and ethyl 
acetate (10 mL), and then acidified to pH 1 with 1 M HCl. The biphasic solution was shaken 
well, and the layers were separated. The aq. layer was further extracted with a portion of ethyl 
acetate (10 mL). The organic layers were combined and then washed with water (2x 10 mL) 
followed by brine (10 mL). The organic layers were then dried over MgSO4, filtered and 
concentrated by rotary evaporation (30 
o
C , 3 mm Hg). Purification by silica gel flash column 
chromatography (12:1, hexanes/ethyl acetate, 20 mm diameter, 15 cm SiO2) afforded 169 mg 
(84%) of 120 as a pale oil. The spectral data matched those reported in the literature.
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Data for 120: 
 
1
H NMR:  (400 MHz, CDCl3)  
  δ 7.38 (d, J = 6.9 Hz, 2H, HC(12)), 7.33 (t, J = 7.7 Hz, 2H, HC(13)), 7.24 (t, J = 
7.2 Hz, 1H, HC(14)), 7.20 (dd, J = 7.5, 1.6 Hz, 1H, HC(3)), 7.14 (td, J = 7.7, 1.7 
Hz, 1H, HC(5)), 6.93 (td, J = 7.4, 1.1 Hz, 1H, HC(4)), 6.81 (dd, J = 8.0, 1.2 Hz, 
1H, HC(6)), 6.48 (dt, J = 15.9, 1.4 Hz, 1H, HC(10)), 6.33 (dt, J = 15.8, 6.9 Hz, 
1H, HC(9)), 4.69 (s, 1H, OH), 2.84 (dd, J = 8.8, 6.6 Hz, 2H, HC(7)), 2.62–2.54 
(app q,  J = 7.5 Hz, 2H, HC(8)). 
 13
C NMR: (126 MHz, CDCl3) 
  δ 153.7, 137.9, 130.7, 130.6, 130.4, 128.7, 127.5, 127.2, 126.2, 121.1, 115.5, 
115.1, 33.5, 30.4. 
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 MS:  (EI, 70 eV, m/z) 
  224 (59, M
+
), 117 (100), 115 (26), 107 (97), 91 (20), 77 (20) 
 
Preparation of (E)-2-(4-Phenylbut-3-en-1-yl)phenol  (120) [DJK-15-15] 
 
 To a 50-mL Schlenk flask under argon was added BuLi (2.23 M in hexanes, 9.5 mL, 21 
mmol, 2.1 equiv) followed by a further 4 mL of hexanes. Tetramethylethylenediamine (TMEDA, 
2.44 g, 21 mmol, 2.1 equiv) was added via syringe and the flask was placed in a -78 
o
C bath (dry 
ice/i-PrOH). The internal temperature was monitored until it dropped below -40 
o
C. Cresol (1.08 
g, 10 mmol) was dissolved in hexanes (6 mL) and added to the cold mixture as a solution. To 
this cold mixture was then added solid KOt-Bu (2.36 g, 21 mmol, 2.1 equiv). The formation of a 
yellow suspension was observed. The flask was then removed from the -78 
o
C bath and placed in 
a -20 
o
C bath (i-PrOH, IBC-4A cryocool) and the solution within allowed to stir for 30 min. The 
flask was then removed and allowed to warm to rt over 15 min. THF (10 mL) was added. The 
flask was then returned to the aforementioned -78 
o
C bath and the internal temperature was 
monitored until it was below -60 
o
C and then allowed to equilibrate for a further 20 min. 
Cinnamyl chloride (1.98 g, 13 mmol, 1.3 equiv) was dissolved in THF (2 mL) and added to the 
mixture. The solution was then allowed to warm to rt and stirred for 1 h. The reaction was 
quenched by the addition of aq. sat. NH4Cl (10 mL). The mixture was transferred to a 250-mL 
separatory funnel and the pH adjusted to <1 with 6 M HCl. The layers were separated and the aq. 
layer was extracted with ether (2x 30 mL). The organic layers were combined, dried over 
MgSO4, filtered and concentrated (30 
o
C, 3 mm Hg). The product was purified by two successive 
silica gel flash column chromatography operations (1, 9:1 hexanes/ethyl acetate, 30 mm 
diameter, 15 cm SiO2; 2, 50:1 toluene/ethyl acetate, 30 mm diameter, 14 cm SiO2) and then 
distilled under vacuum to afford 330 mg (15%) of 120 a clear oil.  The spectroscopic data match 
those reported in the literature.
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Data for 120: 
 
1
H NMR:  (400 MHz, CDCl3)  
  δ 7.38 (d, J = 6.9 Hz, 2H, HC(12)), 7.33 (t, J = 7.7 Hz, 2H, HC(13)), 7.24 (t, J = 
7.2 Hz, 1H, HC(14)), 7.20 (dd, J = 7.5, 1.6 Hz, 1H, HC(3)), 7.14 (td, J = 7.7, 1.7 
Hz, 1H, HC(5)), 6.93 (td, J = 7.4, 1.1 Hz, 1H, HC(4)), 6.81 (dd, J = 8.0, 1.2 Hz, 
1H, HC(6)), 6.48 (dt, J = 15.9, 1.4 Hz, 1H, HC(10)), 6.33 (dt, J = 15.8, 6.9 Hz, 
1H, HC(9)), 4.69 (s, 1H, OH), 2.84 (dd, J = 8.8, 6.6 Hz, 2H, HC(7)), 2.62–2.54 
(app q,  J = 7.5 Hz, 2H, HC(8)). 
 
Preparation of  (E)-2-(5-Phenylpent-4-en-1-yl)phenol (130b) [DJK-DR-9004] 
 
 Dichloromethane was degassed by purging with argon for 30 min. To a 10-mL flask was 
added Grubbs-I-indenylidene catalyst (46 mg, 0.05 mmol, 0.033 equiv) in a glovebox. The flask 
was transferred to a Schlenk line and degassed dichloromethane (3 mL), 142q (241 mg, 1.5 
mmol) and styrene (890 μL, 7.5 mmol, 5 equiv) were added in order.  The solution was stirred 
for 24 h, whereupon a second portion of catalyst (23 mg, 0.025 mmol, 0.016 equiv) was added. 
The solution was then stirred for a further 24 h. The solution was then transferred to a 100 mL 
RB-flask, and the volatiles were removed by rotary evaporation (30 
o
C. 3 mm Hg). The material 
was redissolved in 10 mL of CH2Cl2 and adsorbed onto Celite. Purification by silica gel flash 
column chromatography (12:1, hexanes/ethyl acetate, 20 mm diameter, 16 cm SiO2) followed by 
distillation afforded 150 mg (42%) of 130b as a clear oil.  
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Data for 130b: 
 bp: 150 
o
C, (ABT), 0.05 mm Hg  
 
1
H NMR:  (400 MHz, CDCl3)  
  δ 7.35 (d, J = 8.1 Hz, 2H, HC(13)), 7.30 (t, J = 7.6 Hz, 2H, HC(14)), 7.20 (t, J = 
7.2 Hz, 1H, HC(15)), 7.14 (d, J = 7.4 Hz, 1H, HC(3), 7.09 (t, J = 7.7 Hz, 1H, 
HC(5)), 6.88 (t, J = 7.4 Hz, 1H, HC(4)), 6.76 (d, J = 8.0 Hz, 1H, HC(6)), 6.42 (d, 
J = 16.1 Hz, 1H, HC(11), 6.26 (dt, J = 15.9, 6.7 Hz, 1H, HC(10), 4.65 (s, 1H, 
OH), 2.68 (t, J = 7.7 Hz, 1H, HC(7), 2.29 (q, J = 6.9 Hz, 1H, HC(9)), 1.82 (p, J = 
7.4 Hz, 1H, HC(8)). 
 
13
C NMR: (126 MHz, CDCl3) 
  δ 153.8 (C1), 138.1 (C12), 130.9 (C3), 130.6 (C11), 130.5 (C10), 128.8 (C14), 
128.6 (C2), 127.4 (C5), 127.2 (C15), 126.3 (C13), 121.1 (C4), 115.6 (C6), 33.0 
(C9), 29.7 (C7), 29.6 (C8). 
 IR: (ATR, cm
-1
)  
  3401 (br), 3059 (w), 3025 (w), 2926 (w), 2857 (w), 1650 (w), 1592.1 (w), 1490 
(m), 1454 (s), 1327 (m), 1234 (m), 1169 (w), 1104 (w), 1068 (w), 1042 (w), 1028 
(w), 963 (s), 933 (w), 911 (w), 842 (w), 747 (s), 691 (s).  
 MS:  (EI, 70 eV, m/z) 
  238 (100, M
+
), 147 (45), 131 (34), 117 (42), 107 (74), 91 (43), 77 (25)  
 TLC: Rf 0.44 (4:1 hexanes/ethyl acetate) [UV, CAM] 
 Analysis: C16H16O (224.34) 
 Calcd: C,   85.67; H,  7.61%  
 Found: C,   85.27; H,  7.43% 
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Preparation of Ethyl (E)-7-(2-Hydroxyphenyl)hept-4-enoate (138) [DJK-15-83] 
 
 To a 50-mL round bottom flask equipped with a stir bar was added, under argon, LiI 
(1.87 g, 14 mmol, 4.0 equiv) and NaCN (189 mg, 3.85 mmol, 1.1 equiv). To this was added 
DMSO (10 mL) and the solution was stirred for 15 min. The diester 137
160
 (1.12 g, 3.5 mmol) 
was then dissolved in DMSO (10 mL) and added to the stirring solution. The solution was heated 
to 160 
o
C (internal temperature, oil bath) for 3 h. Consumption of starting material was followed 
by TLC. The flask was then removed from the heat source and allowed to cool to rt. The solution 
was transferred to a 125-mL separatory funnel and diluted with water (50 mL) and ethyl acetate 
(50 mL). Use of other solvent ratios occasionally resulted in persistent emulsions. The layers 
were separated and the aq. layer was extracted with ethyl acetate (50 mL). The organic layers 
were washed thoroughly (5x 30 mL water) then was washed with brine (15 mL), dried over 
MgSO4, filtered, and concentrated by rotary evaporation (30 
o
C, 3 mm Hg). The material was 
then redissolved in 10 mL of diethyl ether and adsorbed onto Celite. Purification by silica gel 
flash chromatography (7:1, hexanes/ethyl acetate, 20 mm diameter, 18 cm SiO2) followed by 
bulb-to-bulb vacuum distillation afforded 476 mg (57%) of 138 as a clear oil.    
Data for 138: 
 bp: 130 
o
C, (ABT), 0.05 mm Hg 
 
1
H NMR:  (500 MHz, CDCl3) 
  7.15–7.05 (m, 2H, HC(3), HC(5)), 6.87 (t, J = 7.4 Hz, 1H, HC(4)), 6.78 (d, J = 7.9 
Hz, 1H, HC(6)), 5.57 (dt, J = 15.3, 6.7 Hz, 1H, HC(9)), 5.47 (dt, J = 15.3, 6.0 Hz, 
1H, HC(10)), 5.24 (s, 1H, OH), 4.16 (q, J = 7.1 Hz, 2H, HC(14)), 2.68 (dd, J = 
8.7, 6.7 Hz, 2H, HC(11)), 2.42–2.26 (m, 6H, HC(7), HC(8), HC(10)), 1.28 (t, J = 
7.1 Hz, 3H, HC(15)). 
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13
C NMR: (126 MHz, CDCl3) 
   173.8 (C13), 153.9 (C1), 131.2 (C9), 130.5 (C3), 129.1 (C10), 128.2 (C2), 127.4 
(C5), 120.9 (C4), 115.6 (C6), 60.7 (C14), 34.5 (C7/C8/C10), 32.9 (C7/C8/C10), 
30.4(C11), 28.1 (C7/C8/C10), 14.5 (C15). 
 IR: (ATR, cm
-1
) 
  3416 (br), 2981 (w), 2926 (w), 2854 (w), 1706 (s), 1608 (w), 1593 (w), 1504 (w), 
1490 (w), 1455 (s), 1372 (m), 1344 (w), 1299 (w), 1232 (s), 1176 (s), 1150 (s), 
1101 (m), 1033 (m), 968 (m), 850 (m), 751 (s). 
 MS: (EI, 70 eV, m/z) 
  248 (29, M
+
), 107 (100) 
 TLC: Rf 0.31 (4:1, hexanes/ethyl acetate) [UV, CAM] 
 Analysis: C15H20O3 (248.32) 
 Calcd: C,   72.55; H,   8.12%  
 Found: C,   72.43; H,   8.14% 
 
Preparation of (E)-7-(2-Hydroxyphenyl)hept-4-enoic acid (139) [DJK-15-34] 
  
 To a 10-mL Schlenk flask under argon was added ester 138 (447 mg, 1.8 mmol), and 
THF (10 mL). Water was added via syringe (2.5 mL) followed by solid LiOH•H2O (272 mg, 
6.48 mmol, 3.6 equiv). The solution was allowed to stir 16 h at rt. The mixture was transferred to 
a 60-mL separatory funnel,  diluted with ether (30 mL) and water (20 mL). The biphasic mixture 
was acidified with 1 M HCl to pH <2, whereupon a white precipitate formed, which disappeared 
upon thorough shaking. The layers were separated and the aq. layer was extracted with ether (2x 
15 mL). The organic layers were combined, washed with brine (15 mL), dried over MgSO4, 
filtered, and concentrated by rotary evaporation (30 
o
C, 3 mm Hg). The material was redissolved 
in 10 mL of diethyl ether and then was adsorbed onto Celite. Purification by silica gel flash 
column chromatography (4:1, hexanes/ethyl acetate, 30 mm diameter, 16 cm SiO2) followed by 
recrystallization from hexanes (5 mL) afforded 326 mg (83%) of 139 as white spindles.    
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Data for 139: 
 mp: 108-110 
o
C (hexanes) 
 
1
H NMR:  (500 MHz, CDCl3) 
  δ 7.17–7.08 (m, 2H, HC(3), HC(5)), 6.91 (t, J = 7.4 Hz, 1H, HC(4)), 6.80 (d, J = 
7.9 Hz, 1H, HC(2)), 5.60 (dt, J = 15.6, 6.5 Hz, 1H, HC(9)), 5.50 (dt, J = 15.4, 6.3 
Hz, 1H, HC(10)), 2.70 (dd, J = 8.5, 6.6 Hz, 2H, HC(8)), 2.45 (t, J = 7.1 Hz, 2H, 
HC(11)), 2.35 (app p, J = 6.8 Hz, 4H, HC(7), HC(12)).  
 
13
C NMR: (126 MHz, CDCl3) 
  δ 179.0 (C13), 153.6 (C1), 131.4 (C10), 130.6 (C5), 128.8 (C9), 128.0 (C2) , 
127.4 (C3), 121.1 (C4),  115.6 (C6), 34.1 (C11), 32.9 (C7), 30.3 (C8), 27.8 (C12)  
 IR: (ATR, cm
-1
) 
  3184 (br), 3042 (w), 2934 (w), 2908 (w), 1703 (s), 1613 (w), 1591 (m), 1503 (w), 
1455 (s), 1441 (m), 1425 (m), 1409 (m), 1373 (m), 1280 (m), 1262 (w), 1236 (s), 
1192 (s), 1109 (w), 1041 (w), 990 (w), 974 (s), 930 (w), 909 (w), 845 (w), 821 
(m), 747 (s), 688 (w). 
 MS: (EI, 70 eV, m/z) 
  220 (16, M
+
), 137 (16), 107 (100) 
 TLC: Rf 0.06 (4:1 hexanes/ethyl acetate) [UV, CAM] 
 Analysis: C13H16O3 (220.27) 
 Calcd: C, 70.89; H,  7.32%  
 Found: C, 71.12; H,  7.24% 
 
 
Preparation of (E)-2-(7-Hydroxyhept-3-en-1-yl)phenol (140) [DJK-15-84] 
 
 To a 50-mL Schlenk flask under argon was added lithium aluminium hydride (126 mg, 
3.3 mmol, 1.5 equiv)  and THF (4 mL). The flask was placed in an ice bath for 10 min. Ester 138 
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(520 mg, 2.2 mmol) was dissolved in THF (4 mL) and added dropwise to the cold solution. The 
solution was then allowed to stir at 0 
o
C for 2 h. The flask was then once again placed in an ice 
bath for 15 min. The reaction was quenched by the addition of water (2 mL, dropwise) with 
substantial gas evolution and the formation of copious amounts of solids. After addition of water 
was complete, a further 5 mL of water were added, followed by dropwise addition of 6 M HCl to 
pH <2. The resulting biphasic mixture was transferred to a 125-mL separatory funnel and then 
was shaken well. The layers were separated and the aq. layer was extracted with diethyl ether (3x 
20mL). The organic layers were combined, washed with brine (15 mL), dried over MgSO4, 
filtered and concentrated by rotary evaporation (30 
o
C, 3 mm Hg). The resulting material was 
dissolved in 10 mL of ether and adsorbed onto Celite. Purification by silica gel flash column 
chromatography (3:1 hexanes/ethyl acetate, 20 mm diameter, 17 cm SiO2) followed by bulb-to-
bulb distillation afforded 416 mg (91%) of 140 as a clear oil. 
Data for 140: 
 bp: 140 
o
C, (ABT), 0.05 mm Hg 
 
1
H NMR: (500 MHz, CDCl3) 
  δ 7.17–7.07 (m, 2H, HC(3), HC(5)), 6.90 (t, J = 8.0 Hz, 1H, HC(4)), 6.79 (d, J = 
8.2 Hz, 1H, HC(6)), 5.56 (dt, J = 15.1, 6.5 Hz, 1H, HC(9)), 5.48 (dt, J = 15.6, 6.5 
Hz, 1H, HC(10)), 3.65 (t, J = 6.5 Hz, 2H, HC(13)), 2.71 (dd, J = 8.3, 6.8 Hz, 2H, 
HC(7)), 2.35 (q, J = 7.4 Hz, 2H, HC(8)), 2.12 (q, J = 6.8 Hz, 2H, HC(11)), 1.65 
(p, J = 6.8 Hz, 2H, HC(12)). 
 
13
C NMR:  (126 MHz, CDCl3) 
  δ 154.2 (C1), 130.8 (C10), 130.5 (C5), 130.3 (C9), 128.5 (C2), 127.3 (C3), 120.7 
(C4), 115.7 (C6), 62.6 (C13), 33.1 (C8), 32.2 (C12), 30.3 (C7), 29.0 (C11). 
 IR: (ATR, cm
-1
) 
  3307 (br), 3033 (w), 2932 (w), 2851 (w), 1607 (w), 1592 (w), 1504 (w), 1489 (w), 
1455 (m), 1354 (w), 1238 (m), 1178 (w), 1153 (w), 1094 (w), 1042 (m), 1015 (w), 
968 (w) , 929 (w), 847 (w), 750 (s). 
 MS:  (EI, 70 eV, m/z) 
  206 (20, M
+
), 120 (14), 107 (100) 
 TLC: Rf 0.1 (4:1 hexanes/ethyl acetate) [UV, CAM] 
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 Analysis: C13H18O2 (206.29) 
 Calcd: C,   75.69; H,  8.80%  
 Found: C,   75.48; H,  8.56% 
 
Preparation of (E)-2-(7-Methoxyhept-3-en-1-yl)phenol (141) [A, DJK-EK9014], [B, DJK-
16-22] 
 
 
This compound was prepared in two ways:  
Method A:  
 To a 10-mL Schlenk flask in a glovebox was added  NaH (27 mg, 1.1 mmol, 2.1 equiv). 
The flask was transferred to the Schlenk line and THF (1.5 mL) was added. To this was added  
the alcohol 140 (103 mg, 0.5 mmol) in THF (0.5 mL). The solution was stirred for 15 min at rt 
and MeI (34 μL, 0.55 mmol, 1.1 equiv) was added dropwise. The solution was then allowed to 
stir at rt for 16 h. The reaction was quenched by the addition of water (1 mL) and 1 M HCl (0.5 
mL). The mixture was transferred to a 60-mL separatory funnel, diluted with ether (10 mL) and 
water (10 mL) and the pH adjusted to <2 with 3 M HCl. The layers were separated and the aq. 
layer was extracted  with ether (2x 10 mL). The organic layers were combined, washed with 
brine (15 mL), dried over MgSO4 and concentrated by rotary evaporation (30 
o
C, 3 mm Hg) . 
Purification by silica gel flash column chromatography (12:1 hexanes/ethyl acetate, 20 mm 
diameter, 16 cm SiO2)  afforded 63 mg (57%) of 141 as a clear oil.  
Method B: 
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 To a 10-mL Schlenk flask was added 140', (368 mg, 1.3 mmol) and THF (15 mL). The 
flask was cooled to -76 
o
C (internal temperature, dry ice/i-PrOH). BuLi (2.3 M, 620 μL, 1.43 
mmol, 1.1 equiv) was added via syringe and the solution was allowed to stir for for 1 h. 
Triisopropyl borate (489 mg,  2.6 mmol, 2.0 equiv) was added via syringe and the solution was 
allowed to warm to rt. After stirring for 6 h at rt, the flask was placed in an ice bath. In a separate 
25-mL RB-flask, a basic hydrogen peroxide solution was prepared by combining 20 mL of 30% 
H2O2 with 2 g of NaOH. A portion of this solution (2 mL) was then added dropwise to the flask 
containing the borate (strong exotherm) followed by the remaining 8 mL of basic peroxide and 
the solution allowed to stir for 5 h at rt. The excess peroxide solution was quenched with sat. aq. 
Na2S2O3. After the allotted time had passed, the mixture was transferred to a 125-mL separatory 
funnel and sat. aq. Na2S2O3 was added until no more peroxide was evident  (Quantifix test strip). 
The mixture was then diluted with ether (15 mL) and water (15 mL) and acidified with 1 M HCl 
to pH <2. The layers were separated and the aq. layer was extracted with ether (3x 10 mL). The 
organic layers were combined, dried over MgSO4, filtered and concentrated by rotary 
evaporation (30 
o
C, 3 mm Hg). Purification by silica gel flash column chromatography (12:1 
hexanes/ethyl acetate, 20 mm diameter, 16 cm SiO2) followed by bulb-to-bulb vacuum 
distillation afforded 213 mg of 141 as a clear oil (76%).   
 
Data for 141: 
 bp: 100 
o
C (ABT), 0.05 mm Hg  
 
1
H NMR: (500 MHz, CDCl3) 
  δ 7.15–7.05 (m, 2H, HC(3), HC(5)), 6.88 (t, J = 7.6 Hz, 1H, HC(4)), 6.77 (d, J = 
8.0 Hz, 1H, HC(6)), 5.62–5.38 (m, 2H, HC(9), HC(10)), 3.45–3.32 (m, 5H, 
HC(13), HC(14)), 2.68 (dd, J = 8.6, 6.7 Hz, 2H, HC(7)), 2.32 (app q, J = 7.8 Hz, 
2H, HC(8)), 2.11–2.01 (app q, J = 7.7 Hz, 2H, HC(11)), 1.64 (app p, J = 7.2, 6.8 
Hz, 2H, HC(12)). 
 
13
C NMR:  (126 MHz, CDCl3) 
  δ 153.8 (C1), 130.7 (C9), 130.5 (C5), 130.3 (C10), 128.2 (C2), 127.4 (C3), 120.9 
(C4), 115.6 (C6), 72.4 (C13), 58.7 (C14), 33.0 (C8), 30.5 (C7), 29.5 (C11), 29.3 
(C12). 
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 IR: (ATR, cm
-1
) 
   3308 (br), 2930 (w), 2852 (w), 1607 (w), 1593 (w), 1504 (w), 1489 (w), 1455 (s), 
1353 (w), 1234 (m), 1179 (m), 1099 (m), 1042 (w), 968 (m), 931 (w), 847 (w), 
750 (s).  
 MS:  (EI, 70 eV, m/z) 
  220 (17, M
+
), 149 (15), 107 (100), 81 (35) 
 TLC: Rf 0.33 (4:1 hexanes/ethyl acetate) [UV, CAM] 
 Analysis: C14H20O2 (220.31) 
 Calcd: C,   76.33; H,  9.15%  
 Found: C,   76.10; H,  8.91% 
 
Optimization of the Phenoxysulfenylation Reaction (Table 17) 
 
General Procedure  
 To a 1-dram vial flushed with nitrogen and equipped with a stir bar was added the 
substrate followed by CH2Cl2. The electrophile and the catalyst were then added as solids and the 
solution was placed in an i-PrOH bath maintained at -20 
o
C by a Neslab IBC-4A cryocool for 
temperature control. The solution was allowed to equilibrate for 20 min and MsOH was added 
neat via syringe. The solution was stirred for the specified time, and then was quenched with 
Et3N (50 μL).  
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Phenoxysulfenylation in the presence of catalyst 62b (Table 17 Entry 1) [DJK-7-26] 
 
 Following General Procedure 10, 142a (21 mg, 0.1 mmol), 56 (25.6 mg, 0.1 mmol, 1.0 
equiv) and (R)-62b (5.2 mg, 0.01 mmol, 0.1 equiv) and CH2Cl2 (0.25 mL) were combined in a 1-
dram vial. The vial was cooled to -20 
o
C in an i-PrOH bath and MsOH (5 μL, 0.077 mmol, 0.77 
equiv) was added directly. The solution was stirred for 24 h, then was quenched with Et3N (50 
μL). The volatiles were removed under rotary evaporation (30 oC, 3 mm Hg) and the residue was 
then directly subjected to silica gel flash column chromatography (40:1 hexanes/ethyl acetate, 10 
mm diameter, 16 cm SiO2) to afford 11 mg (35%) of 143a as a white solid. 
 CSP-SFC: (2R,3S)-143a tmaj 13.6 min, (65.6%), (2S,3R)-143a tmin 18.8 min, (34.4%) 
(Chiralpak AD, 220 nm, 200 bar, 40 
o
C, 95:5, sCO2/MeOH, 2 mL/min) 
 
Phenoxysulfenylation in the presence of catalyst 62e (Table 17 Entry 2) [DJK-7-30] 
 
 Following General Procedure 10, 142a (21 mg, 0.1 mmol), 56 (25.6 mg, 0.1 mmol, 1.0 
equiv) and (S)-62e (5.2 mg, 0.01 mmol, 0.1 equiv) and CH2Cl2 (0.25 mL) were combined in a 1-
dram v ial. The solution was cooled to -20 
o
C in an i-PrOH bath and MsOH (5 μL, 0.077 mmol, 
0.77 equiv) was added directly. The solution was stirred for 24 h, then was quenched with Et3N 
(50 μL). The volatiles were removed under rotary evaporation  (30 oC, 3 mm Hg) and the residue 
was then directly subjected to silica gel flash column chromatography (40:1 hexanes/ethyl 
acetate, 10 mm diameter, 16 cm SiO2) to afford 14 mg (46%) of 143a as a white solid. 
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 CSP-SFC: (2R,3S)-143a tmin 13.7 min, (5.1%), (2S,3R)-143a tmaj 18.9 min, (94.9%) 
(Chiralpak AD, 220 nm, 200 bar, 40 
o
C, 95:5, sCO2/MeOH, 2 mL/min) 
 
Phenoxysulfenylation in the presence of catalyst 62d (Table 17 Entry 3) [DJK-7-29] 
 
 Following General Procedure 10, 142a (21 mg, 0.1 mmol), 56 (25.6 mg, 0.1 mmol, 1.0 
equiv) and (S)-62d (5.5 mg, 0.01 mmol, 0.1 equiv) and CH2Cl2 (0.25 mL) were combined in a 1-
dram vial. The solution was cooled to -20 
o
C in an i-PrOH bath and MsOH (5 μL, 0.077 mmol, 
0.77 equiv) was added directly. The solution was stirred for 24 h, then was quenched with Et3N 
(50 μL). The volatiles were removed under rotary evaporation (30 oC, 3 mm Hg) and the residue 
was then directly subjected to silica gel flash column chromatography (40:1 hexanes/ethyl 
acetate, 10 mm diameter, 16 cm SiO2) to afford 9 mg (27%) of 143a as a white solid. 
 CSP-SFC: (2R,3S)-143a tmin 13.6 min, (6.9%), (2S,3R)-143a tmaj 18.8 min, (93.1%) 
(Chiralpak AD, 220 nm, 200 bar, 40 
o
C, 95:5, sCO2/MeOH, 2 mL/min) 
 
Phenoxysulfenylation at 0.15M concentration (Table 17 Entry 4) [DJK-10-90] 
 
 Following General Procedure 10, 142a (21 mg, 0.1 mmol), 56 (25.6 mg, 0.1 mmol, 1.0 
equiv) and (S)-62e (5.2 mg, 0.01 mmol, 0.1 equiv) and CH2Cl2 (0.63 mL) were combined in a 1-
dram vial. The solution was cooled to -20 
o
C in an i-PrOH bath and MsOH (5 μL, 0.077 mmol, 
0.77 equiv) was added directly. The solution was stirred for 24 h, then was quenched with Et3N 
(50 μL). The volatiles were removed under rotary evaporation (30 oC, 3 mm Hg) and the residue 
311 
 
was then directly subjected to silica gel flash column chromatography (5:1 
hexanes/dichloromethane, 10 mm diameter, 16 cm SiO2) to afford 29 mg (92%) of 143a as a 
white solid. 
 CSP-SFC: (2R,3S)-4a tmin 13.6 min, (5.4%), (2S,3R)-4a tmaj 18.8 min, (94.6%), (Chiralpak 
AD, 220 nm, 200 bar, 40 
o
C, 95:5 sCO2/MeOH, 2 mL/min) 
  
Phenoxysulfenylation with 0.5 equiv MsOH (Table 17 Entry 5) [DJK-18-54] 
 
 Following General Procedure 10, 142a (21 mg, 0.1 mmol), 56 (25.6 mg, 0.1 mmol, 1.0 
equiv) and (S)-62e (5.2 mg, 0.01 mmol, 0.1 equiv) and CH2Cl2 (0.63 mL) were combined in a 1-
dram vial. The solution was cooled to -20 
o
C in an i-PrOH bath and MsOH (3.3 μL, 0.051 mmol, 
0.51 equiv) was added directly. The solution was stirred for 24 h, then was quenched with Et3N 
(50 μL). The volatiles were removed under rotary evaporation (30 oC, 3 mm Hg) and the residue 
was then directly subjected to silica gel flash column chromatography (5:1 
hexanes/dichloromethane, 10 mm diameter, 16 cm SiO2) to afford 30.2 mg (95%) of 143a as a 
white solid. 
 CSP-SFC: (2R,3S)-143a, tmin 13.7 min, (4.7%), (2S,3R)-143a tmaj 18.9 min, (95.3%) 
(Chiralpak AD, 220 nm, 200 bar, 40 
o
C, 95:5, sCO2/MeOH, 2 mL/min) 
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Phenoxysulfenylation with 0.25 equiv MsOH (Table 17 Entry 6) [DJK-18-55] 
 
 Following General Procedure 10, 142a (21 mg, 0.1 mmol), 56 (25.6 mg, 0.1 mmol, 1.0 
equiv) and (S)-62e (5.2 mg, 0.01 mmol, 0.1 equiv) and CH2Cl2 (0.63 mL) were combined in a 1-
dram vial. The solution was cooled to -20 
o
C in an i-PrOH bath and MsOH (1.7 μL, 0.026 mmol, 
0.26 equiv) was added directly. The solution was stirred for 24 h, then was quenched with Et3N 
(50 μL). The volatiles were removed under rotary evaporation (30 oC, 3 mm Hg) and the residue 
was then directly subjected to silica gel flash column chromatography (5:1 
hexanes/dichloromethane, 10 mm diameter, 16 cm SiO2) to afford 29.8 mg (94%) of 143a as a 
white solid. 
 CSP-SFC: (2R,3S)-143a tmin 13.4 min, (4.3%), (2S,3R)-143a tmaj 16.0 min, (95.7%) 
(Chiralpak AD, 220 nm, 200 bar, 40 
o
C, 95:5 sCO2/MeOH, 2 mL/min) 
 
 Phenoxysulfenylation with 0.1 equiv MsOH (Table 17 Entry 7) [DJK-18-56] 
 
 Following General Procedure 10, 142a (21 mg, 0.1 mmol), 56 (25.6 mg, 0.1 mmol, 1.0 
equiv) and (S)-62e (5.2 mg, 0.01 mmol, 0.1 equiv) and CH2Cl2 (0.63 mL) were combined in a 1-
dram vial. The solution was cooled to -20 
o
C in an i-PrOH bath and MsOH (0.65 μL, 0.010 
mmol, 0.10 equiv) was added directly. The solution was stirred for 24 h, then was quenched with 
Et3N (50 μL). The volatiles were removed under rotary evaporation (30 
o
C, 3 mm Hg) and the 
residue was then directly subjected to silica gel flash column chromatography (5:1 
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hexanes/dichloromethane, 10 mm diameter, 16 cm SiO2) to afford 10.3 mg (32%) of 143a as a 
white solid (32%). 10.7 mg (51%) of 142a was recovered as well. 
 CSP-SFC: (2R,3S)-143a tmin 13.4 min, (5.1%), (2S,3R)-143a tmaj 16.0 min, (94.9%) 
(Chiralpak AD, 220 nm, 200 bar, 40 
o
C, 95:5, sCO2/MeOH, 2 mL/min) 
 
Phenoxysulfenylation with 0.5 equiv EtSO3H (Table 17 Entry 8) [DJK-18-57] 
 
 Following General Procedure 10, 142a (21 mg, 0.1 mmol), 56 (25.6 mg, 0.1 mmol, 1.0 
equiv) and (S)-62e (5.2 mg, 0.01 mmol, 0.1 equiv) and CH2Cl2 (0.63 mL) were combined in a 1-
dram vial. The solution was cooled to -20 
o
C in an i-PrOH bath and EtSO3H (4 μL, 0.049 mmol, 
0.49 equiv) was added directly. The solution was stirred for 24 h, then was quenched with Et3N 
(50 μL). The volatiles were removed under rotary evaporation (30 oC, 3 mm Hg) and the residue 
was then directly subjected to silica gel flash column chromatography (5:1 
hexanes/dichloromethane, 10 mm diameter, 16 cm SiO2) to afford 30.6 mg (96%) of 143a as a 
white solid. 
 CSP-SFC: (2R,3S)-143a tmin 13.4 min, (5.7%), (2S,3R)-143a tmaj 16.0 min, (94.3%) 
(Chiralpak AD, 220 nm, 200 bar, 40 
o
C, 95:5 sCO2/MeOH, 2 mL/min) 
 
Descriptive Phenoxysulfenylation of Alkenes (Table 18) 
 
General Procedure  
 To a 10-mL, oven-dried flask equipped with a magnetic stir bar under an argon 
atmosphere was added substrate and CH2Cl2. The catalyst and the electrophile were added as 
solids and allowed to dissolve to obtain a clear or pale yellow solution. The reaction vessel was 
placed in an i-PrOH bath kept at constant temperature by means of a Neslab IBC-4A cryocool 
with probe. The reaction mixture was cooled to the appropriate reaction temperature and the 
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internal temperature was checked. After the temperature stabilized to +/- 2 
o
C, MsOH was added 
to the stirring reaction mixture via syringe. (Note: It is important to not let the acid touch the 
walls of the reaction vessel as it may immediately freeze.) After addition of the acid, rapid 
formation of a yellow color can be observed. The reaction mixture was then stirred for the 
appropriate time. Over the course of the reaction, white crystals of phthalimide precipitate out of 
the mixture. After the reaction is complete as judged by TLC and 
1
H NMR spectroscopy, Et3N 
was added directly to the cold reaction mixture. The flask was then allowed to warm to rt, 
whereupon the white crystals slowly dissolve to afford a homogenous solution. This solution was 
then either: (1) poured into a separatory funnel containing 1 M NaOH solution, shaken well, 
extracted with dichloromethane, dried and concentrated or (2) directly concentrated. 
Subsequently 
1
H NMR spectra of the crude residue was recorded. Products were purified by 
silica flash chromatography and analytically pure samples were obtained by recrystallization or 
distillation as specified.   
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Preparation of (2S,3R)-2-Phenyl-3-(phenylthio)chromane (143a) (Table 18 Entry 1) [DJK-
13-98] 
 
 Following General Procedure 11, 142a (210 mg, 1.0 mmol) was weighed into a dried 10-
mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 56 (255 mg, 1.0 mmol, 1.0 equiv) 
and catalyst (S)-62e (52 mg, 0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-
PrOH bath and cooled to -20 
oC (probe). After equilibration (ca. 20 min), MsOH (17 μL, 0.25 
mmol, 0.25 equiv) was added directly via syringe. The solution was allowed to stir for 24 h at 
constant temperature during which time phthalimide precipitated. Upon consumption of the 
starting material (TLC, 
1H NMR), the reaction was quenched with triethylamine (300 μL) and 
allowed to warm to rt, whereupon the white solid dissolved. The solution was transferred to a 60-
mL separatory funnel, then was diluted with CH2Cl2 (10 mL) and 1 M NaOH (15 mL). The 
phases were separated and the aq. layer was extracted with 15 mL of CH2Cl2. The organic phases 
were combined, dried over MgSO4, filtered and concentrated by rotary evaporation (30 
o
C, 3 mm 
Hg). Purification by silica gel flash column chromatography (40:1, hexanes/ethyl acetate, 20 mm 
diameter, 16 cm SiO2) followed by recrystallization from hexanes (3 mL) afforded, in two crops, 
268 mg (84%) of 143a as white needles.  
Data for 143a: 
 mp: 121-122 
o
C (hexanes) 
 
1
H NMR:  (500 MHz, CDCl3)  
  δ 7.41–7.32 (m, 5 H, HC(aryl)), 7.30 (m, 2H, HC(aryl)), 7.26 (m, 3 H, HC(aryl)), 
7.20 (t, J = 7.8 Hz, 1H, HC(7)), 7.08 (d, J = 7.5 Hz, 1H, HC(5)), 6.97 (d, J = 8 
Hz, 1H, HC(8)), 6.94 (t, J = 8 Hz, 1H, HC(6)), 5.09 (d, J = 7.8 Hz, 1H, HC(2)), 
3.81 (ddd, J = 9.5, 7.7, 5.2 Hz, 1H, HC(3)), 3.15 (dd, J = 16.6, 5.1 Hz, 1H, 
HC(4)), 2.99 (dd, J = 16.6, 9.1 Hz, 1H, HC(4)) 
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13
C NMR:  (126 MHz, CDCl3) 
  δ 154.3 (C9), 139.4 (C15), 133.7 (C11), 133.3 (C17), 129.5 (C5), 129.1 (C13), 
128.6 (C12), 128.6 (C14), 128.1 (C7), 127.7 (C18), 127.3 (C16), 121.0 (C6), 
120.7 (C10), 116.8 (C8), 81.2 (C2), 47.2 (C3), 31.8 (C4).  
 IR:  (ATR, cm
-1
) 
  2912 (w), 1583 (w), 1487 (m), 1449 (w), 1439 (w), 1427 (w), 1306 (w), 1277 (w), 
1222 (m), 1205 (w), 1193 (w), 1150 (w), 1111 (w), 1086 (w), 1069 (w), 1024 (w), 
1000 (m), 969 (w), 904 (w), 851 (w), 831 (w), 797 (w), 757 (s), 750 (s), 727 (w), 
716 (m), 700 (s). 
 MS:  (EI, 70 eV, m/z) 
  318 (36, M
+
), 208 (40), 200 (100), 199 (98), 119 (19) 
 TLC: Rf 0.48 (1:1, hexanes/CH2Cl2) [UV, CAM] 
 Opt. Rot.: [α]D
23
 = -40.0 (c = 0.87, CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
 CSP-SFC: (2R,3S)-143a tmin 13.4 min, (5.1%), (2S,3R)-143a tmaj 18.5 min, (94.9%) 
(Chiralpak AD, 220 nm, 200 bar, 40 
o
C, 95:5, sCO2/MeOH, 2 mL/min) 
 Analysis: C21H18OS (318.43) 
 Calcd:   C, 79.21; H, 5.70%  
 Found:  C, 78.91; H, 5.62% 
 
Preparation of (2S,3R)-6-Methyl-2-phenyl-3-(phenylthio)chromane (143b) (Table 18 Entry 
2) [DJK-CV-1410] 
 
 Following General Procedure 11, 142b (224 mg, 1.0 mmol) was weighed into a dried 10-
mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 56 (255 mg, 1.0 mmol, 1.0 equiv) 
and catalyst (S)-62e (52 mg, 0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-
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PrOH bath and cooled to -20 
o
C (probe). After equilibration (ca. 20 min), MsOH (17 μL, 0.25 
mmol, 0.25 equiv) was added directly via syringe. The solution was allowed to stir for 24 h at 
constant temperature during which time phthalimide precipitated. Upon consumption of the 
starting material (TLC, 
1
H NMR), the reaction was quenched with triethylamine (300 μL) and 
the mixture was then allowed to warm to rt, whereupon the white solid dissolved. The solution 
was transferred to a 60-mL separatory funnel, then was diluted with CH2Cl2 (10 mL) and 1 M 
NaOH (15 mL). The phases were separated and the aq. layer was extracted with 15 mL of 
CH2Cl2. The organic phases were combined, dried over MgSO4, filtered and concentrated by 
rotary evaporation (30 
o
C, 3 mm Hg). Purification by silica gel flash column chromatography 
(4:1, hexanes/CHCl3 to 3:1, hexanes/CHCl3, 20 mm diameter, 20 cm SiO2) followed by 
recrystallization from hexanes (3 mL) afforded, in two crops, 272 mg (82%) of 143b as white 
needles.  
Data for 143b: 
 mp:  114-115 
o
C (hexanes) 
 
1
H NMR:   (500 MHz,CDCl3)  
  δ 7.40–7.29 (m, 7H, HC(aryl)), 7.27–7.23 (m, 3H, HC(aryl))), 7.00 (d, J = 8.5 Hz, 
1H, HC(7)), 6.88, (s, 1H, HC(5)), 6.87 (d, J = 8.5 Hz, 1H, HC(8)), 5.06 (d, J = 7.7 
Hz, 1H, HC(2)), 3.80 (ddd, J = 8.8, 7.6, 5.2 Hz, 1H, HC(3)), 3.09 (dd, J = 16.6, 
5.2 Hz, 1H, HC(4)), 2.95 (dd, J = 16.6, 8.9 Hz, 1H, HC(4)), 2.31 (s, 3H, HC(19)). 
 
13
C NMR:  (126 MHz,CDCl3) 
  δ 152.1 (C9), 139.6 (C15), 133.8 (C11), 133.2 (C17), 130.2 (C6), 129.9 (C5), 
129.1 (C13), 128.7 (C7), 128.6 (C12), 128.5 (C14), 127.7 (C18), 127.3 (C16), 
120.3 (C10), 116.5 (C8), 81.1 (C2), 47.3 (C3), 31.7 (C4), 20.8 (C19).   
 IR:  (ATR, cm
-1
)  
  2923 (w), 1588 (w), 1497 (m), 1474 (w), 1457 (w), 1436 (w), 1301 (w), 1239 (m), 
1227 (s), 1148 (w), 1127 (w), 1027 (w), 988 (m), 937 (w), 909 (w), 880 (w), 852 
(w), 831 (m), 818 (w), 798 (w), 745 (s), 729 (w), 691 (s).                                                                                                                 
 MS: (EI, 70 eV, m/z) 
  332 (60, M
+
), 200 (88), 199 (80),  133 (60),  91 (100)  
 TLC: Rf 0.67 (1:1, hexanes/CH2Cl2) [UV, CAM] 
 Opt. Rot.: [α]D
23
 = -32.9 (c = 0.88 in CHCl3) 
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 CD: (-), Cotton sign, 230-280 nm 
 CSP-SFC: (2R,3S)-143b tmin 10.2 min (5.0%), (2S,3R)-143b tmaj 14.3 min (95.0%) (Chiralpak 
AD, 220 nm, 200 bar, 40 
o
C, 85:15 sCO2/MeOH, 2 mL/min) 
 Analysis: C22H20OS (332.46)  
 Calcd:  C, 79.48; H, 6.06%  
 Found:  C, 79.15; H, 5.97% 
 
Preparation of (2S,3R)-8-Methyl-2-phenyl-3-(phenylthio)chromane (143c) (Table 18 Entry 
3) [DJK-CV-1411] 
 
 Following General Procedure 11, 142c (224 mg, 1.0 mmol) was weighed into a dried 10-
mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 56 (255 mg, 1.0 mmol, 1.0 equiv) 
and catalyst (S)-62e (52 mg, 0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-
PrOH bath and cooled to -20 
oC (probe). After equilibration (ca. 20 min), MsOH (17 μL, 0.25 
mmol, 0.25 equiv) was added directly via syringe. The solution was allowed to stir for 24 h at 
constant temperature during which time phthalimide precipitated. Upon consumption of the 
starting material (TLC, 
1H NMR), the reaction was quenched with triethylamine (300 μL) and 
the mixture was allowed to warm to rt, whereupon the white solid dissolved. The solution was 
transferred to a 60-mL separatory funnel, diluted with CH2Cl2 (10 mL) and 1 M NaOH (15 mL). 
The phases were separated and the aq. layer was extracted with 15 mL CH2Cl2. The organic 
phases were combined, dried over MgSO4, filtered and concentrated by rotary evaporation (30 
o
C, 3 mm Hg). Purification by silica gel flash column chromatography (60:1, hexanes/ethyl 
acetate then 40:1, hexanes/ethyl acetate, 30 mm diameter, 16 cm SiO2) afforded a white solid.  
Recrystallization from hexanes (3 mL) afforded, in two crops, 259 mg (78%) of 143c as white 
needles (78%).  
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Data for 143c: 
 mp: 89-90 
o
C (hexanes) 
 
1
H NMR:  (500 MHz, CDCl3)  
  δ 7.38–7.30 (m, 5H, HC(aryl)), 7.28 (d, J = 2.1 Hz, 2H, HC(aryl)), 7.25–7.19 (m, 
3H, HC(aryl)), 7.05 (d, J = 7.5 Hz, 1H, HC(5)), 6.88 (dd, J = 7.7, 1.9 Hz, 1H, 
HC(7)), 6.81 (t, J = 7.4 Hz, 1H, HC(6)), 5.11 (d, J = 7.6 Hz, 1H, HC(2)), 3.75 
(ddd, J = 8.9, 7.5, 5.0 Hz, 1H, HC(3)), 3.08 (dd, J = 16.6, 5.1 Hz, 1H, HC(4)), 
2.95 (dd, J = 16.5, 8.8 Hz, 1H, HC(4)), 2.23 (s, 3H, HC(19)). 
 
13
C NMR:  (101 MHz, CDCl3)  
  δ 152.4 (C9), 139.9 (C15), 133.9 (C11), 133.0 (C17), 129.2 (C5), 129.2 (C16), 
128.6 (C13), 128.4 (C18), 127.6 (C14), 127.1 (C7, C16), 126.0 (C10), 120.4 (C6), 
120.1 (C8), 81.0 (C2),  47.3 (C3), 31.8 (C4), 16.4 (C19). 
 IR:  (ATR, cm
-1
) 
  1594 (w), 1467 (m), 1432 (w), 1379 (w), 1304 (w), 1259 (w), 1239 (w), 1204 (s), 
1101 (w), 1072 (w), 1026 (w), 985 (m), 959 (w), 924 (w), 910 (w), 828 (w), 798 
(w), 757 (s), 744 (s), 728 (m), 699 (s).      
  MS: (EI, 70 eV, m/z) 
  332 (43, M
+
), 222 (48), 200 (100), 199 (60), 149 (20),  133 (41) 
 TLC: Rf 0.77 (1:1, hexanes/CH2Cl2) [UV, CAM] 
 Opt. Rot.: [α]D
23
 = -4.5 (c = 0.88 in CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
 CSP-SFC:  (2R,3S)-143c tmin 10.5 (4.0%), (2S,3R)-143c tmaj 11.8 (96.0%) (Chiralpak AD, 220 
nm, 200 bar, 40 
o
C, 95:5, sCO2/MeOH, 2 mL/min) 
 Analysis: C22H20OS (332.46) 
 Calcd:  C, 79.48; H, 6.06%  
 Found:  C, 79.54; H, 6.19% 
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Preparation of (2R,3S)-3-Phenyl-2-(phenylthio)-2,3-dihydro-1H-benzo[f]chromene (4d) 
(Table 18 Entry 4) [DJK-12-57] 
 
 Following General Procedure 11, 143d (260 mg, 1.0 mmol) was weighed into a dried 10-
mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 56 (255 mg, 1.0 mmol, 1.0 equiv) 
and catalyst (S)-62e (52 mg, 0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-
PrOH bath and cooled to -20 
oC (probe). After equilibration (ca. 20 min), MsOH (17 μL, 0.25 
mmol, 0.25 equiv) was added directly via syringe. The solution was allowed to stir for 24 h at 
constant temperature during which time phthalimide precipitated. Upon consumption of the 
starting material (TLC, 
1H NMR), the reaction was quenched with triethylamine (300 μL) and 
then was allowed to warm to rt, whereupon the white solid dissolved. The solution was 
transferred to a 60-mL separatory funnel, diluted with CH2Cl2 (10 mL) and 1 M NaOH (15 mL). 
The phases were separated and the aq. layer was extracted with 15 mL of CH2Cl2. The organic 
phases were combined, dried over MgSO4, filtered and concentrated by rotary evaporation (30 
o
C, 3 mm Hg).  Purification by silica gel flash column chromatography (60:1, hexanes/ethyl 
acetate then 40:1, hexanes/ethyl acetate, 20 mm diameter, 16 cm SiO2) followed by 
recrystallization (hexanes, 3 mL, ether, 0.2 mL) afforded, in two crops, 290 mg (79%) of 143d as 
pale pink prisms. 
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Data for 143d: 
 mp:  136-138 
o
C (hexanes/ether) 
 
1
H NMR: (500 MHz, CDCl3) 
  δ 7.83 (d, J = 7.8 Hz, 1H, HC(5)), 7.77 (d, J = 8.5, 1H, HC(8)), 7.72 (d, J = 8.9 
Hz, 1H, HC(9)), 7.53 (dd, J = 8.3, 7.0 Hz, 1H, HC(7)), 7.46–7.38 (m, 4H, 
HC(aryl), HC(6)), 7.38–7.27 (m, 4H, HC(aryl)), 7.27–7.22 (m, 3H HC(aryl)), 7.19 
(d, 1H, 8.9 Hz, HC(10)), 5.15 (d, J = 8.0 Hz, 1H, HC(2)), 3.95 (ddd, J = 8.9, 8.0, 
5.6, 1H, HC(3)), 3.49 (dd, J = 16.8, 5.6 Hz, 1H, HC(4)), 3.26 (dd, J = 16.8, 8.9 
Hz, 1H, HC(4)). 
 
13
C NMR: (101 MHz, CDCl3) 
  δ 152.0 (C11), 139.1 (C19), 133.9 (C14), 133.3 (C21), 132.9 (C12), 129.4 (C13), 
129.2 (C17), 128.8 (C18), 128.7 (C5), 128.7 (C16), 128.6 (C9), 127.8 (C22), 
127.5 (C20), 126.9 (C7), 123.8 (C6), 122.0 (C8), 118.9 (C10), 112.7 (C12), 81.2 
(C2), 47.4 (C3), 28.9 (C4).   
 IR:  (ATR, cm
-1
) 
  3054 (w), 1621 (w), 1596 (m), 1508 (w), 1466 (m), 1456 (w), 1433 (m), 1397 (m), 
1259 (w), 1227 (s), 1166 (m), 1140 (w), 1080 (w), 1066 (m), 1024 (w), 991 (s), 
971 (s), 913 (w), 862 (w), 847 (w), 818 (s), 801 (m), 767 (s), 746 (s), 736 (s), 703 
(s). 
 MS:  (EI, 70 eV, m/z) 
  368 (65, M
+
), 318 (25), 258 (44), 208 (32), 200 (97), 199 (100), 169 (49), 168 
(46) 
 TLC: Rf 0.74 (1:1, hexanes/CH2Cl2) [UV, CAM] 
 Opt. Rot.: [α]D
23
 = -89.4 (c = 0.86 in CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
CSP-HPLC: (2S,3R)-143d tmin 11.3 (6.8%), (2R,3S)-143d tmaj 17.6 (93.2%) (Chiralpak AD, 
220 nm, 95:5, hexanes/i-PrOH, 0.8 mL/min) 
 Analysis: C25H20OS (368.49) 
 Calcd:  C, 81.49; H, 5.47% 
 Found:  C, 81.32; H, 5.50% 
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Preparation of (2S,3R)-6-Methoxy-2-phenyl-3-(phenylthio)chromane (4e) (Table 18 Entry 
5) [DJK-CV-1412] 
 
 Following General Procedure 11, 142e (240 mg, 1.0 mmol) was weighed into a dried 10-
mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 56 (255 mg, 1.0 mmol, 1.0 equiv) 
and catalyst (S)-62e (52 mg, 0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-
PrOH bath and cooled to -20 
oC (probe). After equilibration (ca. 20 min), MsOH (17 μL, 0.25 
mmol, 0.25 equiv) was added directly via syringe. The solution was allowed to stir for 24 h at 
constant temperature during which time phthalimide precipitated. Upon consumption of the 
starting material (TLC, 
1H NMR), the reaction was quenched with triethylamine (300 μL) and 
the mixture was allowed to warm to rt, whereupon the white solid dissolved. The solution was 
transferred to a 60-mL separatory funnel, then was diluted with CH2Cl2 (10 mL) and 1 M NaOH 
(15 mL). The phases were separated and the aq. layer was extracted with 15 mL of CH2Cl2. The 
organic phases were combined, dried over MgSO4, filtered and concentrated by rotary 
evaporation (30 
o
C, 3 mm Hg). Purification by silica gel flash column chromatography (60:1, 
hexanes/ethyl acetate to 40:1, hexanes/ethyl acetate, 30 mm diameter, 18 cm SiO2) followed by 
recrystallization from hexanes (3 mL) afforded, in two crops, 293 mg (84%) of 143e white 
needles.  
Data for 143e: 
 mp:  128-129 
o
C (hexanes) 
 
1
H NMR:  (500 MHz, CDCl3) 
   δ 7.42–7.26 (m, 7H, HC(aryl)), 7.25–7.19 (m, 3H, HC(aryl)), 6.87 (d, J = 8.9 Hz, 
1H, HC(8)), 6.75 (dd, J = 8.9, 2.8 Hz, 1H, HC(7)), 6.58 (d, J = 3.1, 1H, HC(5)), 
5.02 (dd, J = 7.7, 1.2 Hz, 1H, HC(2)), 3.83–3.72 (m, 4H, HC(3), HC(19)), 3.09 
(dd, J = 16.7, 5.2 Hz, 1H, HC(4)), 2.95 (dd, J = 16.7, 8.9 Hz, 1H, HC(4)). 
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13
C NMR: (126 MHz, CDCl3) 
  δ 153.9 (C9), 148.3 (C6), 139.5 (C15), 133.7 (C11), 133.2 (C17), 129.1 (C13), 
128.6 (C12), 128.6 (C14), 127.7 (C18), 127.3 (C16), 121.3 (C10), 117.5 (C8), 
114.2 (C7), 113.9 (C5), 81.1 (C2), 56.0 (C19), 47.2 (C3), 32.1 (C4).   
 IR:  (ATR, cm
-1
) 
  2835 (w), 1583 (w), 1496 (m), 1457 (w), 1429 (m), 1293 (w), 1245 (w), 1224 (s), 
1209 (s), 1151 (m), 1122 (w), 1086 (w), 1040 (s), 994 (s), 934 (w), 909 (w), 875 
(w), 851 (w), 820 (m), 787 (w), 742 (s), 727 (s). 
 MS:  (EI, 70 eV, m/z) 
  348 (69, M
+
), 199 (42), 149 (56), 91 (100) 
 TLC: Rf 0.44 (1:1, hexanes/CH2Cl2) [UV, CAM] 
 Opt. Rot.: [α]D
23
 = -36.2 (c = 0.96 in CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
 CSP-SFC: (2R,3S)-143e tmin 13.9 min (5.6%), (2S,3R)-143e tmaj 16.0 min (94.4%) (Chiralpak 
AD, 220 nm, 200 bar, 40 
o
C, 85:15, sCO2/MeOH, 2mL/min) 
 Analysis: C22H20O2S (348.46) 
 Calcd: C, 75.83; H, 5.79%  
 Found: C, 76.04; H, 5.57% 
 
Preparation of (2S,3R)-6-Bromo-2-phenyl-3-(phenylthio)chromane (4f) (Table 18 Entry 6) 
[DJK-12-58] 
 
 Following General Procedure 11, 142f (289 mg, 1.0 mmol) was weighed into a dried 10-
mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 56 (255 mg, 1.0 mmol, 1.0 equiv) 
and catalyst (S)-62e (52 mg, 0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-
PrOH bath and cooled to -20 
o
C (probe). After equilibration (ca. 20 min), MsOH (17 μL, 0.25 
324 
 
mmol, 0.25 equiv) was added directly via syringe. The solution was allowed to stir for 36 h at 
constant temperature during which time phthalimide precipitated. Upon consumption of the 
starting material (TLC, 
1
H NMR), the reaction was quenched with triethylamine (300 μL) and 
the mixture was allowed to warm to rt, whereupon the white solid dissolved. The solution was 
transferred to a 60-mL separatory funnel, then was diluted with CH2Cl2 (10 mL) and 1 M NaOH 
(15 mL). The phases were separated and the aq. layer was extracted with 15 mL of CH2Cl2. The 
organic phases were combined, dried over MgSO4, filtered and concentrated by rotary 
evaporation (30 
o
C, 3 mm Hg). Purification by silica gel flash column chromatography (60:1, 
hexanes/ethyl acetate, then 40:1, hexanes/ethyl acetate, 20 mm diameter, 16 cm SiO2) followed 
by recrystallization (hexanes, 3 mL, ether, 0.2 mL), afforded, in two crops, 320 mg (81%) of 
143f a white solid.  
Data for 143f: 
 mp: 138-139 
o
C (hexanes/ether) 
 
1
H NMR: (500 MHz, CDCl3) 
  δ 7.40–7.24 (m, 11H, HC(aryl), HC(7)), 7.19 (d, J = 2.4 Hz, 1H, HC(5)), 6.85 (d, 
J = 8.7 Hz, 1H, HC(8)), 5.10 (d, J = 7.3 Hz, 1H, HC(2)), 3.77 (ddd, J = 8.7, 7.3, 
5.1 Hz, 1H, HC(3)), 3.07 (dd, J = 16.8, 5.1 Hz, 1H, HC(4)), 2.92 (dd, J = 16.7, 8.5 
Hz, 1H, HC(4)). 
 
13
C NMR:  (126 MHz, CDCl3) 
  δ 153.4 (C9), 139.1 (C15), 133.4 (C17), 133.3 (C11), 132.1 (C5), 131.0 (C7), 
129.2 (C13), 128.7 (C12, C14), 128.0 (C18), 127.0 (C16), 122.8 (C6), 118.6 (C8), 
113.0 (C10), 81.0 (C2), 46.7 (C3), 31.0 (C4).  
 IR:  (ATR, cm
-1
) 
  3037 (w), 1573 (w), 1473 (m), 1432 (w), 1405 (w), 1288 (w), 1232 (s), 1182 (m), 
1121 (m), 1088 (w), 1067 (w), 1027 (w), 977 (m), 935 (w), 911 (w), 890 (m), 866 
(m), 844 (w), 830 (w), 815 (w), 799 (w), 776 (w), 743 (s), 699 (s).  
 MS:  (EI, 70 eV, m/z) 
  397 (18, M
+
), 395 (18, M
+
), 199 (100), 91 (88)   
 TLC: Rf 0.44 (1:1, hexanes/CH2Cl2) [UV, CAM] 
 Opt. Rot.: [α]D
23
 = -49.2 (c = 0.84 in CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
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CSP-HPLC: (2R,3S)-143f, tmin 9.3 (6.2%), (2S,3R)-143f, tmaj 10.4 (93.8%) (Chiralpak AD, 220 
nm, 95:5, hexanes/i-PrOH, 0.8 mL/min) 
 Analysis: C21H17BrOS (397.33) 
 Calcd: C, 63.48; H, 4.31%  
 Found: C, 63.38; H, 4.30% 
 
Preparation of (2S,3R)-6-Chloro-2-phenyl-3-(phenylthio)chromane (4g) (Table 18 Entry 7) 
[DJK-17-19] 
 
 Following General Procedure 11, 142g (245 mg, 1.0 mmol) was weighed into a dried 10-
mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 56 (255 mg, 1.0 mmol, 1.0 equiv) 
and catalyst (S)-62e (52 mg, 0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-
PrOH bath and cooled to -20 
o
C (probe). After equilibration (ca. 20 min), MsOH (17 μL, 0.25 
mmol, 0.25 equiv) was added directly via syringe. The solution was allowed to stir for 36 h at 
constant temperature during which time phthalimide precipitated. Upon consumption of the 
starting material (TLC, 
1
H NMR), the reaction was quenched with triethylamine (300 μL) and 
the mixture was allowed to warm to rt, whereupon the white solid dissolved. The material was 
transferred to a 250-mL RB-flask using 20 mL CH2Cl2 and concentrated by rotary evaporation 
(30 
o
C, 3 mm Hg). The material was then redissolved in 10 mL of CH2Cl2 and then adsorbed 
onto Celite. Purification by silica gel flash column chromatography (5:1, hexanes/CH2Cl2, 20 
mm diameter, 16 cm SiO2) followed by recrystallization from hexanes (3 mL) afforded, in two 
crops, 248 mg (70%) of 143g as white needles.  
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Data for 143g: 
 mp: 144-145 
o
C (hexanes) 
 
1
H NMR: (500 MHz, CDCl3)  
  δ 7.38–7.29 (m, 7H, HC(aryl)), 7.29–7.25 (m, 3H, HC(aryl)), 7.15 (dd, J = 8.7, 
2.5 Hz, 1H, HC(7)), 7.04 (d, J = 2.6 Hz, 1H, HC(5)), 6.90 (d, J = 8.7, 1H, HC(8)), 
5.09 (d, J = 7.3 Hz, 1H, HC(2)), 3.77 (ddd, J = 8.5, 7.3, 5.1 Hz, 1H, HC(3)), 3.07 
(dd, J = 16.8, 5.1 Hz, 1H, HC(4)), 2.92 (dd, J = 16.8, 8.5 Hz, 1H, HC(4)). 
 
13
C NMR:  (126 MHz, CDCl3) 
  δ 152.9 (C9), 148.7 (C6) 139.1 (C15), 133.4 (C17), 133.3 (C11), 129.2 (C13), 
129.1 (C5), 128.7 (C12), 128.1 (C7), 128.0 (C14/C18), 127.0 (C16), 125.7 
(C14/C18), 122.2 (C10), 118.1 (C8), 81.0 (C2), 46.7 (C3), 31.2 (C4).   
 IR:  (ATR, cm
-1
) 
  3059 (w), 1578 (w), 1476 (m), 1432 (w), 1411 (w), 1290 (w), 1235 (s), 1187 (m), 
1123 (m), 1068 (w), 1027 (w), 981 (m), 935 (m), 898 (m), 875 (s), 849 (w), 831 
(m), 794 (w), 781 (w), 743 (s), 699 (s). 
 MS:  (EI, 70 eV, m/z) 
  354 (12, M
+
), 352 (20, M
+
),  247 (44),  199 (89), 149 (36),  133 (41),  107 (23), 91 
(80) 
 TLC: Rf 0.45 (1:1, hexanes/CH2Cl2) [UV, CAM] 
 Opt. Rot.: [α]D
23
 = -42.6 (c =1.12 in CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
CSP-HPLC:  (2R,3S)-143g tmin 9.2 (6.2%), (2S,3R)-143g tmin 12.4 (93.8%) (Chiralpak AD, 220 
nm, 95:5, hexanes/i-PrOH, 0.8 mL/min) 
 Analysis: C21H17ClOS (352.88) 
 Calcd: C, 71.48; H, 4.86% 
 Found: C, 71.73; H, 5.11% 
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Preparation of (2S,3R)-6-Fluoro-2-phenyl-3-(phenylthio)chromane (143h) (Table 18 Entry 
8) [DJK-CV-1409] 
 
 Following General Procedure 11, 142h (228 mg, 1.0 mmol) was weighed into a dried 10-
mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 56 (255 mg, 1.0 mmol, 1.0 equiv) 
and catalyst (S)-62e (52 mg, 0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-
PrOH bath and cooled to -20 
o
C (probe). After equilibration (ca. 20 min), MsOH (17 μL, 0.25 
mmol, 0.25 equiv) was added directly via syringe. The solution was allowed to stir for 36 h at 
constant temperature during which time phthalimide precipitated. Upon consumption of the 
starting material (TLC, 
1
H NMR), the reaction was quenched with triethylamine (300 μL) and 
the mixture was allowed to warm to rt, whereupon the white solid dissolved. The solution was 
transferred to a 60-mL separatory funnel, diluted with CH2Cl2 (10 mL) and 1 M NaOH (15 mL). 
The phases were separated and the aq. layer was extracted with 15 mL of CH2Cl2. The organic 
phases were combined, dried over MgSO4, filtered and concentrated by rotary evaporation (30 
o
C, 3 mm Hg). Purification by silica gel flash column chromatography (6:1, hexanes/CHCl3 then 
4:1, then 3:1, hexanes/CHCl3, 20 mm diameter, 17 cm SiO2) followed by recystallization from 
hexanes (3 mL) afforded, in two crops, 289 mg (86%) of 143h as white needles. 
Data for 143h: 
 mp: 111-112 
o
C (hexanes) 
 
1
H NMR:  (500 MHz,  CDCl3) 
  δ 7.38–7.32 (m, 5H, HC(aryl)), 7.30 (m, 2H, HC(aryl)), 7.28–7.24 (m, 3H, 
HC(aryl)), 6.93–6.88 (m, 2H, HC(8), HC(5)), 6.81–6.74 (d, J = 8.4 Hz, 1H, 
HC(7)), 5.07 (d, J = 7.6 Hz, 1H, HC(2)), 3.78 (ddd, J = 8.6, 7.5, 5.2 Hz, 1H, 
(HC(3)), 3.10 (dd, J = 16.9, 5.2 Hz, 1H, HC(4)), 2.95 (dd, J = 16.8, 8.8 Hz, 1H, 
HC(4)). 
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13
C NMR:  (126 MHz, CDCl3) 
  δ 157.2 (d, J = 238.9 Hz, C6), 150.3 (C9), 139.2 (C15), 133.4 (C11), 133.4 (C17), 
129.2 (C13), 128.7 (C12,C14), 127.9 (C18), 127.2 (C16), 121.8 (d, J = 7.4 Hz, 
C10), 117.7 (d, J = 8.1 Hz, C8), 115.4 (d, J = 22.8 Hz, C7), 114.9 (d, J = 23.2 Hz, 
C5), 81.1 (C2), 46.8 (C3), 31.7 (C4).   
 
19
F NMR:  (470 MHz, CDCl3) 
  δ -124.03 (app q, J = 7.3 Hz). 
 IR: (ATR, cm
-1
) 
   3072 (w), 1580 (w), 1491 (s), 1473 (m), 1458 (w), 1438 (w), 1429 (m), 1374 (w), 
1332 (w), 1283 (w), 1240 (m), 1222(s), 1203 (s), 1140 (m), 1103 (w), 1087 (w), 
1067 (w), 1036 (w), 984 (s), 948 (m), 933 (m), 911 (w), 873 (m), 850 (m), 827 
(m), 792 (m), 744 (s), 730 (s). 
 MS: (EI, 70 eV, m/z) 
  336 (33, M
+
), 226 (27), 199 (100), 91 (93)  
 TLC: Rf 0.49 (1:1, hexanes/CH2Cl2) [UV, CAM] 
 Opt. Rot.: [α]D
23
 = -23.4 (c = 0.94 in CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
 CSP-SFC: (2R,3S)-143h tmin 9.0 min (6.8%), (2S,3R)-143h tmaj 11.6 min (93.2%) (Chiralpak 
AD, 220 nm, 95:5, hexanes/i-PrOH, 0.8 mL/min) 
 Analysis: C21H17FOS (336.42) 
 Calcd: C, 74.97; H, 5.09%  
 Found: C, 74.73; H, 5.02% 
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Preparation of (2S,3R)-3-((2,6-Diisopropylphenyl)thio)-2-phenyl-6-
(trifluoromethyl)chromane (143i) (Table 18 Entry 9) [DJK-17-47] 
 
 Following General Procedure 11, 143i (276 mg, 1.0 mmol) was weighed into a dried 10-
mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 103 (339 mg, 1.0 mmol, 1.0 equiv) 
and catalyst (S)-62e (52 mg, 0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-
PrOH bath and stirred at rt. MsOH (17 μL, 0.25 mmol, 0.25 equiv) was added directly via 
syringe. The solution was allowed to stir for 12 h at constant temperature during which time 
phthalimide precipitated. Upon consumption of the starting material (TLC, 
1
H NMR), the 
reaction was quenched with triethylamine (300 μL) and the mixture was allowed to warm to rt, 
whereupon the white solid dissolved. The material was transferred to a 250 mL RB-flask using 
20 mL of CH2Cl2 and concentrated by rotary evaporation (30 
o
C, 3 mm Hg) to afford a pale 
yellow residue. The material was then redissolved in 10 mL CH2Cl2 and adsorbed onto Celite. 
Purification by silica gel flash column chromatography of the adsorbed material (5:1, 
hexanes/CH2Cl2, 20 mm diameter, 16 cm SiO2) followed by recrystallization from hexanes (3 
mL) afforded, in two crops, 416 mg (89%) of 143i as white prisms.  
Data for 143i: 
 mp:  137-140 
o
C (hexanes) 
 
1
H NMR:  (500 MHz, CDCl3) 
  δ 7.44 (dd, J = 8.5 Hz, 2.2 Hz, 1H, HC(7)), 7.34 (m, 4H, HC(aryl)), 7.25 (m, 2H, 
HC(aryl)), 7.22–7.20 (br s, 1H, HC(5)), 7.18 (d, J = 7.7 Hz, 2H, HC(17)), 7.04 (d, 
J = 8.6 Hz, 1H, HC(8)), 5.19 (d, J = 5.5 Hz, 1H, HC(2)), 3.75 (p, J = 6.9 Hz, 2H, 
HC(19)), 3.50 (q, J = 5.6 Hz, 1H, HC(3)), 2.77 (d, J = 5.5 Hz, 2H, HC(4)), 1.18 
(d, J = 6.9 Hz, 12H, HC(20)). 
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13
C NMR: (126 MHz, CDCl3) 
   δ 156.6 (C15), 154.2 (C9), 139.6 (C11), 130.0 (C14), 128.8 (C13), 128.7 (C16), 
128.6 (C18), 127.1 (C5), 126.2 (C12), 125.5 (C7), 124.1 (C17), 120.6 (C4), 117.0 
(C8), 79.8 (C2) , 47.2 (C3), 31.8 (C19), 29.1 (C4), 24.7 (m, C20).   
 
19
F NMR:  (376 MHz, CDCl3)  
  δ -61.87 (s) 
 IR: (ATR, cm
-1
) 
  2961 (w), 2926 (w), 1738(w), 1620 (w), 1594 (w), 1507 (w), 1455 (w), 1380 (w), 
1361 (w), 1330 (s), 1292 (m), 1241 (s), 1188 (w), 1159 (s), 1115 (s), 1070 (w), 
1050 (w), 1032 (w), 990 (m), 971(m), 936 (w), 905 (m), 889 (m), 846 (m), 799 
(m), 781 (w), 748 (m), 740 (m), 696 (s). 
 MS:   (EI, 70 eV, m/z) 
  470 (25, M
+
), 283 (100),  276 (21),  194 (22), 149 (51) 
 TLC: Rf 0.65 (1:1, hexanes/CH2Cl2) [UV, CAM] 
 Opt. Rot.:  [α]D
23
 = -7.0 (c = 0.9 in CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
 Analysis: C28H29F3OS (470.59) 
 Calcd: C, 71.46; H, 6.21%  
 Found: C, 71.38; H, 6.22% 
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Preparation of (2S,3R)-3-((2,6-Diisopropylphenyl)sulfonyl)-2-phenyl-6-(trifluoromethyl)-
chromane (155i) [DJK-17-48] 
 
 To determine enantiomeric composition, 143i was oxidized to the sulfone 155i. To a 4-
dram vial under nitrogen was added solid 143i (20 mg, 0.04 mmol, 1 equiv), followed by CH2Cl2 
(1mL) and solid mCPBA (18 mg, 0.11 mmol, 2.5 equiv). The resulting solution was stirred at rt 
for 3 h. The solution was then diluted with hexanes (3 mL) and directly purified by silica gel 
flash column chromatography (9:1, hexanes/ethyl acetate, 20 mm diameter, 16 cm SiO2) to 
afford 22 mg of 155i as a white solid. The product sulfone was then analyzed by chiral stationary 
phase HPLC. 
Data for 155i: 
 
1
H NMR:  (500 MHz, CDCl3) 
  δ 7.56–7.44 (m, 2H, HC(7), HC(5)), 7.35 (d, J = 7.7 Hz, 3H, HC(aryl)), 7.31–7.27 
(m, 5H, HC(aryl)), 7.19 (dd, J = 6.7, 2.9 Hz, 2H, HC(aryl)), 7.08 (d, J = 8.5 Hz, 
1H, HC(8)), 5.82 (d, J = 4.4 Hz, 1H, HC(2)), 4.04 (p, J = 6.7 Hz, 2H, HC(19)), 
3.86 (app q, J = 5.8 Hz, 1H, HC(3)), 3.30 (dd, J = 17.5, 5.5 Hz, 1H, HC(4)), 3.03 
(dd, J = 17.5, 6.4 Hz, 1H, HC(4)), 1.30 (d, J = 6.7 Hz, 6H, HC(20)), 1.25 (d, J = 
6.7 Hz, 6H, HC(21)). 
 13
C NMR: (126 MHz, CDCl3) 
  δ 151.2, 138.2, 133.6, 129.1, 128.9, 126.6, 126.4, 126.2, 119.1, 117.4, 74.9, 62.5, 
30.0, 25.3, 25.2, 22.6. 
CSP-HPLC:   (2S,3R)-155i tmaj 6.9 min (95.2%) (2R,3S)-155i tmin 7.7 min (4.8%) (Chiralpak 
AD, 220 nm, 95:5, hexanes/i-PrOH, 0.8 mL/min) 
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Preparation of (2S,3R)-2-(Furan-2-yl)-3-(phenylthio)chromane (143j) (Table 19 Entry 1) 
[DJK-DR-9009] 
 
 For compound 143j, General Procedure 11 was modified as following: To a dried 10-mL 
Schlenk flask was added CH2Cl2 (7 mL), electrophile 56 (255 mg, 1.0 mmol, 1.0 equiv) and 
catalyst (S)-62e (52 mg, 0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-PrOH 
bath and cooled to -20 
o
C (probe). After equilibration (ca. 20 min), MsOH (17 μL, 0.25 mmol, 
0.25 equiv) was added directly via syringe, and allowed to stir for 5 min. Substrate 142j (200 
mg, 1.0 mmol) was then added directly to the cold solution. The solution was allowed to stir for 
24 h at constant temperature during which time phthalimide precipitated. Upon consumption of 
the starting material (TLC, 
1H NMR), the reaction was quenched with triethylamine (300 μL) 
and then was allowed to warm to rt, whereupon the white solid dissolved. The solution was 
transferred to a 60-mL separatory funnel, diluted with CH2Cl2 (10 mL) and 1 M NaOH (15 mL). 
The phases were separated and the aq. layer was extracted with 15 mL of CH2Cl2. The organic 
phases were combined, dried over MgSO4, filtered and concentrated by rotary evaporation (30 
o
C, 3 mm Hg). The material was dissolved in CH2Cl2 (10 mL) and adsorbed onto Celite. 
Purification by silica gel flash column chromatography (5:1, hexanes/CH2Cl2, 20 mm
 
diameter, 
16 cm SiO2), followed by recrystallization from hexanes (3 mL) afforded, in two crops, 271 mg 
(88%) of 143j as white needles.  
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Data for 143j: 
 mp:  72-73 
o
C (hexanes) 
 
1
H NMR:  (500 MHz, CDCl3) 
  δ 7.44–7.38 (m, 2H, HC(17)), 7.36–7.26 (m, 4H, HC(14), HC(16), HC(18)), 7.16 
(dd, J = 8.4, 7.4, 1H, HC(7)), 7.06 (d, J = 7.2 Hz, 1H, HC(5)), 6.96–6.88 (m, 2H, 
HC(8), HC(6)), 6.45–6.39 (m, 1H, HC(12), 6.35 (ddd, J = 3.2, 1.8, 1.0 Hz, 1H, 
HC(13), 5.09 (dd, J = 8.1, 1.1 Hz, 1H, HC(2)), 3.98 (ddd, J = 9.2, 8.1, 5.4, 1H, 
HC(3)), 3.21 (dd, J = 16.6, 5.4 Hz, 1H, HC(4)), 3.03–2.89 (dd, J = 16.6, 9.2 Hz, 
1H HC(4)). 
 
13
C NMR:  (126 MHz, CDCl3) 
  δ 153.7 (C9), 151.5 (C11), 142.9 (C14), 133.6 (C117), 132.9 (C15), 129.5 (C5), 
129.1 (C16), 128.0 (C7), 127.9 (C18), 121.2 (C6), 120.5 (C10), 116.9 (C8), 110.6 
(C13), 109.9 (C12), 74.6 (C2), 44.3 (C3), 31.7 (C4).  
 IR:  (ATR, cm
-1
) 
  3058 (w), 1733 (w), 1583 (m), 1504 (w), 1487 (m), 1476 (m), 1453 (m), 1439 (w), 
1349 (w), 1331 (w), 1301 (w), 1279 (w), 1234 (s), 1217 (m), 1190 (w), 1170 (w), 
1150 (m), 1111 (m), 1079 (w), 1033 (m), 1013 (m), 978 (s), 931 (m), 902 (m), 
885 (m), 876 (m), 846 (w), 820 (m), 778 (w), 747 (s), 728 (s), 703 (m). 
 MS:  (EI, 70eV, m/z) 
  308 (31, M
+
), 199 (29), 190 (46), 81 (100). 
 TLC: Rf 0.42 (1:1, hexanes/CH2Cl2) [UV, CAM] 
 Opt. Rot.: [α]D
23
 = -55.5 (c = 0.96 in CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
CSP-HPLC: (2R,3S)-143j tmin 8.7 min (7.5%), (2S,3R)-143j tmaj 9.7 min (92.5%) (Chiralpak 
AD, 220 nm, 95:5, hexanes/i-PrOH, 0.8 mL/min) 
 Analysis: C19H16O2S (308.40) 
 Calcd: C, 74.00; H, 5.23%  
 Found: C, 73.83; H, 5.16% 
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Preparation of (2R,3R)-3-(Phenylthio)-2-(thiophen-2-yl)chromane (143k) (Table 19 Entry 
2) [DJK-DR-9008] 
 
 Following General Procedure 11, 142k (216 mg, 1.0 mmol) was weighed into a dried 10-
mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 56 (255 mg, 1.0 mmol, 1.0 equiv) 
and catalyst (S)-62e (52 mg, 0.1 mmol, 0.1 equiv) was added. The flask was placed in an i-PrOH 
bath and cooled to -20 
o
C (probe). After equilibration (ca. 20 min), MsOH (17 μL, 0.25 mmol, 
0.25 equiv) was added directly via syringe. The solution was allowed to stir for 24 h at constant 
temperature during which time phthalimide precipitated. Upon consumption of the starting 
material (TLC, 
1
H NMR), the reaction was quenched with triethylamine (300 μL) and then was 
allowed to warm to rt, whereupon the white solid dissolved. The solution was transferred to a 60-
mL separatory funnel, diluted with CH2Cl2 (10 mL) and 1 M NaOH (15 mL). The phases were 
separated and the aq. layer was extracted with 15 mL of CH2Cl2. The organic phases were 
combined, dried over MgSO4, filtered and concentrated by rotary evaporation (30 
o
C, 3 mm Hg). 
Purification by silica gel flash column chromatography (60:1, hexanes/ethyl acetate then 40:1, 
hexanes/ethyl acetate, 30 mm diameter, 15 cm SiO2) afforded 278 mg (86%) of 143k as white 
prisms.   
Data for 143k: 
 mp:  98-99 
o
C (hexanes/ethyl acetate) 
 
1
H NMR:  (500 MHz, CDCl3) 
  δ 7.39 (m, 2H, HC(17)), 7.30 (m, 4H, HC(16), HC(18), HC(7)), 7.19 (t, J = 8.3 
Hz, 1H, HC(6)), 7.13 (d, J = 3.5 Hz, 1H, HC(12)), 7.06 (d, J = 7.5 Hz, 1H, HC(5), 
6.99 (t, J  = 4.0 Hz, 1H, HC(13)), 6.94 (m, 2H, HC(14), HC(8)), 5.36 (d, J = 7.6 
Hz, 1H, HC(2)), 3.80 (td, J = 8.1, 5.4 Hz, 1H, HC(3)), 3.21 (dd, J = 16.7, 5.3 Hz, 
1H, HC(4)), 2.99 (dd, J = 16.7, 8.7 Hz, 1H, HC(4)). 
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13
C NMR: (126 MHz,
 
CDCl3) 
  δ 153.6 (C9), 142.6 (C15), 133.4 (C17), 133.3 (C11), 129.5 (C13), 129.2 (C16), 
128.1 (C12), 127.9 (C18) , 126.8 (C6), 126.5 (C5), 126.0 (C7), 121.3 (C14), 120.4 
(C10), 117.0 (C8), 77.0 (C2), 47.7 (C3), 31.6 (C4).   
 IR:  (ATR, cm
-1
) 
  2923 (w), 1582 (w), 1485 (m), 1456 (w), 1437 (w), 1345 (w), 1305 (w), 1275 (w), 
1233 (w), 1219 (s), 1191 (m), 1149 (w), 1120 (w), 1104 (w), 1078 (m), 1042 (w), 
1026 (w), 991 (m), 965 (m), 900 (w), 846 (m), 839 (m), 757 (s), 747 (s), 710 (s). 
 MS:  (EI, 70 eV, m/z) 
  324 (15, M
+
),  215 (30),  205 (26),  97 (100) 
 TLC: Rf 0.42 (1:1, hexanes/CH2Cl2) [UV, CAM] 
 Opt. Rot.: [α]D
23
 = -49.8 (c = 0.95 in CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
CSP-HPLC: (2R,3R)-143k tmaj 26.6 min (93.9%), (2S,3S)-143k tmaj 34.2 min (6.1%) (Reverse-
Phase Chiralpak OJ-RH, 220 nm, 65:35, MeCN/H2O, 0.5 mL/min) 
 Analysis: C19H16OS2 (324.46) 
 Calcd: C, 70.33; H, 4.97%  
 Found: C, 69.93; H, 4.83% 
 
Preparation of (2S,3R)-2-Phenethyl-3-(phenylthio)chromane (143l) and (R)-2-((S)-3-
Phenyl-1-(phenylthio)propyl)-2,3-dihydrobenzofuran (144l) (Table 19 Entry 3) [DJK-DR-
9054] 
 Following General Procedure 11, 142l (238 mg, 1.0 mmol) was weighed into a dried 10-
mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 56 (255 mg, 1.0 mmol, 1.0 equiv) 
and catalyst (S)-62e (52 mg, 0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-
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PrOH bath and cooled to -20 
oC (probe). After equilibration (ca. 20 min), MsOH (17 μL, 0.25 
mmol, 0.25 equiv) was added directly via syringe. The solution was allowed to stir for 24 h at 
constant temperature during which time phthalimide precipitated. Upon consumption of the 
starting material (TLC, 
1H NMR), the reaction was quenched with triethylamine (300 μL) and 
then was allowed to warm to rt, whereupon the white solid dissolved. The solution was 
transferred to a 60-mL separatory funnel, then was diluted with CH2Cl2 (10 mL) and 1 M NaOH 
(15 mL). The phases were separated and the aq. layer was extracted with 15 mL of CH2Cl2. The 
organic phases were combined, dried over MgSO4, filtered and concentrated (30 
o
C, 3 mm Hg). 
The crude 143l/144l ratio (1.5:1) was established by 
1
H NMR spectroscopy. The material was 
dissolved in 10 mL of CH2Cl2 and adsorbed onto Celite. Purification by silica gel flash column 
chromatography of this material (60:1, hexanes/ethyl acetate then 40:1, hexanes/ethyl acetate, 30 
mm diameter, 14 cm SiO2) followed by bulb-to-bulb distillation afforded 258 mg (74%) of a 
1.5:1 mixture of 143l/144l as a clear oil.  
Data for mixture: 
 bp: 120
o
C (ABT), 0.05 mm Hg 
 1
H NMR: (500 MHz, CDCl3) 
  δ 7.51–7.40 (m, 5H, HC(aryl)), 7.32 (m, 13H, HC(aryl)), 7.25 (m, 7H, HC(aryl)), 
7.21–7.09 (m, 4H, HC(aryl)), 7.02 (d, J = 7.6 Hz, 1H, HC(aryl)), 6.97–6.81 (m, 
4H), 6.74 (d, J = 8.0 Hz, 1H)  
 IR:  (ATR, cm
-1
) 
  3025 (w), 2923 (w), 1599 (w), 1584 (m), 1488 (m), 1479 (m), 1455 (m), 1437 
(m), 1303 (w), 1231 (s), 1174 (w), 1111 (w), 1088 (w), 1066 (w), 1024 (w), 964 
(w), 942 (w), 872 (w), 796 (w), 744 (s).  
 MS:  (EI, 70 eV, m/z) 
  346 (73, M
+
), 145 (30), 131 (41), 117 (65), 91 (100), 69 (29) 
 TLC: Rf 0.49 (1:1, hexanes/CH2Cl2) [UV, CAM] 
 CSP-SFC: (2R,3S)-143l, tmin 16.2 (3.4%), (2S,3R)-143l tmaj 17.7 (96.6%), (2S,10R)-144l, tmin 
13.3 (3.7%), (2S,10R)-144l tmaj 14.7 (96.3%) (Chiralpak AD, 220 nm, 95:5 
sCO2/MeOH, 2 mL/min) 
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 Analysis: C23H22OS (346.49) 
 Calcd: C, 79.73; H, 6.40%  
 Found: C, 79.87; H, 6.51% 
  
Diagnostic for 144l: 
 1
H NMR:  (500 MHz, CDCl3) 
   δ 4.86 (dt, J = 9.1, 7.4 Hz, 1H, HC(2)), 3.35 (dd, J = 15.9, 9.2 Hz, 1H, HC(3)), 
3.29 (ddd, J = 10.2, 7.0, 3.6 Hz, 1H, HC(10)), 3.22–3.15 (m, 2H, HC(3), HC(12)), 
2.88 (m, HC(12)),  2.26 (dddd, J = 14.3, 9.6, 7.1, 3.6 Hz, 1H, HC(11)), 1.95 (dtd, 
J = 14.4, 9.6, 4.9 Hz, 1H, HC(11)). 
 
13
C NMR:  (126 MHz, CDCl3) 
   δ 85.1 (C2), 53.9 (C10), 34.2 (C3), 33.1 (C12), 32.7 (C11) 
Diagnostic for 143l: 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 4.06 (td, J = 8.4, 2.9 Hz, 1H, HC(2)), 3.45 (ddd, J = 9.0, 7.9, 5.3 Hz, 1H, 
HC(3)), 3.15–3.08 (m, 1H, HC(4)), 3.00–2.91 (m, 1H, HC(4)), 2.91–2.82 (m, 2H, 
HC(12)), 2.36 (dddd, J = 14.0, 10.0, 7.3, 3.0 Hz, 1H, HC(11)), 2.10 (dtd, J = 14.0, 
9.0, 5.0 Hz, 1H, HC(11)) 
 13
C NMR:  (126 MHz, CDCl3)  
  δ 77.4 (C2), 45.0 (C3), 35.0 (C11), 31.7 (C4), 31.4 (C12) 
  
Preparation of (S)-3-((2,6-Diisopropylphenyl)thio)-2,2-dimethylchromane (143m) (Table 19 
Entry 4) [DJK-DR-9079] 
 
 Following General Procedure 11, 142m (162 mg, 1.0 mmol) was weighed into a dried 
10-mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 103 (339 mg, 1.0 mmol, 1.0 
equiv) and catalyst  (S)-62e (52 mg, 0.1 mmol, 0.1 equiv) were added. The flask was placed in an 
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i-PrOH bath and cooled to 0 
oC (probe). MsOH (17 μL, 0.25 mmol, 0.25 equiv) was added 
directly via syringe. The solution was allowed to stir for 24 h at constant temperature during 
which time phthalimide precipitated. Upon consumption of the starting material (TLC, 
1
H 
NMR), the reaction was quenched with triethylamine (300 μL) and then was allowed to warm to 
rt, whereupon the white solid dissolved. The solution was transferred to a 60-mL separatory 
funnel, diluted with CH2Cl2 (10 mL) and 1 M NaOH (15 mL). The phases were separated and 
the aq. layer was extracted with 15 mL of CH2Cl2. The organic phases were combined, dried 
over MgSO4, filtered and concentrated (30 
o
C, 3 mm Hg). The material was then dissolved in 10 
mL of CH2Cl2 and adsorbed onto Celite. Purification by silica gel flash column chromatography 
of this material (5:1, hexanes/CH2Cl2, 20 mm diameter, 16 cm SiO2) followed by 
recrystallization (EtOH, 5 mL), afforded, in two crops, 330 mg (93%) of 143m as white needles.  
Data for 143m: 
 mp:  74-75 
o
C (EtOH) 
 
1
H NMR:  (400 MHz, CDCl3) 
  δ 7.35 (t, J = 7.8 Hz, 1H, HC(15)), 7.18 (d, J = 7.7 Hz, 2H, HC(14)), 7.08 (t, J = 
8.1 Hz, 1H, HC(7)), 6.89 (d, J = 7.3 Hz, 1H, HC(5)), 6.83–6.75 (m, 2H, HC(6), 
HC(8)), 3.89 (p, J = 6.8 Hz, 2H, HC(16)), 3.16 (dd, J = 8.1, 6.9 Hz, 1H, HC(3)), 
2.72 (d, J = 7.2 Hz, 2H, HC(4)), 1.55 (s, 3H, HC(11)), 1.49 (s, 3H, HC(11)), 1.24 
(d, J = 6.8 Hz, 6H, HC(17)), 1.18 (d, J = 6.8 Hz, 6H, HC(17)). 
 
13
C NMR:  (101 MHz, CDCl3) 
  δ 154.2 (C12), 153.2 (C9), 129.7 (C15), 129.5 (C13), 129.4 (C7), 127.9 (C5), 
124.1 (C14), 120.6 (C13), 120.4 (C6), 117.4 (C8), 77.5 (C2), 52.1 (C3), 31.8 
(C16), 31.7 (C16), 29.8 (C4), 27.9 (C11), 25.0 (C17), 24.5 (C17), 22.2 (C11).   
 IR:  (ATR, cm
-1
) 
  3058 (w), 2962 (m), 2928 (m), 2867 (w), 1609 (w), 1583 (m), 1489 (s), 1455 (s), 
1420 (w), 1382 (m), 1368 (m), 1360 (w), 1315 (w), 1301 (m), 1265 (s), 1252 (m), 
1236 (s), 1178 (m), 1150 (s), 1127 (s), 1099 (s), 1052 (m), 1033 (m), 974 (w), 944 
(s), 927 (m), 896 (w), 858 (s), 847 (w), 825 (w), 804 (m), 748 (s), 741 (s), 713 
(m).  
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 MS:  (EI, 70 eV, m/z) 
  354 (69, M
+
),  235 (98), 194 (28), 161 (100), 149 (33), 145 (60),  119 (71), 91 
(41) 
 TLC: Rf 0.60 (1:1, hexanes/CH2Cl2) [UV, CAM] 
 Opt. Rot.: [α]D
23
 = -104.8 (c = 0.79 in CHCl3) 
 CD: (+), Cotton sign, 230-280 nm 
 Analysis: C23H30OS (354.55) 
 Calcd: C, 77.92; H, 8.53%  
 Found: C, 77.71; H, 8.31% 
 
Preparation of (S)-3-((2,6-Diisopropylphenyl)sulfonyl)-2,2-dimethylchromane (155m) 
[DJK-14-97] 
 
 To determine enantiomeric composition, 143m was oxidized to the sulfone. To a 4-dram 
vial was added solid 143m (20 mg, 0.055 mmol, 1 equiv), followed by CH2Cl2 (1 mL) and 
mCPBA (25 mg, 0.15 mmol, 2.5 equiv) The solution was stirred at rt for 3 h. The solution was 
diluted with hexanes (3 mL) and then directly purified by silica gel flash column 
chromatography (9:1, hexanes/ethyl acetate, 20 mm diameter, 16 cm SiO2) to afford 21 mg of 
155m as a white solid. The product was analyzed by chiral stationary phase HPLC.   
Data for 155m: 
 
1
H NMR:  (500 MHz, CDCl3) 
  δ 7.55 (t, J = 7.8 Hz, 1H, HC(15)), 7.41(d, J =7.8 Hz, 2H, HC(14)), 7.14 (t, J = 
7.7 Hz, 1H, HC(7), 6.97 (d, J = 7.6 Hz, 1H, HC(6)), 6.91–6.79 (m, 2H, HC(5), 
HC(8)), 4.26 (q, J = 7.0 Hz, 2H, HC(16)), 3.54 (ddd, J = 13.0, 5.3, 2.0 Hz, 1H, 
HC(3)), 3.36 (dd, J = 16.2, 12.7 Hz, 1H, HC(4)), 2.73 (dd, J = 16.2, 5.2 Hz, 1H, 
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HC(4)), 1.84 (s, 3H, HC(11)), 1.56 (s, 3H, HC(11)), 1.36 (d, J = 6.9, 6H, HC(17)), 
1.29 (d, J = 6.7 Hz, 6H, HC(17)). 
 
13
C NMR: (126 MHz, CDCl3) 
  δ 151.6, 133.5, 129.2, 128.3, 126.6, 121.0, 118.9, 117.6, 76.5, 66.6, 30.0, 29.3, 
25.2, 21.8. 
CSP-HPLC: (R)-155m tmin 55.9 min (4.6%), (S)-155m tmaj 60.0 (95.4%) (Reverse-phase 
Chiralpak AD-RH, 220 nm, 45:55, MeCN/H2O, 0.15 mL/min) 
 
Preparation of (2S,3R)-2-Phenyl-3-(phenylthio)-2,3,4,5-tetrahydrobenzo[b]oxepine (143n) 
(Table 19 Entry 5) [DJK-DY-7309] 
 
 Following General Procedure 11, 142n (224mg, 1.0 mmol) was weighed into a dried 10-
mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 56 (255 mg, 1.0 mmol, 1.0 equiv) 
and catalyst (S)-62e (52 mg, 0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-
PrOH bath and cooled to -20 
oC (probe). After equilibration (ca. 20 min), MsOH (33 μL, 0.5 
mmol, 0.5 equiv) was added directly via syringe. The solution was allowed to stir for 18 h at 
constant temperature during which time phthalimide precipitated. Upon consumption of the 
starting material (TLC, 
1H NMR), the reaction was quenched with triethylamine (300 μL) and 
then was allowed to warm to rt, whereupon the white solid dissolved. The solution was 
transferred to a 60-mL separatory funnel, then was diluted with CH2Cl2 (10 mL) and 1 M NaOH 
(15 mL). The phases were separated and the aq. layer was extracted with 15 mL of CH2Cl2. The 
organic phases were combined, dried over MgSO4, filtered and concentrated by rotary 
evaporation (30 
o
C, 3 mm Hg). The residue was taken up in 10 mL of CH2Cl2 and then adsorbed 
onto Celite. Purification by silica gel flash column chromatography of this material (5:1, 
hexanes/CH2Cl2, 20 mm diameter, 16 cm SiO2) followed by bulb-to-bulb distillation afforded 
304 mg (92%) of 143n as a clear oil.  
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Data for 143n: 
 bp:  150 
o
C (ABT), 0.05 mm Hg 
 
1
H NMR:  (500 MHz, CDCl3) 
  δ 7.49 (m, 2H, HC(aryl)), 7.43–7.34 (m, 3H, HC(aryl)), 7.25–7.12 (m, 7H), 7.05 
(t, J = 7.4, 1H, HC(7)), 6.97 (d, J = 7.9, 1H, HC(9)), 4.61 (dd, J = 10.6, 1H, 
HC(2)), 3.85 (ddd, J = 10.6, 8.6, 4.2, 1H, HC(3)), 3.05 (dt, J = 6.9, 2.8 Hz, 2H, 
HC(5)), 2.63 (ddd, J = 12.1, 10.4, 4.2 Hz, 1H, HC(4)), 1.91 (dt, J = 14.5, 8.7 Hz, 
1H, HC(4)). 
 
13
C NMR:  (126 MHz, CDCl3) 
  δ 159.25 (C10), 140.66 (C16), 134.32 (C12), 134.25 (C11), 132.92 (C18), 130.22 
(C15), 128.96 (C14), 128.49 (C13), 128.44 (C8), 127.68 (C17), 127.64 (C6), 
127.36 (C19), 123.99 (C7), 121.62 (C9), 88.36 (C2), 55.46 (C3), 33.38 (C4), 
30.88 (C5)   
 IR:  (ATR, cm
-1
) 
  3060 (w), 3031 (w), 2930 (w), 1603 (w), 1581 (w), 1487 (s), 1453 (m), 1438 (m), 
1350 (w), 1303 (w), 1260 (w), 1232 (s), 1187 (m), 1155 (w), 1106 (w), 1090 (w), 
1042 (m), 1024 (w), 978 (m), 939 (w), 914 (m), 887 (w), 754 (s), 738 (s). 
 MS:  (EI, 70 eV, m/z) 
  340 (25, M
+
), 199 (56), 133 (100), 115 (26), 107 (24)  
 TLC: Rf 0.50 (1:1, hexanes/CH2Cl2) [UV, CAM] 
 Opt. Rot.: [α]D
23
 = +39.6 (0.96 in CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
 CSP-SFC: (2R,3S)-143n tmin 7.6 (5.6%), (2S,3R)-143n tmaj 8.1 min (94.4%) (Chiralpak AD, 
220 nm, 97:3, hexanes/i-PrOH, 0.8 mL/min) 
 Analysis: C22H20OS (332.46) 
 Calcd: C, 79.48; H, 6.06%  
 Found: C, 79.53; H, 6.09% 
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Preparation of (R)-2-((S)-((2,6-Diisopropylphenyl)thio)(phenyl)methyl)-2,3,4,5-
tetrahydrobenzo[b]oxepine (144o) (Table 19 Entry 6) [DJK-17-24] 
 
 Following General Procedure 11, 142o (238 mg, 1.0 mmol) was weighed into a dried 10-
mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 103 (339 mg, 1.0 mmol, 1.0 equiv) 
and catalyst (S)-62e (52 mg, 0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-
PrOH bath and cooled to 0 
oC (probe). After equilibration (ca. 20 min), MsOH (33 μL, 0.5 
mmol, 0.5 equiv) was added directly via syringe. The solution was allowed to stir for 24 h at 
constant temperature during which time phthalimide precipitated. Upon consumption of the 
starting material (TLC, 
1H NMR), the reaction was quenched with triethylamine (300 μL) and 
then was allowed to warm to rt, whereupon the white solid dissolved. The material was 
transferred to a 250-mL RB flask using CH2Cl2 (20 mL) and concentrated by rotary evaporation 
(30 
o
C, 3 mm Hg). Purification by silica gel flash column chromatography (5:1 hexanes/CH2Cl2, 
20 mm diameter, 17 cm SiO2) followed by recrystallization (MeOH, 3 mL) afforded, in two 
crops, 327 mg (76%) of 144o as white needles.  
Data for 144o: 
 mp:  52-55 
o
C (MeOH) 
 
1
H NMR:  (500 MHz,CDCl3) 
  δ 7.31–7.29 (m, 1H, HC(20)), 7.28–7.24 (m, 5H, H-aryl), 7.14 (ddd, J = 7.0, 4.2 
Hz, 2H, H-aryl, HC(6), HC(8)), 7.11 (d, J = 7.7 Hz, 2H, HC(19)), 7.01 (t, J = 7.4 
Hz, 1H, HC(7)), 6.86 (d, J = 8.2Hz, 1H, HC(9)), 4.15 (ddd, J = 11.0, 6.2, 1.5 Hz, 
1H, HC(2)), 3.81–3.67 (m, 3H, HC(12), HC(21)), 2.89 (dd, J = 14.4, 12.1, 1H, 
HC(5)), 2.78–2.67 (m, 1H, HC(5)), 2.31–2.19 (m, 1H, HC(3)), 2.12–1.98 (m, 1H, 
HC(4)), 1.76 (dddd, J = 14.2, 12.0, 10.9, 3.6 Hz, 1H, HC(3)), 1.66–1.47 (m, 1H, 
HC(4)), 1.16 (d, J = 6.9 Hz, 6H, HC(22)), 0.97 (d, J = 6.8 Hz, 6H, HC(22)). 
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13
C NMR:  (126 MHz, CDCl3) 
  δ 159.62 (C17), 153.91 (C10), 140.17 (C18), 136.01 (C18), 131.07 (C13), 130.25 
(C8), 129.37 (C20), 129.27 (C15), 128.06 (C14), 127.53 (C6), 127.26 (C16), 
123.84 (C7), 123.77 (C19), 121.83 (C9), 85.71 (C2), 62.24 (C12), 36.19 (C3), 
33.96 (C5), 31.70 (C21), 26.28 (C4), 24.77 (C22), 24.16 (C22). 
 IR:  (ATR, cm
-1
) 
  3057 (w), 3026 (w), 2960 (m), 2924 (m), 2865 (w), 1602 (w), 1580 (w), 1487 (s), 
1453 (m), 1382 (w), 1360 (m), 1305 (w), 1231 (s), 1209 (m), 1178 (w), 1107 (w), 
1075 (w), 1052 (m), 953 (m), 924 (w), 861 (w), 801 (m), 755 (s), 743 (s), 733 (s), 
720 (m). 
 MS:  (EI, 70 eV, m/z) 
  430 (39, M
+
), 283 (72), 237 (61), 147 (41), 107 (62), 91 (100) 
 TLC: Rf 0.8 (1:1, hexanes/CH2Cl2) [UV, CAM] 
 Opt. Rot.:  [α]D
23
 = -144.2 (c = 0.74 in CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
 Analysis: C29H34OS (430.65) 
 Calcd: C, 80.88; H, 7.96%  
 Found: C, 80.79; H, 7.91% 
 
Preparation of (R)-2-((S)-((2,6-Diisopropylphenyl)sulfonyl)(phenyl)methyl)-2,3,4,5-
tetrahydrobenzo[b]oxepine (155o) [DJK-17-50] 
 
 To determine enantiomeric composition, 5o was oxidized to the sulfone 155o. To a 4-
dram vial was added solid 144o (20 mg, 0.05 mmol 1 equiv), followed by CH2Cl2 (1 mL) and 
mCPBA (22 mg, 0.13 mmol, 2.7 equiv) The solution was stirred at rt for 3 h. The solution was 
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diluted with hexanes (3 mL) and then directly purified by silica gel flash column 
chromatography (9:1, hexanes/ethyl acetate, 20 mm diameter, 16 cm SiO2) to afford 21 mg 
(99%) of 155o as a white solid which was analyzed by chiral stationary phase HPLC.   
Data for 155o: 
 1
H NMR: (400 MHz, CDCl3) 
  δ 7.40 (t, J = 7.9 Hz, 2H, HC(aryl)), 7.34–7.04 (m, 10H, HC(aryl)), 7.04–6.90 (m, 
1H, HC(aryl)), 4.86 (ddd, J = 11.0, 4.3, 1.5 Hz, 1H, HC(2)), 4.19 (d, J = 4.3 Hz, 
1H, HC(12)), 2.91–2.78 (m, 1H, HC(5)), 2.68 (dd, J = 14.3, 5.9 Hz, 1H, HC(5)), 
1.99 (tdd, J = 10.6, 7.9, 4.3 Hz, 2H, HC(4)), 1.82–1.46 (m, 2H, HC(3)), 1.43–1.00 
(m, 12H, HC(22)). 
 
13
C NMR: (126 MHz, CDCl3) 
  δ 159.3, 135.8, 134.1, 133.0, 132.3, 130.7, 130.3, 130.1, 129.2, 128.5, 127.9, 
126.0, 124.2, 122.5, 80.5, 79.7, 76.6, 36.6, 33.8, 30.0, 26.3. 
CSP-HPLC : (2S,12R)-155o  tmin 6.7 min (7.4 %), (2R,12S)-155o tmaj 7.2 min (92.6%) (BG, 220 
nm, 95:5, hexanes/i-PrOH, 0.8 mL/min) 
 
Preparation of (R)-2-(((2,6-Diisopropylphenyl)thio)methyl)chromane (144p) (Table 19 
Entry 7) [DJK-14-51] 
 
 Following General Procedure 11, 142p (148 mg, 1.0 mmol) was weighed into a dried 10-
mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 103 (339 mg, 1.0 mmol, 1.0 equiv) 
and catalyst (S)-62e (52 mg, 0.1 mmol, 0.1 equiv) was added. The flask was placed in an i-PrOH 
bath and cooled to 0 
oC (probe). After equilibration (ca. 20 min), MsOH (33 μL, 0.5 mmol, 0.5 
equiv) was added directly via syringe. The solution was allowed to stir for 12 h at constant 
temperature during which time phthalimide precipitated. Upon consumption of the starting 
material (TLC, 
1H NMR), the reaction was quenched with triethylamine (300 μL) and then was 
allowed to warm to rt, whereupon the white solid dissolved. The solution was transferred to a 60-
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mL separatory funnel, diluted with CH2Cl2 (10 mL) and 1 M NaOH (15 mL). The phases were 
separated and the aq. layer was extracted with CH2Cl2 (15 mL). The organic phases were 
combined, dried over MgSO4, filtered and concentrated by rotary evaporation (30 
o
C, 3 mm Hg). 
The residue was dissolved in 10 mL of CH2Cl2 and adsorbed onto Celite. Purification by silica 
gel flash column chromatography (5:1, hexanes/CH2Cl2, 20 mm diameter, 16 cm SiO2) followed 
by bulb-to-bulb distillation afforded 308 mg (91%) of 144p as a clear oil.  
Data for 144p: 
 bp:  160 
o
C (ABT), 0.05 mm Hg  
 
1
H NMR:  (500 MHz, CDCl3) 
  δ 7.37 (t, J = 7.7 Hz, 1H, HC(15)), 7.23 (d, J = 7.7 Hz, 2H, HC(14)), 7.17–7.11 (t, 
J = 7.6 Hz, 1H, HC(7)), 7.09 (d, J = 7.7, 1H, HC(5)), 6.89 (t, J = 7.4, 1H, HC(6)), 
6.85 (d, J = 8.3, 1H, HC(8)), 4.16–3.99 (m, 3H, HC(2), HC(16)), 3.06 (dd, J = 
12.9, 6.2 Hz, 1H, HC(11)), 2.92 (dd, J = 12.9, 6.6 Hz, 1H, HC(11)), 2.90–2.80 (m, 
2H, HC(4)), 2.24 (ddd, J = 13.4, 6.0, 3.7 Hz, 1H, HC(3)), 1.88 (dddd, J = 13.4, 
10.7, 9.7, 5.7 Hz, 1H, HC(3)), 1.30 (dd, J = 6.9, 3.9 Hz, 12H, HC(17)). 
 
13
C NMR:  (101 MHz, CDCl3)  
  δ 154.8 (C12), 153.6 (C9), 131.6 (C4), 129.7 (C7), 129.5 (C14), 127.5 (C5), 124.0 
(C10), 122.0 (C13), 120.5 (C6), 117.1 (C8), 74.8 (C2), 42.6 (C11), 31.8 (C3), 27.1 
(C4), 24.8 (C17), 24.7 C(17).   
 IR:  (ATR, cm
-1
) 
  3054 (w), 2960 (m), 2924 (m), 2866 (w), 1610 (w), 1582 (m), 1487 (s), 1456 (s), 
1420 (w), 1382 (w), 1361 (w), 1339 (w), 1301 (m), 1274 (w), 1232 (s), 1113 (m), 
1075 (w), 1050 (s), 1029 (w), 996 (m), 930 (w), 886 (w), 842 (w), 800 (m), 
750(s), 710 (w). 
 MS:  (EI, 70 eV, m/z) 
  340 (88, M
+
), 194 (29), 161 (49), 147 (47), 133 (100)  
 TLC: Rf 0.61 (1:1, hexanes/CH2Cl2) [UV, CAM] 
 Opt. Rot.: [α]D
23
 = +69.7 (c = 1.01 in CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
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 Analysis: C22H28OS (340.53) 
 Calcd: C, 77.60; H, 8.29%  
 Found: C, 77.54; H, 7.93% 
 
Preparation of of (R)-2-(((2,6-Diisopropylphenyl)sulfonyl)methyl)chromane (155p) [DJK-
14-94] 
 
 To determine enantiomeric composition, 144p was oxidized to the sulfone. To a 4-dram 
vial was added solid 144p (20 mg, 0.06 mmol 1 equiv), followed by CH2Cl2 (1 mL) and mCPBA 
(26 mg, 0.15 mmol, 2.5 equiv) The solution was stirred at rt for 3 h. The material was then 
diluted with hexanes (3 mL) and directly purified by silica gel flash column chromatography (9:1 
hexanes/ethyl acetate, 20 mm diameter, 16 cm SiO2) to afford 22 mg (99%) of 155p as a white 
solid. The product was analyzed by chiral stationary phase HPLC.  
Data for 155p: 
 1
H NMR: (500 MHz, CDCl3) 
  δ 7.53 (t, J = 7.8 Hz, 1H, HC(15)), 7.37 (d, J = 7.8 Hz, 2H, HC(14)), 7.01 (d, J = 
7.5, 1H, HC(5)), 6.95 (t, J = 7.8 Hz, 1H, HC(7)), 6.81 (t, J = 7.4, 1H, HC(7)), 6.20 
(d, J = 8.2, 1H, HC(8)), 4.77 (dddd, J = 8.8, 7.3, 4.4, 2.7 Hz, 1H, HC(2)), 4.21 (p, 
J = 6.7 Hz, 2H, HC(16)), 3.74 (dd, J = 14.3, 7.4 Hz, 1H, HC(11)), 3.37 (dd, J = 
14.4, 4.4 Hz, 1H, HC(11)), 2.88 (ddd, J = 16.0, 9.5, 6.1 Hz, 1H, HC(4)), 2.77 (dt, 
J = 16.7, 5.4 Hz, 1H, HC(4)), 2.25 (dddd, J = 13.8, 6.2, 5.1, 2.7 Hz, 1H, HC(3)), 
1.90 (dddd, J = 13.5, 9.5, 8.8, 5.7 Hz, 1H, HC(3)), 1.28 (d, J = 6.7 Hz, 6H, 
HC(17)), 1.23 (d, J = 6.8 Hz, 6H, HC(17)). 
 13
C NMR: (126 MHz, CDCl3)  
  δ 153.3, 151.3, 136.2, 133.1, 129.6, 127.6, 126.2, 121.2, 121.0, 117.0, 70.3, 62.4, 
29.9, 27.4, 25.2, 25.0, 23.7. 
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CSP-HPLC:  (R)-155p tmin 8.4 (97.2%), (S)-155p tmaj 9.0  min (2.8%) (Chiralpak AD, 220 nm, 
95:5, hexanes/i-PrOH, 0.8 mL/min) 
 
Preparation of (R)-2-(((2,6-Diisopropylphenyl)thio)methyl)-2,3,4,5-tetrahydrobenzo-
[b]oxepine (144q) (Table 19 Entry 8) [DJK-14-54] 
 
 Following General Procedure 11, 142q (162 mg, 1.0 mmol) was weighed into a dried 10 
mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 56 (255 mg, 1.0 mmol, 1.0 equiv) 
and catalyst (S)-62e (52 mg, 0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-
PrOH bath and cooled to 0 
oC (probe). After equilibration (ca. 20 min), MsOH (33 μL, 0.5 
mmol, 0.5 equiv) was added directly via syringe. The solution was allowed to stir for 48 h at 
constant temperature during which time phthalimide precipitated. Upon consumption of the 
starting material (TLC, 
1H NMR), the reaction was quenched with triethylamine (300 μL) and 
then was allowed to warm to rt, whereupon the white solid dissolved. The solution was 
transferred to a 60-mL separatory funnel, diluted with CH2Cl2 (10 mL) and 1 M NaOH (15 mL). 
The phases were separated and the aq. layer was extracted with 15 mL of CH2Cl2. The organic 
phases were combined, dried over MgSO4, filtered and concentrated by rotary evaporation (30 
o
C, 3 mm Hg). Purification by silica gel flash column chromatography (5:1, hexanes/CH2Cl2, 20 
mm diameter, 20 cm SiO2) followed by bulb-to-bulb distillation afforded 296 mg (84%) of 144q 
as a clear viscous oil (84%).  
Data for 144q: 
 bp: 180 
o
C (ABT), 0.05 mm Hg 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.34 (t, J = 7.7 Hz, 1H, HC(16)),  7.21–7.17 (m, 3H, HC(8), HC(15)), 7.17–7.12 
(m, 2H, HC(6), HC(9)), 7.03 (ddt, J = 8.9, 7.2 Hz, 1H, HC(7)), 4.02 (p, J = 6.8 
Hz, 2H, HC(17)), 3.79 (ddd, J = 10.2, 8.0, 4.0 Hz, 1H, HC(2)), 3.15 (dd, J = 12.0 
Hz, 8.0 Hz, 1H, HC(12)), 2.93 (dd, J = 14.4, 12.0 Hz, 1H, HC(5)), 2.74 (ddd, J = 
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14.9, 12.6, 5.3 Hz, 2H, HC(12), HC(5)), 2.12–1.97 (m, 2H, HC(4), HC(3)), 1.91–
1.79 (m, 1H, HC(3)), 1.60–1.48 (m, 1H, HC(4)) 1.28 (d, J = 6.8 Hz, 6H, HC(18)), 
1.23 (d, J = 6.8 Hz, 6H, HC(18)). 
 
13
C NMR:  (126 MHz, CDCl3) 
  δ 159.1 (C13), 153.5 (C10), 135.8 (C14), 132.3 (C14), 130.3 (C6), 129.3 (C16), 
127.6 (C8) , 123.9 (C15), 123.8 (C7), 121.9 (C9), 110.0 (C11), 82.6 (C2) , 44.7 
(C12), 37.0 (C3), 33.9 (C5), 31.8 (C17), 25.9 (C4), 24.7 (C18), 24.6 (C18). 
 IR: (ATR, cm
-1
)  
  3055 (w), 2960 (m), 2924 (m), 2865 (w), 1602 (w), 1579 (w), 1487 (s), 1454 (m), 
1382 (w), 1360 (m), 1306 (w), 1231(s), 1194 (w), 1178 (w), 1105 (w), 1065 (m), 
1052 (m), 1035 (m), 1019 (m), 955 (s), 926 (m), 864 (w), 830 (w), 799 (s), 762 
(s), 736 (s), 718 (w).  
 MS:  (EI, 70 eV, m/z) 
  354 (82, M
+
), 194 (100), 160 (81), 153 (51), 151 (51),  107 (98) 
 TLC: Rf 0.56 (1:1 hexanes:CH2Cl2) [UV, CAM] 
 Opt. Rot.: [α]D
23
 = +36.9 (c = 1.1 in CHCl3) 
 CD: (+), Cotton sign, 230-280 nm 
 Analysis: C23H30OS (354.55) 
 Calcd: C, 77.92; H, 8.53%  
 Found: C, 77.75; H, 8.25% 
 
Preparation of (R)-2-(((2,6-Diisopropylphenyl)sulfonyl)methyl)-2,3,4,5-tetrahydrobenzo-
[b]oxepine (155q) [DJK-14-95] 
 
 To determine enantiomeric composition, 144q was oxidized to the sulfone. To a 4-dram 
vial was added neat 144q (20 mg, 0.06 mmol 1 equiv), followed by CH2Cl2 (1 mL) and mCPBA 
(26 mg, 0.15 mmol, 2.5 equiv) The solution was stirred at rt for 3 h. The material was diluted 
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with hexanes (3 mL) and then directly purified by silica gel flash column chromatography (9:1, 
hexanes/ethyl acetate, 20 mm diameter, 16 cm SiO2) to afford 20 mg of a white solid which was 
analyzed by chiral stationary phase HPLC.   
Data for 155q: 
 1
H NMR: (500 MHz, CDCl3) 
  δ 7.54 (t, J = 7.8 Hz, 1H, HC(16)), 7.39 (d, J = 7.7 Hz, 2H, HC(15)), 7.08 (d, J = 
7.3 Hz, 1H, HC(6)), 7.02 (t, J = 7.6, 1H, HC(8)), 6.96 (t, J = 7.3, 1H, HC(7)), 6.51 
(d, J = 7.8 Hz, 1H, HC(9)), 4.32 (dt, J = 9.0, 3.6, 1H, HC(2)), 4.22 (p, J = 6.7 Hz, 
2H, HC(17)), 3.85 (dd, J = 14.4, 7.1 Hz, 1H, HC(12)), 3.32 (dd, J = 14.3, 3.5 Hz, 
1H, HC(12)), 2.94–2.80 (m, 1H, HC(5)), 2.80–2.68 (m, 1H, HC(5)), 2.15–1.90 
(m, 3H, HC(3), HC(4)), 1.72–1.46 (m, 1H, HC(3), HC(4)), 1.30 (d, J = 6.7 Hz, 
6H, HC(18), 1.24 (d, J = 6.7 Hz, 6H, HC(18)). 
 13
C NMR: (126 MHz, CDCl3) 
  δ 158.4, 151.4, 136.0, 135.4, 133.2, 130.2, 127.6, 126.4, 126.4, 124.2, 121.9, 76.8, 
64.6, 38.2, 33.6, 29.9, 25.9, 25.3, 24.9. 
CSP-HPLC: (S)-155q tmaj 10.5 min (2.3%), (R)-155q tmin 11.1 min (97.7%) (Chiralpak AD, 
220 nm, 95:5, hexanes/i-PrOH, 0.8 mL/min) 
 
Preparation of Ethyl (S)-1-((R)-chroman-2-yl)-1-(phenylthio)butanoate (144r) (Table 19 
Entry 9) [DJK-DY-7308] 
 
 Following General Procedure 11, 142r (248 mg, 1.0 mmol) was weighed into a dried 10-
mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 56 (255 mg, 1.0 mmol, 1.0 equiv) 
and catalyst (S)-62e (52 mg, 0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-
PrOH bath and cooled to -20 
o
C (probe). After equilibration (ca. 20 min), MsOH (33 μL, 0.5 
mmol, 0.5 equiv) was added directly via syringe. The solution was allowed to stir for 24 h at 
constant temperature during which time phthalimide precipitated. Upon consumption of the 
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starting material (TLC, 
1H NMR), the reaction was quenched with triethylamine (300 μL) and 
then was  allowed to warm to rt, whereupon the white solid dissolved. The solution was 
transferred to a 60-mL separatory funnel, then was diluted with CH2Cl2 (10 mL) and 1 M NaOH 
(15 mL). The phases were separated and the aq. layer was extracted with CH2Cl2 (15 mL). The 
organic phases were combined, dried over MgSO4, filtered and concentrated by rotary 
evaporation (30 
o
C, 3 mm Hg). The material was dissolved in ethyl acetate (10 mL) and adsorbed 
onto Celite. Purification by silica gel flash column chromatography (20:1, hexanes/ethyl acetate, 
20 mm diameter, 16 cm SiO2) followed by bulb-to-bulb distillation afforded 286 mg (80%) of 
144r as a clear viscous oil.  
Data for 144r: 
 bp: 180 
o
C (ABT), 0.05 mm Hg 
 
1
H NMR: (500 MHz, CDCl3) 
  δ 7.52 (d, J = 7.3 Hz, 2H, HC(19)), 7.37–7.31 (m, 2H, HC(16)), 7.30–7.28 (m, 
1H, HC(20)), 7.11 (dd, J = 8.2, 7.4, 1H, HC(7)), 7.07 (d, J = 7.5 Hz, 1H, HC(5)), 
6.87 (t, J = 7.3 Hz, 1H, HC(6)), 6.81 (d, J = 8.2 Hz, 1H, HC(8)), 4.22–4.07 (m, 
3H, HC(2), HC(15)), 3.38–3.28 (m, 1H, HC(11)), 2.91–2.73 (m, 3H, HC(13), 
HC(4)), 2.71–2.63 (m, 1H, HC(13)), 2.42–2.32 (m, 2H, HC(3), HC(12)), 2.06–
1.90 (m, 2H, HC(12), HC(3)), 1.28 (t, J = 7.2 Hz, 3H, HC(16)). 
 
13
C NMR:  (101 MHz, CDCl3) 
  δ 173.7 (C14), 154.8 (C9), 135.4 (C17), 132.7 (C19), 129.7 (C5), 129.3 (C18), 
127.5 (C7,C20), 122.2 (C10), 120.6 (C6), 117.1 (C8), 78.4 (C2), 60.7 (C15), 53.5 
(C11), 32.0 (C13), 26.4 (C3), 25.1 (C4), 24.9 (C12), 14.5 (C16).   
 IR:  (ATR, cm
-1
) 
  2930 (w), 1729 (s), 1609 (w), 1582 (m), 1487 (s), 1457 (m), 1438 (m), 1373 (m), 
1302 (m), 1273 (m), 1231 (s), 1183 (s), 1150 (m), 1103 (m), 1067 (m), 1024 (m), 
995 (m), 935 (w), 883 (w), 852 (w), 832 (w), 749 (s). 
 MS:  (EI, 70 eV, m/z) 
  356 (36, M
+
), 311 (22), 247 (100), 201 (58), 177 (43), 159 (65), 149 (81), 133 
(100), 107 (62) . 
 TLC: Rf 0.22 (1:1, hexanes/CH2Cl2) [UV, CAM] 
 Opt. Rot.: [α]D
23
 = +92.0 (c = 0.70 in CHCl3) 
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 CD: (+), Cotton sign, 230-280 nm 
CSP-HPLC: (2S,11R)-144r tmin 16.5 min (6.8%),(2R,11S)-144r tmaj 24.7 min (93.2%) 
(Chiralcel OJ, 220 nm, 95:5 hexanes/i-PrOH, 0.8 mL/min) 
 Analysis: C21H24O3S (356.48) 
 Calcd: C, 70.76; H, 6.79%  
 Found: C, 70.82; H, 6.67% 
 
Preparation of (R)-2-((S)-4-Methoxy-1-(phenylthio)butyl)chromane (144s) (Table 19 Entry 
10) [DJK-EK-9062] 
 
 Following General Procedure 11, 142s (220 mg, 1.0 mmol) was weighed into a dried 10-
mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 56 (255 mg, 1.0 mmol, 1.0 equiv) 
and catalyst (S)-62e (52 mg, 0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-
PrOH bath and cooled to -20 
o
C (probe). After equilibration (ca. 20 min), MsOH (33 μL, 0.5 
mmol, 0.5 equiv) was added directly via syringe. The solution was allowed to stir for 24 h at 
constant temperature during which time phthalimide precipitated. Upon consumption of the 
starting material (TLC, 
1
H NMR), the reaction was quenched with triethylamine (300 μL) and 
then was allowed to warm to rt, whereupon the white solid dissolved. The material was 
transferred to a 250-mL RB-flask using 20 mL of CH2Cl2 and concentrated by rotary evaporation 
(30 
o
C, 3 mm Hg). The material was dissolved in 10 mL of CH2Cl2 and adsorbed onto Celite. 
Purification by silica gel flash column chromatography (5:1, hexanes/CH2Cl2, 20 mm diameter, 
18 cm SiO2) followed by bulb-to-bulb distillation afforded 287 mg (88%) of 144s as a clear 
viscous oil. 
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Data for 144s: 
 bp:  150 
o
C (ABT), 0.05 mm Hg 
 
1
H NMR:
  
(500 MHz, CDCl3) 
  δ 7.56–7.48 (m, 2H, HC(18)), 7.32 (t, J = 6.8, 2H, HC(17)), 7.29–7.25 (m, 1H, 
HC(19)), 7.11 (t J = 7.3 Hz, 1H, HC(7)), 7.06 (d, J = 7.3 Hz, 1H, HC(5)), 6.86 (t, 
J = 7.4 Hz, 1H, HC(6)), 6.79 (d, J = 8.1 Hz, 1H, HC(8)), 4.12 (ddd, J = 9.9, 6.5, 
2.2 Hz, 1H, HC(2)), 3.52–3.41 (m, 2H, HC(14)), 3.37 (s, 3H, HC(15)), 3.33 (ddd, 
J = 8.9, 6.5, 3.3 Hz, 1H, HC(11)), 2.90–2.81 (m, 1H, HC(4)), 2.80–2.72 (m, 1H, 
HC(4)), 2.26 (dddd, J = 13.4, 5.8, 3.5, 2.3 Hz, 1H, HC(3)), 2.13–1.92 (m, 3H, 
HC(3), HC(12), HC(13)), 1.88–1.76 (m, 1H, HC(13)), 1.76–1.67 (m, 1H, 
HC(12)). 
 
13
C NMR:  (101 MHz, CDCl3) 
  δ 154.9 (C9), 136.1 (C16), 132.4 (C18), 129.7 (C5), 129.2 (C17), 127.5 (C7), 
127.2 (C19), 122.3 (C10), 120.4 (C6), 117.0 (C8), 78.5 (C2), 72.9 (C14), 58.9 
(C15), 54.1 (C11), 28.0 (C3), 27.5 (C12), 25.0 (C4), 24.9 (C11).   
 IR: (ATR, cm
-1
)  
  2924 (w), 2855 (w), 1736 (w), 1609 (w), 1582 (m), 1487 (s), 1456 (m), 1438 (m), 
1374 (w) 1302 (m), 1273 (w), 1232 (s), 1194(m), 1114 (s), 1051 (m), 1024 (m), 
995 (m), 886 (m), 850 (w), 830 (w), 748 (s). 
 MS:  (EI, 70 eV, m/z) 
  328 (58, M
+
), 219 (69), 195 (52), 187 (36), 163 (84), 133 (97), 107 (100), 85 (50), 
69 (66). 
 TLC: Rf 0.15 (1:1, hexanes/CH2Cl2) [UV, CAM] 
 Opt. Rot.: [α]D
23
 = +81.4 (c = 0.68 in CHCl3) 
 CD: (+), Cotton sign, 230-280 nm 
CSP-HPLC: (2S,11R)-144s tmin 10.4 (3.3%), (2R,11S)-144s tmaj 13.4 min (96.7%) (Chiralcel 
OJ, 220 nm, 95:5, hexanes/i-PrOH, 0.8 mL/min) 
 Analysis: C20H24O2S (328.47) 
 Calcd: C, 73.13; H, 7.37%  
 Found: C, 73.41; H, 7.28% 
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Preparation of (S)-5-((R)-3-(2-Hydroxyphenyl)-1-(phenylthio)propyl)-dihydrofuran-2(3H)-
one (147t) (Table 19 Entry 11) [DJK-15-44] 
 
 Following General Procedure 11, 145t (220 mg, 1.0 mmol) was weighed into a dried 10-
mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 56 (255 mg, 1.0 mmol, 1.0 equiv) 
and catalyst (S)-62e (52 mg, 0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-
PrOH bath and cooled to -20 
o
C (probe). After equilibration (ca. 20 min), MsOH (33 μL, 0.5 
mmol, 0.5 equiv) was added directly via syringe. The solution was allowed to stir for 24 h at 
constant temperature during which time phthalimide precipitated. Upon consumption of the 
starting material (TLC, 
1H NMR), the reaction was quenched with triethylamine (300 μL) and 
then was allowed to warm to rt, whereupon the white solid dissolved. The solution was 
transferred to a 60-mL separatory funnel, then was diluted with CH2Cl2 (10 mL) and 1 M NaOH 
(15 mL). The phases were separated and the aq. layer was extracted with 15 mL of CH2Cl2. The 
organic phases were combined, dried over MgSO4, filtered and concentrated by rotary 
evaporation (30 
o
C, 3 mm Hg). Purification by silica gel flash column chromatography (6:1, 
hexanes/ethyl acetate, then 3:1, hexanes/ethyl acetate then 2:1, hexanes/ethyl acetate, 30 mm 
diameter, 16 cm SiO2) followed by bulb-to-bulb distillation afforded  300 mg (92%) of 147t as a 
clear viscous oil. 
Data for 147t: 
 bp:  120 
o
C (ABT), 2.4x 10
-5 
mm Hg 
 
1
H NMR:  (500 MHz, CDCl3) 
  δ 7.53–7.48 (m, 2H, HC(17)), 7.37–7.31 (m, 3H, HC(16), HC(18)), 7.17–7.11 (m, 
2H, HC(12), HC(14)), 6.90 (t, J = 7.5 Hz, 1H, HC(13)), 6.82 (d, J = 8.2, 1H, 
HC(11)), 5.09 (s, 1H, OH)), 4.59 (q, J = 7.3 Hz, 1H, HC(5)), 3.26–3.15 (m, 1H, 
HC(6)), 3.08 (ddd, J = 13.9, 9.2, 4.9 Hz, 1H, HC(8)), 2.88 (ddd, J = 14.1, 9.1, 7.1 
Hz, 1H, HC(8)), 2.68–2.49 (m, 2H, HC(3)), 2.41 (dddd, J = 13.1, 9.6, 7.1, 4.9 Hz, 
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1H, HC(4)), 2.28–2.18 (m, 1H, HC(7)), 2.14–2.01 (m, 1H, HC(4)), 1.87 (dtd, J = 
14.2, 9.5, 4.9 Hz, 1H, HC(7)). 
 
13
C NMR:  (126 MHz, CDCl3) 
  δ 176.9 (C2), 153.9 (C10), 133.9 (C15), 133.0 (C17), 130.7 (C12), 129.4 (C16), 
128.1 (C18), 127.9 (C14), 127.1 (C9), 121.2 (C13), 115.8 (C11), 82.6 (C5), 54.2 
(C6), 31.8 (C8), 29.0 (C3), 27.4 (C4), 26.1 (C7). 
 IR:  (ATR, cm
-1
) 
  3360 (br), 2924 (w), 1749 (s), 1582 (w), 1504 (w), 1488 (w), 1455 (s), 1438 (w), 
1345 (w), 1303 (w), 1230 (s), 1180 (s), 1100 (w), 1068 (w), 1023 (w), 913 (w), 
846 (w), 748 (s). 
 MS:  (EI, 70eV, m/z) 
  328 (9), 249 (21),  247 (83), 201 (38),  177 (27),  159 (44), 149 (60),  133 (100), 
107 (68) 
 TLC: Rf 0.05 (4:1, hexanes/ethyl acetate) [UV, CAM] 
 Opt. Rot.: [α]D
23
 = +35.4 (c = 0.68 in CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
CSP-HPLC:    (5R,6S)-147t tmin 20.2 min (7.8%), (5S,6R)-147t tmin 23.5 min (92.2%) (Reverse 
Phase Chiralpak AD-RH, 220 nm, 48:52, H2O/MeCN, 0.3 mL/min) 
 Analysis: C19H20O3S (328.43) 
 Calcd: C, 69.49; H, 6.14%  
 Found: C, 69.56; H, 6.08% 
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Preparation of ((R)-3-(Phenylthio)-3-((S)-tetrahydrofuran-2-yl)propyl)phenol (147u) and 2-
((R)-3-(phenylthio)-3-((S)-tetrahydrofuran-2-yl)propyl)phenol (148u) (Table 19 Entry 12) 
[DJK-EK-9063] 
 
 Following General Procedure 11, 146u (206 mg, 1.0 mmol) was weighed into a dried 10-
mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 56 (255 mg, 1.0 mmol, 1.0 equiv) 
and catalyst (S)-62e (52 mg, 0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-
PrOH bath and cooled to -20 
oC (probe). After equilibration (ca. 20 min), MsOH (33 μL, 0.5 
mmol, 0.5 equiv) was added directly via syringe. The solution was allowed to stir for 24 h at 
constant temperature during which time phthalimide precipitated. Upon consumption of the 
starting material (TLC, 
1H NMR), the reaction was quenched with triethylamine (300 μL) and 
then was allowed to warm to rt, whereupon the white solid dissolved. The solution was 
transferred to a 60-mL separatory funnel, then was diluted with CH2Cl2 (10 mL) and 1 M NaOH 
(15 mL). The phases were separated and the aq. layer was extracted with 15 mL of CH2Cl2. The 
organic phases were combined, dried over MgSO4, filtered and concentrated by rotary 
evaporation (30 
o
C, 3 mm Hg). The crude ratio of 147u:148u (1.1:1) was established by 
1
H 
NMR spectroscopy. Purification by silica gel flash column chromatography (12:1, hexanes/ethyl 
acetate, 30 mm diameter, 16 cm SiO2) followed by bulb-to-bulb distillation afforded 276 mg 
(88%) of a 1:1 mixture of 147u:148u as a clear oil.  
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Data for 147u: 
 bp:  180 
o
C (ABT), 0.05 mm Hg 
 
1
H NMR:  (500 MHz, CDCl3) 
  δ 7.41–7.37 (m, 2H, HC(17)), 7.34–7.22 (m, 3H, HC(16), HC(18)), 7.16 (dd, J = 
7.9, 7.3 Hz, 1H, HC(12)), 7.07 (dd, J = 7.5 Hz, 1H, HC(14)), 6.89 (d, J = 8.1 Hz, 
1H, HC(11)), 6.85 (t, 7.8 Hz, 1H, HC(13)), 6.82 (br s, 1H, OH), 4.06 (ddd, J = 
8.7, 7.7, 6.4 Hz, 1H, HC(2)), 4.01 (dt, J = 8.0, 6.9 Hz, 1H, HC(5)), 3.90 (td, J = 
7.9, 6.2 Hz, 1H, HC(5)), 3.12 (dt, J = 8.9, 5.5 Hz, 1H, HC(6)), 2.93 (ddd, J = 13.9, 
9.0, 6.8 Hz, 1H, HC(8)), 2.79 (ddd, J = 14.4, 9.1, 6.1 Hz, 1H, HC(8)), 2.21 (dddd, 
J = 12.6, 7.9, 6.4, 5.0 Hz, 1H, HC(3)), 2.16–1.89 (m, 4H, HC(4), HC(8)), 1.77 
(ddt, J = 12.5, 8.4, 7.6 Hz, 1H, HC(7)).  
 
13
C NMR:  (126 MHz,CDCl3) 
  δ 154.8 (C10), 134.7 (C15), 132.0 (C17), 130.5 (C14), 129.2 (C16), 127.9 (C12), 
127.3 (C18), 127.1 (C9), 120.4 (C13), 116.3 (C11), 82.7 (C2), 68.8 (C5), 52.3 
(C6), 34.1 (C7), 31.4 (C3), 27.6 (C8), 25.9 (C4). 
 IR:  (ATR, cm
-1
) 
  3306 (br), 2927 (w), 2866 (w), 1737 (w), 1582 (m), 1488 (m), 1455 (s), 1438 (m), 
1359 (m), 1232 (s), 1177 (m), 1088 (m), 1041 (s), 921 (m), 843 (w), 746 (s). 
 MS:  (EI, 70 eV, m/z) 
  314 (47, M
+
), 133 (67), 107 (100), 71 (62) 
 TLC: Rf 0.25 (4:1, hexanes/ethyl acetate) [UV, CAM] 
 Opt. Rot.: [α]D
23
 = -17.3 (c = 0.52 in CHCl3)  
 CD: (-), Cotton sign, 230-280 nm 
Data for 148u: 
 
1
H NMR: (400 MHz, CDCl3) 
  δ 7.31 (m, 3H, HC(aryl)), 7.24 (m, 3H, HC(aryl)), 7.17–7.05 (m, 2H, HC(12), 
H(C14)), 6.86 (m, 2H, HC(11), HC(13)), 4.04 (dd, J = 11.4, 4.0, 1H, HC(2)), 3.41 
(td, J = 11.7, 2.7 Hz, 1H, HC(5)), 3.16 (td, J = 9.9, 2.8 Hz, 1H, HC(5)), 2.91–2.67 
(m, 2H, HC(3), HC(8)), 2.62 (ddd, J = 14.3, 6.1, 4.2 Hz, 1H, HC(8)), 2.45 (dddd, 
J = 13.9, 10.9, 6.1, 2.8 Hz, 1H, HC(3)), 2.17–2.01 (m, 1H, HC(4)), 2.01–1.57 (m, 
3H, HC(3), HC(4), HC(7)), 1.53–1.34 (m, 1H, HC(7)). 
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 13
C NMR:  (101 MHz,  CDCl3) 
  δ 155.0 (C10), 135.0 (C15), 133.7 (C17), 130.7 (C14), 129.2 (C16), 128.0 (C12), 
124.4 (C9), 120.7 (C13), 116.4 (C11), 79.7 (C2), 68.3 (C5), 49.3 (9), 34.6 (C8), 
31.7 (C4), 27.0 (C3), 25.2 (C7).  
  
 
CSP-HPLC: (2R,6S)-148u tmaj 19.2 min (97.1%), (2S,6R)-148u tmin 20.83 min (2.9%) 
(Chiralpak AD, 220 nm, 90:10, hexanes/i-PrOH, 0.6 mL/min) 
  (2R,3S)-147u, tmaj 14.6 min (96.9%), (2S,3R)-147u, tmin 18.1 min (3.1%) 
(Chiralpak AD 220 nm, 90:10 hexanes/i-PrOH, 0.6 mL/min) 
 Analysis: C19H22O2S (314.44) 
 Calcd: C, 72.58; H, 7.05%  
 Found: C, 72.64; H, 6.95% 
 
Preparation of ((4R,5S)-5-Phenoxyoctan-4-yl)(phenyl)sulfide (149) (Table 20 Entry 1) 
[DJK-16-40] 
 
 Following General Procedure 11, 4-octene (112 mg, 1.0 mmol) was weighed into a dried 
10-mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 56 (255 mg, 1.0 mmol, 1.0 
equiv) and catalyst (S)-62e (52 mg, 0.1 mmol, 0.1 equiv) were added. The flask was placed in an 
i-PrOH bath and cooled to -20 
oC (probe). After equilibration (ca. 20 min), MsOH (33 μL, 0.5 
mmol, 0.5 equiv) was added directly via syringe. The solution was allowed to stir for 24 h at 
constant temperature during which time phthalimide precipitated. Upon consumption of the 
starting material (TLC, 
1H NMR), the reaction was quenched with triethylamine (300 μL) and 
then was allowed to warm to rt, whereupon the white solid dissolved. The solution was 
transferred to a 60-mL separatory funnel, then was diluted with CH2Cl2 (10 mL) and 1 M NaOH 
(15 mL). The phases were separated and the aq. layer was extracted with 15 mL of CH2Cl2. The 
organic phases were combined, dried over MgSO4, filtered and concentrated by rotary 
evaporation (30 
o
C, 3 mm Hg). Purification by silica gel flash column chromatography (5:1 
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hexanes/dichloromethane, 30 mm diameter, 16 cm SiO2) followed by bulb-to-bulb distillation 
afforded  229 mg (73%) of 149 as a clear viscous oil. This compound was not further 
characterized 
Data for 149:  
 
1
H NMR:  (500 MHz, CDCl3) 
   δ 7.55 – 7.45 (m, 1H), 7.38 – 7.10 (m, 6H), 6.91 (t, J = 7.4 Hz, 1H), 6.84 – 6.77 
(m, 2H), 4.39 (dt, J = 8.1, 4.3 Hz, 1H), 3.34 (dt, J = 8.7, 4.2 Hz, 1H), 1.55 (s, 8H), 
0.90 (dt, J = 13.4, 7.2 Hz, 6H). 
CSP-HPLC:  (4R,5S)-149 tmaj 4.8 min (93.0%), (4S,5R)-149 tmin 5.2 min (7.0%) (Chiralpak OJ-
H, 220 nm, 97:3, hexanes/i-PrOH, 0.8 mL/min) 
 
Preparation of ((1S,2R)-1-Phenoxy-1-phenylpropan-2-yl)(phenyl)sulfide (150) (Table 20 
Entry 2) [DJK-16-41] 
 
 Following General Procedure 11, 4-octene (112 mg, 1.0 mmol) was weighed into a dried 
10-mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 56 (255 mg, 1.0 mmol, 1.0 
equiv) and catalyst (S)-62e (52 mg, 0.1 mmol, 0.1 equiv) were added. The flask was placed in an 
i-PrOH bath and cooled to -20 
oC (probe). After equilibration (ca. 20 min), MsOH (33 μL, 0.5 
mmol, 0.5 equiv) was added directly via syringe. The solution was allowed to stir for 24 h at 
constant temperature during which time phthalimide precipitated. Upon consumption of the 
starting material (TLC, 
1H NMR), the reaction was quenched with triethylamine (300 μL) and 
then was allowed to warm to rt, whereupon the white solid dissolved. The solution was 
transferred to a 60-mL separatory funnel, then was diluted with CH2Cl2 (10 mL) and 1 M NaOH 
(15 mL). The phases were separated and the aq. layer was extracted with 15 mL of CH2Cl2. The 
organic phases were combined, dried over MgSO4, filtered and concentrated by rotary 
evaporation (30 
o
C, 3 mm Hg). Purification by silica gel flash column chromatography (5:1 
hexanes/dichloromethane, 30 mm diameter, 16 cm SiO2) followed by bulb-to-bulb distillation 
afforded 140 mg (44%) of 150 as a clear viscous oil. 
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Data for 150:  
 
1
H NMR:  (500 MHz, CDCl3) 
   δ 7.41 – 7.15 (m, 13H), 6.80 – 6.74 (m, 2H), 4.04 – 3.94 (m, 1H), 3.91 (d, J = 
10.2 Hz, 1H), 1.26 (d, J = 6.5 Hz, 3H). 
CSP-HPLC: Reverse-Phase, (1R,2S)-150 tmin 16.0 min (82.1%), (1S,2R)-150 tmin 16.0 min 
(17.9%) (Chiralpak AD-RH, 220 nm, 65:35, H2O/MeCN, 0.6 mL/min) 
 
Manipulations of 143a  
Preparation of (R)-2-Phenylchromane (154a) [DJK-19-16] 
 
 To a 50-mL Schlenk flask under argon was added i-PrOH (20 mL), followed by solid 
143a (238 mg, 0.75 mmol). The solid was dissolved by heating, and the flask was then cooled in 
an ice bath (internal temperature <5 
o
C). Solid NiCl2•6H2O (600 mg, 2.5 mmol, 3.3 equiv) to 
form a green solution. In a seperate flask, NaBH4 (300 mg, 7.9 mmol, 10.5 equiv) was dissolved 
in EtOH (20 mL) with stirring. This flask was then also cooled in an ice bath (internal 
temperature 3 
o
C). The cold borohydride solution in ethanol was cannulated into the flask 
containing the substrate and the nickel chloride. The solution turned black, and gas evolution was 
observed. The flask was maintained in the ice bath for a further 4 h. The resulting black 
suspension was filtered through Celite while cold and the filter cake was washed with CH2Cl2 
(2x25 mL). The filtrate was then concentrated by rotary evaporation (30 
o
C, 3 mm Hg). 
Purification of the residue by silica gel flash column chromatography (9:1, hexanes/CH2Cl2, 20 
mm diameter, 15 cm SiO2) afforded  111 mg (71%) of 154 as a white solid. The spectroscopic 
data match those reported in the literature.
171
 Absolute configuration was established by 
correlation with the known optical rotation.
103
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Data for 154: 
 
1
H NMR: (500 MHz, CDCl3) 
  δ 7.47 (d, J = 7.5 Hz, 2H, HC((11)), 7.43 (t, J = 7.4 Hz, 2H, HC(10)), 7.36 (t, J = 
7.2 Hz, 1H, HC(12)), 7.17 (t, J = 7.7 Hz, 1H, HC(7)), 7.13 (d, J = 7.1 Hz, 1H, 
HC(5)), 6.95 (d, J = 7.5 Hz, 1H, HC(8)), 6.92 (t, J = 7.4 Hz, 1H, HC(6)), 5.11 (dd, 
J = 10.2, 2.5 Hz, 1H, HC(2)), 3.05 (ddd, J = 17.0, 11.4, 5.9 Hz, 1H, HC(4)), 2.85 
(ddd, J = 16.5, 5.3, 3.3 Hz, 1H, HC(4)), 2.26 (dddd, J = 13.7, 5.9, 3.3, 2.4 Hz, 1H, 
HC(3)), 2.14 (dddd, J = 13.7, 11.2, 10.2, 5.3 Hz, 1H, HC(3)). 
 
13
C NMR: (126 MHz, CDCl3) 
  δ 155.1, 141.7, 129.5, 128.5, 128.4, 127.8, 127.3, 125.9, 121.8, 120.3, 116.9, 77.7, 
29.9, 25.0. 
 MS:  (EI, 70 eV, m/z) 
  210 (100, M
+
), 129 (32), 171 (14), 119 (14), 104 (27), 77 (12) 
 Opt. Rot: [α]D
23
 = +16.6 (c = 1.05 in CHCl3)  
 
Preparation of (2S,3R)-2-Phenyl-3-((R,S)-phenylsulfinyl)chromane (151a/b) [DJK-17-62] 
 
 To a 250-mL RB-flask under argon was added MeOH (100 mL) and 143a (2.23 g, 7.0 
mmol). Sodium periodate (1.65 mg, 7.7 mmol, 1.1 equiv) was added as a solid resulting in a 
heterogenous solution. The mixture was then heated to 50 
o
C for 16 h. TLC analysis showed 
trace amounts of remaining starting material, however, formation of the corresponding sulfone 
was also observed and the flask therefore removed from heat. After the solution cooled to rt, 
water (100 mL) and CH2Cl2 (100 mL) was added to afford a clear, biphasic mixture. The mixture 
was transferred to a 500-mL separatory funnel, was shaken thoroughly, and the layers were 
separated. The aq. layer was extracted with further CH2Cl2 (2x 50 mL). The organic layers were 
combined, washed with water (25 mL), brine (25 mL), dried over MgSO4, filtered and 
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concentrated by rotary evaporation (30 
o
C, 3 mm Hg). Analysis of the crude material by 
1
H 
NMR spectroscopy revealed a 2:1 diastereomeric mixture. Purification by silica gel flash column 
chromatography (9:1, hexanes/ethyl acetate, then 4:1, hexanes/ethyl acetate, 30 mm diameter, 16 
cm SiO2) separated the diastereomers. Recombination of the diastereomers 151a and 151b, 
followed by recrystallization (EtOH, 2 mL) afforded, in two crops, 284 mg (85% combined 
yield) of a 2:1 mixture of 151a/151b as white to pale yellow prisms. 
Data for 151a:  
 mp: 138-140 
o
C (EtOH) 
 
1
H NMR:  (400 MHz, CDCl3) 
  δ 7.59–7.39 (m, 10H, HC(aryl)), 7.12 (t, J =8.4 Hz, 1H, HC(7)), 7.03 (d, J = 8.4 
Hz, 1H, HC(5)), 6.95–6.84 (m, 2H, HC(6), HC(8)), 5.12 (d, J = 9.1 Hz, 1H, 
HC(2)), 3.50 (dd, J = 16.9, 10.2 Hz, 1H, HC(4)), 3.12 (ddd, J = 10.3, 9.1, 5.4 Hz, 
1H, HC(3)), 2.31 (dd, J = 16.8, 5.4 Hz, 1H, HC(4)). 
 
13
C NMR: (126 MHz, CDCl3) 
  δ 154.2 (C9), 141.4 (C15), 138.2 (C11), 131.3 (C18), 130.2 (C7), 129.5 (C17), 
129.4 (C14), 129.3 (C13), 127.9 (C5), 127.6 (C16), 124.6 (C12), 121.5 (C6), 
120.2 (C10), 117.0 (C8), 77.7 (C2), 63.5 (C3), 20.4 (C4). 
 IR: (ATR, cm
-1
)  
  3050 (w), 1609 (w), 1583 (w), 1487 (m), 1455 (m), 1443 (m), 1369 (w), 1298 (w), 
1232 (s), 1194 (w), 1177 (w), 1110(w), 1085 (m), 1034 (s), 999 (m), 931 (m), 910 
(m), 873 (w), 840 (w), 830 (w), 788 (m), 747 (s), 698 (s), 686 (s) 
 MS:  (EI, 70 eV, m/z)  
  335 (M+H
+
,
 
100),  209 (66) 
 TLC: Rf 0.2 (4:1 hexanes/ethyl acetate) [UV, CAM] 
 Analysis: C21H18O2S (334.43) 
 Calcd: C,   75.42; H,  5.43%    
 Found: C,   75.06; H,  5.23% 
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Data for 151b:  
 1
H NMR: (500 MHz,CDCl3)  
  δ 7.72–7.65 (m, 2H, HC(aryl)), 7.61–7.53 (m, 3H, HC(aryl)), 7.37–7.33 (m, 4H, 
HC(aryl)), 7.27 (m, 2H, HC(aryl)), 7.10 (d, J = 8.4 Hz, 1H, HC(5)), 6.97–6.92 (m, 
2H, HC(6), HC(8)), 6.09 (dd, J = 3.1, 1.5 Hz, 1H, HC(2)), 3.42 (dt, J = 5.2, 3.2 
Hz, 1H, HC(3)), 2.82 (dd, J = 17.7, 5.2 Hz, 1H, HC(4)), 2.38 (ddd, J = 17.7, 2.9, 
1.2 Hz, 2H, HC(4)). 
 
Preparation of (S)-2-Phenyl-2H-chromene (154b) [DJK-17-64] 
 
 To a 10-mL Schlenk flask under argon was added a 1:1 diastereomeric mixture of 
sulfoxides 151a,b (334 mg, 1.0 mmol) and toluene (10 mL). Trimethylphosphite (236 μL, 2.0 
mmol, 2 equiv) was added via syringe. The solution was then heated to reflux in an oil bath for 4 
h. After the reaction was complete (TLC), the flask was removed from the oil bath and allowed 
to cool to rt. The solution was concentrated by rotary evaporation (30 
o
C, 3 mm Hg). Purification 
by silica gel flash column chromatography (9:1 hexanes/CH2Cl2 then 5:1 hexanes/CH2Cl2, 20 
mm diameter, 16 cm SiO2) afforded 193 mg (92%)of 154b a clear oil. The spectroscopic data 
match those reported in the literature.
103
 The rotation is in agreement with the absolute 
configuration shown.
163
  
Data for 154b: 
 
1
H NMR: (500 MHz, CDCl3) 
  δ 7.53–7.46 (m, 2H, HC(aryl)), 7.47–7.33 (m, 3H, HC(aryl)), 7.16 (t, J = 7.8 Hz, 
1H, HC(7)), 7.06 (d, J = 7.5 Hz, 1H, HC(5)), 6.91 (t, J = 7.4 Hz, 1H, HC(6)), 6.84 
(d, J = 8.0 Hz, 1H, HC(8)), 6.58 (d, J = 9.8 Hz, 1H, HC(4)), 5.97 (d, J = 2.1 Hz, 
1H, HC(2)), 5.85 (dd, J = 9.9, 3.3 Hz, 1H, HC(3)) 
 13
C NMR:  153.2, 140.9, 129.5, 128.6, 128.3, 127.0, 126.6, 124.8, 124.0, 121.3, 121.2, 116.0, 
77.2  
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 MS:  (EI, 70 eV, m/z) 
  208 (90, M
+
), 207 (100), 178 (15), 131 (41) 
 Opt. Rot: [α]D
23
 = +97.6 (c = 1.1 in CHCl3)  
  
 
Preparation of (S)-2-Phenyl-3-(phenylthio)-2H-chromene (152) [DJK-17-63] 
 
 To a 50-mL Schlenk flask under argon was added a 1:1 mixture of  151a,b (334 mg, 1 
mmol) and toluene (8 mL). To this was added pyridine (805 μL, 10 mmol, 10 equiv) via syringe 
followed by trifluoroacetic anhydride (278 μL, 2.0 mmol, 2.0 equiv). The solution was then 
heated to 80 
o
C (internal temperature, oil bath) for 4 h. The flask was then removed from the heat 
source and allowed to cool to rt. The mixture was transferred to a 60-mL separatory funnel and 
diluted with water (10 mL) and ether (15 mL). The layers were separated and the aq. layer 
extracted with ether (2x 10 mL). The organic layers were combined, dried over MgSO4, and 
concentrated by rotary evaporation (30 
o
C, 3 mm Hg). Purification by silica gel flash column 
chromatography (9:1, hexanes/CH2Cl2 then 5:1, hexanes/CH2Cl2, 20 mm diameter, 16 cm SiO2) 
followed by recrystallization (hexanes, 2 mL) afforded 292 mg (92%) of 152 as white prisms.  
Data for 152:  
 mp: 86-88 
o
C (hexanes) 
 
1
H NMR:  (500 MHz, CDCl3) 
  δ 7.49 (d, J = 6.6 Hz, 2H, HC(aryl)), 7.43–7.32 (m, 8H, HC(aryl)), 7.12 (t, J = 7.7 
Hz, 1H, HC(7)), 7.00 (d, J = 7.6, Hz, 1H, HC(5)), 6.90 (t, J = 7.5 Hz, 1H, HC(6)), 
6.78 (d, J = 8.0 Hz, 1H, HC(8)), 6.66 (s, 1H, HC(4)), 5.75 (s, 1H, HC(2)). 
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13
C NMR: (126 MHz, CDCl3) 
  δ 151.8 (C9), 138.5 (C15), 132.5 (C17), 132.3 (C11), 131.4 (C13), 129.7 (C9), 
129.6 (C16), 129.1 (C18), 128.7 (C13), 128.3 (C14), 128.0 (C12), 126.3 (C7), 
125.4 (C4), 122.4 (C10), 121.8 (C6), 116.5 (C8), 79.6 (C2)  
 IR: (ATR, cm
-1
) 
  3047 (w), 3028 (w), 2942 (w), 1902 (w), 1736 (w), 1704 (w), 1625 (w), 1600 (w), 
1581 (w), 1570 (w), 1483 (m), 1473 (m), 1450 (m), 1437 (m), 1348 (w), 1326 
(m), 1301 (w), 1258 (m), 1223 (m), 1206 (m), 1194 (m), 1160 (w), 1148 (w), 
1115 (m), 1078 (w), 1065 (m), 1045 (m),1022 (m), 1000 (w), 962 (m), 937 (m), 
924 (m), 905 (m), 889 (m), 854 (m), 832 (w), 776 (m), 764 (m), 747 (s), 737 (s), 
697 (s), 688 (s)  
 MS:  (EI, 70 eV, m/z) 
  316 (40, M
+
), 207 (100),  178 (23)   
 TLC: Rf 0.57 (4:1 hexanes/ethyl acetate) [UV, CAM] 
 Analysis: C21H16OS (316.42) 
 Calcd: C,   79.71; H,  5.10%  
 Found: C,   79.31; H,  4.97% 
 
Attempted Conditions for the Pummerer Rearrangement of 151 
 
General Procedure  
 To a 5-mL oven- or flame-dried Schlenk flask was added a 151a, 151b or a mixture 
thereof , followed by solvent and additives. The solution was then heated to the specified 
temperature and then stirred. Aliquots for NMR were obtained by adding ~5 μL of solution to an 
NMR tube containing 0.7 mL of CDCl3. Ratios were determined by integration of peaks at 5.97 
(154b), 5.7 ppm (152) and 3.8 ppm (143a).  
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Attempted Preparation of  (S)-2-phenylchroman-3-one with Ac2O  [DJK-17-75] 
 
 Sulfoxide 151 (33.4 mg, 0.1 mmol) was added to a Schlenk flask. Acetic anhydride (1 
mL) was added and the reaction heated to 110 
o
C for 2 h. Analysis by 
1
H NMR of the reaction 
showed primarily formation of elimination product 152. No further manipulations were 
performed.  
 
Attempted Preparation of  (S)-2-phenylchroman-3-one with Ac2O and AcOH [DJK-17-76] 
 
 Sulfoxide 151 (33.4 mg, 0.1 mmol) was added to a Schlenk flask. Acetic anhydride (0.75 
mL) and acetic acid (0.25 mL) were added and the reaction heated to 110 
o
C for 2 h. Analysis by 
1
H NMR of the reaction showed primarily formation of 154b. No further manipulations were 
performed.  
 
Attempted Preparation of  (S)-2-phenylchroman-3-one with SOCl2 [DJK-17-82] 
 
 Sulfoxide 151 (33.4 mg, 0.1 mmol) was added to a Schlenk flask, followed by CH2Cl2. 
Thionyl chloride (47.6 mg, 0.4 mmol, 4.0 equiv) was added dropwise. The solution was stirred 
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for 1 h at rt. Analysis of the reaction by 
1
H NMR spectroscopy showed a 0.75:1:0.1 mixture of 
143a:151:152. No further manipulations were performed.  
 
Attempted Preparation of  (S)-2-phenylchroman-3-one with (COCl)2 [DJK-17-81] 
 
 Sulfoxide 151 (33.4 mg, 0.1 mmol) was added to a Schlenk flask, followed by CH2Cl2 (1 
mL). Oxalyl chloride (50.8 mg, 0.4 mmol, 4.0 equiv) was added dropwise. The solution was 
stirred for 1 h at rt. Analysis of the reaction by 
1
H NMR spectroscopy showed a 1:1 mixture of 
152 and 143a. No further manipulations were performed.  
 
Attempted Preparation of  (S)-2-phenylchroman-3-one with (COCl)2 and K2CO3 [DJK-17-
83] 
 
 Sulfoxide 151 (33.4 mg, 0.1 mmol) was added to a Schlenk flask, followed by CH2Cl2 (1 
mL) and K2CO3 (55.3 mg, 0.4 mmol, 4.0 equiv). Oxalyl chloride (50.8 mg, 0.4 mmol, 4.0 equiv) 
was added dropwise. The solution was stirred for 2 h at rt. Analysis of the reaction by 
1
H NMR 
spectroscopy showed a 3.5:1 mixture of 143a and 152 and leftover starting material. No further 
manipulations were performed.  
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Attempted Preparation of  (S)-2-phenylchroman-3-one with (COCl)2 and KOAc [DJK-17-
84] 
 
 Sulfoxide 151 (33.4 mg, 0.1 mmol) was added to a Schlenk flask, followed by CH2Cl2 (1 
mL) and KOAc (39.3 mg, 0.4 mmol, 4.0 equiv). Oxalyl chloride (50.8 mg, 0.4 mmol, 4.0 equiv) 
was added dropwise. The solution was stirred for 2 h at rt. Analysis of the reaction by 
1
H NMR 
spectroscopy showed a 4.8:1 mixture of 143a and 152 and leftover starting material. No further 
manipulations were performed.  
 
Attempted Preparation of  (S)-2-phenylchroman-3-one with (COCl)2 and Pyridine [DJK-
17-85] 
 
 Sulfoxide 151 (33.4 mg, 0.1 mmol) was added to a Schlenk flask, followed by CH2Cl2 (1 
mL) and pyridine (31.6 mg, 0.4 mmol, 4.0 equiv). Oxalyl chloride (50.8 mg, 0.4 mmol, 4.0 
equiv) was added dropwise. The solution was stirred for 2 h at rt. Analysis of the reaction by 
1
H 
NMR spectroscopy showed a 1:1.25 mixture of 152 and 143a. No further manipulations were 
performed.  
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Attempted Preparation of  (S)-2-phenylchroman-3-one with PhI(OAc)2 [DJK-17-86] 
 
 Sulfoxide 151 (33.4 mg, 0.1 mmol) was added to a Schlenk flask, followed by 
dichloroethane (1 mL). Diacetoxyiodobenzene (64.4 mg, 0.2 mmol, 2.0 equiv) was added 
dropwise. The solution was stirred for 12 h at rt. Analysis of the reaction by 
1
H NMR 
spectroscopy showed only starting material. No further manipulations were performed.  
 
 
Attempted Preparation of  (S)-2-phenylchroman-3-one with TBSOTf and Et3N [DJK-17-
88] 
 
 Sulfoxide 151 (33.4 mg, 0.1 mmol) was added to a Schlenk flask, followed by 
dichloromethane (1 mL) and Et3N (20.2 mg, 0.2 mmol, 2 equiv). TBSOTf (52.9 mg, 0.2 mmol, 2 
equiv) was added dropwise. The solution was stirred for 1 h at rt. Analysis of the reaction by 
1
H 
NMR spectroscopy showed an 8:1 mixture of 151:152. No further manipulations were 
performed.  
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 5.6. Crystal Structures.  
Crystallographic Data for 102  
 
  Crystal data and structure refinement for bc11tasq. 
Identification code  bc11tasq 
Empirical formula  C66 H76 Cl12 N6 O2 P2 Sb2 Se2 
Formula weight  1874.09 
Temperature  193(2) K 
Wavelength  1.54178 Å 
Crystal system  Triclinic 
Space group  P-1    
Unit cell dimensions a = 12.0050(6) Å a= 67.081(2)°. 
 b = 12.2783(6) Å b= 73.258(2)°. 
 c = 14.5779(7) Å g = 88.706(2)°. 
Volume 1885.47(16) Å3 
Z 1 
Density (calculated) 1.651 Mg/m3 
Absorption coefficient 11.470 mm-1 
F(000) 934 
Crystal size 0.374 x 0.215 x 0.172 mm3 
Theta range for data collection 3.45 to 67.82°. 
Index ranges -14<=h<=14, -14<=k<=14, -16<=l<=17 
Reflections collected 23671 
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Independent reflections 6453 [R(int) = 0.0376] 
Completeness to theta = 67.82° 94.4 %  
Absorption correction Integration 
Max. and min. transmission 0.3726 and 0.1241 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6453 / 499 / 556 
Goodness-of-fit on F2 1.047 
Final R indices [I>2sigma(I)] R1 = 0.0300, wR2 = 0.0805 
R indices (all data) R1 = 0.0315, wR2 = 0.0816 
Largest diff. peak and hole 0.511 and -0.432 e.Å-3 
 
 Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for bc11tasq.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________
__  
 x y z U(eq) 
______________________________________________________________________________
__   
Sb(1) -127(5) 4413(4) 2512(3) 38(1) 
Cl(1) 1698(7) 3617(9) 2293(6) 101(2) 
Cl(2) -476(8) 3773(6) 1285(4) 56(2) 
Cl(3) -1950(6) 5195(6) 2703(6) 69(1) 
Cl(4) 221(7) 5042(8) 3744(5) 74(2) 
Cl(5) -1008(8) 2579(4) 3876(4) 57(2) 
Cl(6) 771(8) 6246(6) 1151(5) 66(1) 
Sb(1B) 56(8) 4348(7) 2492(7) 42(2) 
Cl(1B) 1247(10) 2788(10) 2581(8) 82(3) 
Cl(2B) -635(15) 4023(14) 1258(11) 64(5) 
Cl(3B) -1114(14) 5917(11) 2404(10) 104(4) 
Cl(4B) 701(14) 4684(13) 3747(11) 85(5) 
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Cl(5B) -1467(9) 2969(11) 3835(8) 80(3) 
Cl(6B) 1589(11) 5721(12) 1136(9) 115(4) 
Sb(1C) 158(5) 4446(4) 2521(3) 37(1) 
Cl(1C) 2013(5) 3720(6) 2244(6) 70(1) 
Cl(2C) -203(6) 3843(7) 1287(5) 53(1) 
Cl(3C) -1657(7) 5240(9) 2754(7) 82(2) 
Cl(4C) 545(8) 5059(7) 3742(5) 69(2) 
Cl(5C) -684(6) 2591(5) 3866(5) 62(2) 
Cl(6C) 1016(9) 6304(6) 1156(6) 78(2) 
Se(1) 137(1) 9337(1) 797(1) 41(1) 
P(1) 2029(1) 9990(1) 333(1) 33(1) 
N(2) 2168(2) 11434(2) -286(2) 37(1) 
N(3) 2920(2) 9529(2) -496(2) 34(1) 
N(1) 2366(6) 9525(7) 1411(3) 40(1) 
C(1) 1801(5) 8404(5) 2307(3) 47(1) 
C(2) 926(5) 8600(5) 3210(4) 59(1) 
C(3) 1201(5) 9687(6) 3379(5) 65(2) 
C(4) 2446(6) 9969(7) 3293(4) 69(2) 
C(5) 3234(8) 10677(7) 2164(5) 59(1) 
C(6) 3449(5) 10026(6) 1444(5) 49(1) 
N(1B) 2160(20) 9400(20) 1498(9) 40(3) 
C(1B) 1409(18) 8415(16) 2428(12) 47(3) 
C(2B) 1381(17) 8417(12) 3474(10) 57(3) 
C(3B) 1474(18) 9579(15) 3562(15) 63(3) 
C(4B) 2600(20) 10350(20) 3123(16) 64(3) 
C(5B) 3220(30) 10740(20) 1950(16) 59(4) 
C(6B) 3290(18) 9770(20) 1544(17) 50(3) 
C(7) 1380(2) 12156(3) 179(2) 46(1) 
C(8) 3238(2) 12050(2) -1095(2) 37(1) 
C(9) 3883(3) 12852(2) -916(2) 46(1) 
C(10) 4881(3) 13476(2) -1644(2) 49(1) 
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C(11) 5311(2) 13330(2) -2599(2) 45(1) 
C(12) 6366(3) 13967(3) -3357(3) 57(1) 
C(13) 6795(3) 13801(3) -4257(3) 64(1) 
C(14) 6197(3) 12964(3) -4425(3) 58(1) 
C(15) 5182(2) 12320(3) -3708(2) 48(1) 
C(16) 4681(2) 12501(2) -2773(2) 40(1) 
C(17) 3595(2) 11872(2) -2011(2) 36(1) 
C(18) 2926(2) 11009(2) -2191(2) 33(1) 
C(19) 2558(2) 11330(2) -3104(2) 35(1) 
C(20) 2624(3) 12522(2) -3821(2) 45(1) 
C(21) 2298(3) 12791(3) -4697(2) 55(1) 
C(22) 1900(3) 11872(3) -4921(2) 56(1) 
C(23) 1797(3) 10730(3) -4245(2) 50(1) 
C(24) 2092(2) 10422(2) -3307(2) 40(1) 
C(25) 1916(2) 9237(2) -2565(2) 42(1) 
C(26) 2173(2) 8948(2) -1655(2) 39(1) 
C(27) 2680(2) 9845(2) -1476(2) 33(1) 
C(28) 3479(2) 8429(2) -109(2) 42(1) 
______________________________________________________________________________
__  
Bond lengths [Å] and angles [°] for  bc11tasq. 
_____________________________________________________  
Sb(1)-Cl(4)  2.350(4) 
Sb(1)-Cl(2)  2.352(4) 
Sb(1)-Cl(5)  2.356(4) 
Sb(1)-Cl(3)  2.357(4) 
Sb(1)-Cl(6)  2.358(4) 
Sb(1)-Cl(1)  2.366(5) 
Sb(1B)-Cl(3B)  2.342(7) 
Sb(1B)-Cl(2B)  2.348(7) 
Sb(1B)-Cl(1B)  2.350(7) 
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Sb(1B)-Cl(4B)  2.353(7) 
Sb(1B)-Cl(5B)  2.354(7) 
Sb(1B)-Cl(6B)  2.363(7) 
Sb(1C)-Cl(2C)  2.340(5) 
Sb(1C)-Cl(4C)  2.341(5) 
Sb(1C)-Cl(5C)  2.354(5) 
Sb(1C)-Cl(3C)  2.356(5) 
Sb(1C)-Cl(1C)  2.364(4) 
Sb(1C)-Cl(6C)  2.369(5) 
Se(1)-P(1)  2.2441(6) 
Se(1)-Se(1)#1  2.3728(5) 
P(1)-N(1)  1.619(3) 
P(1)-N(1B)  1.621(8) 
P(1)-N(2)  1.633(2) 
P(1)-N(3)  1.638(2) 
N(2)-C(8)  1.445(3) 
N(2)-C(7)  1.483(3) 
N(3)-C(27)  1.440(3) 
N(3)-C(28)  1.475(3) 
N(1)-C(6)  1.472(5) 
N(1)-C(1)  1.480(5) 
C(1)-C(2)  1.527(6) 
C(1)-H(1A)  0.9900 
C(1)-H(1B)  0.9900 
C(2)-C(3)  1.507(7) 
C(2)-H(2A)  0.9900 
C(2)-H(2B)  0.9900 
C(3)-C(4)  1.500(8) 
C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
C(4)-C(5)  1.544(6) 
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C(4)-H(4A)  0.9900 
C(4)-H(4B)  0.9900 
C(5)-C(6)  1.515(6) 
C(5)-H(5A)  0.9900 
C(5)-H(5B)  0.9900 
C(6)-H(6A)  0.9900 
C(6)-H(6B)  0.9900 
N(1B)-C(6B)  1.466(10) 
N(1B)-C(1B)  1.477(9) 
C(1B)-C(2B)  1.517(10) 
C(1B)-H(1C)  0.9900 
C(1B)-H(1D)  0.9900 
C(2B)-C(3B)  1.491(10) 
C(2B)-H(2C)  0.9900 
C(2B)-H(2D)  0.9900 
C(3B)-C(4B)  1.487(11) 
C(3B)-H(3C)  0.9900 
C(3B)-H(3D)  0.9900 
C(4B)-C(5B)  1.535(10) 
C(4B)-H(4C)  0.9900 
C(4B)-H(4D)  0.9900 
C(5B)-C(6B)  1.517(10) 
C(5B)-H(5C)  0.9900 
C(5B)-H(5D)  0.9900 
C(6B)-H(6C)  0.9900 
C(6B)-H(6D)  0.9900 
C(7)-H(7A)  0.9800 
C(7)-H(7B)  0.9800 
C(7)-H(7C)  0.9800 
C(8)-C(17)  1.381(4) 
C(8)-C(9)  1.411(4) 
375 
 
C(9)-C(10)  1.350(4) 
C(9)-H(9A)  0.9500 
C(10)-C(11)  1.419(4) 
C(10)-H(10A)  0.9500 
C(11)-C(12)  1.415(4) 
C(11)-C(16)  1.421(4) 
C(12)-C(13)  1.358(5) 
C(12)-H(12A)  0.9500 
C(13)-C(14)  1.400(5) 
C(13)-H(13A)  0.9500 
C(14)-C(15)  1.367(4) 
C(14)-H(14A)  0.9500 
C(15)-C(16)  1.423(4) 
C(15)-H(15A)  0.9500 
C(16)-C(17)  1.439(4) 
C(17)-C(18)  1.488(3) 
C(18)-C(27)  1.377(3) 
C(18)-C(19)  1.431(4) 
C(19)-C(20)  1.417(4) 
C(19)-C(24)  1.423(4) 
C(20)-C(21)  1.360(4) 
C(20)-H(20A)  0.9500 
C(21)-C(22)  1.417(5) 
C(21)-H(21A)  0.9500 
C(22)-C(23)  1.347(5) 
C(22)-H(22A)  0.9500 
C(23)-C(24)  1.417(4) 
C(23)-H(23A)  0.9500 
C(24)-C(25)  1.409(4) 
C(25)-C(26)  1.358(4) 
C(25)-H(25A)  0.9500 
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C(26)-C(27)  1.414(4) 
C(26)-H(26A)  0.9500 
C(28)-H(28A)  0.9800 
C(28)-H(28B)  0.9800 
C(28)-H(28C)  0.9800 
 
Cl(4)-Sb(1)-Cl(2) 179.7(3) 
Cl(4)-Sb(1)-Cl(5) 89.3(2) 
Cl(2)-Sb(1)-Cl(5) 90.4(2) 
Cl(4)-Sb(1)-Cl(3) 90.4(2) 
Cl(2)-Sb(1)-Cl(3) 89.7(2) 
Cl(5)-Sb(1)-Cl(3) 90.4(2) 
Cl(4)-Sb(1)-Cl(6) 90.4(3) 
Cl(2)-Sb(1)-Cl(6) 89.8(2) 
Cl(5)-Sb(1)-Cl(6) 179.5(3) 
Cl(3)-Sb(1)-Cl(6) 90.0(3) 
Cl(4)-Sb(1)-Cl(1) 90.7(3) 
Cl(2)-Sb(1)-Cl(1) 89.2(3) 
Cl(5)-Sb(1)-Cl(1) 89.6(3) 
Cl(3)-Sb(1)-Cl(1) 178.8(3) 
Cl(6)-Sb(1)-Cl(1) 89.9(3) 
Cl(3B)-Sb(1B)-Cl(2B) 89.7(5) 
Cl(3B)-Sb(1B)-Cl(1B) 179.3(5) 
Cl(2B)-Sb(1B)-Cl(1B) 90.8(5) 
Cl(3B)-Sb(1B)-Cl(4B) 89.2(5) 
Cl(2B)-Sb(1B)-Cl(4B) 178.6(6) 
Cl(1B)-Sb(1B)-Cl(4B) 90.3(4) 
Cl(3B)-Sb(1B)-Cl(5B) 91.5(5) 
Cl(2B)-Sb(1B)-Cl(5B) 89.2(5) 
Cl(1B)-Sb(1B)-Cl(5B) 89.0(4) 
Cl(4B)-Sb(1B)-Cl(5B) 89.9(5) 
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Cl(3B)-Sb(1B)-Cl(6B) 88.9(5) 
Cl(2B)-Sb(1B)-Cl(6B) 90.5(5) 
Cl(1B)-Sb(1B)-Cl(6B) 90.7(5) 
Cl(4B)-Sb(1B)-Cl(6B) 90.4(5) 
Cl(5B)-Sb(1B)-Cl(6B) 179.5(5) 
Cl(2C)-Sb(1C)-Cl(4C) 179.3(3) 
Cl(2C)-Sb(1C)-Cl(5C) 90.5(3) 
Cl(4C)-Sb(1C)-Cl(5C) 89.9(3) 
Cl(2C)-Sb(1C)-Cl(3C) 90.6(2) 
Cl(4C)-Sb(1C)-Cl(3C) 90.0(3) 
Cl(5C)-Sb(1C)-Cl(3C) 91.5(3) 
Cl(2C)-Sb(1C)-Cl(1C) 89.7(2) 
Cl(4C)-Sb(1C)-Cl(1C) 89.8(2) 
Cl(5C)-Sb(1C)-Cl(1C) 90.6(2) 
Cl(3C)-Sb(1C)-Cl(1C) 177.9(3) 
Cl(2C)-Sb(1C)-Cl(6C) 89.1(3) 
Cl(4C)-Sb(1C)-Cl(6C) 90.5(3) 
Cl(5C)-Sb(1C)-Cl(6C) 179.4(3) 
Cl(3C)-Sb(1C)-Cl(6C) 88.9(3) 
Cl(1C)-Sb(1C)-Cl(6C) 89.1(3) 
P(1)-Se(1)-Se(1)#1 94.31(2) 
N(1)-P(1)-N(2) 114.4(3) 
N(1B)-P(1)-N(2) 119.9(10) 
N(1)-P(1)-N(3) 109.8(3) 
N(1B)-P(1)-N(3) 113.4(12) 
N(2)-P(1)-N(3) 104.41(10) 
N(1)-P(1)-Se(1) 105.4(2) 
N(1B)-P(1)-Se(1) 96.3(8) 
N(2)-P(1)-Se(1) 108.04(8) 
N(3)-P(1)-Se(1) 115.08(8) 
C(8)-N(2)-C(7) 116.9(2) 
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C(8)-N(2)-P(1) 120.66(17) 
C(7)-N(2)-P(1) 119.75(18) 
C(27)-N(3)-C(28) 117.9(2) 
C(27)-N(3)-P(1) 115.13(16) 
C(28)-N(3)-P(1) 120.11(17) 
C(6)-N(1)-C(1) 115.8(4) 
C(6)-N(1)-P(1) 120.2(4) 
C(1)-N(1)-P(1) 122.1(4) 
N(1)-C(1)-C(2) 113.3(5) 
N(1)-C(1)-H(1A) 108.9 
C(2)-C(1)-H(1A) 108.9 
N(1)-C(1)-H(1B) 108.9 
C(2)-C(1)-H(1B) 108.9 
H(1A)-C(1)-H(1B) 107.7 
C(3)-C(2)-C(1) 116.4(4) 
C(3)-C(2)-H(2A) 108.2 
C(1)-C(2)-H(2A) 108.2 
C(3)-C(2)-H(2B) 108.2 
C(1)-C(2)-H(2B) 108.2 
H(2A)-C(2)-H(2B) 107.3 
C(4)-C(3)-C(2) 117.3(5) 
C(4)-C(3)-H(3A) 108.0 
C(2)-C(3)-H(3A) 108.0 
C(4)-C(3)-H(3B) 108.0 
C(2)-C(3)-H(3B) 108.0 
H(3A)-C(3)-H(3B) 107.2 
C(3)-C(4)-C(5) 114.2(5) 
C(3)-C(4)-H(4A) 108.7 
C(5)-C(4)-H(4A) 108.7 
C(3)-C(4)-H(4B) 108.7 
C(5)-C(4)-H(4B) 108.7 
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H(4A)-C(4)-H(4B) 107.6 
C(6)-C(5)-C(4) 115.7(5) 
C(6)-C(5)-H(5A) 108.4 
C(4)-C(5)-H(5A) 108.4 
C(6)-C(5)-H(5B) 108.4 
C(4)-C(5)-H(5B) 108.4 
H(5A)-C(5)-H(5B) 107.4 
N(1)-C(6)-C(5) 113.3(4) 
N(1)-C(6)-H(6A) 108.9 
C(5)-C(6)-H(6A) 108.9 
N(1)-C(6)-H(6B) 108.9 
C(5)-C(6)-H(6B) 108.9 
H(6A)-C(6)-H(6B) 107.7 
C(6B)-N(1B)-C(1B) 117.8(10) 
C(6B)-N(1B)-P(1) 113.0(15) 
C(1B)-N(1B)-P(1) 128.2(13) 
N(1B)-C(1B)-C(2B) 115.6(10) 
N(1B)-C(1B)-H(1C) 108.4 
C(2B)-C(1B)-H(1C) 108.4 
N(1B)-C(1B)-H(1D) 108.4 
C(2B)-C(1B)-H(1D) 108.4 
H(1C)-C(1B)-H(1D) 107.4 
C(3B)-C(2B)-C(1B) 118.8(11) 
C(3B)-C(2B)-H(2C) 107.6 
C(1B)-C(2B)-H(2C) 107.6 
C(3B)-C(2B)-H(2D) 107.6 
C(1B)-C(2B)-H(2D) 107.6 
H(2C)-C(2B)-H(2D) 107.0 
C(4B)-C(3B)-C(2B) 122.3(13) 
C(4B)-C(3B)-H(3C) 106.8 
C(2B)-C(3B)-H(3C) 106.8 
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C(4B)-C(3B)-H(3D) 106.8 
C(2B)-C(3B)-H(3D) 106.8 
H(3C)-C(3B)-H(3D) 106.6 
C(3B)-C(4B)-C(5B) 117.2(12) 
C(3B)-C(4B)-H(4C) 108.0 
C(5B)-C(4B)-H(4C) 108.0 
C(3B)-C(4B)-H(4D) 108.0 
C(5B)-C(4B)-H(4D) 108.0 
H(4C)-C(4B)-H(4D) 107.2 
C(6B)-C(5B)-C(4B) 115.2(13) 
C(6B)-C(5B)-H(5C) 108.5 
C(4B)-C(5B)-H(5C) 108.5 
C(6B)-C(5B)-H(5D) 108.5 
C(4B)-C(5B)-H(5D) 108.5 
H(5C)-C(5B)-H(5D) 107.5 
N(1B)-C(6B)-C(5B) 113.3(13) 
N(1B)-C(6B)-H(6C) 108.9 
C(5B)-C(6B)-H(6C) 108.9 
N(1B)-C(6B)-H(6D) 108.9 
C(5B)-C(6B)-H(6D) 108.9 
H(6C)-C(6B)-H(6D) 107.7 
N(2)-C(7)-H(7A) 109.5 
N(2)-C(7)-H(7B) 109.5 
H(7A)-C(7)-H(7B) 109.5 
N(2)-C(7)-H(7C) 109.5 
H(7A)-C(7)-H(7C) 109.5 
H(7B)-C(7)-H(7C) 109.5 
C(17)-C(8)-C(9) 121.7(2) 
C(17)-C(8)-N(2) 121.0(2) 
C(9)-C(8)-N(2) 117.2(2) 
C(10)-C(9)-C(8) 120.6(3) 
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C(10)-C(9)-H(9A) 119.7 
C(8)-C(9)-H(9A) 119.7 
C(9)-C(10)-C(11) 120.8(3) 
C(9)-C(10)-H(10A) 119.6 
C(11)-C(10)-H(10A) 119.6 
C(12)-C(11)-C(10) 121.0(3) 
C(12)-C(11)-C(16) 120.1(3) 
C(10)-C(11)-C(16) 118.9(2) 
C(13)-C(12)-C(11) 121.1(3) 
C(13)-C(12)-H(12A) 119.5 
C(11)-C(12)-H(12A) 119.5 
C(12)-C(13)-C(14) 119.4(3) 
C(12)-C(13)-H(13A) 120.3 
C(14)-C(13)-H(13A) 120.3 
C(15)-C(14)-C(13) 121.4(3) 
C(15)-C(14)-H(14A) 119.3 
C(13)-C(14)-H(14A) 119.3 
C(14)-C(15)-C(16) 120.9(3) 
C(14)-C(15)-H(15A) 119.6 
C(16)-C(15)-H(15A) 119.6 
C(11)-C(16)-C(15) 117.1(2) 
C(11)-C(16)-C(17) 119.9(2) 
C(15)-C(16)-C(17) 123.0(2) 
C(8)-C(17)-C(16) 117.9(2) 
C(8)-C(17)-C(18) 121.7(2) 
C(16)-C(17)-C(18) 120.2(2) 
C(27)-C(18)-C(19) 118.1(2) 
C(27)-C(18)-C(17) 119.5(2) 
C(19)-C(18)-C(17) 122.4(2) 
C(20)-C(19)-C(24) 117.9(2) 
C(20)-C(19)-C(18) 123.0(2) 
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C(24)-C(19)-C(18) 119.1(2) 
C(21)-C(20)-C(19) 121.3(3) 
C(21)-C(20)-H(20A) 119.4 
C(19)-C(20)-H(20A) 119.4 
C(20)-C(21)-C(22) 120.2(3) 
C(20)-C(21)-H(21A) 119.9 
C(22)-C(21)-H(21A) 119.9 
C(23)-C(22)-C(21) 120.1(3) 
C(23)-C(22)-H(22A) 119.9 
C(21)-C(22)-H(22A) 119.9 
C(22)-C(23)-C(24) 121.1(3) 
C(22)-C(23)-H(23A) 119.5 
C(24)-C(23)-H(23A) 119.5 
C(25)-C(24)-C(23) 121.3(2) 
C(25)-C(24)-C(19) 119.5(2) 
C(23)-C(24)-C(19) 119.2(3) 
C(26)-C(25)-C(24) 121.3(2) 
C(26)-C(25)-H(25A) 119.4 
C(24)-C(25)-H(25A) 119.4 
C(25)-C(26)-C(27) 119.1(2) 
C(25)-C(26)-H(26A) 120.4 
C(27)-C(26)-H(26A) 120.4 
C(18)-C(27)-C(26) 122.5(2) 
C(18)-C(27)-N(3) 119.1(2) 
C(26)-C(27)-N(3) 118.4(2) 
N(3)-C(28)-H(28A) 109.5 
N(3)-C(28)-H(28B) 109.5 
H(28A)-C(28)-H(28B) 109.5 
N(3)-C(28)-H(28C) 109.5 
H(28A)-C(28)-H(28C) 109.5 
H(28B)-C(28)-H(28C) 109.5 
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_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 -x,-y+2,-z       
 
Anisotropic displacement parameters  (Å2x 103) for bc11tasq.  The anisotropic 
displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
Sb(1) 48(1)  36(1) 27(1)  -13(1) -9(1)  7(1) 
Cl(1) 65(3)  137(5) 66(2)  -15(3) -7(2)  49(3) 
Cl(2) 99(4)  33(2) 32(2)  -14(1) -13(2)  -2(2) 
Cl(3) 65(2)  87(2) 72(2)  -47(2) -24(2)  36(2) 
Cl(4) 85(3)  99(3) 52(2)  -41(1) -24(2)  -16(2) 
Cl(5) 80(4)  48(2) 29(1)  -12(1) -1(2)  -13(2) 
Cl(6) 95(3)  40(2) 49(2)  1(1) -29(2)  -21(1) 
Sb(1B) 46(4)  33(2) 38(3)  -14(2) 3(2)  -20(2) 
Cl(1B) 94(5)  98(6) 73(5)  -58(4) -22(4)  38(5) 
Cl(2B) 98(8)  59(8) 43(5)  -20(4) -30(5)  -3(6) 
Cl(3B) 122(7)  95(6) 102(6)  -36(5) -50(5)  57(5) 
Cl(4B) 90(7)  87(8) 104(7)  -56(5) -43(5)  3(5) 
Cl(5B) 72(5)  97(7) 55(4)  -28(5) 1(4)  -2(5) 
Cl(6B) 123(7)  81(6) 101(6)  -26(5) 11(5)  -27(5) 
Sb(1C) 45(1)  34(1) 31(1)  -13(1) -10(1)  3(1) 
Cl(1C) 45(2)  82(2) 62(2)  -16(1) -5(2)  12(2) 
Cl(2C) 61(2)  67(3) 41(2)  -36(2) -11(1)  13(2) 
Cl(3C) 74(3)  129(4) 73(2)  -65(2) -33(2)  59(3) 
Cl(4C) 82(4)  76(3) 63(2)  -33(1) -36(2)  -6(2) 
Cl(5C) 67(3)  58(2) 39(1)  0(1) -10(1)  -21(1) 
Cl(6C) 109(4)  46(2) 61(2)  -10(2) -12(2)  -19(2) 
Se(1) 38(1)  44(1) 33(1)  -7(1) -8(1)  -1(1) 
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P(1) 36(1)  35(1) 30(1)  -15(1) -9(1)  4(1) 
N(2) 41(1)  36(1) 36(1)  -20(1) -8(1)  6(1) 
N(3) 39(1)  31(1) 33(1)  -13(1) -9(1)  5(1) 
N(1) 40(3)  47(2) 32(2)  -15(2) -12(1)  2(2) 
C(1) 49(3)  53(2) 35(2)  -12(2) -15(2)  4(2) 
C(2) 57(2)  77(3) 34(2)  -17(2) -6(2)  -7(2) 
C(3) 57(3)  89(3) 47(3)  -34(2) -3(2)  -1(2) 
C(4) 72(3)  92(4) 50(3)  -38(3) -15(2)  -5(3) 
C(5) 65(2)  74(3) 45(3)  -31(2) -15(2)  -14(2) 
C(6) 41(2)  65(3) 47(2)  -23(2) -18(2)  -1(2) 
N(1B) 39(5)  49(5) 38(4)  -22(4) -18(4)  0(4) 
C(1B) 51(6)  54(5) 35(4)  -12(4) -21(4)  -4(5) 
C(2B) 56(5)  70(4) 40(4)  -17(4) -14(4)  -2(4) 
C(3B) 66(5)  84(5) 42(4)  -31(4) -10(4)  -9(4) 
C(4B) 64(5)  79(5) 52(5)  -36(5) -9(4)  -13(5) 
C(5B) 56(5)  75(5) 46(5)  -26(5) -12(5)  -11(4) 
C(6B) 50(5)  59(5) 42(4)  -23(4) -11(4)  0(4) 
C(7) 52(1)  46(2) 47(2)  -30(1) -10(1)  12(1) 
C(8) 42(1)  30(1) 38(1)  -15(1) -11(1)  4(1) 
C(9) 58(2)  38(1) 47(2)  -24(1) -16(1)  3(1) 
C(10) 57(2)  37(1) 58(2)  -25(1) -18(1)  -4(1) 
C(11) 50(1)  34(1) 50(2)  -16(1) -12(1)  -1(1) 
C(12) 56(2)  42(2) 60(2)  -15(1) -7(1)  -13(1) 
C(13) 58(2)  55(2) 59(2)  -17(2) 2(1)  -16(1) 
C(14) 56(2)  59(2) 49(2)  -22(1) 2(1)  -9(1) 
C(15) 51(1)  45(2) 43(2)  -21(1) -5(1)  -3(1) 
C(16) 44(1)  32(1) 41(1)  -14(1) -10(1)  1(1) 
C(17) 42(1)  30(1) 37(1)  -16(1) -12(1)  4(1) 
C(18) 35(1)  32(1) 31(1)  -17(1) -4(1)  2(1) 
C(19) 38(1)  35(1) 32(1)  -16(1) -6(1)  4(1) 
C(20) 58(2)  37(1) 40(1)  -15(1) -13(1)  4(1) 
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C(21) 71(2)  46(2) 43(2)  -9(1) -21(1)  6(1) 
C(22) 71(2)  61(2) 35(1)  -17(1) -19(1)  5(2) 
C(23) 58(2)  56(2) 39(1)  -25(1) -13(1)  -2(1) 
C(24) 42(1)  43(1) 35(1)  -20(1) -5(1)  0(1) 
C(25) 52(1)  38(1) 39(1)  -22(1) -9(1)  -4(1) 
C(26) 46(1)  31(1) 37(1)  -14(1) -7(1)  -1(1) 
C(27) 35(1)  32(1) 32(1)  -16(1) -6(1)  5(1) 
C(28) 42(1)  36(1) 45(1)  -14(1) -10(1)  10(1) 
______________________________________________________________________________ 
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Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for bc11tasq. 
______________________________________________________________________________
__  
 x  y  z  U(eq) 
______________________________________________________________________________
__  
  
H(1A) 2413 7939 2565 56 
H(1B) 1393 7929 2065 56 
H(2A) 151 8648 3091 71 
H(2B) 858 7892 3862 71 
H(3A) 967 10381 2865 78 
H(3B) 706 9592 4083 78 
H(4A) 2781 9215 3596 83 
H(4B) 2455 10432 3715 83 
H(5A) 2875 11410 1854 71 
H(5B) 3999 10920 2194 71 
H(6A) 3893 10583 729 59 
H(6B) 3937 9375 1678 59 
H(1C) 1678 7655 2406 56 
H(1D) 601 8442 2383 56 
H(2C) 642 7962 3993 68 
H(2D) 2027 7974 3684 68 
H(3C) 910 10065 3242 76 
H(3D) 1190 9414 4317 76 
H(4C) 3140 9921 3508 76 
H(4D) 2447 11072 3268 76 
H(5C) 2816 11387 1559 71 
H(5D) 4029 11082 1798 71 
H(6C) 3859 10060 835 60 
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H(6D) 3583 9075 2002 60 
H(7A) 1248 12863 -381 69 
H(7B) 1740 12399 602 69 
H(7C) 631 11682 621 69 
H(9A) 3614 12955 -278 55 
H(10A) 5301 14019 -1515 58 
H(12A) 6781 14519 -3233 68 
H(13A) 7493 14249 -4769 76 
H(14A) 6503 12842 -5052 70 
H(15A) 4807 11744 -3835 57 
H(20A) 2902 13146 -3687 55 
H(21A) 2336 13598 -5161 66 
H(22A) 1706 12062 -5550 67 
H(23A) 1522 10122 -4399 60 
H(25A) 1612 8630 -2704 50 
H(26A) 2015 8153 -1146 47 
H(28A) 4019 8311 -703 63 
H(28B) 2877 7751 285 63 
H(28C) 3912 8493 347 63 
______________________________________________________________________________
__ 
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 Torsion angles [°] for bc11tasq. 
________________________________________________________________  
Se(1)#1-Se(1)-P(1)-N(1) 162.8(3) 
Se(1)#1-Se(1)-P(1)-N(1B) 164.4(12) 
Se(1)#1-Se(1)-P(1)-N(2) 40.12(8) 
Se(1)#1-Se(1)-P(1)-N(3) -76.06(8) 
N(1)-P(1)-N(2)-C(8) 93.6(3) 
N(1B)-P(1)-N(2)-C(8) 102.0(12) 
N(3)-P(1)-N(2)-C(8) -26.4(2) 
Se(1)-P(1)-N(2)-C(8) -149.36(17) 
N(1)-P(1)-N(2)-C(7) -67.3(4) 
N(1B)-P(1)-N(2)-C(7) -58.9(12) 
N(3)-P(1)-N(2)-C(7) 172.7(2) 
Se(1)-P(1)-N(2)-C(7) 49.7(2) 
N(1)-P(1)-N(3)-C(27) 177.5(3) 
N(1B)-P(1)-N(3)-C(27) 168.4(8) 
N(2)-P(1)-N(3)-C(27) -59.39(18) 
Se(1)-P(1)-N(3)-C(27) 58.85(17) 
N(1)-P(1)-N(3)-C(28) 27.2(3) 
N(1B)-P(1)-N(3)-C(28) 18.1(8) 
N(2)-P(1)-N(3)-C(28) 150.26(18) 
Se(1)-P(1)-N(3)-C(28) -91.49(18) 
N(1B)-P(1)-N(1)-C(6) -175(10) 
N(2)-P(1)-N(1)-C(6) -46.5(7) 
N(3)-P(1)-N(1)-C(6) 70.4(7) 
Se(1)-P(1)-N(1)-C(6) -165.1(5) 
N(1B)-P(1)-N(1)-C(1) 21(9) 
N(2)-P(1)-N(1)-C(1) 149.6(5) 
N(3)-P(1)-N(1)-C(1) -93.4(6) 
Se(1)-P(1)-N(1)-C(1) 31.1(7) 
C(6)-N(1)-C(1)-C(2) 89.3(7) 
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P(1)-N(1)-C(1)-C(2) -106.2(8) 
N(1)-C(1)-C(2)-C(3) -33.0(8) 
C(1)-C(2)-C(3)-C(4) -42.3(7) 
C(2)-C(3)-C(4)-C(5) 84.0(8) 
C(3)-C(4)-C(5)-C(6) -66.2(9) 
C(1)-N(1)-C(6)-C(5) -78.5(7) 
P(1)-N(1)-C(6)-C(5) 116.7(8) 
C(4)-C(5)-C(6)-N(1) 52.9(8) 
N(1)-P(1)-N(1B)-C(6B) -2(8) 
N(2)-P(1)-N(1B)-C(6B) -57(2) 
N(3)-P(1)-N(1B)-C(6B) 66.9(19) 
Se(1)-P(1)-N(1B)-C(6B) -172.2(17) 
N(1)-P(1)-N(1B)-C(1B) -170(12) 
N(2)-P(1)-N(1B)-C(1B) 135(2) 
N(3)-P(1)-N(1B)-C(1B) -101(3) 
Se(1)-P(1)-N(1B)-C(1B) 20(3) 
C(6B)-N(1B)-C(1B)-C(2B) 39(3) 
P(1)-N(1B)-C(1B)-C(2B) -153(2) 
N(1B)-C(1B)-C(2B)-C(3B) 34(3) 
C(1B)-C(2B)-C(3B)-C(4B) -75(2) 
C(2B)-C(3B)-C(4B)-C(5B) 57(3) 
C(3B)-C(4B)-C(5B)-C(6B) -45(3) 
C(1B)-N(1B)-C(6B)-C(5B) -90(2) 
P(1)-N(1B)-C(6B)-C(5B) 100(3) 
C(4B)-C(5B)-C(6B)-N(1B) 72(3) 
C(7)-N(2)-C(8)-C(17) -133.8(3) 
P(1)-N(2)-C(8)-C(17) 64.8(3) 
C(7)-N(2)-C(8)-C(9) 45.0(3) 
P(1)-N(2)-C(8)-C(9) -116.4(2) 
C(17)-C(8)-C(9)-C(10) 0.0(4) 
N(2)-C(8)-C(9)-C(10) -178.8(3) 
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C(8)-C(9)-C(10)-C(11) -0.7(5) 
C(9)-C(10)-C(11)-C(12) -178.9(3) 
C(9)-C(10)-C(11)-C(16) -0.9(4) 
C(10)-C(11)-C(12)-C(13) 178.1(3) 
C(16)-C(11)-C(12)-C(13) 0.0(5) 
C(11)-C(12)-C(13)-C(14) -1.6(6) 
C(12)-C(13)-C(14)-C(15) 0.8(6) 
C(13)-C(14)-C(15)-C(16) 1.6(5) 
C(12)-C(11)-C(16)-C(15) 2.3(4) 
C(10)-C(11)-C(16)-C(15) -175.8(3) 
C(12)-C(11)-C(16)-C(17) -178.7(3) 
C(10)-C(11)-C(16)-C(17) 3.2(4) 
C(14)-C(15)-C(16)-C(11) -3.1(4) 
C(14)-C(15)-C(16)-C(17) 177.9(3) 
C(9)-C(8)-C(17)-C(16) 2.3(4) 
N(2)-C(8)-C(17)-C(16) -178.9(2) 
C(9)-C(8)-C(17)-C(18) 178.8(2) 
N(2)-C(8)-C(17)-C(18) -2.4(4) 
C(11)-C(16)-C(17)-C(8) -3.9(4) 
C(15)-C(16)-C(17)-C(8) 175.0(3) 
C(11)-C(16)-C(17)-C(18) 179.6(2) 
C(15)-C(16)-C(17)-C(18) -1.5(4) 
C(8)-C(17)-C(18)-C(27) -54.7(3) 
C(16)-C(17)-C(18)-C(27) 121.7(3) 
C(8)-C(17)-C(18)-C(19) 127.5(3) 
C(16)-C(17)-C(18)-C(19) -56.1(3) 
C(27)-C(18)-C(19)-C(20) 171.4(2) 
C(17)-C(18)-C(19)-C(20) -10.7(4) 
C(27)-C(18)-C(19)-C(24) -8.0(3) 
C(17)-C(18)-C(19)-C(24) 169.8(2) 
C(24)-C(19)-C(20)-C(21) -2.6(4) 
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C(18)-C(19)-C(20)-C(21) 178.0(3) 
C(19)-C(20)-C(21)-C(22) -1.1(5) 
C(20)-C(21)-C(22)-C(23) 2.8(5) 
C(21)-C(22)-C(23)-C(24) -0.6(5) 
C(22)-C(23)-C(24)-C(25) 175.9(3) 
C(22)-C(23)-C(24)-C(19) -3.1(4) 
C(20)-C(19)-C(24)-C(25) -174.4(2) 
C(18)-C(19)-C(24)-C(25) 5.1(3) 
C(20)-C(19)-C(24)-C(23) 4.6(4) 
C(18)-C(19)-C(24)-C(23) -176.0(2) 
C(23)-C(24)-C(25)-C(26) -178.4(3) 
C(19)-C(24)-C(25)-C(26) 0.6(4) 
C(24)-C(25)-C(26)-C(27) -3.1(4) 
C(19)-C(18)-C(27)-C(26) 5.6(3) 
C(17)-C(18)-C(27)-C(26) -172.3(2) 
C(19)-C(18)-C(27)-N(3) -172.90(19) 
C(17)-C(18)-C(27)-N(3) 9.2(3) 
C(25)-C(26)-C(27)-C(18) -0.1(4) 
C(25)-C(26)-C(27)-N(3) 178.5(2) 
C(28)-N(3)-C(27)-C(18) -136.4(2) 
P(1)-N(3)-C(27)-C(18) 72.6(2) 
C(28)-N(3)-C(27)-C(26) 45.0(3) 
P(1)-N(3)-C(27)-C(26) -106.0(2) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 -x,-y+2,-z       
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Crystal Structure of (R)-62b 
 
  Crystal data and structure refinement for bc56ras. 
Identification code  bc56ras 
Empirical formula  C28 H30 N3 P Se 
Formula weight  518.48 
Temperature  193(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P2(1)    
Unit cell dimensions a = 16.6637(6) Å  
 b = 9.1966(5) Å  
 c = 16.8975(7) Å  
Volume 2435.84(19) Å3 
Z 4 
Density (calculated) 1.414 Mg/m3 
Absorption coefficient 2.863 mm-1 
F(000) 1072 
Crystal size 0.344 x 0.177 x 0.04 mm3 
Theta range for data collection 2.78 to 67.27°. 
Index ranges -19<=h<=19, -10<=k<=9, -19<=l<=20 
Reflections collected 17531 
Independent reflections 6815 [R(int) = 0.0730] 
Completeness to theta = 67.27° 97.5 %  
Absorption correction Integration 
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Max. and min. transmission 0.9023 and 0.6321 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6815 / 2368 / 1165 
Goodness-of-fit on F2 1.027 
Final R indices [I>2sigma(I)] R1 = 0.0520, wR2 = 0.1265 
R indices (all data) R1 = 0.0618, wR2 = 0.1359 
Absolute structure parameter 0.01(2) 
Largest diff. peak and hole 0.782 and -0.425 e.Å-3 
 
 Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for bc56ras.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________
__  
 x y z U(eq) 
______________________________________________________________________________
__   
P(1) 2068(1) 5405(2) 8330(1) 38(1) 
Se(1) 829(1) 4595(1) 8072(1) 61(1) 
N(1) 2671(8) 5656(13) 9356(4) 37(2) 
C(1) 2259(11) 6609(13) 9759(11) 37(2) 
C(2) 2266(9) 8094(12) 9593(10) 36(2) 
C(3) 1732(10) 9060(13) 9871(10) 34(2) 
C(4) 1593(11) 10507(15) 9627(11) 37(2) 
C(5) 1058(9) 11374(15) 9878(10) 37(2) 
C(6) 663(8) 10851(17) 10429(8) 36(2) 
C(7) 779(8) 9437(17) 10692(9) 38(2) 
C(8) 1318(8) 8484(15) 10428(8) 37(2) 
C(9) 1408(8) 7010(15) 10639(8) 37(2) 
C(10) 1834(9) 6086(15) 10303(9) 39(2) 
C(21) 3101(15) 4361(19) 9836(13) 39(3) 
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N(2) 2137(10) 7050(10) 7945(7) 44(2) 
C(11) 2770(10) 8118(18) 8357(8) 40(2) 
C(12) 2836(9) 8646(15) 9138(8) 35(2) 
C(13) 3528(9) 9641(18) 9554(8) 37(2) 
C(14) 3699(8) 10115(16) 10399(8) 39(2) 
C(15) 4324(9) 11092(17) 10749(8) 43(2) 
C(16) 4858(9) 11589(17) 10326(9) 44(2) 
C(17) 4746(8) 11123(17) 9533(9) 40(2) 
C(18) 4076(9) 10133(18) 9130(8) 38(2) 
C(19) 3968(8) 9578(16) 8325(8) 39(2) 
C(20) 3348(8) 8595(15) 7953(7) 40(2) 
C(22) 1526(15) 7430(20) 7108(10) 59(4) 
N(1B) 2587(10) 5782(16) 9360(5) 39(2) 
C(1B) 2179(14) 6831(15) 9715(14) 37(2) 
C(2B) 2223(11) 8293(14) 9513(12) 37(2) 
C(3B) 1718(12) 9356(16) 9762(12) 35(2) 
C(4B) 1637(13) 10795(16) 9493(14) 35(2) 
C(5B) 1151(11) 11762(17) 9746(12) 38(2) 
C(6B) 706(10) 11321(19) 10271(11) 38(3) 
C(7B) 746(9) 9910(20) 10538(10) 36(2) 
C(8B) 1238(9) 8864(16) 10275(10) 36(2) 
C(9B) 1259(10) 7397(17) 10501(10) 37(2) 
C(10B) 1691(11) 6398(16) 10220(12) 39(2) 
C(21B) 2923(17) 4470(20) 9873(16) 40(4) 
N(2B) 2012(12) 7050(11) 7903(8) 41(2) 
C(11B) 2669(12) 8110(20) 8249(10) 41(2) 
C(12B) 2788(11) 8713(19) 9026(10) 37(2) 
C(13B) 3488(11) 9720(20) 9382(9) 38(2) 
C(14B) 3662(10) 10368(19) 10191(9) 39(2) 
C(15B) 4339(12) 11260(20) 10515(10) 44(3) 
C(16B) 4855(11) 11633(19) 10050(11) 42(3) 
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C(17B) 4701(10) 11080(20) 9266(11) 43(2) 
C(18B) 4017(10) 10100(20) 8915(10) 39(2) 
C(19B) 3807(10) 9570(20) 8089(9) 41(2) 
C(20B) 3155(11) 8627(19) 7758(9) 43(2) 
C(22B) 1541(18) 7080(30) 6988(10) 60(5) 
N(3) 2682(10) 4292(18) 8023(15) 45(2) 
C(23) 3587(10) 4700(20) 8269(10) 48(2) 
C(24) 3911(10) 4850(20) 7535(10) 55(2) 
C(25) 3198(13) 4730(20) 6669(11) 72(3) 
C(26) 2878(14) 3290(30) 6390(11) 67(3) 
C(27) 2249(13) 2660(30) 6770(11) 61(3) 
C(28) 2511(16) 2800(20) 7713(11) 53(2) 
N(3B) 2648(6) 4320(11) 7969(8) 44(2) 
C(23B) 3472(6) 4741(13) 7912(7) 53(2) 
C(24B) 3483(8) 5112(12) 7044(7) 64(2) 
C(25B) 2857(8) 4184(14) 6327(7) 62(2) 
C(26B) 2805(7) 2649(15) 6501(6) 60(2) 
C(27B) 2205(7) 2244(13) 6967(6) 53(2) 
C(28B) 2452(8) 2770(12) 7861(6) 46(2) 
P(2) 6428(1) 8824(2) 6809(1) 42(1) 
Se(2) 5340(1) 7860(1) 6945(1) 45(1) 
N(4) 7271(5) 7811(14) 7389(7) 43(2) 
C(31) 8104(6) 8176(14) 7340(6) 38(2) 
C(32) 8230(7) 7954(15) 6587(7) 36(2) 
C(33) 8934(9) 8650(19) 6438(7) 39(2) 
C(34) 9041(11) 8620(20) 5646(8) 44(2) 
C(35) 9697(9) 9394(17) 5503(9) 47(2) 
C(36) 10263(8) 10200(16) 6157(10) 49(2) 
C(37) 10197(7) 10226(15) 6929(10) 50(2) 
C(38) 9555(6) 9412(14) 7107(8) 43(2) 
C(39) 9441(6) 9399(15) 7921(7) 47(2) 
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C(40) 8760(6) 8814(15) 8033(7) 42(2) 
C(51) 7297(9) 6951(18) 8136(7) 47(3) 
N(5) 6561(7) 8891(12) 5875(4) 37(2) 
C(41) 6779(7) 7557(14) 5580(11) 34(2) 
C(42) 7608(6) 7057(14) 5926(11) 32(2) 
C(43) 7835(9) 5669(18) 5674(17) 33(2) 
C(44) 8664(9) 5051(18) 6039(14) 38(2) 
C(45) 8836(8) 3675(15) 5851(11) 41(2) 
C(46) 8201(9) 2874(15) 5220(8) 42(2) 
C(47) 7423(9) 3443(14) 4859(9) 39(2) 
C(48) 7198(8) 4834(15) 5068(12) 36(2) 
C(49) 6357(8) 5406(15) 4721(11) 38(2) 
C(50) 6149(7) 6703(15) 4993(11) 34(2) 
C(52) 5907(9) 9807(16) 5277(10) 48(3) 
N(4B) 7352(4) 8011(14) 7346(6) 42(2) 
C(31B) 8093(6) 8544(14) 7175(7) 41(2) 
C(32B) 8213(7) 8097(14) 6449(7) 36(2) 
C(33B) 8908(8) 8685(18) 6234(8) 39(2) 
C(34B) 9007(10) 8410(20) 5450(8) 41(2) 
C(35B) 9646(8) 9105(16) 5231(8) 44(2) 
C(36B) 10209(8) 10050(15) 5805(10) 45(2) 
C(37B) 10125(7) 10371(13) 6549(10) 45(2) 
C(38B) 9472(6) 9705(13) 6786(8) 43(2) 
C(39B) 9351(6) 10012(14) 7580(8) 46(2) 
C(40B) 8692(6) 9479(16) 7759(7) 46(2) 
C(51B) 7429(9) 7620(20) 8203(6) 52(3) 
N(5B) 6428(7) 8615(12) 5814(4) 36(2) 
C(41B) 6751(6) 7296(14) 5593(11) 32(2) 
C(42B) 7617(6) 7011(14) 5901(10) 33(2) 
C(43B) 7933(9) 5622(19) 5746(16) 33(2) 
C(44B) 8788(8) 5162(17) 6172(13) 37(2) 
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C(45B) 9069(8) 3862(15) 5991(10) 43(2) 
C(46B) 8509(8) 2914(15) 5390(9) 43(2) 
C(47B) 7696(8) 3300(13) 4996(9) 40(2) 
C(48B) 7377(8) 4654(14) 5153(11) 36(2) 
C(49B) 6505(8) 5055(15) 4790(10) 37(2) 
C(50B) 6201(7) 6325(16) 5002(11) 35(2) 
C(52B) 5729(9) 9312(17) 5126(10) 50(3) 
N(6) 6363(8) 10630(8) 6777(9) 48(2) 
C(53) 6921(8) 11583(13) 6459(8) 45(2) 
C(54) 7474(9) 12659(17) 7067(10) 53(2) 
C(55) 7009(10) 14028(14) 7223(10) 57(2) 
C(56) 6514(10) 13807(15) 7802(10) 61(2) 
C(57) 6162(10) 12343(15) 7849(8) 59(2) 
C(58) 5769(8) 11468(16) 7088(9) 54(2) 
N(6B) 6558(5) 10530(7) 7138(5) 44(2) 
C(53B) 7268(6) 11436(10) 7043(7) 53(2) 
C(54B) 7183(8) 13048(12) 7113(7) 58(2) 
C(55B) 6294(7) 13690(12) 6645(6) 59(2) 
C(56B) 5692(7) 13616(12) 7130(7) 60(2) 
C(57B) 5471(6) 12158(11) 7363(6) 52(2) 
C(58B) 6170(6) 11112(11) 7741(5) 47(2) 
______________________________________________________________________________
__ 
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 Bond lengths [Å] and angles [°] for  bc56ras. 
_____________________________________________________  
P(1)-N(3B)  1.644(5) 
P(1)-N(3)  1.651(7) 
P(1)-N(2B)  1.664(7) 
P(1)-N(2)  1.665(6) 
P(1)-N(1B)  1.696(6) 
P(1)-N(1)  1.699(6) 
P(1)-Se(1)  2.0977(14) 
N(1)-C(1)  1.422(9) 
N(1)-C(21)  1.482(10) 
C(1)-C(2)  1.396(10) 
C(1)-C(10)  1.421(9) 
C(2)-C(3)  1.445(9) 
C(2)-C(12)  1.498(8) 
C(3)-C(4)  1.389(11) 
C(3)-C(8)  1.443(10) 
C(4)-C(5)  1.366(10) 
C(4)-H(4A)  0.9500 
C(5)-C(6)  1.396(13) 
C(5)-H(5A)  0.9500 
C(6)-C(7)  1.367(15) 
C(6)-H(6A)  0.9500 
C(7)-C(8)  1.431(11) 
C(7)-H(7A)  0.9500 
C(8)-C(9)  1.397(12) 
C(9)-C(10)  1.350(11) 
C(9)-H(9A)  0.9500 
C(10)-H(10A)  0.9500 
C(21)-H(21A)  0.9800 
C(21)-H(21B)  0.9800 
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C(21)-H(21C)  0.9800 
N(2)-C(11)  1.437(9) 
N(2)-C(22)  1.477(10) 
C(11)-C(12)  1.375(8) 
C(11)-C(20)  1.427(9) 
C(12)-C(13)  1.453(9) 
C(13)-C(18)  1.414(9) 
C(13)-C(14)  1.426(10) 
C(14)-C(15)  1.351(11) 
C(14)-H(14A)  0.9500 
C(15)-C(16)  1.394(12) 
C(15)-H(15A)  0.9500 
C(16)-C(17)  1.358(12) 
C(16)-H(16A)  0.9500 
C(17)-C(18)  1.422(11) 
C(17)-H(17A)  0.9500 
C(18)-C(19)  1.406(11) 
C(19)-C(20)  1.356(11) 
C(19)-H(19A)  0.9500 
C(20)-H(20A)  0.9500 
C(22)-H(22A)  0.9800 
C(22)-H(22B)  0.9800 
C(22)-H(22C)  0.9800 
N(1B)-C(1B)  1.426(9) 
N(1B)-C(21B)  1.484(10) 
C(1B)-C(2B)  1.395(11) 
C(1B)-C(10B)  1.421(9) 
C(2B)-C(3B)  1.443(9) 
C(2B)-C(12B)  1.496(8) 
C(3B)-C(4B)  1.390(12) 
C(3B)-C(8B)  1.437(10) 
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C(4B)-C(5B)  1.365(10) 
C(4B)-H(4B)  0.9500 
C(5B)-C(6B)  1.397(14) 
C(5B)-H(5B)  0.9500 
C(6B)-C(7B)  1.364(15) 
C(6B)-H(6B)  0.9500 
C(7B)-C(8B)  1.432(11) 
C(7B)-H(7B)  0.9500 
C(8B)-C(9B)  1.399(13) 
C(9B)-C(10B)  1.349(12) 
C(9B)-H(9B)  0.9500 
C(10B)-H(10B)  0.9500 
C(21B)-H(21D)  0.9800 
C(21B)-H(21E)  0.9800 
C(21B)-H(21F)  0.9800 
N(2B)-C(11B)  1.434(9) 
N(2B)-C(22B)  1.477(11) 
C(11B)-C(12B)  1.376(9) 
C(11B)-C(20B)  1.424(10) 
C(12B)-C(13B)  1.451(9) 
C(13B)-C(18B)  1.413(10) 
C(13B)-C(14B)  1.427(10) 
C(14B)-C(15B)  1.352(12) 
C(14B)-H(14B)  0.9500 
C(15B)-C(16B)  1.390(13) 
C(15B)-H(15B)  0.9500 
C(16B)-C(17B)  1.359(13) 
C(16B)-H(16B)  0.9500 
C(17B)-C(18B)  1.419(11) 
C(17B)-H(17B)  0.9500 
C(18B)-C(19B)  1.404(11) 
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C(19B)-C(20B)  1.355(12) 
C(19B)-H(19B)  0.9500 
C(20B)-H(20B)  0.9500 
C(22B)-H(22D)  0.9800 
C(22B)-H(22E)  0.9800 
C(22B)-H(22F)  0.9800 
N(3)-C(28)  1.464(12) 
N(3)-C(23)  1.470(11) 
C(23)-C(24)  1.518(15) 
C(23)-H(23A)  0.9900 
C(23)-H(23B)  0.9900 
C(24)-C(25)  1.545(15) 
C(24)-H(24A)  0.9900 
C(24)-H(24B)  0.9900 
C(25)-C(26)  1.452(18) 
C(25)-H(25A)  0.9900 
C(25)-H(25B)  0.9900 
C(26)-C(27)  1.516(15) 
C(26)-H(26A)  0.9900 
C(26)-H(26B)  0.9900 
C(27)-C(28)  1.508(12) 
C(27)-H(27A)  0.9900 
C(27)-H(27B)  0.9900 
C(28)-H(28A)  0.9900 
C(28)-H(28B)  0.9900 
N(3B)-C(23B)  1.460(9) 
N(3B)-C(28B)  1.460(10) 
C(23B)-C(24B)  1.512(14) 
C(23B)-H(23C)  0.9900 
C(23B)-H(23D)  0.9900 
C(24B)-C(25B)  1.558(14) 
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C(24B)-H(24C)  0.9900 
C(24B)-H(24D)  0.9900 
C(25B)-C(26B)  1.450(17) 
C(25B)-H(25C)  0.9900 
C(25B)-H(25D)  0.9900 
C(26B)-C(27B)  1.516(14) 
C(26B)-H(26C)  0.9900 
C(26B)-H(26D)  0.9900 
C(27B)-C(28B)  1.503(10) 
C(27B)-H(27C)  0.9900 
C(27B)-H(27D)  0.9900 
C(28B)-H(28C)  0.9900 
C(28B)-H(28D)  0.9900 
P(2)-N(6B)  1.654(6) 
P(2)-N(6)  1.665(7) 
P(2)-N(5)  1.666(6) 
P(2)-N(4B)  1.674(6) 
P(2)-N(5B)  1.692(6) 
P(2)-N(4)  1.693(6) 
P(2)-Se(2)  2.1013(13) 
N(4)-C(31)  1.457(10) 
N(4)-C(51)  1.478(10) 
C(31)-C(32)  1.373(9) 
C(31)-C(40)  1.429(10) 
C(32)-C(33)  1.432(9) 
C(32)-C(42)  1.489(8) 
C(33)-C(34)  1.410(11) 
C(33)-C(38)  1.430(10) 
C(34)-C(35)  1.391(11) 
C(34)-H(34A)  0.9500 
C(35)-C(36)  1.397(15) 
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C(35)-H(35A)  0.9500 
C(36)-C(37)  1.346(15) 
C(36)-H(36A)  0.9500 
C(37)-C(38)  1.419(14) 
C(37)-H(37A)  0.9500 
C(38)-C(39)  1.452(14) 
C(39)-C(40)  1.325(14) 
C(39)-H(39A)  0.9500 
C(40)-H(40A)  0.9500 
C(51)-H(51A)  0.9800 
C(51)-H(51B)  0.9800 
C(51)-H(51C)  0.9800 
N(5)-C(41)  1.417(9) 
N(5)-C(52)  1.474(9) 
C(41)-C(42)  1.383(8) 
C(41)-C(50)  1.413(10) 
C(42)-C(43)  1.436(9) 
C(43)-C(48)  1.424(9) 
C(43)-C(44)  1.426(9) 
C(44)-C(45)  1.359(11) 
C(44)-H(44A)  0.9500 
C(45)-C(46)  1.425(13) 
C(45)-H(45A)  0.9500 
C(46)-C(47)  1.338(13) 
C(46)-H(46A)  0.9500 
C(47)-C(48)  1.412(12) 
C(47)-H(47A)  0.9500 
C(48)-C(49)  1.423(11) 
C(49)-C(50)  1.364(12) 
C(49)-H(49A)  0.9500 
C(50)-H(50A)  0.9500 
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C(52)-H(52A)  0.9800 
C(52)-H(52B)  0.9800 
C(52)-H(52C)  0.9800 
N(4B)-C(31B)  1.445(10) 
N(4B)-C(51B)  1.455(11) 
C(31B)-C(32B)  1.372(9) 
C(31B)-C(40B)  1.428(10) 
C(32B)-C(33B)  1.432(9) 
C(32B)-C(42B)  1.490(8) 
C(33B)-C(34B)  1.412(11) 
C(33B)-C(38B)  1.428(10) 
C(34B)-C(35B)  1.392(11) 
C(34B)-H(34B)  0.9500 
C(35B)-C(36B)  1.400(14) 
C(35B)-H(35B)  0.9500 
C(36B)-C(37B)  1.343(15) 
C(36B)-H(36B)  0.9500 
C(37B)-C(38B)  1.419(14) 
C(37B)-H(37B)  0.9500 
C(38B)-C(39B)  1.451(14) 
C(39B)-C(40B)  1.328(14) 
C(39B)-H(39B)  0.9500 
C(40B)-H(40B)  0.9500 
C(51B)-H(51D)  0.9800 
C(51B)-H(51E)  0.9800 
C(51B)-H(51F)  0.9800 
N(5B)-C(41B)  1.427(9) 
N(5B)-C(52B)  1.483(9) 
C(41B)-C(42B)  1.382(8) 
C(41B)-C(50B)  1.418(10) 
C(42B)-C(43B)  1.440(9) 
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C(43B)-C(48B)  1.423(9) 
C(43B)-C(44B)  1.424(9) 
C(44B)-C(45B)  1.357(11) 
C(44B)-H(44B)  0.9500 
C(45B)-C(46B)  1.420(13) 
C(45B)-H(45B)  0.9500 
C(46B)-C(47B)  1.340(13) 
C(46B)-H(46B)  0.9500 
C(47B)-C(48B)  1.413(12) 
C(47B)-H(47B)  0.9500 
C(48B)-C(49B)  1.421(11) 
C(49B)-C(50B)  1.369(12) 
C(49B)-H(49B)  0.9500 
C(50B)-H(50B)  0.9500 
C(52B)-H(52D)  0.9800 
C(52B)-H(52E)  0.9800 
C(52B)-H(52F)  0.9800 
N(6)-C(58)  1.483(11) 
N(6)-C(53)  1.504(11) 
C(53)-C(54)  1.497(15) 
C(53)-H(53A)  0.9900 
C(53)-H(53B)  0.9900 
C(54)-C(55)  1.548(16) 
C(54)-H(54A)  0.9900 
C(54)-H(54B)  0.9900 
C(55)-C(56)  1.492(14) 
C(55)-H(55A)  0.9900 
C(55)-H(55B)  0.9900 
C(56)-C(57)  1.481(15) 
C(56)-H(56A)  0.9900 
C(56)-H(56B)  0.9900 
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C(57)-C(58)  1.470(13) 
C(57)-H(57A)  0.9900 
C(57)-H(57B)  0.9900 
C(58)-H(58A)  0.9900 
C(58)-H(58B)  0.9900 
N(6B)-C(58B)  1.480(10) 
N(6B)-C(53B)  1.499(10) 
C(53B)-C(54B)  1.498(14) 
C(53B)-H(53C)  0.9900 
C(53B)-H(53D)  0.9900 
C(54B)-C(55B)  1.540(15) 
C(54B)-H(54C)  0.9900 
C(54B)-H(54D)  0.9900 
C(55B)-C(56B)  1.497(13) 
C(55B)-H(55C)  0.9900 
C(55B)-H(55D)  0.9900 
C(56B)-C(57B)  1.479(14) 
C(56B)-H(56C)  0.9900 
C(56B)-H(56D)  0.9900 
C(57B)-C(58B)  1.478(12) 
C(57B)-H(57C)  0.9900 
C(57B)-H(57D)  0.9900 
C(58B)-H(58C)  0.9900 
C(58B)-H(58D)  0.9900 
 
N(3B)-P(1)-N(2B) 110.2(9) 
N(3)-P(1)-N(2B) 112.2(11) 
N(3B)-P(1)-N(2) 106.3(8) 
N(3)-P(1)-N(2) 108.0(10) 
N(3B)-P(1)-N(1B) 110.2(7) 
N(3)-P(1)-N(1B) 107.1(10) 
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N(2B)-P(1)-N(1B) 101.1(6) 
N(2)-P(1)-N(1B) 97.8(8) 
N(3B)-P(1)-N(1) 104.0(6) 
N(3)-P(1)-N(1) 100.9(9) 
N(2B)-P(1)-N(1) 104.2(7) 
N(2)-P(1)-N(1) 100.4(5) 
N(3B)-P(1)-Se(1) 111.6(3) 
N(3)-P(1)-Se(1) 112.7(6) 
N(2B)-P(1)-Se(1) 109.0(6) 
N(2)-P(1)-Se(1) 115.8(5) 
N(1B)-P(1)-Se(1) 114.1(7) 
N(1)-P(1)-Se(1) 117.4(5) 
C(1)-N(1)-C(21) 117.1(8) 
C(1)-N(1)-P(1) 111.0(10) 
C(21)-N(1)-P(1) 117.3(11) 
C(2)-C(1)-C(10) 120.1(7) 
C(2)-C(1)-N(1) 117.9(7) 
C(10)-C(1)-N(1) 122.0(8) 
C(1)-C(2)-C(3) 119.2(6) 
C(1)-C(2)-C(12) 119.1(7) 
C(3)-C(2)-C(12) 121.7(8) 
C(4)-C(3)-C(8) 118.5(7) 
C(4)-C(3)-C(2) 123.5(7) 
C(8)-C(3)-C(2) 118.0(7) 
C(5)-C(4)-C(3) 121.9(9) 
C(5)-C(4)-H(4A) 119.1 
C(3)-C(4)-H(4A) 119.1 
C(4)-C(5)-C(6) 120.7(10) 
C(4)-C(5)-H(5A) 119.6 
C(6)-C(5)-H(5A) 119.6 
C(7)-C(6)-C(5) 119.9(8) 
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C(7)-C(6)-H(6A) 120.1 
C(5)-C(6)-H(6A) 120.1 
C(6)-C(7)-C(8) 121.0(9) 
C(6)-C(7)-H(7A) 119.5 
C(8)-C(7)-H(7A) 119.5 
C(9)-C(8)-C(7) 122.5(8) 
C(9)-C(8)-C(3) 119.3(7) 
C(7)-C(8)-C(3) 118.0(9) 
C(10)-C(9)-C(8) 121.9(8) 
C(10)-C(9)-H(9A) 119.0 
C(8)-C(9)-H(9A) 119.0 
C(9)-C(10)-C(1) 120.5(9) 
C(9)-C(10)-H(10A) 119.7 
C(1)-C(10)-H(10A) 119.7 
C(11)-N(2)-C(22) 117.3(9) 
C(11)-N(2)-P(1) 124.6(9) 
C(22)-N(2)-P(1) 118.1(10) 
C(12)-C(11)-C(20) 120.3(7) 
C(12)-C(11)-N(2) 120.8(7) 
C(20)-C(11)-N(2) 118.9(8) 
C(11)-C(12)-C(13) 118.6(6) 
C(11)-C(12)-C(2) 120.9(7) 
C(13)-C(12)-C(2) 120.1(7) 
C(18)-C(13)-C(14) 117.8(7) 
C(18)-C(13)-C(12) 120.0(7) 
C(14)-C(13)-C(12) 122.3(7) 
C(15)-C(14)-C(13) 120.3(8) 
C(15)-C(14)-H(14A) 119.8 
C(13)-C(14)-H(14A) 119.8 
C(14)-C(15)-C(16) 121.6(9) 
C(14)-C(15)-H(15A) 119.2 
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C(16)-C(15)-H(15A) 119.2 
C(17)-C(16)-C(15) 120.3(8) 
C(17)-C(16)-H(16A) 119.8 
C(15)-C(16)-H(16A) 119.8 
C(16)-C(17)-C(18) 119.8(8) 
C(16)-C(17)-H(17A) 120.1 
C(18)-C(17)-H(17A) 120.1 
C(19)-C(18)-C(13) 118.8(7) 
C(19)-C(18)-C(17) 121.2(8) 
C(13)-C(18)-C(17) 120.0(8) 
C(20)-C(19)-C(18) 121.2(7) 
C(20)-C(19)-H(19A) 119.4 
C(18)-C(19)-H(19A) 119.4 
C(19)-C(20)-C(11) 121.0(7) 
C(19)-C(20)-H(20A) 119.5 
C(11)-C(20)-H(20A) 119.5 
C(1B)-N(1B)-C(21B) 116.4(9) 
C(1B)-N(1B)-P(1) 114.9(13) 
C(21B)-N(1B)-P(1) 113.2(14) 
C(2B)-C(1B)-C(10B) 120.4(8) 
C(2B)-C(1B)-N(1B) 118.4(8) 
C(10B)-C(1B)-N(1B) 121.0(9) 
C(1B)-C(2B)-C(3B) 119.8(7) 
C(1B)-C(2B)-C(12B) 118.6(8) 
C(3B)-C(2B)-C(12B) 121.6(8) 
C(4B)-C(3B)-C(8B) 119.0(8) 
C(4B)-C(3B)-C(2B) 123.4(8) 
C(8B)-C(3B)-C(2B) 117.4(8) 
C(5B)-C(4B)-C(3B) 121.3(10) 
C(5B)-C(4B)-H(4B) 119.3 
C(3B)-C(4B)-H(4B) 119.3 
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C(4B)-C(5B)-C(6B) 120.6(11) 
C(4B)-C(5B)-H(5B) 119.7 
C(6B)-C(5B)-H(5B) 119.7 
C(7B)-C(6B)-C(5B) 120.6(9) 
C(7B)-C(6B)-H(6B) 119.7 
C(5B)-C(6B)-H(6B) 119.7 
C(6B)-C(7B)-C(8B) 120.4(10) 
C(6B)-C(7B)-H(7B) 119.8 
C(8B)-C(7B)-H(7B) 119.8 
C(9B)-C(8B)-C(7B) 122.0(9) 
C(9B)-C(8B)-C(3B) 120.1(8) 
C(7B)-C(8B)-C(3B) 117.9(10) 
C(10B)-C(9B)-C(8B) 121.8(9) 
C(10B)-C(9B)-H(9B) 119.1 
C(8B)-C(9B)-H(9B) 119.1 
C(9B)-C(10B)-C(1B) 120.2(9) 
C(9B)-C(10B)-H(10B) 119.9 
C(1B)-C(10B)-H(10B) 119.9 
N(1B)-C(21B)-H(21D) 109.5 
N(1B)-C(21B)-H(21E) 109.5 
H(21D)-C(21B)-H(21E) 109.5 
N(1B)-C(21B)-H(21F) 109.5 
H(21D)-C(21B)-H(21F) 109.5 
H(21E)-C(21B)-H(21F) 109.5 
C(11B)-N(2B)-C(22B) 118.3(10) 
C(11B)-N(2B)-P(1) 121.2(12) 
C(22B)-N(2B)-P(1) 113.7(12) 
C(12B)-C(11B)-C(20B) 119.6(8) 
C(12B)-C(11B)-N(2B) 120.4(8) 
C(20B)-C(11B)-N(2B) 119.8(8) 
C(11B)-C(12B)-C(13B) 119.3(7) 
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C(11B)-C(12B)-C(2B) 120.4(8) 
C(13B)-C(12B)-C(2B) 120.3(8) 
C(18B)-C(13B)-C(14B) 118.0(8) 
C(18B)-C(13B)-C(12B) 119.5(7) 
C(14B)-C(13B)-C(12B) 122.5(8) 
C(15B)-C(14B)-C(13B) 120.9(9) 
C(15B)-C(14B)-H(14B) 119.6 
C(13B)-C(14B)-H(14B) 119.6 
C(14B)-C(15B)-C(16B) 120.7(10) 
C(14B)-C(15B)-H(15B) 119.7 
C(16B)-C(15B)-H(15B) 119.7 
C(17B)-C(16B)-C(15B) 120.8(9) 
C(17B)-C(16B)-H(16B) 119.6 
C(15B)-C(16B)-H(16B) 119.6 
C(16B)-C(17B)-C(18B) 120.2(9) 
C(16B)-C(17B)-H(17B) 119.9 
C(18B)-C(17B)-H(17B) 119.9 
C(19B)-C(18B)-C(13B) 118.5(8) 
C(19B)-C(18B)-C(17B) 122.0(9) 
C(13B)-C(18B)-C(17B) 119.3(9) 
C(20B)-C(19B)-C(18B) 121.8(8) 
C(20B)-C(19B)-H(19B) 119.1 
C(18B)-C(19B)-H(19B) 119.1 
C(19B)-C(20B)-C(11B) 120.6(9) 
C(19B)-C(20B)-H(20B) 119.7 
C(11B)-C(20B)-H(20B) 119.7 
N(2B)-C(22B)-H(22D) 109.5 
N(2B)-C(22B)-H(22E) 109.5 
H(22D)-C(22B)-H(22E) 109.5 
N(2B)-C(22B)-H(22F) 109.5 
H(22D)-C(22B)-H(22F) 109.5 
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H(22E)-C(22B)-H(22F) 109.5 
C(28)-N(3)-C(23) 113.5(10) 
C(28)-N(3)-P(1) 128.9(14) 
C(23)-N(3)-P(1) 115.9(11) 
N(3)-C(23)-C(24) 114.0(12) 
N(3)-C(23)-H(23A) 108.8 
C(24)-C(23)-H(23A) 108.8 
N(3)-C(23)-H(23B) 108.8 
C(24)-C(23)-H(23B) 108.8 
H(23A)-C(23)-H(23B) 107.7 
C(23)-C(24)-C(25) 113.3(11) 
C(23)-C(24)-H(24A) 108.9 
C(25)-C(24)-H(24A) 108.9 
C(23)-C(24)-H(24B) 108.9 
C(25)-C(24)-H(24B) 108.9 
H(24A)-C(24)-H(24B) 107.7 
C(26)-C(25)-C(24) 116.6(14) 
C(26)-C(25)-H(25A) 108.1 
C(24)-C(25)-H(25A) 108.1 
C(26)-C(25)-H(25B) 108.1 
C(24)-C(25)-H(25B) 108.1 
H(25A)-C(25)-H(25B) 107.3 
C(25)-C(26)-C(27) 116.2(13) 
C(25)-C(26)-H(26A) 108.2 
C(27)-C(26)-H(26A) 108.2 
C(25)-C(26)-H(26B) 108.2 
C(27)-C(26)-H(26B) 108.2 
H(26A)-C(26)-H(26B) 107.4 
C(28)-C(27)-C(26) 114.9(11) 
C(28)-C(27)-H(27A) 108.5 
C(26)-C(27)-H(27A) 108.5 
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C(28)-C(27)-H(27B) 108.5 
C(26)-C(27)-H(27B) 108.5 
H(27A)-C(27)-H(27B) 107.5 
N(3)-C(28)-C(27) 114.0(12) 
N(3)-C(28)-H(28A) 108.7 
C(27)-C(28)-H(28A) 108.7 
N(3)-C(28)-H(28B) 108.7 
C(27)-C(28)-H(28B) 108.7 
H(28A)-C(28)-H(28B) 107.6 
C(23B)-N(3B)-C(28B) 115.2(6) 
C(23B)-N(3B)-P(1) 123.2(7) 
C(28B)-N(3B)-P(1) 120.3(8) 
N(3B)-C(23B)-C(24B) 116.5(10) 
N(3B)-C(23B)-H(23C) 108.2 
C(24B)-C(23B)-H(23C) 108.2 
N(3B)-C(23B)-H(23D) 108.2 
C(24B)-C(23B)-H(23D) 108.2 
H(23C)-C(23B)-H(23D) 107.3 
C(23B)-C(24B)-C(25B) 113.9(8) 
C(23B)-C(24B)-H(24C) 108.8 
C(25B)-C(24B)-H(24C) 108.8 
C(23B)-C(24B)-H(24D) 108.8 
C(25B)-C(24B)-H(24D) 108.8 
H(24C)-C(24B)-H(24D) 107.7 
C(26B)-C(25B)-C(24B) 116.5(10) 
C(26B)-C(25B)-H(25C) 108.2 
C(24B)-C(25B)-H(25C) 108.2 
C(26B)-C(25B)-H(25D) 108.2 
C(24B)-C(25B)-H(25D) 108.2 
H(25C)-C(25B)-H(25D) 107.3 
C(25B)-C(26B)-C(27B) 116.2(9) 
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C(25B)-C(26B)-H(26C) 108.2 
C(27B)-C(26B)-H(26C) 108.2 
C(25B)-C(26B)-H(26D) 108.2 
C(27B)-C(26B)-H(26D) 108.2 
H(26C)-C(26B)-H(26D) 107.4 
C(28B)-C(27B)-C(26B) 116.0(8) 
C(28B)-C(27B)-H(27C) 108.3 
C(26B)-C(27B)-H(27C) 108.3 
C(28B)-C(27B)-H(27D) 108.3 
C(26B)-C(27B)-H(27D) 108.3 
H(27C)-C(27B)-H(27D) 107.4 
N(3B)-C(28B)-C(27B) 114.4(8) 
N(3B)-C(28B)-H(28C) 108.7 
C(27B)-C(28B)-H(28C) 108.7 
N(3B)-C(28B)-H(28D) 108.7 
C(27B)-C(28B)-H(28D) 108.7 
H(28C)-C(28B)-H(28D) 107.6 
N(6B)-P(2)-N(5) 103.8(5) 
N(6)-P(2)-N(5) 87.8(6) 
N(6B)-P(2)-N(4B) 104.5(6) 
N(6)-P(2)-N(4B) 120.1(7) 
N(5)-P(2)-N(4B) 97.9(5) 
N(6B)-P(2)-N(5B) 113.4(5) 
N(6)-P(2)-N(5B) 95.9(6) 
N(4B)-P(2)-N(5B) 100.3(5) 
N(6B)-P(2)-N(4) 109.8(6) 
N(6)-P(2)-N(4) 126.9(7) 
N(5)-P(2)-N(4) 102.6(5) 
N(5B)-P(2)-N(4) 103.5(6) 
N(6B)-P(2)-Se(2) 112.5(2) 
N(6)-P(2)-Se(2) 112.0(4) 
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N(5)-P(2)-Se(2) 121.1(4) 
N(4B)-P(2)-Se(2) 114.9(4) 
N(5B)-P(2)-Se(2) 110.6(4) 
N(4)-P(2)-Se(2) 106.3(4) 
C(31)-N(4)-C(51) 114.8(7) 
C(31)-N(4)-P(2) 117.3(8) 
C(51)-N(4)-P(2) 124.6(8) 
C(32)-C(31)-C(40) 120.3(8) 
C(32)-C(31)-N(4) 117.8(7) 
C(40)-C(31)-N(4) 121.8(8) 
C(31)-C(32)-C(33) 119.2(7) 
C(31)-C(32)-C(42) 119.4(8) 
C(33)-C(32)-C(42) 121.3(8) 
C(34)-C(33)-C(38) 117.9(8) 
C(34)-C(33)-C(32) 122.3(7) 
C(38)-C(33)-C(32) 119.8(8) 
C(35)-C(34)-C(33) 121.0(9) 
C(35)-C(34)-H(34A) 119.5 
C(33)-C(34)-H(34A) 119.5 
C(34)-C(35)-C(36) 119.5(11) 
C(34)-C(35)-H(35A) 120.3 
C(36)-C(35)-H(35A) 120.3 
C(37)-C(36)-C(35) 121.4(9) 
C(37)-C(36)-H(36A) 119.3 
C(35)-C(36)-H(36A) 119.3 
C(36)-C(37)-C(38) 120.7(10) 
C(36)-C(37)-H(37A) 119.6 
C(38)-C(37)-H(37A) 119.6 
C(37)-C(38)-C(33) 119.1(10) 
C(37)-C(38)-C(39) 123.8(9) 
C(33)-C(38)-C(39) 116.9(8) 
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C(40)-C(39)-C(38) 122.2(8) 
C(40)-C(39)-H(39A) 118.9 
C(38)-C(39)-H(39A) 118.9 
C(39)-C(40)-C(31) 120.3(9) 
C(39)-C(40)-H(40A) 119.9 
C(31)-C(40)-H(40A) 119.9 
C(41)-N(5)-C(52) 118.2(9) 
C(41)-N(5)-P(2) 115.7(11) 
C(52)-N(5)-P(2) 111.5(9) 
C(42)-C(41)-C(50) 120.6(7) 
C(42)-C(41)-N(5) 118.6(7) 
C(50)-C(41)-N(5) 120.7(7) 
C(41)-C(42)-C(43) 119.7(6) 
C(41)-C(42)-C(32) 118.3(7) 
C(43)-C(42)-C(32) 121.9(7) 
C(48)-C(43)-C(44) 118.2(7) 
C(48)-C(43)-C(42) 119.0(7) 
C(44)-C(43)-C(42) 122.7(7) 
C(45)-C(44)-C(43) 121.3(9) 
C(45)-C(44)-H(44A) 119.3 
C(43)-C(44)-H(44A) 119.3 
C(44)-C(45)-C(46) 119.6(9) 
C(44)-C(45)-H(45A) 120.2 
C(46)-C(45)-H(45A) 120.2 
C(47)-C(46)-C(45) 119.8(9) 
C(47)-C(46)-H(46A) 120.1 
C(45)-C(46)-H(46A) 120.1 
C(46)-C(47)-C(48) 122.7(9) 
C(46)-C(47)-H(47A) 118.7 
C(48)-C(47)-H(47A) 118.7 
C(47)-C(48)-C(49) 122.7(8) 
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C(47)-C(48)-C(43) 118.1(8) 
C(49)-C(48)-C(43) 119.1(8) 
C(50)-C(49)-C(48) 120.7(7) 
C(50)-C(49)-H(49A) 119.6 
C(48)-C(49)-H(49A) 119.6 
C(49)-C(50)-C(41) 120.6(8) 
C(49)-C(50)-H(50A) 119.7 
C(41)-C(50)-H(50A) 119.7 
C(31B)-N(4B)-C(51B) 119.3(8) 
C(31B)-N(4B)-P(2) 115.5(8) 
C(51B)-N(4B)-P(2) 113.8(8) 
C(32B)-C(31B)-C(40B) 121.2(8) 
C(32B)-C(31B)-N(4B) 118.1(7) 
C(40B)-C(31B)-N(4B) 120.7(8) 
C(31B)-C(32B)-C(33B) 119.4(7) 
C(31B)-C(32B)-C(42B) 119.2(8) 
C(33B)-C(32B)-C(42B) 121.5(8) 
C(34B)-C(33B)-C(38B) 117.9(8) 
C(34B)-C(33B)-C(32B) 122.3(7) 
C(38B)-C(33B)-C(32B) 119.5(8) 
C(35B)-C(34B)-C(33B) 120.8(9) 
C(35B)-C(34B)-H(34B) 119.6 
C(33B)-C(34B)-H(34B) 119.6 
C(34B)-C(35B)-C(36B) 119.5(10) 
C(34B)-C(35B)-H(35B) 120.3 
C(36B)-C(35B)-H(35B) 120.3 
C(37B)-C(36B)-C(35B) 121.8(9) 
C(37B)-C(36B)-H(36B) 119.1 
C(35B)-C(36B)-H(36B) 119.1 
C(36B)-C(37B)-C(38B) 120.1(10) 
C(36B)-C(37B)-H(37B) 119.9 
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C(38B)-C(37B)-H(37B) 119.9 
C(37B)-C(38B)-C(33B) 119.8(10) 
C(37B)-C(38B)-C(39B) 122.5(9) 
C(33B)-C(38B)-C(39B) 117.7(8) 
C(40B)-C(39B)-C(38B) 121.6(8) 
C(40B)-C(39B)-H(39B) 119.2 
C(38B)-C(39B)-H(39B) 119.2 
C(39B)-C(40B)-C(31B) 120.2(9) 
C(39B)-C(40B)-H(40B) 119.9 
C(31B)-C(40B)-H(40B) 119.9 
N(4B)-C(51B)-H(51D) 109.5 
N(4B)-C(51B)-H(51E) 109.5 
H(51D)-C(51B)-H(51E) 109.5 
N(4B)-C(51B)-H(51F) 109.5 
H(51D)-C(51B)-H(51F) 109.5 
H(51E)-C(51B)-H(51F) 109.5 
C(41B)-N(5B)-C(52B) 115.4(9) 
C(41B)-N(5B)-P(2) 118.9(10) 
C(52B)-N(5B)-P(2) 117.7(9) 
C(42B)-C(41B)-C(50B) 119.2(7) 
C(42B)-C(41B)-N(5B) 120.1(7) 
C(50B)-C(41B)-N(5B) 120.5(7) 
C(41B)-C(42B)-C(43B) 120.0(7) 
C(41B)-C(42B)-C(32B) 119.9(7) 
C(43B)-C(42B)-C(32B) 119.9(7) 
C(48B)-C(43B)-C(44B) 118.1(7) 
C(48B)-C(43B)-C(42B) 119.4(7) 
C(44B)-C(43B)-C(42B) 122.5(7) 
C(45B)-C(44B)-C(43B) 120.7(8) 
C(45B)-C(44B)-H(44B) 119.6 
C(43B)-C(44B)-H(44B) 119.6 
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C(44B)-C(45B)-C(46B) 120.6(9) 
C(44B)-C(45B)-H(45B) 119.7 
C(46B)-C(45B)-H(45B) 119.7 
C(47B)-C(46B)-C(45B) 120.1(9) 
C(47B)-C(46B)-H(46B) 120.0 
C(45B)-C(46B)-H(46B) 120.0 
C(46B)-C(47B)-C(48B) 121.4(8) 
C(46B)-C(47B)-H(47B) 119.3 
C(48B)-C(47B)-H(47B) 119.3 
C(47B)-C(48B)-C(49B) 122.8(8) 
C(47B)-C(48B)-C(43B) 119.1(8) 
C(49B)-C(48B)-C(43B) 117.9(8) 
C(50B)-C(49B)-C(48B) 121.6(7) 
C(50B)-C(49B)-H(49B) 119.2 
C(48B)-C(49B)-H(49B) 119.2 
C(49B)-C(50B)-C(41B) 120.9(8) 
C(49B)-C(50B)-H(50B) 119.5 
C(41B)-C(50B)-H(50B) 119.5 
N(5B)-C(52B)-H(52D) 109.5 
N(5B)-C(52B)-H(52E) 109.5 
H(52D)-C(52B)-H(52E) 109.5 
N(5B)-C(52B)-H(52F) 109.5 
H(52D)-C(52B)-H(52F) 109.5 
H(52E)-C(52B)-H(52F) 109.5 
C(58)-N(6)-C(53) 113.1(8) 
C(58)-N(6)-P(2) 123.5(8) 
C(53)-N(6)-P(2) 123.4(7) 
C(54)-C(53)-N(6) 116.9(10) 
C(54)-C(53)-H(53A) 108.1 
N(6)-C(53)-H(53A) 108.1 
C(54)-C(53)-H(53B) 108.1 
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N(6)-C(53)-H(53B) 108.1 
H(53A)-C(53)-H(53B) 107.3 
C(53)-C(54)-C(55) 115.3(11) 
C(53)-C(54)-H(54A) 108.4 
C(55)-C(54)-H(54A) 108.4 
C(53)-C(54)-H(54B) 108.4 
C(55)-C(54)-H(54B) 108.4 
H(54A)-C(54)-H(54B) 107.5 
C(56)-C(55)-C(54) 114.9(11) 
C(56)-C(55)-H(55A) 108.5 
C(54)-C(55)-H(55A) 108.5 
C(56)-C(55)-H(55B) 108.5 
C(54)-C(55)-H(55B) 108.5 
H(55A)-C(55)-H(55B) 107.5 
C(57)-C(56)-C(55) 118.4(10) 
C(57)-C(56)-H(56A) 107.7 
C(55)-C(56)-H(56A) 107.7 
C(57)-C(56)-H(56B) 107.7 
C(55)-C(56)-H(56B) 107.7 
H(56A)-C(56)-H(56B) 107.1 
C(58)-C(57)-C(56) 121.2(11) 
C(58)-C(57)-H(57A) 107.0 
C(56)-C(57)-H(57A) 107.0 
C(58)-C(57)-H(57B) 107.0 
C(56)-C(57)-H(57B) 107.0 
H(57A)-C(57)-H(57B) 106.8 
C(57)-C(58)-N(6) 116.2(10) 
C(57)-C(58)-H(58A) 108.2 
N(6)-C(58)-H(58A) 108.2 
C(57)-C(58)-H(58B) 108.2 
N(6)-C(58)-H(58B) 108.2 
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H(58A)-C(58)-H(58B) 107.4 
C(58B)-N(6B)-C(53B) 114.7(7) 
C(58B)-N(6B)-P(2) 122.4(6) 
C(53B)-N(6B)-P(2) 120.6(6) 
C(54B)-C(53B)-N(6B) 116.3(8) 
C(54B)-C(53B)-H(53C) 108.2 
N(6B)-C(53B)-H(53C) 108.2 
C(54B)-C(53B)-H(53D) 108.2 
N(6B)-C(53B)-H(53D) 108.2 
H(53C)-C(53B)-H(53D) 107.4 
C(53B)-C(54B)-C(55B) 116.1(9) 
C(53B)-C(54B)-H(54C) 108.3 
C(55B)-C(54B)-H(54C) 108.3 
C(53B)-C(54B)-H(54D) 108.3 
C(55B)-C(54B)-H(54D) 108.3 
H(54C)-C(54B)-H(54D) 107.4 
C(56B)-C(55B)-C(54B) 114.1(8) 
C(56B)-C(55B)-H(55C) 108.7 
C(54B)-C(55B)-H(55C) 108.7 
C(56B)-C(55B)-H(55D) 108.7 
C(54B)-C(55B)-H(55D) 108.7 
H(55C)-C(55B)-H(55D) 107.6 
C(57B)-C(56B)-C(55B) 117.4(8) 
C(57B)-C(56B)-H(56C) 108.0 
C(55B)-C(56B)-H(56C) 108.0 
C(57B)-C(56B)-H(56D) 108.0 
C(55B)-C(56B)-H(56D) 108.0 
H(56C)-C(56B)-H(56D) 107.2 
C(58B)-C(57B)-C(56B) 118.3(9) 
C(58B)-C(57B)-H(57C) 107.7 
C(56B)-C(57B)-H(57C) 107.7 
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C(58B)-C(57B)-H(57D) 107.7 
C(56B)-C(57B)-H(57D) 107.7 
H(57C)-C(57B)-H(57D) 107.1 
C(57B)-C(58B)-N(6B) 113.7(7) 
C(57B)-C(58B)-H(58C) 108.8 
N(6B)-C(58B)-H(58C) 108.8 
C(57B)-C(58B)-H(58D) 108.8 
N(6B)-C(58B)-H(58D) 108.8 
H(58C)-C(58B)-H(58D) 107.7 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
 Anisotropic displacement parameters  (Å2x 103) for bc56ras.  The anisotropic 
displacement factor exponent takes the form:  -2 2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
P(1) 39(1)  45(1) 29(1)  -4(1) 9(1)  4(1) 
Se(1) 43(1)  84(1) 52(1)  -7(1) 10(1)  -7(1) 
N(1) 40(4)  42(4) 30(3)  -8(3) 12(3)  4(3) 
C(1) 36(3)  46(3) 28(3)  -3(3) 10(3)  0(3) 
C(2) 35(3)  45(3) 27(3)  -5(3) 11(2)  -1(3) 
C(3) 34(3)  41(4) 24(4)  -8(3) 9(3)  -4(3) 
C(4) 35(3)  48(5) 30(5)  -6(4) 12(3)  -1(4) 
C(5) 34(4)  43(5) 34(5)  -2(4) 11(3)  1(4) 
C(6) 32(3)  43(6) 34(5)  -2(5) 14(3)  2(4) 
C(7) 34(3)  47(5) 35(4)  -5(4) 13(3)  -1(4) 
C(8) 35(3)  44(5) 33(4)  -7(3) 12(3)  -2(3) 
C(9) 35(4)  45(5) 33(4)  -5(4) 14(3)  -5(4) 
C(10) 37(4)  47(4) 31(4)  -4(3) 9(3)  0(3) 
C(21) 38(9)  43(5) 35(5)  -2(4) 12(5)  -1(4) 
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N(2) 51(4)  45(4) 31(3)  -3(3) 8(3)  9(3) 
C(11) 47(4)  42(3) 31(3)  0(3) 11(3)  13(3) 
C(12) 38(3)  42(3) 28(3)  3(3) 13(3)  8(3) 
C(13) 38(3)  46(3) 31(4)  4(3) 17(3)  5(3) 
C(14) 41(3)  54(4) 25(4)  5(4) 13(3)  0(3) 
C(15) 45(3)  61(5) 25(5)  8(4) 15(4)  -3(3) 
C(16) 47(3)  59(4) 31(5)  7(4) 20(4)  -4(3) 
C(17) 46(3)  53(4) 27(5)  8(4) 23(4)  2(3) 
C(18) 44(3)  45(3) 29(4)  5(4) 19(3)  9(3) 
C(19) 50(4)  46(3) 25(5)  12(4) 18(4)  10(3) 
C(20) 53(4)  45(3) 22(4)  4(3) 11(3)  13(3) 
C(22) 75(6)  44(8) 45(6)  -10(5) 4(5)  13(6) 
N(1B) 37(4)  42(4) 35(4)  -5(3) 9(3)  5(4) 
C(1B) 37(3)  44(4) 28(3)  -5(3) 11(3)  0(3) 
C(2B) 36(3)  45(3) 28(3)  -4(3) 10(3)  0(3) 
C(3B) 34(3)  46(4) 26(4)  -7(4) 12(3)  -3(3) 
C(4B) 32(4)  45(5) 30(5)  -2(4) 12(3)  -1(4) 
C(5B) 35(4)  45(5) 34(5)  0(4) 11(3)  -2(4) 
C(6B) 38(4)  44(6) 35(5)  -1(5) 14(3)  1(5) 
C(7B) 34(3)  44(6) 34(4)  0(5) 17(3)  -1(4) 
C(8B) 32(3)  44(5) 30(4)  -7(4) 8(3)  -1(4) 
C(9B) 34(4)  43(5) 33(4)  -5(4) 11(3)  -4(4) 
C(10B) 36(4)  42(5) 36(4)  -5(4) 9(3)  -4(4) 
C(21B) 28(8)  51(6) 36(6)  -4(5) 3(5)  9(5) 
N(2B) 48(5)  44(4) 31(4)  -5(3) 12(3)  10(3) 
C(11B) 47(4)  42(3) 32(4)  0(3) 11(3)  13(3) 
C(12B) 38(3)  42(3) 32(4)  0(3) 15(3)  8(3) 
C(13B) 40(3)  44(3) 29(4)  5(3) 13(3)  8(3) 
C(14B) 39(3)  53(4) 28(5)  8(4) 14(4)  0(3) 
C(15B) 47(4)  60(4) 29(5)  8(4) 16(4)  -4(3) 
C(16B) 44(4)  56(4) 31(6)  9(5) 20(5)  -3(3) 
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C(17B) 46(4)  51(4) 36(6)  8(5) 21(4)  8(3) 
C(18B) 44(3)  46(3) 30(5)  7(4) 17(4)  11(3) 
C(19B) 55(5)  43(4) 27(5)  10(4) 16(4)  12(4) 
C(20B) 54(5)  44(4) 30(4)  7(4) 12(4)  13(4) 
C(22B) 79(7)  44(9) 39(6)  3(7) -2(6)  23(7) 
N(3) 54(4)  49(4) 37(4)  -5(4) 22(3)  3(4) 
C(23) 57(4)  53(4) 41(4)  -9(5) 26(4)  1(4) 
C(24) 66(5)  60(5) 48(5)  -13(5) 30(4)  -10(4) 
C(25) 88(5)  72(6) 57(5)  -14(5) 25(5)  -12(5) 
C(26) 85(5)  63(6) 55(5)  -14(5) 28(4)  -7(5) 
C(27) 74(5)  56(5) 53(5)  -12(5) 23(4)  1(5) 
C(28) 65(4)  47(4) 46(4)  -5(4) 19(4)  3(4) 
N(3B) 50(3)  47(3) 37(3)  -4(3) 18(2)  3(3) 
C(23B) 57(3)  56(4) 53(4)  -12(4) 27(3)  1(3) 
C(24B) 80(5)  64(4) 59(4)  -24(4) 35(4)  -13(4) 
C(25B) 87(4)  60(5) 49(4)  -22(4) 34(3)  -15(4) 
C(26B) 79(4)  56(5) 52(4)  -12(4) 34(3)  -4(4) 
C(27B) 69(4)  46(4) 49(4)  -2(3) 26(3)  0(3) 
C(28B) 62(3)  45(3) 37(3)  0(3) 22(3)  4(3) 
P(2) 38(1)  36(1) 58(1)  -3(1) 25(1)  3(1) 
Se(2) 40(1)  48(1) 51(1)  12(1) 20(1)  3(1) 
N(4) 37(3)  54(4) 41(3)  -6(3) 15(3)  1(3) 
C(31) 36(3)  40(4) 37(3)  -7(3) 13(2)  5(3) 
C(32) 34(3)  33(3) 39(3)  -4(3) 10(2)  4(3) 
C(33) 35(3)  38(3) 44(4)  -4(4) 13(3)  1(3) 
C(34) 44(3)  39(4) 48(4)  -4(4) 14(4)  -3(3) 
C(35) 46(3)  42(5) 54(5)  -4(4) 18(4)  -3(3) 
C(36) 46(4)  42(4) 56(6)  -7(5) 14(4)  -8(3) 
C(37) 41(4)  44(4) 57(5)  -8(4) 7(4)  -3(3) 
C(38) 36(3)  39(4) 50(4)  -10(4) 10(3)  3(3) 
C(39) 43(3)  42(5) 44(4)  -10(4) -2(3)  5(3) 
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C(40) 42(3)  41(5) 39(4)  -6(4) 7(3)  12(3) 
C(51) 44(5)  59(8) 30(5)  -3(5) 1(4)  -10(5) 
N(5) 33(3)  28(4) 53(3)  7(3) 18(3)  -1(3) 
C(41) 36(3)  32(4) 33(3)  6(3) 12(2)  0(3) 
C(42) 35(3)  34(3) 30(3)  2(3) 13(3)  0(2) 
C(43) 34(3)  36(3) 31(4)  -1(3) 13(3)  0(3) 
C(44) 34(4)  41(4) 34(5)  -5(3) 6(3)  3(3) 
C(45) 32(5)  44(4) 39(5)  -5(4) 1(4)  6(4) 
C(46) 38(6)  44(4) 37(5)  -9(4) 5(5)  6(4) 
C(47) 38(5)  40(4) 31(4)  -5(3) 3(4)  1(4) 
C(48) 36(4)  39(3) 31(4)  -2(3) 9(3)  -2(3) 
C(49) 39(4)  38(5) 31(4)  1(4) 3(3)  -2(3) 
C(50) 36(3)  35(5) 28(3)  9(4) 8(3)  3(3) 
C(52) 39(6)  36(7) 66(6)  8(6) 13(5)  -2(5) 
N(4B) 37(3)  54(4) 39(3)  -8(3) 17(3)  5(3) 
C(31B) 39(3)  44(4) 40(3)  -10(3) 14(3)  2(3) 
C(32B) 33(3)  36(3) 36(3)  -3(3) 10(2)  6(3) 
C(33B) 34(3)  38(3) 45(4)  -8(3) 13(3)  3(3) 
C(34B) 44(3)  36(5) 46(4)  -7(4) 19(4)  2(3) 
C(35B) 47(4)  38(5) 48(5)  -10(4) 17(4)  -5(3) 
C(36B) 44(4)  41(4) 50(5)  -10(5) 14(4)  -3(3) 
C(37B) 44(4)  38(4) 48(5)  -8(5) 11(4)  -2(3) 
C(38B) 39(3)  39(4) 50(4)  -8(4) 11(3)  3(3) 
C(39B) 46(3)  41(5) 47(4)  -12(4) 9(3)  -4(3) 
C(40B) 46(3)  45(4) 46(4)  -12(4) 14(3)  3(3) 
C(51B) 47(5)  73(8) 31(4)  -23(5) 9(4)  -6(6) 
N(5B) 30(3)  31(4) 53(3)  8(3) 19(3)  1(3) 
C(41B) 34(3)  33(4) 33(3)  7(3) 14(2)  1(3) 
C(42B) 34(3)  34(3) 31(3)  3(3) 12(3)  1(2) 
C(43B) 35(3)  37(3) 27(4)  -2(3) 11(3)  0(3) 
C(44B) 33(4)  39(4) 33(5)  -4(3) 4(3)  2(3) 
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C(45B) 35(5)  43(4) 39(5)  -9(4) -4(4)  5(4) 
C(46B) 34(5)  43(4) 38(5)  -8(4) -4(4)  6(4) 
C(47B) 36(5)  42(4) 33(4)  -10(3) 0(4)  -2(4) 
C(48B) 34(4)  42(3) 28(4)  0(3) 7(3)  0(3) 
C(49B) 38(4)  42(5) 28(4)  1(4) 7(3)  -4(3) 
C(50B) 32(3)  39(5) 32(3)  5(4) 9(3)  1(3) 
C(52B) 47(6)  39(7) 69(6)  26(6) 25(5)  10(5) 
N(6) 57(4)  48(4) 52(5)  3(4) 35(4)  4(4) 
C(53) 63(5)  39(5) 46(5)  4(4) 36(4)  5(4) 
C(54) 70(5)  39(5) 58(4)  0(4) 32(4)  4(4) 
C(55) 79(5)  41(4) 58(4)  -1(4) 31(4)  8(4) 
C(56) 83(5)  48(5) 59(5)  -8(4) 36(4)  8(4) 
C(57) 74(4)  54(4) 56(4)  -2(4) 32(3)  10(4) 
C(58) 64(4)  50(4) 54(4)  -2(4) 29(3)  9(4) 
N(6B) 51(3)  41(3) 47(4)  2(3) 25(3)  2(3) 
C(53B) 59(4)  42(3) 62(4)  0(4) 27(3)  -1(3) 
C(54B) 71(4)  45(4) 63(4)  1(4) 28(4)  0(4) 
C(55B) 82(4)  47(4) 56(4)  8(4) 32(3)  10(4) 
C(56B) 78(4)  52(4) 58(4)  -1(4) 32(3)  13(4) 
C(57B) 67(4)  49(4) 46(4)  -2(3) 26(3)  18(3) 
C(58B) 59(4)  43(4) 46(3)  0(3) 27(3)  5(3) 
______________________________________________________________________________  
 
 Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for bc56ras. 
______________________________________________________________________________
__  
 x  y  z  U(eq) 
______________________________________________________________________________
__  
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H(4A) 1878 10905 9276 45 
H(5A) 954 12344 9675 45 
H(6A) 315 11478 10622 43 
H(7A) 496 9080 11055 46 
H(9A) 1162 6647 11031 45 
H(10A) 1849 5078 10430 47 
H(21A) 3323 4595 10437 58 
H(21B) 3574 4071 9648 58 
H(21C) 2691 3560 9740 58 
H(14A) 3371 9743 10717 47 
H(15A) 4401 11450 11298 52 
H(16A) 5302 12257 10594 52 
H(17A) 5114 11457 9249 48 
H(19A) 4336 9898 8037 47 
H(20A) 3299 8218 7414 49 
H(22A) 1839 7755 6743 88 
H(22B) 1148 8205 7165 88 
H(22C) 1185 6567 6859 88 
H(4B) 1926 11111 9127 42 
H(5B) 1115 12744 9562 46 
H(6B) 372 12006 10444 46 
H(7B) 445 9629 10900 43 
H(9B) 960 7096 10862 44 
H(10B) 1669 5402 10360 46 
H(21D) 3347 4753 10412 60 
H(21E) 3191 3826 9571 60 
H(21F) 2454 3950 9977 60 
H(14B) 3298 10168 10505 47 
H(15B) 4463 11641 11067 53 
H(16B) 5322 12277 10284 50 
H(17B) 5054 11361 8951 51 
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H(19B) 4130 9886 7754 50 
H(20B) 3021 8307 7193 51 
H(22D) 1546 8070 6776 90 
H(22E) 951 6770 6879 90 
H(22F) 1815 6419 6702 90 
H(23A) 3933 3960 8663 57 
H(23B) 3672 5639 8574 57 
H(24A) 4339 4076 7578 66 
H(24B) 4202 5797 7575 66 
H(25A) 2712 5341 6683 87 
H(25B) 3413 5161 6241 87 
H(26A) 3371 2617 6519 80 
H(26B) 2601 3307 5771 80 
H(27A) 1693 3157 6513 73 
H(27B) 2163 1619 6619 73 
H(28A) 2054 2389 7896 63 
H(28B) 3031 2206 7974 63 
H(23C) 3879 3934 8139 64 
H(23D) 3685 5594 8281 64 
H(24C) 4070 4974 7036 77 
H(24D) 3336 6152 6931 77 
H(25C) 2280 4608 6185 75 
H(25D) 3028 4275 5822 75 
H(26C) 3384 2305 6835 72 
H(26D) 2626 2118 5960 72 
H(27C) 1632 2634 6649 63 
H(27D) 2157 1171 6969 63 
H(28C) 1979 2557 8073 56 
H(28D) 2957 2214 8209 56 
H(34A) 8659 8068 5203 53 
H(35A) 9760 9373 4965 57 
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H(36A) 10703 10742 6054 59 
H(37A) 10585 10795 7360 60 
H(39A) 9868 9823 8390 57 
H(40A) 8708 8820 8576 51 
H(51A) 7715 6166 8222 70 
H(51B) 6732 6536 8050 70 
H(51C) 7461 7583 8633 70 
H(44A) 9105 5613 6421 46 
H(45A) 9376 3249 6139 50 
H(46A) 8331 1939 5056 51 
H(47A) 7005 2888 4446 46 
H(49A) 5935 4879 4295 46 
H(50A) 5575 7035 4785 40 
H(52A) 5951 9716 4716 72 
H(52B) 5995 10824 5459 72 
H(52C) 5339 9491 5259 72 
H(34B) 8634 7754 5066 50 
H(35B) 9699 8936 4696 53 
H(36B) 10663 10476 5665 54 
H(37B) 10503 11045 6916 54 
H(39B) 9753 10609 7981 55 
H(40B) 8618 9720 8276 55 
H(51D) 7888 6907 8421 77 
H(51E) 6890 7202 8208 77 
H(51F) 7561 8493 8558 77 
H(44B) 9165 5773 6586 44 
H(45B) 9645 3582 6269 52 
H(46B) 8712 2006 5268 51 
H(47B) 7325 2650 4602 48 
H(49B) 6124 4426 4390 45 
H(50B) 5614 6560 4751 42 
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H(52D) 5916 9476 4642 76 
H(52E) 5583 10245 5322 76 
H(52F) 5228 8677 4959 76 
H(53A) 7295 10946 6263 54 
H(53B) 6550 12124 5964 54 
H(54A) 7932 12974 6855 63 
H(54B) 7749 12163 7612 63 
H(55A) 7437 14801 7458 69 
H(55B) 6614 14379 6675 69 
H(56A) 6887 14078 8376 73 
H(56B) 6031 14503 7637 73 
H(57A) 6632 11755 8233 70 
H(57B) 5730 12458 8126 70 
H(58A) 5432 12125 6632 65 
H(58B) 5366 10776 7201 65 
H(53C) 7808 11127 7477 63 
H(53D) 7318 11221 6488 63 
H(54C) 7600 13526 6897 70 
H(54D) 7342 13301 7716 70 
H(55C) 6362 14720 6508 71 
H(55D) 6039 13161 6108 71 
H(56C) 5942 14185 7654 72 
H(56D) 5156 14107 6795 72 
H(57C) 5160 12292 7763 63 
H(57D) 5069 11705 6850 63 
H(58C) 5946 10291 7982 56 
H(58D) 6619 11597 8207 56 
______________________________________________________________________________
__  
 
 Torsion angles [°] for bc56ras. 
431 
 
________________________________________________________________  
N(3B)-P(1)-N(1)-C(1) 178.8(8) 
N(3)-P(1)-N(1)-C(1) 179.8(10) 
N(2B)-P(1)-N(1)-C(1) 63.4(11) 
N(2)-P(1)-N(1)-C(1) 69.0(11) 
N(1B)-P(1)-N(1)-C(1) 3(9) 
Se(1)-P(1)-N(1)-C(1) -57.3(9) 
N(3B)-P(1)-N(1)-C(21) -42.9(13) 
N(3)-P(1)-N(1)-C(21) -41.9(14) 
N(2B)-P(1)-N(1)-C(21) -158.4(15) 
N(2)-P(1)-N(1)-C(21) -152.7(12) 
N(1B)-P(1)-N(1)-C(21) 141(11) 
Se(1)-P(1)-N(1)-C(21) 81.0(12) 
C(21)-N(1)-C(1)-C(2) 145.5(17) 
P(1)-N(1)-C(1)-C(2) -76.1(17) 
C(21)-N(1)-C(1)-C(10) -36(2) 
P(1)-N(1)-C(1)-C(10) 102.5(14) 
C(10)-C(1)-C(2)-C(3) -9(2) 
N(1)-C(1)-C(2)-C(3) 169.3(14) 
C(10)-C(1)-C(2)-C(12) 169.9(12) 
N(1)-C(1)-C(2)-C(12) -11(2) 
C(1)-C(2)-C(3)-C(4) -169.7(15) 
C(12)-C(2)-C(3)-C(4) 11(2) 
C(1)-C(2)-C(3)-C(8) 10(2) 
C(12)-C(2)-C(3)-C(8) -169.4(11) 
C(8)-C(3)-C(4)-C(5) -2(2) 
C(2)-C(3)-C(4)-C(5) 177.5(14) 
C(3)-C(4)-C(5)-C(6) 3(2) 
C(4)-C(5)-C(6)-C(7) -3.1(18) 
C(5)-C(6)-C(7)-C(8) 1.7(17) 
C(6)-C(7)-C(8)-C(9) -175.8(11) 
432 
 
C(6)-C(7)-C(8)-C(3) -0.5(17) 
C(4)-C(3)-C(8)-C(9) 176.1(13) 
C(2)-C(3)-C(8)-C(9) -3.5(18) 
C(4)-C(3)-C(8)-C(7) 0.6(18) 
C(2)-C(3)-C(8)-C(7) -179.0(12) 
C(7)-C(8)-C(9)-C(10) 171.7(11) 
C(3)-C(8)-C(9)-C(10) -3.6(17) 
C(8)-C(9)-C(10)-C(1) 4.3(18) 
C(2)-C(1)-C(10)-C(9) 2(2) 
N(1)-C(1)-C(10)-C(9) -176.3(14) 
N(3B)-P(1)-N(2)-C(11) -90.6(14) 
N(3)-P(1)-N(2)-C(11) -87.7(15) 
N(2B)-P(1)-N(2)-C(11) 143(11) 
N(1B)-P(1)-N(2)-C(11) 23.2(14) 
N(1)-P(1)-N(2)-C(11) 17.5(16) 
Se(1)-P(1)-N(2)-C(11) 144.9(11) 
N(3B)-P(1)-N(2)-C(22) 87.0(19) 
N(3)-P(1)-N(2)-C(22) 90(2) 
N(2B)-P(1)-N(2)-C(22) -39(9) 
N(1B)-P(1)-N(2)-C(22) -159.2(19) 
N(1)-P(1)-N(2)-C(22) -164.9(17) 
Se(1)-P(1)-N(2)-C(22) -38(2) 
C(22)-N(2)-C(11)-C(12) 122(2) 
P(1)-N(2)-C(11)-C(12) -60(2) 
C(22)-N(2)-C(11)-C(20) -60(3) 
P(1)-N(2)-C(11)-C(20) 118.0(15) 
C(20)-C(11)-C(12)-C(13) -3(2) 
N(2)-C(11)-C(12)-C(13) 175.4(15) 
C(20)-C(11)-C(12)-C(2) -176.5(13) 
N(2)-C(11)-C(12)-C(2) 2(2) 
C(1)-C(2)-C(12)-C(11) 57.3(19) 
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C(3)-C(2)-C(12)-C(11) -123.4(17) 
C(1)-C(2)-C(12)-C(13) -116.3(17) 
C(3)-C(2)-C(12)-C(13) 63.0(18) 
C(11)-C(12)-C(13)-C(18) 5(2) 
C(2)-C(12)-C(13)-C(18) 178.5(13) 
C(11)-C(12)-C(13)-C(14) -173.0(15) 
C(2)-C(12)-C(13)-C(14) 1(2) 
C(18)-C(13)-C(14)-C(15) 5(2) 
C(12)-C(13)-C(14)-C(15) -177.0(14) 
C(13)-C(14)-C(15)-C(16) -5(2) 
C(14)-C(15)-C(16)-C(17) 2(2) 
C(15)-C(16)-C(17)-C(18) 1(2) 
C(14)-C(13)-C(18)-C(19) 174.3(14) 
C(12)-C(13)-C(18)-C(19) -4(2) 
C(14)-C(13)-C(18)-C(17) -3(2) 
C(12)-C(13)-C(18)-C(17) 179.1(14) 
C(16)-C(17)-C(18)-C(19) -177.0(14) 
C(16)-C(17)-C(18)-C(13) 0(2) 
C(13)-C(18)-C(19)-C(20) 0(2) 
C(17)-C(18)-C(19)-C(20) 177.6(12) 
C(18)-C(19)-C(20)-C(11) 1.6(19) 
C(12)-C(11)-C(20)-C(19) 0(2) 
N(2)-C(11)-C(20)-C(19) -178.6(13) 
N(3B)-P(1)-N(1B)-C(1B) 174.0(9) 
N(3)-P(1)-N(1B)-C(1B) 175.1(11) 
N(2B)-P(1)-N(1B)-C(1B) 57.5(14) 
N(2)-P(1)-N(1B)-C(1B) 63.4(12) 
N(1)-P(1)-N(1B)-C(1B) 178(11) 
Se(1)-P(1)-N(1B)-C(1B) -59.4(11) 
N(3B)-P(1)-N(1B)-C(21B) -48.9(15) 
N(3)-P(1)-N(1B)-C(21B) -47.9(16) 
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N(2B)-P(1)-N(1B)-C(21B) -165.5(14) 
N(2)-P(1)-N(1B)-C(21B) -159.5(16) 
N(1)-P(1)-N(1B)-C(21B) -45(10) 
Se(1)-P(1)-N(1B)-C(21B) 77.6(14) 
C(21B)-N(1B)-C(1B)-C(2B) 149(2) 
P(1)-N(1B)-C(1B)-C(2B) -75(2) 
C(21B)-N(1B)-C(1B)-C(10B) -35(3) 
P(1)-N(1B)-C(1B)-C(10B) 100.8(18) 
C(10B)-C(1B)-C(2B)-C(3B) -5(3) 
N(1B)-C(1B)-C(2B)-C(3B) 171.2(18) 
C(10B)-C(1B)-C(2B)-C(12B) 176.2(16) 
N(1B)-C(1B)-C(2B)-C(12B) -8(3) 
C(1B)-C(2B)-C(3B)-C(4B) -171(2) 
C(12B)-C(2B)-C(3B)-C(4B) 8(3) 
C(1B)-C(2B)-C(3B)-C(8B) 5(3) 
C(12B)-C(2B)-C(3B)-C(8B) -176.0(14) 
C(8B)-C(3B)-C(4B)-C(5B) 4(3) 
C(2B)-C(3B)-C(4B)-C(5B) 179.9(18) 
C(3B)-C(4B)-C(5B)-C(6B) -1(2) 
C(4B)-C(5B)-C(6B)-C(7B) 0(2) 
C(5B)-C(6B)-C(7B)-C(8B) -1(2) 
C(6B)-C(7B)-C(8B)-C(9B) -176.6(14) 
C(6B)-C(7B)-C(8B)-C(3B) 3(2) 
C(4B)-C(3B)-C(8B)-C(9B) 175.2(16) 
C(2B)-C(3B)-C(8B)-C(9B) -1(2) 
C(4B)-C(3B)-C(8B)-C(7B) -5(2) 
C(2B)-C(3B)-C(8B)-C(7B) 179.0(15) 
C(7B)-C(8B)-C(9B)-C(10B) 176.8(14) 
C(3B)-C(8B)-C(9B)-C(10B) -3(2) 
C(8B)-C(9B)-C(10B)-C(1B) 3(2) 
C(2B)-C(1B)-C(10B)-C(9B) 1(3) 
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N(1B)-C(1B)-C(10B)-C(9B) -175.2(17) 
N(3B)-P(1)-N(2B)-C(11B) -84.4(14) 
N(3)-P(1)-N(2B)-C(11B) -81.7(15) 
N(2)-P(1)-N(2B)-C(11B) -29(9) 
N(1B)-P(1)-N(2B)-C(11B) 32.2(17) 
N(1)-P(1)-N(2B)-C(11B) 26.7(15) 
Se(1)-P(1)-N(2B)-C(11B) 152.8(12) 
N(3B)-P(1)-N(2B)-C(22B) 66(2) 
N(3)-P(1)-N(2B)-C(22B) 69(2) 
N(2)-P(1)-N(2B)-C(22B) 122(11) 
N(1B)-P(1)-N(2B)-C(22B) -177.1(18) 
N(1)-P(1)-N(2B)-C(22B) 177(2) 
Se(1)-P(1)-N(2B)-C(22B) -57(2) 
C(22B)-N(2B)-C(11B)-C(12B) 143(2) 
P(1)-N(2B)-C(11B)-C(12B) -68(3) 
C(22B)-N(2B)-C(11B)-C(20B) -32(3) 
P(1)-N(2B)-C(11B)-C(20B) 117.2(18) 
C(20B)-C(11B)-C(12B)-C(13B) -9(3) 
N(2B)-C(11B)-C(12B)-C(13B) 176.6(19) 
C(20B)-C(11B)-C(12B)-C(2B) 173.7(16) 
N(2B)-C(11B)-C(12B)-C(2B) -1(3) 
C(1B)-C(2B)-C(12B)-C(11B) 58(2) 
C(3B)-C(2B)-C(12B)-C(11B) -121(2) 
C(1B)-C(2B)-C(12B)-C(13B) -120(2) 
C(3B)-C(2B)-C(12B)-C(13B) 61(2) 
C(11B)-C(12B)-C(13B)-C(18B) 2(3) 
C(2B)-C(12B)-C(13B)-C(18B) 179.7(15) 
C(11B)-C(12B)-C(13B)-C(14B) -178.7(19) 
C(2B)-C(12B)-C(13B)-C(14B) -1(3) 
C(18B)-C(13B)-C(14B)-C(15B) -3(2) 
C(12B)-C(13B)-C(14B)-C(15B) 177.6(18) 
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C(13B)-C(14B)-C(15B)-C(16B) 3(2) 
C(14B)-C(15B)-C(16B)-C(17B) -1(3) 
C(15B)-C(16B)-C(17B)-C(18B) -1(2) 
C(14B)-C(13B)-C(18B)-C(19B) -174.5(17) 
C(12B)-C(13B)-C(18B)-C(19B) 5(3) 
C(14B)-C(13B)-C(18B)-C(17B) 1(2) 
C(12B)-C(13B)-C(18B)-C(17B) -179.9(17) 
C(16B)-C(17B)-C(18B)-C(19B) 176.4(17) 
C(16B)-C(17B)-C(18B)-C(13B) 1(2) 
C(13B)-C(18B)-C(19B)-C(20B) -5(2) 
C(17B)-C(18B)-C(19B)-C(20B) 179.7(16) 
C(18B)-C(19B)-C(20B)-C(11B) -1(2) 
C(12B)-C(11B)-C(20B)-C(19B) 8(3) 
N(2B)-C(11B)-C(20B)-C(19B) -176.7(17) 
N(3B)-P(1)-N(3)-C(28) -80(15) 
N(2B)-P(1)-N(3)-C(28) -132.4(17) 
N(2)-P(1)-N(3)-C(28) -138.0(17) 
N(1B)-P(1)-N(3)-C(28) 117.5(19) 
N(1)-P(1)-N(3)-C(28) 117.2(19) 
Se(1)-P(1)-N(3)-C(28) -9(2) 
N(3B)-P(1)-N(3)-C(23) 116(17) 
N(2B)-P(1)-N(3)-C(23) 63.4(18) 
N(2)-P(1)-N(3)-C(23) 57.8(18) 
N(1B)-P(1)-N(3)-C(23) -46.7(19) 
N(1)-P(1)-N(3)-C(23) -47.1(18) 
Se(1)-P(1)-N(3)-C(23) -173.1(13) 
C(28)-N(3)-C(23)-C(24) 70(2) 
P(1)-N(3)-C(23)-C(24) -123.6(19) 
N(3)-C(23)-C(24)-C(25) 8(2) 
C(23)-C(24)-C(25)-C(26) -77(2) 
C(24)-C(25)-C(26)-C(27) 79(2) 
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C(25)-C(26)-C(27)-C(28) -48(3) 
C(23)-N(3)-C(28)-C(27) -94.2(19) 
P(1)-N(3)-C(28)-C(27) 101(3) 
C(26)-C(27)-C(28)-N(3) 57(2) 
N(3)-P(1)-N(3B)-C(23B) -82(15) 
N(2B)-P(1)-N(3B)-C(23B) 46.3(13) 
N(2)-P(1)-N(3B)-C(23B) 40.6(13) 
N(1B)-P(1)-N(3B)-C(23B) -64.4(14) 
N(1)-P(1)-N(3B)-C(23B) -64.9(13) 
Se(1)-P(1)-N(3B)-C(23B) 167.7(9) 
N(3)-P(1)-N(3B)-C(28B) 84(16) 
N(2B)-P(1)-N(3B)-C(28B) -147.2(9) 
N(2)-P(1)-N(3B)-C(28B) -153.0(9) 
N(1B)-P(1)-N(3B)-C(28B) 102.0(11) 
N(1)-P(1)-N(3B)-C(28B) 101.6(10) 
Se(1)-P(1)-N(3B)-C(28B) -25.9(11) 
C(28B)-N(3B)-C(23B)-C(24B) 88.9(12) 
P(1)-N(3B)-C(23B)-C(24B) -104.0(13) 
N(3B)-C(23B)-C(24B)-C(25B) -35.0(15) 
C(23B)-C(24B)-C(25B)-C(26B) -40.9(14) 
C(24B)-C(25B)-C(26B)-C(27B) 84.3(12) 
C(25B)-C(26B)-C(27B)-C(28B) -66.8(13) 
C(23B)-N(3B)-C(28B)-C(27B) -74.9(12) 
P(1)-N(3B)-C(28B)-C(27B) 117.6(12) 
C(26B)-C(27B)-C(28B)-N(3B) 50.9(13) 
N(6B)-P(2)-N(4)-C(31) -63.5(10) 
N(6)-P(2)-N(4)-C(31) -50.4(12) 
N(5)-P(2)-N(4)-C(31) 46.4(11) 
N(4B)-P(2)-N(4)-C(31) -11(5) 
N(5B)-P(2)-N(4)-C(31) 57.9(10) 
Se(2)-P(2)-N(4)-C(31) 174.5(8) 
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N(6B)-P(2)-N(4)-C(51) 94.9(13) 
N(6)-P(2)-N(4)-C(51) 108.0(13) 
N(5)-P(2)-N(4)-C(51) -155.2(12) 
N(4B)-P(2)-N(4)-C(51) 148(7) 
N(5B)-P(2)-N(4)-C(51) -143.7(13) 
Se(2)-P(2)-N(4)-C(51) -27.1(14) 
C(51)-N(4)-C(31)-C(32) 132.9(14) 
P(2)-N(4)-C(31)-C(32) -66.6(15) 
C(51)-N(4)-C(31)-C(40) -50.3(18) 
P(2)-N(4)-C(31)-C(40) 110.2(12) 
C(40)-C(31)-C(32)-C(33) -14(2) 
N(4)-C(31)-C(32)-C(33) 163.0(13) 
C(40)-C(31)-C(32)-C(42) 169.2(12) 
N(4)-C(31)-C(32)-C(42) -13.9(17) 
C(31)-C(32)-C(33)-C(34) -171.8(17) 
C(42)-C(32)-C(33)-C(34) 5(2) 
C(31)-C(32)-C(33)-C(38) 8(2) 
C(42)-C(32)-C(33)-C(38) -175.3(14) 
C(38)-C(33)-C(34)-C(35) -4(3) 
C(32)-C(33)-C(34)-C(35) 175.4(17) 
C(33)-C(34)-C(35)-C(36) 0(3) 
C(34)-C(35)-C(36)-C(37) 1(2) 
C(35)-C(36)-C(37)-C(38) 1(2) 
C(36)-C(37)-C(38)-C(33) -5(2) 
C(36)-C(37)-C(38)-C(39) -179.3(13) 
C(34)-C(33)-C(38)-C(37) 6(2) 
C(32)-C(33)-C(38)-C(37) -173.3(14) 
C(34)-C(33)-C(38)-C(39) -178.7(16) 
C(32)-C(33)-C(38)-C(39) 2(2) 
C(37)-C(38)-C(39)-C(40) 169.3(13) 
C(33)-C(38)-C(39)-C(40) -5(2) 
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C(38)-C(39)-C(40)-C(31) 0(2) 
C(32)-C(31)-C(40)-C(39) 10.3(19) 
N(4)-C(31)-C(40)-C(39) -166.4(12) 
N(6B)-P(2)-N(5)-C(41) 158.8(7) 
N(6)-P(2)-N(5)-C(41) 171.8(9) 
N(4B)-P(2)-N(5)-C(41) 51.7(9) 
N(5B)-P(2)-N(5)-C(41) -52(3) 
N(4)-P(2)-N(5)-C(41) 44.4(9) 
Se(2)-P(2)-N(5)-C(41) -73.8(8) 
N(6B)-P(2)-N(5)-C(52) -62.5(10) 
N(6)-P(2)-N(5)-C(52) -49.5(10) 
N(4B)-P(2)-N(5)-C(52) -169.6(10) 
N(5B)-P(2)-N(5)-C(52) 87(3) 
N(4)-P(2)-N(5)-C(52) -176.9(9) 
Se(2)-P(2)-N(5)-C(52) 65.0(10) 
C(52)-N(5)-C(41)-C(42) 147.7(18) 
P(2)-N(5)-C(41)-C(42) -76(2) 
C(52)-N(5)-C(41)-C(50) -37(2) 
P(2)-N(5)-C(41)-C(50) 98.7(16) 
C(50)-C(41)-C(42)-C(43) 1(3) 
N(5)-C(41)-C(42)-C(43) 176(2) 
C(50)-C(41)-C(42)-C(32) -175.6(15) 
N(5)-C(41)-C(42)-C(32) 0(3) 
C(31)-C(32)-C(42)-C(41) 64(2) 
C(33)-C(32)-C(42)-C(41) -113(2) 
C(31)-C(32)-C(42)-C(43) -113(2) 
C(33)-C(32)-C(42)-C(43) 70(3) 
C(41)-C(42)-C(43)-C(48) 0(4) 
C(32)-C(42)-C(43)-C(48) 176.9(18) 
C(41)-C(42)-C(43)-C(44) -176(2) 
C(32)-C(42)-C(43)-C(44) 0(4) 
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C(48)-C(43)-C(44)-C(45) -3(4) 
C(42)-C(43)-C(44)-C(45) 173(3) 
C(43)-C(44)-C(45)-C(46) 6(3) 
C(44)-C(45)-C(46)-C(47) -5(2) 
C(45)-C(46)-C(47)-C(48) 1(2) 
C(46)-C(47)-C(48)-C(49) -176.2(17) 
C(46)-C(47)-C(48)-C(43) 1(3) 
C(44)-C(43)-C(48)-C(47) 0(3) 
C(42)-C(43)-C(48)-C(47) -177(2) 
C(44)-C(43)-C(48)-C(49) 177(2) 
C(42)-C(43)-C(48)-C(49) 1(4) 
C(47)-C(48)-C(49)-C(50) 174.4(17) 
C(43)-C(48)-C(49)-C(50) -3(3) 
C(48)-C(49)-C(50)-C(41) 5(3) 
C(42)-C(41)-C(50)-C(49) -4(3) 
N(5)-C(41)-C(50)-C(49) -178.7(17) 
N(6B)-P(2)-N(4B)-C(31B) -63.8(9) 
N(6)-P(2)-N(4B)-C(31B) -49.2(10) 
N(5)-P(2)-N(4B)-C(31B) 42.8(9) 
N(5B)-P(2)-N(4B)-C(31B) 53.9(9) 
N(4)-P(2)-N(4B)-C(31B) 167(6) 
Se(2)-P(2)-N(4B)-C(31B) 172.4(6) 
N(6B)-P(2)-N(4B)-C(51B) 79.6(11) 
N(6)-P(2)-N(4B)-C(51B) 94.2(11) 
N(5)-P(2)-N(4B)-C(51B) -173.8(11) 
N(5B)-P(2)-N(4B)-C(51B) -162.7(11) 
N(4)-P(2)-N(4B)-C(51B) -50(5) 
Se(2)-P(2)-N(4B)-C(51B) -44.1(12) 
C(51B)-N(4B)-C(31B)-C(32B) 140.8(14) 
P(2)-N(4B)-C(31B)-C(32B) -77.9(14) 
C(51B)-N(4B)-C(31B)-C(40B) -37.6(19) 
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P(2)-N(4B)-C(31B)-C(40B) 103.7(13) 
C(40B)-C(31B)-C(32B)-C(33B) -6(2) 
N(4B)-C(31B)-C(32B)-C(33B) 175.7(13) 
C(40B)-C(31B)-C(32B)-C(42B) 174.2(13) 
N(4B)-C(31B)-C(32B)-C(42B) -4.2(18) 
C(31B)-C(32B)-C(33B)-C(34B) -171.9(16) 
C(42B)-C(32B)-C(33B)-C(34B) 8(2) 
C(31B)-C(32B)-C(33B)-C(38B) 1(2) 
C(42B)-C(32B)-C(33B)-C(38B) -178.9(13) 
C(38B)-C(33B)-C(34B)-C(35B) 1(2) 
C(32B)-C(33B)-C(34B)-C(35B) 174.3(16) 
C(33B)-C(34B)-C(35B)-C(36B) 2(2) 
C(34B)-C(35B)-C(36B)-C(37B) -3(2) 
C(35B)-C(36B)-C(37B)-C(38B) 2(2) 
C(36B)-C(37B)-C(38B)-C(33B) 0(2) 
C(36B)-C(37B)-C(38B)-C(39B) -179.9(13) 
C(34B)-C(33B)-C(38B)-C(37B) -2(2) 
C(32B)-C(33B)-C(38B)-C(37B) -175.5(14) 
C(34B)-C(33B)-C(38B)-C(39B) 178.2(15) 
C(32B)-C(33B)-C(38B)-C(39B) 5(2) 
C(37B)-C(38B)-C(39B)-C(40B) 173.9(13) 
C(33B)-C(38B)-C(39B)-C(40B) -6(2) 
C(38B)-C(39B)-C(40B)-C(31B) 2(2) 
C(32B)-C(31B)-C(40B)-C(39B) 5(2) 
N(4B)-C(31B)-C(40B)-C(39B) -177.2(12) 
N(6B)-P(2)-N(5B)-C(41B) 148.4(8) 
N(6)-P(2)-N(5B)-C(41B) 159.6(9) 
N(5)-P(2)-N(5B)-C(41B) 116(3) 
N(4B)-P(2)-N(5B)-C(41B) 37.5(10) 
N(4)-P(2)-N(5B)-C(41B) 29.4(10) 
Se(2)-P(2)-N(5B)-C(41B) -84.2(8) 
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N(6B)-P(2)-N(5B)-C(52B) -64.2(11) 
N(6)-P(2)-N(5B)-C(52B) -52.9(11) 
N(5)-P(2)-N(5B)-C(52B) -96(3) 
N(4B)-P(2)-N(5B)-C(52B) -175.0(10) 
N(4)-P(2)-N(5B)-C(52B) 176.9(10) 
Se(2)-P(2)-N(5B)-C(52B) 63.3(11) 
C(52B)-N(5B)-C(41B)-C(42B) 140.5(18) 
P(2)-N(5B)-C(41B)-C(42B) -71(2) 
C(52B)-N(5B)-C(41B)-C(50B) -34(2) 
P(2)-N(5B)-C(41B)-C(50B) 114.1(15) 
C(50B)-C(41B)-C(42B)-C(43B) -11(3) 
N(5B)-C(41B)-C(42B)-C(43B) 174(2) 
C(50B)-C(41B)-C(42B)-C(32B) 173.4(15) 
N(5B)-C(41B)-C(42B)-C(32B) -1(3) 
C(31B)-C(32B)-C(42B)-C(41B) 57(2) 
C(33B)-C(32B)-C(42B)-C(41B) -123.0(19) 
C(31B)-C(32B)-C(42B)-C(43B) -118(2) 
C(33B)-C(32B)-C(42B)-C(43B) 62(3) 
C(41B)-C(42B)-C(43B)-C(48B) 11(4) 
C(32B)-C(42B)-C(43B)-C(48B) -173.4(18) 
C(41B)-C(42B)-C(43B)-C(44B) -168(2) 
C(32B)-C(42B)-C(43B)-C(44B) 7(4) 
C(48B)-C(43B)-C(44B)-C(45B) 2(3) 
C(42B)-C(43B)-C(44B)-C(45B) -178(3) 
C(43B)-C(44B)-C(45B)-C(46B) -2(3) 
C(44B)-C(45B)-C(46B)-C(47B) 0(2) 
C(45B)-C(46B)-C(47B)-C(48B) 1(2) 
C(46B)-C(47B)-C(48B)-C(49B) -175.5(17) 
C(46B)-C(47B)-C(48B)-C(43B) 0(3) 
C(44B)-C(43B)-C(48B)-C(47B) -1(3) 
C(42B)-C(43B)-C(48B)-C(47B) 179(2) 
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C(44B)-C(43B)-C(48B)-C(49B) 174(2) 
C(42B)-C(43B)-C(48B)-C(49B) -5(3) 
C(47B)-C(48B)-C(49B)-C(50B) 175.0(17) 
C(43B)-C(48B)-C(49B)-C(50B) 0(3) 
C(48B)-C(49B)-C(50B)-C(41B) 0(3) 
C(42B)-C(41B)-C(50B)-C(49B) 6(3) 
N(5B)-C(41B)-C(50B)-C(49B) -179.7(17) 
N(6B)-P(2)-N(6)-C(58) -76.5(14) 
N(5)-P(2)-N(6)-C(58) 141.9(12) 
N(4B)-P(2)-N(6)-C(58) -120.3(11) 
N(5B)-P(2)-N(6)-C(58) 134.2(12) 
N(4)-P(2)-N(6)-C(58) -114.0(11) 
Se(2)-P(2)-N(6)-C(58) 19.1(13) 
N(6B)-P(2)-N(6)-C(53) 101.2(18) 
N(5)-P(2)-N(6)-C(53) -40.4(12) 
N(4B)-P(2)-N(6)-C(53) 57.4(14) 
N(5B)-P(2)-N(6)-C(53) -48.2(12) 
N(4)-P(2)-N(6)-C(53) 63.7(14) 
Se(2)-P(2)-N(6)-C(53) -163.2(10) 
C(58)-N(6)-C(53)-C(54) 58.1(16) 
P(2)-N(6)-C(53)-C(54) -119.8(13) 
N(6)-C(53)-C(54)-C(55) -76.6(15) 
C(53)-C(54)-C(55)-C(56) 78.1(17) 
C(54)-C(55)-C(56)-C(57) -29(2) 
C(55)-C(56)-C(57)-C(58) -41(2) 
C(56)-C(57)-C(58)-N(6) 82.6(17) 
C(53)-N(6)-C(58)-C(57) -66.8(16) 
P(2)-N(6)-C(58)-C(57) 111.2(14) 
N(6)-P(2)-N(6B)-C(58B) 114.8(15) 
N(5)-P(2)-N(6B)-C(58B) 154.5(8) 
N(4B)-P(2)-N(6B)-C(58B) -103.5(8) 
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N(5B)-P(2)-N(6B)-C(58B) 148.3(7) 
N(4)-P(2)-N(6B)-C(58B) -96.4(8) 
Se(2)-P(2)-N(6B)-C(58B) 21.8(8) 
N(6)-P(2)-N(6B)-C(53B) -83.2(14) 
N(5)-P(2)-N(6B)-C(53B) -43.6(9) 
N(4B)-P(2)-N(6B)-C(53B) 58.5(9) 
N(5B)-P(2)-N(6B)-C(53B) -49.7(9) 
N(4)-P(2)-N(6B)-C(53B) 65.6(9) 
Se(2)-P(2)-N(6B)-C(53B) -176.2(7) 
C(58B)-N(6B)-C(53B)-C(54B) -34.5(13) 
P(2)-N(6B)-C(53B)-C(54B) 162.2(8) 
N(6B)-C(53B)-C(54B)-C(55B) -43.6(14) 
C(53B)-C(54B)-C(55B)-C(56B) 84.2(12) 
C(54B)-C(55B)-C(56B)-C(57B) -61.3(13) 
C(55B)-C(56B)-C(57B)-C(58B) 47.4(13) 
C(56B)-C(57B)-C(58B)-N(6B) -71.8(11) 
C(53B)-N(6B)-C(58B)-C(57B) 87.2(10) 
P(2)-N(6B)-C(58B)-C(57B) -109.9(9) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
Crystal Structure of 58a 
X-Ray Crystal Structure of 58a 
ORTEP image of X-ray crystal structure of 58a. 
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Distillation of 58a resulted in a viscous yellow oil. Slow cooling to room temperature followed 
by storage at -20 
o
C resulted in clear crystals, which were harvested directly from the mother 
liquor. 
Identification code  bm34oas 
Empirical formula  C17 H18 O S 
Formula weight  270.37 
Temperature  193(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P 21 21 21 
Unit cell dimensions a = 6.1559(8) Å a= 90°. 
 b = 8.6293(11) Å b= 90°. 
 c = 27.248(3) Å g = 90°. 
Volume 1447.4(3) Å3 
Z 4 
Density (calculated) 1.241 Mg/m3 
Absorption coefficient 0.213 mm-1 
F(000) 576 
Crystal size 0.457 x 0.43 x 0.246 mm3 
Theta range for data collection 1.49 to 25.68°. 
Index ranges -7<=h<=7, -10<=k<=10, -33<=l<=33 
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Reflections collected 18385 
Independent reflections 2748 [R(int) = 0.0223] 
Completeness to theta = 25.68° 100.0 %  
Absorption correction Integration 
Max. and min. transmission 0.9693 and 0.9372 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2748 / 0 / 172 
Goodness-of-fit on F2 1.022 
Final R indices [I>2sigma(I)] R1 = 0.0248, wR2 = 0.0652 
R indices (all data) R1 = 0.0255, wR2 = 0.0656 
Absolute structure parameter -0.01(6) 
Largest diff. peak and hole 0.121 and -0.186 e.Å-3 
 
 Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) for 
bm34oas.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________  
 x y z U(eq) 
_____________________________________________________________________________   
S(1) 3082(1) 7171(1) 1017(1) 45(1) 
O(1) -168(2) 9224(1) 2140(1) 36(1) 
C(1) 827(2) 7773(2) 1410(1) 35(1) 
C(2) 1630(2) 8827(2) 1828(1) 32(1) 
C(3) -1081(2) 7871(2) 2369(1) 40(1) 
C(4) -2003(3) 6767(2) 1991(1) 41(1) 
C(5) -251(3) 6321(2) 1621(1) 43(1) 
C(6) 3137(2) 8625(2) 554(1) 35(1) 
C(7) 1369(2) 8852(2) 248(1) 42(1) 
C(8) 1466(3) 9944(2) -123(1) 52(1) 
C(9) 3345(3) 10786(2) -200(1) 55(1) 
C(10) 5123(3) 10550(2) 98(1) 56(1) 
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C(11) 5021(2) 9480(2) 481(1) 46(1) 
C(12) 2668(2) 10326(2) 1662(1) 31(1) 
C(13) 1573(2) 11355(2) 1354(1) 34(1) 
C(14) 2533(2) 12741(2) 1214(1) 39(1) 
C(15) 4599(2) 13119(2) 1375(1) 42(1) 
C(16) 5698(2) 12106(2) 1681(1) 43(1) 
C(17) 4739(2) 10717(2) 1821(1) 38(1) 
 
 
Bond lengths [Å] and angles [°] for  bm34oas. 
_____________________________________________________  
S(1)-C(6)  1.7783(14) 
S(1)-C(1)  1.8290(13) 
O(1)-C(2)  1.4371(16) 
O(1)-C(3)  1.4387(17) 
C(1)-C(5)  1.530(2) 
C(1)-C(2)  1.5382(18) 
C(1)-H(1)  1.0000 
C(2)-C(12)  1.5120(19) 
C(2)-H(2)  1.0000 
C(3)-C(4)  1.514(2) 
C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
C(4)-C(5)  1.526(2) 
C(4)-H(4A)  0.9900 
C(4)-H(4B)  0.9900 
C(5)-H(5A)  0.9900 
C(5)-H(5B)  0.9900 
C(6)-C(7)  1.385(2) 
C(6)-C(11)  1.389(2) 
C(7)-C(8)  1.383(2) 
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C(7)-H(7)  0.9500 
C(8)-C(9)  1.382(3) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.379(3) 
C(9)-H(9)  0.9500 
C(10)-C(11)  1.394(2) 
C(10)-H(10)  0.9500 
C(11)-H(11)  0.9500 
C(12)-C(17)  1.3884(19) 
C(12)-C(13)  1.3969(18) 
C(13)-C(14)  1.387(2) 
C(13)-H(13)  0.9500 
C(14)-C(15)  1.384(2) 
C(14)-H(14)  0.9500 
C(15)-C(16)  1.384(2) 
C(15)-H(15)  0.9500 
C(16)-C(17)  1.390(2) 
C(16)-H(16)  0.9500 
C(17)-H(17)  0.9500 
C(6)-S(1)-C(1) 103.25(6) 
C(2)-O(1)-C(3) 111.34(10) 
C(5)-C(1)-C(2) 110.21(11) 
C(5)-C(1)-S(1) 108.44(9) 
C(2)-C(1)-S(1) 110.98(9) 
C(5)-C(1)-H(1) 109.1 
C(2)-C(1)-H(1) 109.1 
S(1)-C(1)-H(1) 109.1 
O(1)-C(2)-C(12) 107.33(10) 
O(1)-C(2)-C(1) 109.35(11) 
C(12)-C(2)-C(1) 114.87(10) 
O(1)-C(2)-H(2) 108.4 
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C(12)-C(2)-H(2) 108.4 
C(1)-C(2)-H(2) 108.4 
O(1)-C(3)-C(4) 111.20(10) 
O(1)-C(3)-H(3A) 109.4 
C(4)-C(3)-H(3A) 109.4 
O(1)-C(3)-H(3B) 109.4 
C(4)-C(3)-H(3B) 109.4 
H(3A)-C(3)-H(3B) 108.0 
C(3)-C(4)-C(5) 110.09(12) 
C(3)-C(4)-H(4A) 109.6 
C(5)-C(4)-H(4A) 109.6 
C(3)-C(4)-H(4B) 109.6 
C(5)-C(4)-H(4B) 109.6 
H(4A)-C(4)-H(4B) 108.2 
C(4)-C(5)-C(1) 110.37(11) 
C(4)-C(5)-H(5A) 109.6 
C(1)-C(5)-H(5A) 109.6 
C(4)-C(5)-H(5B) 109.6 
C(1)-C(5)-H(5B) 109.6 
H(5A)-C(5)-H(5B) 108.1 
C(7)-C(6)-C(11) 119.62(13) 
C(7)-C(6)-S(1) 120.73(11) 
C(11)-C(6)-S(1) 119.53(11) 
C(8)-C(7)-C(6) 120.14(14) 
C(8)-C(7)-H(7) 119.9 
C(6)-C(7)-H(7) 119.9 
C(9)-C(8)-C(7) 120.40(15) 
C(9)-C(8)-H(8) 119.8 
C(7)-C(8)-H(8) 119.8 
C(10)-C(9)-C(8) 119.77(15) 
C(10)-C(9)-H(9) 120.1 
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C(8)-C(9)-H(9) 120.1 
C(9)-C(10)-C(11) 120.20(16) 
C(9)-C(10)-H(10) 119.9 
C(11)-C(10)-H(10) 119.9 
C(6)-C(11)-C(10) 119.84(15) 
C(6)-C(11)-H(11) 120.1 
C(10)-C(11)-H(11) 120.1 
C(17)-C(12)-C(13) 118.49(13) 
C(17)-C(12)-C(2) 120.20(12) 
C(13)-C(12)-C(2) 121.31(12) 
C(14)-C(13)-C(12) 120.50(13) 
C(14)-C(13)-H(13) 119.8 
C(12)-C(13)-H(13) 119.8 
C(15)-C(14)-C(13) 120.50(14) 
C(15)-C(14)-H(14) 119.8 
C(13)-C(14)-H(14) 119.8 
C(16)-C(15)-C(14) 119.43(14) 
C(16)-C(15)-H(15) 120.3 
C(14)-C(15)-H(15) 120.3 
C(15)-C(16)-C(17) 120.21(13) 
C(15)-C(16)-H(16) 119.9 
C(17)-C(16)-H(16) 119.9 
C(12)-C(17)-C(16) 120.88(13) 
C(12)-C(17)-H(17) 119.6 
C(16)-C(17)-H(17) 119.6 
 
 Anisotropic displacement parameters  (Å2x 103) for bm34oas.  The anisotropic 
displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
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S(1) 55(1)  36(1) 42(1)  -1(1) 7(1)  14(1) 
O(1) 41(1)  32(1) 33(1)  -1(1) 4(1)  1(1) 
C(1) 41(1)  31(1) 33(1)  -2(1) 1(1)  6(1) 
C(2) 35(1)  31(1) 31(1)  1(1) -2(1)  6(1) 
C(3) 47(1)  39(1) 34(1)  6(1) 2(1)  -1(1) 
C(4) 44(1)  37(1) 42(1)  5(1) 0(1)  -4(1) 
C(5) 53(1)  31(1) 43(1)  -2(1) -2(1)  -1(1) 
C(6) 38(1)  33(1) 34(1)  -9(1) 3(1)  4(1) 
C(7) 42(1)  48(1) 35(1)  -9(1) 1(1)  -3(1) 
C(8) 56(1)  66(1) 35(1)  2(1) -1(1)  10(1) 
C(9) 71(1)  48(1) 46(1)  5(1) 17(1)  9(1) 
C(10) 52(1)  48(1) 68(1)  -8(1) 21(1)  -8(1) 
C(11) 37(1)  51(1) 51(1)  -10(1) 3(1)  1(1) 
C(12) 35(1)  30(1) 29(1)  -3(1) 1(1)  6(1) 
C(13) 34(1)  34(1) 34(1)  -2(1) -2(1)  6(1) 
C(14) 48(1)  32(1) 36(1)  2(1) 0(1)  7(1) 
C(15) 46(1)  36(1) 45(1)  1(1) 10(1)  -2(1) 
C(16) 32(1)  47(1) 51(1)  -4(1) 0(1)  -2(1) 
C(17) 35(1)  37(1) 40(1)  0(1) -4(1)  7(1) 
 
 
Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for bm34oas. 
______________________________________________________________________________  
 x  y  z  U(eq) 
______________________________________________________________________________ 
H(1) -258 8353 1208 42 
H(2) 2715 8236 2027 39 
H(3A) -2247 8189 2598 48 
H(3B) 58 7335 2561 48 
H(4A) -3232 7267 1818 50 
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H(4B) -2556 5825 2156 50 
H(5A) -908 5710 1351 51 
H(5B) 858 5668 1784 51 
H(7) 87 8256 293 50 
H(8) 234 10116 -326 63 
H(9) 3411 11525 -458 66 
H(10) 6422 11118 43 67 
H(11) 6237 9334 690 56 
H(13) 159 11104 1238 41 
H(14) 1768 13436 1006 47 
H(15) 5256 14066 1277 51 
H(16) 7113 12360 1794 52 
H(17) 5512 10026 2029 45 
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 Torsion angles [°] for bm34oas. 
________________________________________________________________  
C(6)-S(1)-C(1)-C(5) 147.61(10) 
C(6)-S(1)-C(1)-C(2) -91.19(10) 
C(3)-O(1)-C(2)-C(12) -172.18(10) 
C(3)-O(1)-C(2)-C(1) 62.61(13) 
C(5)-C(1)-C(2)-O(1) -57.56(14) 
S(1)-C(1)-C(2)-O(1) -177.71(8) 
C(5)-C(1)-C(2)-C(12) -178.27(11) 
S(1)-C(1)-C(2)-C(12) 61.58(13) 
C(2)-O(1)-C(3)-C(4) -62.90(14) 
O(1)-C(3)-C(4)-C(5) 56.56(15) 
C(3)-C(4)-C(5)-C(1) -52.00(15) 
C(2)-C(1)-C(5)-C(4) 52.86(15) 
S(1)-C(1)-C(5)-C(4) 174.52(10) 
C(1)-S(1)-C(6)-C(7) -61.41(12) 
C(1)-S(1)-C(6)-C(11) 122.47(11) 
C(11)-C(6)-C(7)-C(8) -1.2(2) 
S(1)-C(6)-C(7)-C(8) -177.36(11) 
C(6)-C(7)-C(8)-C(9) 1.9(2) 
C(7)-C(8)-C(9)-C(10) -0.8(2) 
C(8)-C(9)-C(10)-C(11) -0.8(2) 
C(7)-C(6)-C(11)-C(10) -0.4(2) 
S(1)-C(6)-C(11)-C(10) 175.81(11) 
C(9)-C(10)-C(11)-C(6) 1.4(2) 
O(1)-C(2)-C(12)-C(17) 112.43(13) 
C(1)-C(2)-C(12)-C(17) -125.76(13) 
O(1)-C(2)-C(12)-C(13) -66.72(14) 
C(1)-C(2)-C(12)-C(13) 55.10(16) 
C(17)-C(12)-C(13)-C(14) -0.55(19) 
C(2)-C(12)-C(13)-C(14) 178.61(12) 
454 
 
C(12)-C(13)-C(14)-C(15) 0.5(2) 
C(13)-C(14)-C(15)-C(16) -0.4(2) 
C(14)-C(15)-C(16)-C(17) 0.4(2) 
C(13)-C(12)-C(17)-C(16) 0.51(19) 
C(2)-C(12)-C(17)-C(16) -178.66(12) 
C(15)-C(16)-C(17)-C(12) -0.4(2) 
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